cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,2.6386482274158856
MDST8,654092,-1.4293910300938224,-0.4472857419901597
RKO,52947716,-6.611161073849914,-1.4012147836358484
RKO,56963564,0.5825206420774123,0.2569389627451253
Granta-519,107970,1.5911312599666134,2.3029314718240044
HEL,12003241,-0.3954740832299299,-1.0889198012759371
SK-HEP-1,445091,4.514173662724111,4.3274252089919045
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,2.9860814461500107
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.7705130043498147
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.7724503678159762
HCC15,24775005,4.257174534281358,3.778654827630856
HuP-T3,6450551,3.7588607556856006,2.361538429265863
SaOS-2,72376,-1.862865015628177,-2.110114148114304
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.4240324657892436
Panc 02.03,3062316,2.5231792980774,0.9747482048219924
MOLP-8,6918837,-6.2821371699611515,-3.046222711611649
SW48,1242560,3.5610164041067645,3.534393132486151
RCC10RGB,3062316,3.7206614033239833,0.9747482048219924
IA-LM,25262965,-3.1838216959830796,-1.6224193967571534
BICR 22,3038522,1.9324211832044784,2.9847437848386558
SW1573,4096211,3.236722527011662,1.856021664538426
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-0.8865368208635396
NCI-H2452,2733526,3.4563089712221,3.714359432422819
WM115,44197249,3.814304480361476,3.652871643911023
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.5350305453431912
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,1.3153680794849765
SW948,216345,3.8478701746280506,3.7540083674013296
RKN,2858523,3.2318364946727653,3.0086502241129605
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.3590460953824346
LCLC-97TM1,17759555,4.8791087487812606,3.5392373768677334
ALL-SIL,24771867,-3.516684419884963,1.5171458615349627
WM115,11455910,0.9860510612095932,0.9557745122323711
MOLP-8,11485656,1.8270206697288176,2.2397291078765758
MOLM-13,9866186,-0.4750218873797177,0.7577083020821866
Daudi,445091,3.707432883595851,4.3274252089919045
RERF-LC-MS,9907093,3.840365222907794,4.134688957161641
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,2.474523360549852
IA-LM,49836020,4.225846480888235,2.5464279658175073
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.4199080872215506
HuP-T3,445643,4.0158423100173986,3.9383569867901693
RKO,5351362,1.5688417029382893,1.4604743967139864
SU-DHL-1,25262965,-0.1887460090186497,-1.6224193967571534
MOLP-8,3552672,2.5417747800161483,2.8413574589562494
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.93841691857644
HCC15,24771867,-1.1106317715549263,1.5171458615349627
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-4.875275216600306
COR-L95,25161177,5.647598761093448,4.097137926934978
BFTC-909,16219061,3.736019824418232,3.135611362850641
LCLC-97TM1,3503,2.904492448420953,2.2426858883255045
RKN,5287620,-2.679516494579474,-1.9697846958841214
IA-LM,5281321,-0.2514769440259956,-1.3097742666845045
SK-HEP-1,24964624,3.121305411780932,2.2827362159867324
SaOS-2,9884685,-0.6485333929619777,0.4230357541133405
MOLP-8,44566777,0.3680572795114795,0.6972581949653407
K-562,3081361,1.217245739162405,2.3568884936851697
HuP-T3,53392493,2.0684681956337654,2.4832542501558077
SW48,11404337,-1.6842588085779022,-0.4254091153988029
RKO,24771867,6.323343540042099,1.5171458615349627
MDST8,11497983,4.366208744407351,2.348631818792911
Daudi,6918638,-1.8107043721369585,0.3065957347013626
RERF-LC-MS,107970,3.001301355490032,2.3029314718240044
NCI-H2452,56963564,2.315469414243469,0.2569389627451253
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,1.3153680794849765
MOLM-13,4259181,-1.5110532495146267,0.11236669175956715
RERF-LC-MS,5566,3.05978093065268,3.029152149495273
HEL,44607531,1.529117499700861,1.48117322485652
BFTC-909,25262965,-1.7887871070762158,-1.6224193967571534
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-1.5346517263124715
BICR 31,46191454,1.7584497327325264,1.3518500781597358
UACC-812,426756,4.999419351863596,4.301139445753315
SW1271,9911463,3.695583497273472,3.732908427020576
COR-L105,219104,4.205860409291191,3.5366182443481806
MOLP-8,46943432,-0.8980695552897974,1.70045196562753
MOLM-13,11626560,-0.3289224093786886,1.6795489442409048
SU-DHL-1,73707398,0.2992121771474305,1.180307991266282
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-1.261852028375895
HCC1500,9907093,4.182225492860836,4.134688957161641
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,0.7705130043498147
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.0058447943574325
NCI-H1568,5746,-0.0019321539800122,0.8084551861824514
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.133687221210622
HEL,10385095,1.0320529067741009,1.2480392352773622
P31/FUJ,374536,-2.654779926412406,1.7732341041149164
KU-19-19,119607,4.136898976237774,5.129253777214588
HCC1500,11656518,1.3375266797474916,1.5480979328089313
NCI-H1568,44819697,-2.651253194329211,-0.6109288989041974
COR-L105,6918328,0.8369476830507139,-0.28710840066117727
PaTu 8988t,1750826,2.46453979570572,-1.4739669220989267
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.0163468544412688
HCC1500,6438330,2.8683818740810088,2.016737971321332
HEL,11214940,0.9295508638766669,1.8119431265240042
HCC15,104842,-2.640027553911029,-3.040993872013826
BICR 22,53495165,-1.022289455565369,-0.19108456656304296
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,0.7705130043498147
SW948,11167602,-0.1815305116238505,2.4705816300476062
SaOS-2,119607,5.401113896800015,5.129253777214588
SW1271,444795,4.935671262335122,3.7799917274901733
LS411N,107970,2.4864618038552724,2.3029314718240044
RERF-LC-MS,3025944,4.157794890121567,4.206240213808089
IGROV-1,5282054,3.614574021382022,3.5628845676855256
MOLP-8,5284373,1.9803114216772224,2.7079346453511217
SW1271,46907787,1.639327018501732,1.584957029505121
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,4.13551970928241
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.3848601780620533
ALL-SIL,5351362,0.9273092220520184,1.4604743967139864
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-3.5071094923394703
LCLC-97TM1,54618164,4.1848187977728,4.02740727006158
SK-HEP-1,123631,3.617013696107864,2.2760265557358337
LS180,1641662,3.031869457755623,3.3408828038827
LCLC-97TM1,46199207,3.402623883365983,3.1312366616263048
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.37491183386883553
ALL-SIL,168312962,1.491579787235829,1.48933366232238
IGROV-1,135398516,1.9751898057484376,2.0509021680173207
SK-OV-3,4261,3.2658157069367615,1.4288257082744877
Panc 02.03,11707110,-0.717341284128793,-0.02846554242907695
P31/FUJ,4261,-0.12536828191131,1.4288257082744877
Daudi,53481919,2.490259403593742,3.8547522793737237
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.133687221210622
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.78247230086659
SW1573,12003241,-0.6702221198842615,-1.0889198012759371
COR-L95,11238147,1.8523673489534709,2.694366237977623
SW48,452548,-3.152923699933953,-0.31026393275322106
ALL-SIL,46224516,1.508509192124363,2.370954746557396
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.0276770243216165
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.1312366616263048
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-3.5071094923394703
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,0.17994774592918095
Daudi,6918837,-6.333799665630375,-3.046222711611649
K-562,57330099,5.557476297558147,4.311542343968036
MOLM-13,3038522,-2.559283473550591,2.9847437848386558
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.37491183386883553
SU-DHL-6,9903786,1.8029536633965553,2.756077717004494
Daudi,151289,0.3893937359913983,0.9562867634504244
MOLP-8,51037431,3.96461280344528,3.10082796495436
BICR 31,11152667,-0.7818812516610519,-0.5866736007906306
LS180,46907787,-0.2837252988913812,1.584957029505121
PaTu 8902,16725315,5.393152185048805,4.150060666188836
Panc 02.03,6914657,-4.005158687469553,-4.170094408243688
HuP-T3,54613361,5.307179038572215,-0.11678183903518824
PaTu 8902,107970,2.826401466277882,2.3029314718240044
RKO,25183872,-1.1635703485572924,-0.902802947451298
RCC10RGB,135659046,5.776465120313546,3.604307380358917
BICR 31,16725315,5.360398456728244,4.150060666188836
IA-LM,216239,1.6797579071033788,2.1474208097396077
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.7724503678159762
COR-L105,6610216,4.21117605455994,4.26979744561799
COR-L105,10427712,4.508625829006449,4.184108330161863
NCI-H2452,6610355,4.992583267176856,4.45123297085854
PaTu 8988t,11364421,0.0778741703331701,-2.2476185097624475
RKN,3552672,1.948192158503618,2.8413574589562494
Granta-519,46174525,4.2506809125564615,4.156087356848057
SW1271,44819697,-0.8585090240358869,-0.6109288989041974
WM115,44486219,4.206639028474801,4.281343219898981
MOLP-8,6918736,-3.613498069188207,-1.741781295359962
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.8865368208635396
LS411N,49836020,4.501659667614969,2.5464279658175073
WM115,9927531,5.125567810288171,4.578027762171671
SW1271,24797083,1.5469513987685792,1.277886491385028
HCC1500,1566236,1.5057997400762737,2.2263982365179604
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.0058447943574325
LCLC-97TM1,5566,3.3253657103683976,3.029152149495273
NCI-H1568,1242560,2.6554382745340046,3.534393132486151
RKO,11717001,3.92417498432234,3.961276339234443
SW1271,11612883,2.3755529899406604,2.6386482274158856
Daudi,11396600,1.6595042173405945,3.4309758536883517
P31/FUJ,60700,-1.8341903870446763,-0.4482559328189002
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,1.2349426527428076
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.38762532684053896
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.0086502241129605
IGROV-1,3552672,2.134472496867482,2.8413574589562494
Granta-519,637858,1.0013506713179747,1.8880097009592578
RERF-LC-MS,24753719,5.208830602571573,4.143618673527016
BICR 22,10385095,0.7738978245677988,1.2480392352773622
IA-LM,216468,5.467489395679956,2.5020743765616316
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.510712955745063
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,0.4199080872215506
SK-HEP-1,5738263,4.7811273930471065,3.3050405288071003
SU-DHL-1,44632017,-0.1440136540504316,1.0838611345650022
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,1.7724503678159762
PaTu 8902,11152667,1.2355675895718252,-0.5866736007906306
RCC10RGB,53245473,3.741106102916085,3.5412534206723127
RERF-LC-MS,637858,3.156110522031532,1.8880097009592578
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.78247230086659
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,2.0276770243216165
MOLP-8,23635314,-4.658988245687028,-1.8612337831613235
HCC1500,241158,4.347158152842418,3.598987869990464
NCI-H1568,16065773,2.3280951044534923,2.3641186374244216
COR-L105,24771867,3.297975412837562,1.5171458615349627
COR-L105,11625818,4.2515796910784385,4.10791451089978
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.2349426527428076
IGROV-1,2841722,3.834853118277962,4.375424781932207
SaOS-2,51039095,1.985897726070115,2.682611194240459
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.4539899714896953
COR-L105,44589607,3.154557065472522,2.659070263037081
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.561309020020982
LS411N,9911463,4.267700407985282,3.732908427020576
IGROV-1,4378219,2.016502068118561,2.6822409618839944
Daudi,135659046,3.1156448500687923,3.604307380358917
KU-19-19,16722836,2.3762239171314894,1.5333952667080324
IGROV-1,10410894,3.2660402181528263,3.2189174762180457
Panc 02.03,49793307,-1.288996397670963,-2.848251171596848
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.6778195760397165
MOLM-13,3136844,3.815118683612459,4.214923916993912
MOLP-8,6914657,-3.275680842626438,-4.170094408243688
K-562,9887053,4.062685534067952,3.469815136639831
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,0.9090093368534204
NCI-H1568,52947716,-4.502411459776945,-1.4012147836358484
BFTC-909,11178236,-2.4757289909406683,-3.539769866873396
Daudi,6610355,3.6984054922795906,4.45123297085854
HuP-T3,10184653,2.026243337908569,1.1325795715302809
IA-LM,36462,3.5803800151684384,1.5076124324231743
SU-DHL-6,46907787,-0.6700724490980451,1.584957029505121
HCC15,10231331,4.227224330005602,1.6547412916072393
LS180,135398516,1.9815935031047112,2.0509021680173207
MDST8,53495165,-1.6914230136545845,-0.19108456656304296
SW48,135411,0.1882785626851766,0.5181226666256136
COR-L105,11485656,1.8131666015075352,2.2397291078765758
HCC15,1239801,5.074899811919598,3.981036641317754
SK-CO-1,11497983,-2.036472499029009,2.348631818792911
Granta-519,2742550,3.255820788990773,3.8595787492072238
ALL-SIL,16720766,-0.6951675656481376,0.4291253754884592
COR-L105,11175137,3.2551565890936165,2.477950770888125
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.1345509900924162
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.5350305453431912
IGROV-1,409805,5.990596261907717,4.6745070702664995
Panc 02.03,11485656,5.602754460209725,2.2397291078765758
Granta-519,54619267,3.910643053444693,3.9342007971372475
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.57821899028641
BICR 22,6252,-0.1324642168432157,-0.10942982547788271
MDST8,11404337,0.5498361952050128,-0.4254091153988029
SaOS-2,60750,-3.1697993298632183,-2.435153852929516
SW948,11717001,4.275182691709766,3.961276339234443
MDST8,11175137,2.5746086097463974,2.477950770888125
IGROV-1,322968,4.140599241163106,3.4956311613712456
HCC1500,1242560,3.704354238917139,3.534393132486151
MOLM-13,9911830,-0.5537570191991712,2.4240324657892436
COR-L105,16038120,1.5247864010803889,0.9090093368534204
COR-L105,45279963,3.905008730311125,3.660133434789582
WM115,148198,-2.543343591950365,-3.548509713878981
IGROV-1,2749,2.0319044408234954,1.7932893499757152
K-562,4477,-0.1635303329058878,0.5570685949048098
SK-HEP-1,25227462,1.4628952719758763,-0.4151865926866767
Panc 02.03,23582824,1.3457270338170706,0.7400136078733197
SK-HEP-1,241158,4.116654148222159,3.598987869990464
SK-CO-1,168313047,0.9150038640573646,2.4053217165791536
Granta-519,9823820,3.571742016367909,3.7294514785702977
SK-CO-1,159324,2.1120355222347738,2.0742938672876736
SK-CO-1,10385095,1.4661007046294967,1.2480392352773622
NCI-H2452,71304818,2.7948147605911218,2.396178486082573
MOLP-8,4578,4.125075782233611,4.446937148676336
NCI-H2452,11455910,0.7111396076654327,0.9557745122323711
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-4.864372369867458
LS180,10074640,3.3464344717087333,3.066922642013836
MDST8,71466578,3.80352554053155,3.983075654179168
LS411N,6184667,3.0967158778150465,2.901063659317265
SW948,11317348,1.1175502037929408,2.3090854497210964
MDST8,119607,4.705186592802013,5.129253777214588
SW48,11507802,0.6466338181730511,1.3590460953824346
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.11065310288154762
WM115,5702613,3.6693021536028367,3.145942765655066
SK-CO-1,23725625,2.337747507524157,4.726527081330662
K-562,2749,1.8349792189296796,1.7932893499757152
IA-LM,3825829,4.571991496451351,3.8869840981378028
KU-19-19,104842,-1.861779032385676,-3.040993872013826
SK-HEP-1,12001922,2.448252559355595,1.8522788760744173
HEL,135440466,1.1488755358131115,2.1401473911994366
Panc 02.03,6918328,1.3018368822202735,-0.28710840066117727
SaOS-2,72734382,4.901362762899978,4.3578051352274185
HuP-T3,135421197,1.625440100707307,1.8199795612290348
HCC1500,3384730,2.626558190955656,2.4620443610818112
IGROV-1,51037431,5.669320749085174,3.10082796495436
BFTC-909,4917,2.929839520827846,3.079848880785536
WM115,637858,1.77843641117838,1.8880097009592578
MDST8,44589607,2.007770745404649,2.659070263037081
LCLC-97TM1,5282054,3.1900504557345664,3.5628845676855256
HuP-T3,46199207,3.4499209547515433,3.1312366616263048
BICR 31,25262965,-3.4333038857773093,-1.6224193967571534
LCLC-97TM1,6914657,-1.7973267784986633,-4.170094408243688
MOLM-13,9823820,-0.5140029045699521,3.7294514785702977
RCC10RGB,327653,3.228661308812885,3.018652636936018
NCI-H1568,4705,2.022283964907955,3.0428654274536564
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,2.0276770243216165
RKO,6914657,-2.9196237708628505,-4.170094408243688
WM115,72734382,5.455243998512052,4.3578051352274185
SW48,46398810,2.2376864399879,2.510712955745063
LS411N,2945648,3.381909997555915,2.7548400693819435
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.3153680794849765
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.0665232817889554
ALL-SIL,421610,2.937759224643201,3.1278257636093416
COR-L95,11404337,0.1032061359669597,-0.4254091153988029
WM115,11427553,3.734660617826416,2.578035472123966
HCC15,122327,4.313110702061898,4.7007618437932
Daudi,9444,3.424690286905087,4.054048446110465
Granta-519,4521392,4.382822475618979,4.280943620409205
SW48,31703,-4.626106549902408,-1.182053713238432
RKN,10127622,5.371150210721622,3.6054187258933235
ALL-SIL,71466445,2.2002248480614925,3.3478019143630626
MDST8,656346,0.9697505348816438,0.7582608913284792
Daudi,71680916,3.7291665773697,4.641848024405652
HEL,135398516,1.4688857829361923,2.0509021680173207
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,1.48933366232238
P31/FUJ,9936388,-7.166815071220185,-1.7988236137529168
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.0669311087446527
HCC15,11625818,4.624206979967606,4.10791451089978
LCLC-97TM1,42611257,3.4642891468760957,3.0669311087446527
LCLC-97TM1,5311,1.9621633752287055,1.2663000347984639
RERF-LC-MS,52912189,3.970931922009392,1.6723266261402217
BICR 22,9915743,0.3047863731286212,0.5935480801734145
Granta-519,11612883,3.2575401906490895,2.6386482274158856
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.9860814461500107
NCI-H2452,3543504,4.306818718463235,4.269325105068445
SK-CO-1,676352,2.6575015884388704,2.088896150621564
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-3.5071094923394703
RKN,71304818,2.008207131108322,2.396178486082573
IGROV-1,67156097,0.1763939852409119,-1.0279170724737183
IGROV-1,51039095,1.7163430299301403,2.682611194240459
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,1.2349426527428076
IGROV-1,72193861,2.0623829231433293,1.3858780169906042
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,2.144908880465776
NCI-H1568,11167602,1.5259281753697294,2.4705816300476062
NCI-H1568,52912189,3.4016367932827563,1.6723266261402217
SU-DHL-1,107985,-3.306496987383706,-3.5771139994401464
P31/FUJ,73707386,2.311695228129917,2.6861216111986805
WM115,9884685,-1.925323313513864,0.4230357541133405
SaOS-2,16722836,0.8662367041162377,1.5333952667080324
PaTu 8902,46843906,4.340257675131653,2.723521570705241
BFTC-909,656346,-0.1018552101429806,0.7582608913284792
COR-L95,54618305,4.5292428127427575,4.084826955496459
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.0276770243216165
Daudi,24772860,-3.9771177154169304,-2.2690769633318126
BFTC-909,9911463,4.114346930944119,3.732908427020576
LCLC-97TM1,44197249,3.7483906325702545,3.652871643911023
BFTC-909,6918837,-1.9878509916437357,-3.046222711611649
RERF-LC-MS,24797083,0.2985814331764478,1.277886491385028
P31/FUJ,135928012,4.893710575363991,3.8701906312906376
P31/FUJ,53232,3.343897726239282,2.8161144578264046
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.9218131221296273
MOLP-8,25062766,1.6722099464266416,2.0522756909743434
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,0.7705130043498147
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.37491183386883553
SK-CO-1,262093,3.1807391377127376,2.6275548088442098
LS180,72376,-2.8322202153843703,-2.110114148114304
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,2.3791567205504176
KU-19-19,6918328,0.0154884073180988,-0.28710840066117727
SK-HEP-1,107985,-2.2891993358893856,-3.5771139994401464
PaTu 8988t,216239,1.832862266271042,2.1474208097396077
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.0163468544412688
PaTu 8902,156414,2.7243668654536206,1.1062813598863759
Daudi,16659841,2.946181230411034,3.7845234388741966
LS180,123631,2.1427319304120624,2.2760265557358337
BFTC-909,10385095,0.9839595624316404,1.2480392352773622
NCI-H1568,241158,1.943489424131273,3.598987869990464
UACC-812,44589607,1.3537953197929582,2.659070263037081
Granta-519,11960529,3.2261057296158593,4.006371718195
LCLC-97TM1,25062766,2.2139494005881293,2.0522756909743434
LCLC-97TM1,5291,3.6350350305332424,3.5530526201153183
MOLM-13,44491742,3.7695621371445975,4.1566745174283435
P31/FUJ,3025986,-2.3655111331800067,-0.8978770871810051
PaTu 8988t,2749,1.558615062570056,1.7932893499757152
IGROV-1,2113511,5.982902824257526,5.381335299817078
Daudi,54639126,5.221444108043,4.550433807048704
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.0665232817889554
HCC15,9868037,2.5640614102548556,2.82815333449006
PaTu 8902,6918837,-2.118913626513807,-3.046222711611649
ALL-SIL,23725625,2.2136327630148736,4.726527081330662
COR-L105,11455910,0.425998653780944,0.9557745122323711
K-562,16013152,3.768503882504226,4.119375381760217
Daudi,67156097,-2.7448600083467163,-1.0279170724737183
SW48,6610216,4.461301788418361,4.26979744561799
BICR 22,11977753,-1.1105881150796446,-1.7159558966047241
Daudi,753704,2.787779434331829,4.832125608051433
COR-L105,46943432,2.471907312248233,1.70045196562753
IA-LM,16736978,1.926640001137528,1.3934160091023764
IGROV-1,176870,1.8349827429681411,3.0253996189023358
SK-CO-1,148198,-1.1611262776602205,-3.548509713878981
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,3.5366182443481806
IGROV-1,46943432,4.105714883822214,1.70045196562753
LS411N,168312962,3.224541058203402,1.48933366232238
LS411N,1641662,3.6634193785306337,3.3408828038827
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,1.0163468544412688
LCLC-97TM1,26596,-2.266692800551727,-1.5346517263124715
HEL,151289,0.2321343459174182,0.9562867634504244
Daudi,1285940,3.7558538743643792,4.0494196828548
MOLP-8,2749,1.3302247490678565,1.7932893499757152
RERF-LC-MS,10427712,4.250983789220692,4.184108330161863
WM115,16725315,4.630500047502962,4.150060666188836
Granta-519,9840324,5.864872193260208,5.7711165719697215
HuP-T3,25262965,3.989652761156405,-1.6224193967571534
NCI-H2452,11719255,2.41462187851326,3.1221102230298534
COR-L105,1641662,3.72017777917812,3.3408828038827
SaOS-2,89928392,1.2892186505806515,1.344325138639762
LS411N,969516,3.2917111714105647,2.7772567284956553
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,2.3791567205504176
NCI-H2452,327653,3.049758242791241,3.018652636936018
LS180,4521392,3.9983682640735094,4.280943620409205
IA-LM,2113511,5.955012720035456,5.381335299817078
HCC15,11167602,2.587200682435675,2.4705816300476062
RCC10RGB,9911830,4.5526597563763795,2.4240324657892436
P31/FUJ,168312962,2.530788243280419,1.48933366232238
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.306903331742339
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,2.621607380466062
Granta-519,9933475,1.54115480203428,1.793439230086884
HuP-T3,73707398,1.153693297692098,1.180307991266282
SaOS-2,409805,5.764413924489168,4.6745070702664995
KU-19-19,984333,-0.867877464903324,0.5138000229415411
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.4604743967139864
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.0665232817889554
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-0.8865368208635396
SW48,6918837,-4.354568378072889,-3.046222711611649
LCLC-97TM1,16741245,5.12826814210941,3.801678648950925
NCI-H2452,11507802,3.578778888517491,1.3590460953824346
HEL,11175137,3.15338888234114,2.477950770888125
BICR 22,60750,-4.532323865382038,-2.435153852929516
Granta-519,44491742,4.018752292224149,4.1566745174283435
SK-HEP-1,12003241,-1.7510835313415607,-1.0889198012759371
SU-DHL-6,36314,1.1358641594844867,-1.2422497803043113
HuP-T3,11152667,0.3145958176635,-0.5866736007906306
Granta-519,15547703,2.599412791530534,3.114669509763707
IA-LM,25126798,4.097105087874825,3.7921789378214816
MOLP-8,119182,-1.11255726511749,-1.3340160156368264
BICR 31,65064,5.259646525120305,4.739517756868576
COR-L105,6917907,-5.504495586582428,-4.864372369867458
LCLC-97TM1,11238147,1.840896458617422,2.694366237977623
HEL,51039095,2.698396554100347,2.682611194240459
PaTu 8902,44185566,2.9137350944736653,2.4057100644299436
Daudi,53495165,-3.885820769064659,-0.19108456656304296
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,3.456683733824014
MOLP-8,439501,-2.9296652389863267,-2.2321662354381537
Panc 02.03,4259181,2.0313571914007604,0.11236669175956715
PaTu 8902,126941,-2.2828817630557228,-2.8921209077069348
RKN,5328940,2.201806852003849,1.559061663996469
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-1.6778195760397165
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.7691529831259722
COR-L95,246676,4.317733637680926,4.505551974581321
K-562,135928012,4.4390204871751004,3.8701906312906376
MOLP-8,56946209,-6.528820954061854,-4.2202975286026225
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,2.474523360549852
COR-L105,135421197,1.9442341701951136,1.8199795612290348
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,1.7732341041149164
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,2.0276770243216165
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,2.999158341046921
RCC10RGB,5280436,4.525748645562069,3.153394505533252
NCI-H1568,31703,-1.6950574450364193,-1.182053713238432
SW1271,148198,-2.630785543453804,-3.548509713878981
Granta-519,11964036,1.5223427206827596,1.2382789669868983
MOLM-13,16725315,3.788691115651132,4.150060666188836
Panc 02.03,1716436,3.766168811644757,2.948755251800144
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.3153680794849765
K-562,1566236,1.8179642124055264,2.2263982365179604
RCC10RGB,409805,6.020159348453613,4.6745070702664995
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.9218131221296273
HCC1500,11175137,2.755904594476177,2.477950770888125
HCC1500,11494412,1.8019649514762912,1.4248282417532188
HCC15,10127622,3.735977541508184,3.6054187258933235
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,1.856021664538426
SK-HEP-1,168312962,-1.3309808369359073,1.48933366232238
COR-L105,24180719,3.693037976394381,3.437709308952337
Daudi,46943432,0.8866201698678313,1.70045196562753
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.102163121425029
Granta-519,24180125,1.2477770260094014,2.888353933707551
RKN,9967941,2.6996754619948065,3.6034131982542865
RKN,135398516,1.9656218312143572,2.0509021680173207
KU-19-19,16115403,-3.194116920729502,-4.875275216600306
SW948,56949517,5.5880132005349505,4.259203439290573
NCI-H1568,44632017,0.9967277604489184,1.0838611345650022
COR-L95,11175137,2.52315362607855,2.477950770888125
NCI-H1568,676352,1.7505105304855018,2.088896150621564
NCI-H2452,126941,-2.0674603287446964,-2.8921209077069348
NCI-H2452,4477,0.2060981637085811,0.5570685949048098
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,1.0163468544412688
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,2.9860814461500107
BICR 31,11647372,2.8607835505972035,0.8954839509867156
WM115,52912189,2.2242444616857417,1.6723266261402217
COR-L105,2729026,3.0417945234466863,2.6325975116350393
COR-L95,65064,3.24172080303354,4.739517756868576
IGROV-1,54613361,1.0826132998561049,-0.11678183903518824
NCI-H1568,53232,2.5527200815554587,2.8161144578264046
IGROV-1,9884685,-0.088911709267569,0.4230357541133405
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-3.040993872013826
SW948,16720766,3.3510678765666517,0.4291253754884592
ALL-SIL,135928012,2.5698772014589992,3.8701906312906376
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5350305453431912
COR-L95,56946209,-6.902335125637694,-4.2202975286026225
IA-LM,49867926,4.185996432673056,4.110210541110895
SW948,11625818,3.962309646097391,4.10791451089978
IA-LM,4259181,2.3536383664390734,0.11236669175956715
NCI-H1568,4259181,0.5766231269303183,0.11236669175956715
SW948,6438330,3.286047925562068,2.016737971321332
P31/FUJ,15547703,2.950164329068843,3.114669509763707
COR-L95,1750826,-0.7485912803642704,-1.4739669220989267
HEL,51037431,1.91843497941606,3.10082796495436
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,1.0163468544412688
Granta-519,462382,0.1364457210972633,0.5714028853239661
LCLC-97TM1,11719255,2.8064116850649774,3.1221102230298534
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.261852028375895
MOLP-8,1242560,2.9421278446513393,3.534393132486151
WM115,9911463,2.5241618652619007,3.732908427020576
RKO,3025986,-0.6013959236761957,-0.8978770871810051
PaTu 8902,5335621,4.440333682211631,4.560420742529089
NCI-H2452,19582717,3.9299005055458793,3.9198146524152833
NCI-H2452,171352865,2.832902682703541,3.764962937653422
COR-L105,5566,3.258554573596101,3.029152149495273
BFTC-909,11647372,1.2423847125416496,0.8954839509867156
Daudi,3503,0.8148417795144576,2.2426858883255045
COR-L105,25183872,-0.7403581245059931,-0.902802947451298
ALL-SIL,375860,-1.552794194023853,-0.30112130782396007
HuP-T3,72193861,3.3106720937076233,1.3858780169906042
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.5350305453431912
SW1271,6438330,2.1351654373433764,2.016737971321332
SU-DHL-6,25262965,-2.983432395440536,-1.6224193967571534
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,2.0058447943574325
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.3153680794849765
SU-DHL-1,44489367,4.533806271256096,4.726130190399563
MDST8,31703,-1.4422735490012837,-1.182053713238432
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.28862358029973745
IA-LM,10302451,4.177351274859187,3.0143591766147457
SW48,11214940,3.1705360221414134,1.8119431265240042
RCC10RGB,10074640,3.4095283906874956,3.066922642013836
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.3848601780620533
COR-L105,25227462,0.5095099099095757,-0.4151865926866767
COR-L95,66577038,3.0490878420221934,2.9870697487432882
LS180,46191454,1.5509574675684803,1.3518500781597358
RCC10RGB,65064,5.251967206688168,4.739517756868576
IGROV-1,72376,-2.111352545322758,-2.110114148114304
MOLM-13,89183176,2.661461024404157,3.4938336610308007
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-1.261852028375895
RKO,3384730,1.0492755436091918,2.4620443610818112
SW948,11656518,-0.9054812480406104,1.5480979328089313
ALL-SIL,2949965,1.286096946783907,2.715769249487813
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,2.699201704606489
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,3.456683733824014
K-562,5287620,-0.244838249137823,-1.9697846958841214
Granta-519,3825829,3.4773445434270243,3.8869840981378028
MOLP-8,10385095,0.909191851453096,1.2480392352773622
COR-L95,135928012,3.4969711227856397,3.8701906312906376
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.2359123501503817
UACC-812,25161177,3.457735095549926,4.097137926934978
SK-HEP-1,11178236,-5.847785565222589,-3.539769866873396
SW1573,16741245,2.047879460545898,3.801678648950925
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,1.0163468544412688
K-562,89183176,3.981701702250952,3.4938336610308007
P31/FUJ,9915743,-0.8907797257006451,0.5935480801734145
WM115,3503,1.3325075362119865,2.2426858883255045
PaTu 8988t,44202524,3.9754310935930968,1.9639001504219202
SW948,9952709,2.6604018004594514,2.9381980631482683
Granta-519,56946209,-6.359988120178517,-4.2202975286026225
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.4554460238042177
Daudi,613000,1.9882519691431488,2.227141832343803
RERF-LC-MS,374536,3.716253113618047,1.7732341041149164
LS180,72734382,4.032476699930466,4.3578051352274185
Daudi,1566236,1.0534301581716357,2.2263982365179604
BFTC-909,9868037,3.24226767674478,2.82815333449006
HuP-T3,107985,-4.90392348596967,-3.5771139994401464
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,1.78247230086659
IGROV-1,168312962,3.022863957843741,1.48933366232238
IGROV-1,3081361,0.99973562532788,2.3568884936851697
BFTC-909,5311,1.6846521587280363,1.2663000347984639
NCI-H2452,2841722,4.2339337769073175,4.375424781932207
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-1.57821899028641
RERF-LC-MS,5278396,3.382202757419261,3.517590475337377
COR-L95,44607531,1.1147625805359247,1.48117322485652
SaOS-2,135440466,1.1747227113697256,2.1401473911994366
RCC10RGB,285033,2.114091727684993,-2.1791335812392365
SW1573,448949,2.6434946381292703,1.9537365892294993
SK-CO-1,11964036,1.41955554287601,1.2382789669868983
SK-HEP-1,24901704,5.545234809796251,3.1103746959488285
RERF-LC-MS,71751553,4.213964581210796,4.504570481353087
SW1573,11178236,-2.507507612037206,-3.539769866873396
HCC15,6450551,1.6627728253820353,2.361538429265863
SU-DHL-1,54619267,3.144461009217004,3.9342007971372475
P31/FUJ,11626560,0.2148563033664798,1.6795489442409048
COR-L105,119607,5.370152891195211,5.129253777214588
NCI-H2452,11427553,2.818972077820031,2.578035472123966
HuP-T3,2871966,0.5817483683031975,0.29730316799892464
Granta-519,439501,-6.00499370561019,-2.2321662354381537
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,1.3153680794849765
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.4539899714896953
BICR 22,2945648,3.5832925483527625,2.7548400693819435
NCI-H1568,11228183,4.140816994678141,1.8712017695678478
COR-L95,89928392,1.3878824566143364,1.344325138639762
BICR 22,2871966,0.0284401826322965,0.29730316799892464
HEL,46199207,2.3973871372245372,3.1312366616263048
HCC1500,52912189,2.5783780690097857,1.6723266261402217
KU-19-19,52947716,-4.518413756843173,-1.4012147836358484
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.153394505533252
NCI-H1568,7326481,2.864470016727109,2.957630994714242
RKN,53232,2.2291100881655037,2.8161144578264046
KU-19-19,4477,-0.0533500132034658,0.5570685949048098
SK-OV-3,107970,2.5604111984812152,2.3029314718240044
BICR 22,1242560,3.7933374150058015,3.534393132486151
ALL-SIL,5738263,2.854339564213428,3.3050405288071003
HEL,5329102,1.6539669706420914,2.031058842574058
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.456683733824014
SaOS-2,3854666,0.6354016080385003,1.85063491630251
P31/FUJ,107985,-4.114404549725097,-3.5771139994401464
SK-HEP-1,54619267,4.307302877095537,3.9342007971372475
MOLP-8,11213558,1.2108381509164672,1.4781707184028035
LS180,6914657,-4.58065814502937,-4.170094408243688
HEL,71466380,3.121887792191312,4.275465599745589
COR-L105,25154868,4.769445801979145,4.289494395804131
LCLC-97TM1,25105715,3.527934306265534,3.410449786117574
SW1271,16013152,5.485365595141675,4.119375381760217
ALL-SIL,1750826,-2.8707446972397483,-1.4739669220989267
SW48,44632017,-0.021210675828241,1.0838611345650022
NCI-H1568,4578,4.166510450069308,4.446937148676336
SW948,24180125,1.460789729891403,2.888353933707551
COR-L105,25161177,3.712985248467103,4.097137926934978
P31/FUJ,57519531,1.451496749892495,2.4211376500246136
ALL-SIL,6918837,-4.772645295536399,-3.046222711611649
RKO,16720766,-1.2722083569090707,0.4291253754884592
Daudi,11707110,2.6257952816009498,-0.02846554242907695
PaTu 8988t,24785538,3.127280515757933,1.3344504348570345
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.117207225291035
HEL,46174525,3.393297616528365,4.156087356848057
MDST8,17759555,5.018522859633252,3.5392373768677334
SW1271,53392493,2.79081275696651,2.4832542501558077
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.3848601780620533
SU-DHL-1,9927531,2.969590320438058,4.578027762171671
Daudi,445455,3.7530002864178416,4.540053644561405
SW948,24951314,0.7675285489701543,1.227614980483031
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,1.710700657959646
SK-CO-1,9866186,-0.7388742913087788,0.7577083020821866
RERF-LC-MS,60700,0.497286081450591,-0.4482559328189002
BFTC-909,11364421,-5.034674750215906,-2.2476185097624475
SW1573,49766530,-2.79322841384178,-0.6944377068647134
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,2.9860814461500107
MDST8,25126798,3.890491738661291,3.7921789378214816
HCC1500,3543504,4.272332537756205,4.269325105068445
COR-L95,25062766,3.209944577871265,2.0522756909743434
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.4604743967139864
SK-CO-1,44632017,0.9847861620501556,1.0838611345650022
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.4554460238042177
NCI-H2452,445455,4.8000860101003235,4.540053644561405
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.662752180605146
HuP-T3,439501,-2.469428626730465,-2.2321662354381537
RERF-LC-MS,9884685,0.4531053665233772,0.4230357541133405
RKO,5281321,1.9988379902215376,-1.3097742666845045
NCI-H2452,10410894,4.350169635958685,3.2189174762180457
HuP-T3,24951314,1.4235135044150102,1.227614980483031
SaOS-2,71466445,4.363709574185696,3.3478019143630626
BICR 31,44185566,3.0664042381745946,2.4057100644299436
NCI-H1568,11625818,3.359978935972883,4.10791451089978
BICR 31,3552672,2.13577451695998,2.8413574589562494
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,2.0335760501929605
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.2466540190485103
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.1635123760949786
LCLC-97TM1,119182,-0.294501899208461,-1.3340160156368264
ALL-SIL,52947716,-0.7216046839402591,-1.4012147836358484
RKO,11640390,5.295981617059328,3.2466540190485103
RKO,25150857,2.5785304193211247,2.336756962918186
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.6829735349466532
ALL-SIL,1716436,3.0252724323132374,2.948755251800144
RCC10RGB,262093,2.8343922904091134,2.6275548088442098
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.5181226666256136
SK-HEP-1,439501,-2.4482777943885856,-2.2321662354381537
RKN,71466380,6.199959456698308,4.275465599745589
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,3.9198146524152833
RERF-LC-MS,1242560,3.610791422912421,3.534393132486151
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.5350305453431912
Panc 02.03,66577038,3.3089612685646985,2.9870697487432882
LCLC-97TM1,52947716,-3.0616129604635565,-1.4012147836358484
SU-DHL-1,20959075,-3.3128713931491087,-3.173507428051674
BICR 22,2113511,7.552062733189383,5.381335299817078
SW948,25126798,3.357341035223679,3.7921789378214816
HEL,3854666,0.8085723321900852,1.85063491630251
HCC15,168313047,3.1265794948701338,2.4053217165791536
WM115,107985,-2.5041726579949857,-3.5771139994401464
WM115,42611257,-0.3600732192588895,3.0669311087446527
HCC15,60700,-1.3823438115431317,-0.4482559328189002
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,0.11065310288154762
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,0.9218131221296273
SW48,60750,-4.2221568193195225,-2.435153852929516
NCI-H1568,262093,2.8880881470868585,2.6275548088442098
PaTu 8902,53392493,3.316041661234319,2.4832542501558077
Granta-519,11647372,1.7523915142224398,0.8954839509867156
SK-HEP-1,8515,5.0523689066797495,3.7716438213452004
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,1.1345509900924162
LS180,702558,5.586038369213652,4.9782351440396395
IGROV-1,15983966,1.7101486625531308,-1.6396194068861514
SK-CO-1,6505803,-2.970063061644963,-0.5114413444588124
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.4554460238042177
PaTu 8988t,11485656,1.82057121616084,2.2397291078765758
KU-19-19,2874250,6.302627434426347,4.0377213891771015
MOLM-13,11175137,0.3158641445144168,2.477950770888125
WM115,644241,2.021542714802758,2.1017288356510795
SW48,52947716,1.8444935422046616,-1.4012147836358484
NCI-H1568,10302451,3.040030486332468,3.0143591766147457
COR-L95,44185566,2.2555949878605484,2.4057100644299436
LS411N,16725315,5.1123164266785714,4.150060666188836
BICR 22,25195348,4.085059979970886,3.08171494739702
SaOS-2,5311281,0.944453452900516,2.22503529708604
SW1271,613753,3.197731710568041,3.1495845971526135
IA-LM,9840324,5.344700856558617,5.7711165719697215
LCLC-97TM1,439501,-2.367039612081251,-2.2321662354381537
LS180,9825149,2.508714096118433,2.074054954263997
COR-L105,9911830,1.908645944756667,2.4240324657892436
Granta-519,25126798,3.857539921377872,3.7921789378214816
K-562,11238147,1.4367734907149323,2.694366237977623
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.6778195760397165
IGROV-1,4705,3.3098412390054603,3.0428654274536564
RERF-LC-MS,1716436,4.437154842045929,2.948755251800144
COR-L95,6918638,0.5429028056483723,0.3065957347013626
BICR 22,11507802,1.0844954054416946,1.3590460953824346
Daudi,54626689,2.8292455243221264,4.561309020020982
COR-L105,148124,3.589067174421039,-2.0460232384010055
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,1.2359123501503817
IGROV-1,9825149,2.5588021380929553,2.074054954263997
LS180,2113511,7.0742493322433955,5.381335299817078
MOLP-8,16038120,-1.6086793301450355,0.9090093368534204
KU-19-19,67291369,2.2261044123877656,1.794812676489941
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,2.3791567205504176
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.5114413444588124
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.57821899028641
Granta-519,44462760,4.300929542453815,3.143997930658831
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.144908880465776
KU-19-19,17755052,6.06318579738538,1.7101929835526413
MDST8,11214940,-0.3312007430689519,1.8119431265240042
SaOS-2,57519531,1.7793183342968584,2.4211376500246136
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,2.6829735349466532
LCLC-97TM1,44493528,4.18527882332477,4.333966846288542
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,1.1345509900924162
SW48,10231331,-2.95597966611556,1.6547412916072393
SW948,24797083,1.9027092264791332,1.277886491385028
IGROV-1,11238147,2.1723642292765084,2.694366237977623
COR-L95,17755052,2.817022282186957,1.7101929835526413
LS180,25126798,3.79328534931886,3.7921789378214816
IGROV-1,71304818,2.4878074097553378,2.396178486082573
SK-HEP-1,10302451,4.165168773877425,3.0143591766147457
HCC15,25102847,1.68346873279249,2.3366995460793083
SK-OV-3,15983966,-3.6834707194333927,-1.6396194068861514
HCC1500,54143018,1.195335139641603,0.31711465707788644
COR-L105,11364421,-0.5536252833264237,-2.2476185097624475
RKN,148198,-1.0178445286580065,-3.548509713878981
KU-19-19,400769,-0.482585358097733,-0.7855881743093749
COR-L105,7326481,3.3886978035876547,2.957630994714242
COR-L105,44819697,1.466179589978979,-0.6109288989041974
SW1271,5281672,5.179464513143849,4.4250678360691875
PaTu 8988t,3634881,3.651211463421112,3.1576774496130544
IA-LM,11404337,0.4340662777154989,-0.4254091153988029
NCI-H1568,5287969,-2.4053225408736405,-1.9772070858850965
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-2.435153852929516
COR-L105,54619267,4.07987987500145,3.9342007971372475
SK-OV-3,9907093,4.994966956142975,4.134688957161641
ALL-SIL,11167602,0.1759872916057691,2.4705816300476062
MOLM-13,49836020,-0.1965532240483963,2.5464279658175073
HCC15,52947716,3.127529556956005,-1.4012147836358484
SW1573,4261,3.544037815747042,1.4288257082744877
MOLM-13,6184667,1.666374934082413,2.901063659317265
SK-HEP-1,3854666,3.0622551399292264,1.85063491630251
Granta-519,241158,3.1692083740262373,3.598987869990464
MOLP-8,5978,-7.284134927472065,-2.3753204421143224
LS180,10302451,1.4669812473297774,3.0143591766147457
RKO,16065773,3.3120716405166615,2.3641186374244216
MOLM-13,24964624,0.892926396159225,2.2827362159867324
KU-19-19,11427553,3.4053411651543035,2.578035472123966
SK-CO-1,44137675,3.0714779264964074,3.337336921695599
P31/FUJ,6852167,1.016015239887951,2.69961445504738
HCC1500,5351362,1.2955308259083285,1.4604743967139864
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.2382789669868983
MOLM-13,252682,7.80657372951634,6.516263069090082
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.311542343968036
HCC1500,44607530,1.2894809747133489,1.715838652040812
SW1271,3025944,4.184087558749553,4.206240213808089
HCC15,44493528,4.34604946513687,4.333966846288542
P31/FUJ,6918736,-1.9353169891324984,-1.741781295359962
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,4.725757076386842
K-562,24856436,0.0017034666231649,0.17994774592918095
LS180,216468,-0.2416288368660945,2.5020743765616316
SU-DHL-6,11507802,0.7208159532280615,1.3590460953824346
SW948,5291,4.046310039203204,3.5530526201153183
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.510712955745063
HCC15,11152667,0.1037945221143532,-0.5866736007906306
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,1.2834565267098785
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.7691529831259722
SaOS-2,49766530,0.3706728408995327,-0.6944377068647134
SU-DHL-1,168313016,5.361416197440646,4.725757076386842
HCC15,168312962,2.4994502868710677,1.48933366232238
IGROV-1,24797083,1.5319862293819655,1.277886491385028
WM115,71751553,4.133313051647094,4.504570481353087
SW1271,24951314,2.0404240106098723,1.227614980483031
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-1.6778195760397165
SaOS-2,676352,2.2074841133021432,2.088896150621564
P31/FUJ,322968,1.4419696378870497,3.4956311613712456
SU-DHL-1,10127622,2.7675483211751466,3.6054187258933235
COR-L105,44137675,1.808161252080405,3.337336921695599
PaTu 8988t,11625818,4.482422780967983,4.10791451089978
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.1062813598863759
Panc 02.03,16038120,1.606654693103348,0.9090093368534204
BICR 22,3854666,0.9977305103930704,1.85063491630251
Daudi,46398810,1.6020476162665716,2.510712955745063
COR-L95,984333,1.162546188419483,0.5138000229415411
WM115,1317464,3.7806694387813753,4.148586664919221
K-562,71680916,4.727537128358906,4.641848024405652
BICR 31,25183872,-0.4870171412848909,-0.902802947451298
COR-L105,11626560,2.2911739511823503,1.6795489442409048
SW1271,9936388,2.2656701786136315,-1.7988236137529168
MOLM-13,135421197,0.945680487717708,1.8199795612290348
SK-HEP-1,136227924,3.6301481247272287,2.867001064974719
K-562,375860,-0.3542925626582329,-0.30112130782396007
SK-OV-3,9887053,4.42879128381072,3.469815136639831
LS180,9936388,-5.017955750811216,-1.7988236137529168
SW48,9935249,1.3330175828473068,2.8615383619674972
SW1271,11214940,1.5931636594582963,1.8119431265240042
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.0058447943574325
RKO,67156097,-1.3338800856316015,-1.0279170724737183
LCLC-97TM1,51039095,2.799665973949055,2.682611194240459
MOLM-13,54143018,-1.3895840664016086,0.31711465707788644
Granta-519,5738263,2.4520737989935246,3.3050405288071003
SW1271,2828334,6.430891789984985,6.082620037824382
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,4.860017480413567
HCC15,3136844,4.306118753112888,4.214923916993912
IGROV-1,54454,2.453541831966438,2.548844675602096
BICR 22,9935249,5.2884064452137585,2.8615383619674972
BICR 22,72376,-2.4643814155147634,-2.110114148114304
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.396178486082573
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.0276770243216165
SK-OV-3,25022340,0.9085118587340768,2.219156297475395
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.4705816300476062
P31/FUJ,11238147,2.0504580426090286,2.694366237977623
NCI-H2452,44607531,1.7526351480007742,1.48117322485652
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.7724503678159762
WM115,119607,3.834781850796951,5.129253777214588
IGROV-1,71466445,2.3758001916617797,3.3478019143630626
SaOS-2,54618164,4.337585482929099,4.02740727006158
SaOS-2,46843906,2.56299568717197,2.723521570705241
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.4539899714896953
LCLC-97TM1,2841722,4.284298549740087,4.375424781932207
LS411N,36462,3.380504085081747,1.5076124324231743
COR-L95,637858,1.3348673917451612,1.8880097009592578
HuP-T3,10113978,4.191114511390656,3.010980031724017
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,2.117207225291035
MOLM-13,24772860,-4.1681928866236415,-2.2690769633318126
WM115,9823820,4.472944540337913,3.7294514785702977
MOLM-13,3676137,4.483658238026924,4.517112669127141
MOLP-8,49766530,-0.668776240648524,-0.6944377068647134
SW1271,107970,2.3235168881670285,2.3029314718240044
PaTu 8988t,16065773,3.154821962511545,2.3641186374244216
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,4.13551970928241
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.3153680794849765
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,2.93841691857644
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.0665232817889554
NCI-H2452,11364421,-0.8742390414707,-2.2476185097624475
NCI-H2452,4788,5.30317679490816,5.493389053048461
P31/FUJ,11396600,3.188193103342261,3.4309758536883517
SW48,2130404,2.4705566813277215,3.195187949563447
SU-DHL-6,322968,0.8712022459195665,3.4956311613712456
BICR 22,107985,-3.867593954539223,-3.5771139994401464
COR-L105,46215462,2.588599789838095,1.762132613731386
PaTu 8988t,5287969,-2.0890298278516513,-1.9772070858850965
SaOS-2,9866186,1.0217998308229927,0.7577083020821866
SW948,16065773,2.2305150921307653,2.3641186374244216
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,4.13551970928241
WM115,10127622,-0.9383410403940764,3.6054187258933235
WM115,2733526,4.043531113233861,3.714359432422819
PaTu 8902,49850262,5.593248228762752,3.414452598711333
HCC1500,54613361,2.498230028210423,-0.11678183903518824
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.5350305453431912
Daudi,5746,-2.3170879531966273,0.8084551861824514
MDST8,6610355,3.7892287954147457,4.45123297085854
SK-OV-3,219104,6.736269406359778,3.5366182443481806
MOLP-8,49793307,-5.094504062696007,-2.848251171596848
NCI-H1568,54626689,4.298451601405369,4.561309020020982
IGROV-1,156414,1.4212019235656712,1.1062813598863759
Daudi,4477,-0.8111056564008632,0.5570685949048098
K-562,135398738,1.706304792848783,3.3919135064420334
MOLM-13,57330099,4.105312173478173,4.311542343968036
SW1271,42642645,0.8738549597199083,0.7845058245277501
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.37491183386883553
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,2.0335760501929605
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.117207225291035
Granta-519,16725315,3.130545070245978,4.150060666188836
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,2.6861216111986805
RKO,3854666,1.2691133577357363,1.85063491630251
SaOS-2,119182,-1.602754826097209,-1.3340160156368264
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-2.848251171596848
Granta-519,9843750,4.294258272153345,4.073035208557732
MDST8,5329102,2.639161266907228,2.031058842574058
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,1.2359123501503817
SW48,36314,-6.6979677874770065,-1.2422497803043113
RKO,9825149,2.459088339864112,2.074054954263997
MOLM-13,9911463,2.5287579203643986,3.732908427020576
RERF-LC-MS,44566777,0.4059341966526995,0.6972581949653407
SK-OV-3,10184653,1.9718742380811307,1.1325795715302809
HCC1500,16219061,2.7461663809715375,3.135611362850641
SK-HEP-1,9926054,1.934364320328667,1.9546333131599372
IGROV-1,24901704,3.0789156375765936,3.1103746959488285
BICR 31,9933475,1.7480026685414405,1.793439230086884
COR-L95,3552672,1.407232830890507,2.8413574589562494
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.5350305453431912
COR-L105,66577038,3.4359280481345755,2.9870697487432882
COR-L105,24753719,4.356648297258706,4.143618673527016
ALL-SIL,24978538,-2.389127379896269,0.6273547794147847
SU-DHL-1,3025986,-2.176216514163443,-0.8978770871810051
IA-LM,3062316,1.9598487648076035,0.9747482048219924
MOLP-8,448949,2.0087568721459146,1.9537365892294993
HCC15,89928392,2.045660123087396,1.344325138639762
SK-CO-1,16720766,-0.9325558438762483,0.4291253754884592
IGROV-1,11485656,1.900409616013456,2.2397291078765758
HCC15,44137675,4.493981948720765,3.337336921695599
SaOS-2,5284373,3.659507244236858,2.7079346453511217
COR-L95,44589607,1.7004659608333377,2.659070263037081
PaTu 8988t,16659841,4.413190590676007,3.7845234388741966
MDST8,5311,1.1196330054843209,1.2663000347984639
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,3.8869840981378028
K-562,168313200,4.769830643466651,2.9593589282331023
SU-DHL-1,36314,4.070517798024083,-1.2422497803043113
COR-L95,219104,2.3748233222255144,3.5366182443481806
Granta-519,44566777,1.2837383493022634,0.6972581949653407
WM115,45279963,3.6868070952026506,3.660133434789582
HuP-T3,10127622,4.169685865232827,3.6054187258933235
SaOS-2,54454,3.299905279612609,2.548844675602096
COR-L105,71466445,5.452991683251573,3.3478019143630626
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,1.78247230086659
COR-L105,19582717,3.403236730524823,3.9198146524152833
K-562,11625818,4.129982389727392,4.10791451089978
LCLC-97TM1,3384730,2.793888789676347,2.4620443610818112
BICR 31,4917,3.733916426719056,3.079848880785536
PaTu 8902,54619267,4.2510877724746585,3.9342007971372475
ALL-SIL,25102847,-0.1309610459144975,2.3366995460793083
MOLM-13,23939,5.7894293981406,4.316990186905579
COR-L95,2828334,5.963676169995917,6.082620037824382
PaTu 8988t,44137675,4.243997881661858,3.337336921695599
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.463597576567934
SW948,5978,-3.22198817122066,-2.3753204421143224
RKN,375860,0.0559819210079563,-0.30112130782396007
NCI-H1568,49836020,3.1231470101883336,2.5464279658175073
NCI-H1568,12001922,1.1909466973303815,1.8522788760744173
HuP-T3,135411,0.8125735513868637,0.5181226666256136
NCI-H1568,119607,3.825066299684422,5.129253777214588
WM115,9825149,1.8328544820090609,2.074054954263997
WM115,104842,-0.2362637011987665,-3.040993872013826
P31/FUJ,327653,2.543614095842417,3.018652636936018
RKO,11396600,3.504834935214814,3.4309758536883517
SK-CO-1,135440466,-1.3303352220830715,2.1401473911994366
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.38762532684053896
P31/FUJ,23635314,-1.6494447832357666,-1.8612337831613235
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,2.3791567205504176
SW1271,46215462,2.0233113088179406,1.762132613731386
MOLP-8,969516,1.8716619229833695,2.7772567284956553
K-562,135999136,3.657737204061429,3.6300382464802663
SW1271,9866186,1.0057234740027048,0.7577083020821866
BICR 31,5278396,4.450921628721945,3.517590475337377
HuP-T3,462382,0.4397112913332706,0.5714028853239661
SW48,44202524,0.7134579720144102,1.9639001504219202
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.6778195760397165
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.26979744561799
LCLC-97TM1,3025944,4.079230434060959,4.206240213808089
SW48,46174525,4.111785915347283,4.156087356848057
HCC15,11396600,3.725702968544969,3.4309758536883517
SaOS-2,2949965,2.5764816921436067,2.715769249487813
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.7724503678159762
NCI-H1568,10296883,3.9462373745058863,3.795028277273254
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-1.6778195760397165
Panc 02.03,216345,4.682043945218969,3.7540083674013296
Daudi,26596,-3.612902475241139,-1.5346517263124715
NCI-H2452,262093,3.2163720661137942,2.6275548088442098
PaTu 8902,9936388,2.1491039356268966,-1.7988236137529168
SaOS-2,4477,0.5134457679146515,0.5570685949048098
RERF-LC-MS,4096211,1.8582313750529689,1.856021664538426
SK-HEP-1,53232,2.505434368946379,2.8161144578264046
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.78247230086659
KU-19-19,439501,-2.2192304341921205,-2.2321662354381537
SW48,11222830,1.1015320686905217,1.5350294688251391
P31/FUJ,71680916,4.420716560192731,4.641848024405652
IGROV-1,73707398,0.8848064516600974,1.180307991266282
BICR 31,176870,3.2718013899021607,3.0253996189023358
PaTu 8902,72193861,3.6637635590803384,1.3858780169906042
SW48,10427712,4.323791553226545,4.184108330161863
HuP-T3,5470400,-0.4965810223867313,-0.3765538821264742
BFTC-909,3385,6.578023483143935,3.472185389430271
LS411N,5278396,4.113687735714835,3.517590475337377
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.3791567205504176
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.38762532684053896
P31/FUJ,36462,-0.6599401629031103,1.5076124324231743
IA-LM,24964624,2.660053298461781,2.2827362159867324
Granta-519,4477,0.7960263088071861,0.5570685949048098
WM115,675434,4.127717546006753,4.463597576567934
SW48,2708,3.1864056833879726,4.591243765137335
P31/FUJ,11964036,1.0580497047985076,1.2382789669868983
SK-CO-1,4096211,1.2314360568652074,1.856021664538426
Granta-519,24748573,3.0643863299071668,1.9565115912575295
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.860017480413567
MDST8,6918736,-3.3936356144084066,-1.741781295359962
IGROV-1,3062316,-2.2361832227909075,0.9747482048219924
Daudi,136227331,3.813653547789358,4.306903331742339
MDST8,3385,6.506797592159471,3.472185389430271
MOLP-8,3101542,4.39402228569031,4.518946219608264
PaTu 8988t,19582717,5.440280671607156,3.9198146524152833
ALL-SIL,54618771,-0.3818526805852408,0.9253379925205388
SW948,9911463,3.099005262739027,3.732908427020576
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.8865368208635396
HEL,4259181,-1.3539346499127438,0.11236669175956715
Panc 02.03,702558,5.477624163348055,4.9782351440396395
RCC10RGB,9911463,4.415558893727306,3.732908427020576
P31/FUJ,2828334,6.241721397046506,6.082620037824382
BFTC-909,53232,2.9810373365160316,2.8161144578264046
KU-19-19,1750826,-1.6748688873644846,-1.4739669220989267
WM115,54454,3.1744679186495963,2.548844675602096
LS180,5329102,2.7428602070947266,2.031058842574058
K-562,25102847,1.0686863962440132,2.3366995460793083
NCI-H2452,51039095,3.311280338748592,2.682611194240459
SaOS-2,107985,-4.209612864808627,-3.5771139994401464
RERF-LC-MS,24180719,3.6010609924552455,3.437709308952337
P31/FUJ,9967941,3.859476565836545,3.6034131982542865
ALL-SIL,19582717,3.9660864037028793,3.9198146524152833
BICR 31,448949,3.395825088667814,1.9537365892294993
IGROV-1,9926054,1.8111808945519428,1.9546333131599372
MOLM-13,44632017,0.3571286974750209,1.0838611345650022
RKO,984333,1.1849980625737155,0.5138000229415411
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,4.13551970928241
LS180,5311281,2.3621140012684014,2.22503529708604
IGROV-1,5328940,0.347812751869877,1.559061663996469
SU-DHL-1,126941,-4.504729002827146,-2.8921209077069348
LS180,49850262,4.041689005821524,3.414452598711333
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.2834565267098785
SW48,10113978,2.97157913395206,3.010980031724017
COR-L95,227681,2.232633220711044,2.9941233013598234
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,2.3791567205504176
SW1271,65064,3.2018268639765908,4.739517756868576
Daudi,2733487,3.89488184101632,6.1630813151494985
MDST8,4096211,1.945430248625456,1.856021664538426
MOLM-13,56963564,-0.6687647359934185,0.2569389627451253
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,1.133687221210622
Daudi,216468,0.1519487612341026,2.5020743765616316
COR-L105,11494412,3.277457630260471,1.4248282417532188
BICR 31,31703,-0.4867862372580436,-1.182053713238432
P31/FUJ,49793307,-4.015617000908982,-2.848251171596848
ALL-SIL,6450551,-1.4599471288533186,2.361538429265863
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,1.2359123501503817
SW1271,36462,1.4389686814792042,1.5076124324231743
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.2359123501503817
SW1271,17755052,4.188603356762487,1.7101929835526413
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.054048446110465
Granta-519,9967941,4.009641048767512,3.6034131982542865
HCC1500,25105715,3.368057340132644,3.410449786117574
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.5350305453431912
HEL,2858523,2.985624119180162,3.0086502241129605
SaOS-2,3543504,4.845259948636094,4.269325105068445
HEL,71466578,3.2881122758034413,3.983075654179168
MOLM-13,44185566,-0.1979234147827578,2.4057100644299436
RKO,46215462,1.869666408515056,1.762132613731386
PaTu 8988t,16720766,0.7633491404380248,0.4291253754884592
MDST8,17755052,0.7758841708349149,1.7101929835526413
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-1.261852028375895
Granta-519,16741245,4.459375532286075,3.801678648950925
LCLC-97TM1,36462,0.8347023875377979,1.5076124324231743
HEL,24785538,4.025400084811953,1.3344504348570345
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.7691529831259722
SK-CO-1,54613361,-1.1953747905350511,-0.11678183903518824
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.2834565267098785
Daudi,25105715,2.455657378323054,3.410449786117574
SK-CO-1,3038522,3.74499401693701,2.9847437848386558
LS411N,11625818,4.428513603720294,4.10791451089978
SW948,445643,4.022773961540602,3.9383569867901693
COR-L105,135984461,4.336047626093702,3.6237408287871284
NCI-H1568,71466578,4.264938806787537,3.983075654179168
HuP-T3,11364421,1.6783982807514195,-2.2476185097624475
Daudi,49867926,3.659415180241599,4.110210541110895
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.8865368208635396
SW948,11404337,1.0073661261070797,-0.4254091153988029
SU-DHL-6,5278396,3.0928075812605123,3.517590475337377
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,0.7705130043498147
PaTu 8988t,24964624,3.238300662516523,2.2827362159867324
Granta-519,135411,0.2246473977843227,0.5181226666256136
LS411N,3025986,-2.0648766502168843,-0.8978770871810051
HEL,BRD-K58730230,4.651487565209977,4.39496051692984
K-562,148124,-7.41486725283878,-2.0460232384010055
K-562,10302451,0.1323934402367818,3.0143591766147457
K-562,1641662,2.591871767435193,3.3408828038827
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.02740727006158
Daudi,156422,2.1936092532092295,3.8435202478608215
BFTC-909,44491742,4.0640318167931255,4.1566745174283435
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-1.261852028375895
MOLP-8,135398744,7.476327693514706,6.625444078703129
IGROV-1,54618164,4.2184521751950115,4.02740727006158
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.117207225291035
PaTu 8988t,4259181,-1.3402011211504403,0.11236669175956715
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,1.7724503678159762
KU-19-19,31703,-0.69897788572983,-1.182053713238432
SK-HEP-1,5460769,6.10306620405049,2.3447175553942796
K-562,11404337,1.5978316825317844,-0.4254091153988029
NCI-H2452,9840324,6.282829349463256,5.7711165719697215
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,1.710700657959646
KU-19-19,11214940,3.3843502872937106,1.8119431265240042
MOLM-13,3815108,3.4784839929418343,2.885036533777781
IGROV-1,16065773,3.3717508464278585,2.3641186374244216
Daudi,6252,0.2227136884944618,-0.10942982547788271
SK-OV-3,1641662,4.382504296977698,3.3408828038827
MOLP-8,11238147,1.6731293567937424,2.694366237977623
K-562,44462760,3.6560426907742896,3.143997930658831
RKO,9911463,3.963116579454927,3.732908427020576
KU-19-19,387447,-3.0100561484626738,-4.3765957253648695
LS180,219104,3.901138037988577,3.5366182443481806
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,2.93841691857644
LS180,11609586,3.254650235567635,2.621607380466062
RKO,3025944,4.391654014934833,4.206240213808089
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.4291253754884592
SW1573,11640390,3.5338327701281176,3.2466540190485103
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-4.864372369867458
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.8865368208635396
LCLC-97TM1,2708,5.63991197078878,4.591243765137335
HuP-T3,262093,3.018266583248783,2.6275548088442098
PaTu 8902,3503,3.0706473844938422,2.2426858883255045
HCC15,6918328,-0.0257689511183662,-0.28710840066117727
COR-L105,24797083,1.0360227961267732,1.277886491385028
P31/FUJ,9887053,2.876589254443052,3.469815136639831
WM115,446155,1.535185995815247,2.662752180605146
COR-L105,613753,3.1601590793812,3.1495845971526135
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.37491183386883553
IGROV-1,10385095,1.0670946713416192,1.2480392352773622
NCI-H2452,6252,4.582294901932163,-0.10942982547788271
MOLP-8,72193861,1.011292170776,1.3858780169906042
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,0.7705130043498147
IGROV-1,26596,2.910298792762654,-1.5346517263124715
RERF-LC-MS,11640390,2.8932892314821927,3.2466540190485103
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,2.8341325456747963
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.054048446110465
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,2.3791567205504176
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.456683733824014
SK-OV-3,168313047,2.892407732266751,2.4053217165791536
Daudi,9926054,1.7776420054693636,1.9546333131599372
COR-L105,2749,1.1758378373045044,1.7932893499757152
SK-CO-1,6918837,-2.3986996753086305,-3.046222711611649
IGROV-1,12003241,-2.0122972114546904,-1.0889198012759371
HCC15,9866186,0.9811967871114916,0.7577083020821866
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,2.474523360549852
WM115,9887053,3.7520086754622657,3.469815136639831
COR-L105,9933475,1.7212192557919994,1.793439230086884
MDST8,9967941,4.864965348465847,3.6034131982542865
KU-19-19,5566,3.5813761109507154,3.029152149495273
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.8865368208635396
ALL-SIL,168313016,2.945013463521221,4.725757076386842
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,0.7705130043498147
LCLC-97TM1,216239,3.3274661005628636,2.1474208097396077
UACC-812,9935249,3.1921366544842,2.8615383619674972
KU-19-19,46398810,3.059016393641159,2.510712955745063
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.117207225291035
Daudi,24901704,1.6931015271472445,3.1103746959488285
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.4539899714896953
SU-DHL-1,135440466,0.4118800450630493,2.1401473911994366
IGROV-1,5311,1.0068816368200209,1.2663000347984639
RERF-LC-MS,5329102,2.8374518121885637,2.031058842574058
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.93841691857644
Granta-519,10302451,3.667767303482806,3.0143591766147457
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.11065310288154762
NCI-H1568,4096211,1.8643847121139272,1.856021664538426
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,2.6386482274158856
LS180,44487872,4.564049669792266,4.868560883407912
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,0.7705130043498147
SW948,135411,1.551236240082995,0.5181226666256136
PaTu 8988t,216345,4.148994433618168,3.7540083674013296
LS180,9935249,3.57280690269837,2.8615383619674972
UACC-812,46926350,-4.425607795744521,-4.429063309555999
K-562,46224516,3.0237589268452396,2.370954746557396
SW948,16013152,4.211275799279611,4.119375381760217
BICR 22,10074640,3.373223414806136,3.066922642013836
Granta-519,54618164,3.794628352719798,4.02740727006158
K-562,49793307,-5.346924391172112,-2.848251171596848
IGROV-1,54678924,1.4704159748793169,1.9473085147454567
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,2.699201704606489
IA-LM,24785538,2.950939703376364,1.3344504348570345
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.517590475337377
ALL-SIL,262093,0.6753795238054565,2.6275548088442098
SK-HEP-1,49793307,-1.6219654789172164,-2.848251171596848
UACC-812,9915743,-6.921665690083625,0.5935480801734145
MOLP-8,24964624,0.5129160642166024,2.2827362159867324
SW48,16725315,4.089936042929296,4.150060666188836
P31/FUJ,25102847,1.6695774391929423,2.3366995460793083
MOLM-13,216468,0.0785275755512733,2.5020743765616316
HCC1500,135421197,1.2704457907642457,1.8199795612290348
COR-L95,445643,4.015431140089913,3.9383569867901693
Granta-519,9826308,-1.279512827450026,0.12580254156308923
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.3089350530287187
HCC15,44589607,3.4730057914725005,2.659070263037081
SK-CO-1,73707398,0.894037962240185,1.180307991266282
RERF-LC-MS,46191454,1.934559197398404,1.3518500781597358
PaTu 8902,44491742,4.263402068757711,4.1566745174283435
PaTu 8902,53481919,4.066569856261274,3.8547522793737237
HCC1500,4521392,5.662319691471263,4.280943620409205
BICR 22,11364421,-5.708558910936986,-2.2476185097624475
LCLC-97TM1,6610216,4.478615539127516,4.26979744561799
BICR 22,52912189,1.443997008169696,1.6723266261402217
SW1271,11404337,-3.6050810245472382,-0.4254091153988029
IGROV-1,969516,2.460805405371151,2.7772567284956553
LS411N,25062766,1.7796504921777256,2.0522756909743434
IGROV-1,11977753,-2.2284230058029433,-1.7159558966047241
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.3153680794849765
IA-LM,54618164,4.43488746250501,4.02740727006158
SU-DHL-1,135398738,3.5570959576905983,3.3919135064420334
HCC1500,23725625,5.012282150953445,4.726527081330662
SW948,56973724,2.5267361451247647,2.823032655731692
COR-L105,2742550,3.8597521863519257,3.8595787492072238
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.7724503678159762
SW948,11485656,1.7814283284456571,2.2397291078765758
LS180,56963564,-0.4927248320174067,0.2569389627451253
RKO,9866186,0.3829002704071885,0.7577083020821866
Daudi,44202524,1.1056351253600936,1.9639001504219202
NCI-H1568,11964036,0.8982081488420575,1.2382789669868983
MOLM-13,9915743,0.7456385275428815,0.5935480801734145
Panc 02.03,4788,6.040807258084593,5.493389053048461
SU-DHL-1,10410894,1.885737679840171,3.2189174762180457
WM115,3062316,1.2654694678882143,0.9747482048219924
HuP-T3,148198,-3.5090934063696153,-3.548509713878981
HCC1500,24748573,2.217224851211772,1.9565115912575295
RKN,44185566,3.394049733904779,2.4057100644299436
WM115,73707371,4.316198918387243,5.18278851064184
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,1.7932893499757152
COR-L95,119607,5.444677320305195,5.129253777214588
SW1271,3543504,5.279434126076659,4.269325105068445
RKN,613753,3.037549827357118,3.1495845971526135
MOLP-8,9933475,1.6461417731910544,1.793439230086884
SU-DHL-1,374536,2.32669265560356,1.7732341041149164
NCI-H2452,11222830,1.0864314168284432,1.5350294688251391
BICR 31,16736978,1.5520316002325725,1.3934160091023764
BFTC-909,11656518,3.71751997684089,1.5480979328089313
SW48,49793307,-4.357023521296349,-2.848251171596848
HCC15,676352,2.734399334153108,2.088896150621564
K-562,9933475,1.5582186007451084,1.793439230086884
COR-L105,1716436,2.5827881779858797,2.948755251800144
MOLP-8,71751553,4.257415338539138,4.504570481353087
MOLP-8,11427553,-1.470461076327197,2.578035472123966
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.031058842574058
HCC1500,65064,3.4319990575629484,4.739517756868576
BICR 22,54678924,2.835542995017498,1.9473085147454567
SaOS-2,52947716,3.1327874038156636,-1.4012147836358484
RERF-LC-MS,327653,4.17889189356682,3.018652636936018
RERF-LC-MS,216468,3.2358353560937267,2.5020743765616316
LS180,637858,2.1359320280537704,1.8880097009592578
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,1.5478733404534093
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.6829735349466532
HCC15,25154868,4.699010678354358,4.289494395804131
BFTC-909,1716436,3.115342072857748,2.948755251800144
WM115,208908,3.0871953707393662,1.8663560178908947
COR-L95,5287969,-1.974656124599848,-1.9772070858850965
MOLP-8,9907093,3.7363465424365567,4.134688957161641
RCC10RGB,5738263,4.593697299478501,3.3050405288071003
SU-DHL-1,446155,1.7989638936827528,2.662752180605146
Granta-519,51037431,4.032962229357369,3.10082796495436
BFTC-909,24771867,4.730369684143592,1.5171458615349627
SW1271,9926054,1.9992649208496855,1.9546333131599372
IA-LM,46843906,4.034671652936036,2.723521570705241
PaTu 8902,3634881,3.736044150449037,3.1576774496130544
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.22503529708604
COR-L105,89928392,1.7234999745886912,1.344325138639762
Panc 02.03,6917907,-5.450554920776264,-4.864372369867458
ALL-SIL,216345,2.7239648031314108,3.7540083674013296
Granta-519,5311281,1.2060114833285496,2.22503529708604
RKN,25150857,2.829513348324473,2.336756962918186
RERF-LC-MS,702558,6.005509402748126,4.9782351440396395
Granta-519,44202524,0.8355806814666445,1.9639001504219202
IGROV-1,65064,4.920352624378345,4.739517756868576
HCC15,82146,4.430619158397189,3.596877521367719
IGROV-1,135984461,4.285945029851472,3.6237408287871284
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.144908880465776
RKN,25183872,-1.1518449365963386,-0.902802947451298
SW1271,6450551,2.703162256598128,2.361538429265863
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.6778195760397165
RKN,656346,1.677354805367284,0.7582608913284792
MOLP-8,3503,1.781914224283778,2.2426858883255045
COR-L105,2828334,6.248355208389406,6.082620037824382
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-3.5071094923394703
MOLP-8,135875424,3.0291075959050233,3.743891076041643
HCC15,24748573,2.004363812639911,1.9565115912575295
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.0276770243216165
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.344325138639762
IGROV-1,56649450,0.515518984822669,2.999158341046921
KU-19-19,9444,4.28834999434395,4.054048446110465
Granta-519,3552672,2.198733357723822,2.8413574589562494
SW948,66577038,2.9537896679300655,2.9870697487432882
NCI-H2452,119607,5.591396796149955,5.129253777214588
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,2.699201704606489
HuP-T3,2729026,2.9922624267509317,2.6325975116350393
SK-HEP-1,71466578,6.341226391578653,3.983075654179168
Daudi,24785538,-0.3082535888445589,1.3344504348570345
IGROV-1,5280436,3.2616766817665086,3.153394505533252
RERF-LC-MS,7251185,3.4578262740878976,2.4347287977616
HCC15,156414,2.365134958139565,1.1062813598863759
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.7691529831259722
BICR 31,10127622,3.719060323270891,3.6054187258933235
SaOS-2,15547703,3.066966974063678,3.114669509763707
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,2.0335760501929605
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,0.11065310288154762
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,4.4833676274788345
SU-DHL-1,3689413,-2.511818154735677,-0.4039154566871359
COR-L105,56946209,-4.798718381888378,-4.2202975286026225
IGROV-1,5978,-1.5618214380165825,-2.3753204421143224
BFTC-909,11222830,1.7098036316197358,1.5350294688251391
IGROV-1,216239,2.21703825410177,2.1474208097396077
MDST8,135440466,3.3221976295713342,2.1401473911994366
P31/FUJ,44632017,0.6534437162154956,1.0838611345650022
IGROV-1,219104,3.803083685328391,3.5366182443481806
SaOS-2,637858,1.716758511666406,1.8880097009592578
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.78247230086659
COR-L95,24753719,4.203119149122614,4.143618673527016
HCC1500,3025944,3.928139296588046,4.206240213808089
Panc 02.03,56946209,-4.513446270471167,-4.2202975286026225
HuP-T3,25126798,3.926602492728053,3.7921789378214816
PaTu 8988t,3011155,4.341218756124128,3.2201851439403857
SW48,20959075,-3.67297247887529,-3.173507428051674
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.4199080872215506
BICR 22,44486219,3.936553836391045,4.281343219898981
RERF-LC-MS,6918736,-1.8242544668906209,-1.741781295359962
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.0665232817889554
RKO,44137675,4.282234128328841,3.337336921695599
IA-LM,11626560,2.8197095065502515,1.6795489442409048
SW948,2746,1.2183078272507333,2.8579929499469348
NCI-H1568,168313200,3.516432771095034,2.9593589282331023
IA-LM,262093,2.9896562434219627,2.6275548088442098
MOLP-8,4261,-0.435327551985223,1.4288257082744877
HEL,2708,3.2519957529556716,4.591243765137335
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,2.699201704606489
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,2.6829735349466532
MOLM-13,51039095,-0.7255439577713276,2.682611194240459
IGROV-1,426756,6.142776526139055,4.301139445753315
NCI-H2452,25154868,4.866167054223791,4.289494395804131
PaTu 8902,4705,3.6244040622068256,3.0428654274536564
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.410449786117574
Daudi,135421197,0.2989842149032058,1.8199795612290348
IGROV-1,10427712,3.944243047938238,4.184108330161863
COR-L95,24978538,-1.547703636473998,0.6273547794147847
SaOS-2,52912189,2.036463757447864,1.6723266261402217
PaTu 8902,452548,0.9739796251952438,-0.31026393275322106
IGROV-1,52912189,2.3966568144845666,1.6723266261402217
SU-DHL-1,387447,-5.562438756444553,-4.3765957253648695
HCC15,135398516,2.1695814103654696,2.0509021680173207
SK-CO-1,6610216,4.838209270425191,4.26979744561799
MOLM-13,5351362,0.6925875902125201,1.4604743967139864
HCC15,46191454,1.8626809755345697,1.3518500781597358
SW948,9825149,1.8114941973110277,2.074054954263997
Daudi,54639665,4.383406013207389,2.8742701773668493
HEL,2828334,6.1216048061751795,6.082620037824382
BICR 22,71466445,3.433479198461154,3.3478019143630626
ALL-SIL,9826308,-0.8056632694679019,0.12580254156308923
NCI-H2452,57519531,1.3990882913061125,2.4211376500246136
BICR 22,54613361,0.4978505675466737,-0.11678183903518824
SK-OV-3,135440466,2.5162908691834405,2.1401473911994366
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.2349426527428076
SW48,6852167,2.2630322871527913,2.69961445504738
RKO,11404337,-0.3534280477619294,-0.4254091153988029
ALL-SIL,5291,-1.9713425457655045,3.5530526201153183
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.860017480413567
IGROV-1,24771867,1.9944882740161016,1.5171458615349627
MOLM-13,46224516,1.6904951862054391,2.370954746557396
SW48,119607,5.387394946551996,5.129253777214588
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.5350305453431912
BICR 22,49836020,2.6142262300183305,2.5464279658175073
BICR 22,16720766,0.4876582946813295,0.4291253754884592
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,2.0742938672876736
SK-CO-1,123631,1.846760097113305,2.2760265557358337
BFTC-909,36462,4.374665451212183,1.5076124324231743
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,2.9860814461500107
RKO,5328940,1.7974237645790871,1.559061663996469
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.5350305453431912
ALL-SIL,5281321,-2.461016259028612,-1.3097742666845045
P31/FUJ,568763,-0.9310646254211032,0.28862358029973745
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,2.93841691857644
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.78247230086659
WM115,3081361,1.7542351340434374,2.3568884936851697
Panc 02.03,676352,3.0262590525496895,2.088896150621564
Panc 02.03,44462760,5.147948611944762,3.143997930658831
COR-L95,11228183,-1.8408108773608771,1.8712017695678478
WM115,56973724,4.208743527700851,2.823032655731692
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,2.9860814461500107
HEL,65628,4.10911337005638,4.026684176415168
Daudi,11612883,1.1925703345745973,2.6386482274158856
RCC10RGB,24856436,4.070420512574028,0.17994774592918095
COR-L105,46199207,3.6604959991625825,3.1312366616263048
Granta-519,25195348,3.9328442274761217,3.08171494739702
NCI-H1568,1750826,-3.116085482779225,-1.4739669220989267
IA-LM,12001922,1.9531449792239188,1.8522788760744173
IGROV-1,19582717,6.764352444432722,3.9198146524152833
HCC15,10113978,2.260363506948615,3.010980031724017
SK-HEP-1,10074640,3.7857764861964935,3.066922642013836
PaTu 8988t,6918328,1.905296387062238,-0.28710840066117727
HuP-T3,24785538,1.540895569713237,1.3344504348570345
BICR 31,5281321,1.1837918014475457,-1.3097742666845045
MOLM-13,216345,0.0865178974102724,3.7540083674013296
HCC15,448949,2.8674184346568414,1.9537365892294993
K-562,44566777,1.311822236929868,0.6972581949653407
HEL,452548,-1.769607447996444,-0.31026393275322106
SU-DHL-1,11507802,0.9378608618407872,1.3590460953824346
SU-DHL-6,2113511,5.89050983447184,5.381335299817078
SaOS-2,54613361,0.0035364978270003,-0.11678183903518824
SaOS-2,24748573,1.7294478830476196,1.9565115912575295
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,2.82815333449006
HuP-T3,49766530,1.2218451996302029,-0.6944377068647134
HEL,262093,2.3252232523203995,2.6275548088442098
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.144908880465776
MOLP-8,675434,3.835070621627746,4.463597576567934
RKN,16725315,3.256745916563384,4.150060666188836
RERF-LC-MS,5746,1.1068525081764873,0.8084551861824514
SaOS-2,11964036,0.5086023979470407,1.2382789669868983
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,1.7724503678159762
LCLC-97TM1,126941,-2.218385477362075,-2.8921209077069348
HCC15,54618771,1.6567762934530044,0.9253379925205388
RKO,2113511,4.623772297498578,5.381335299817078
RKN,9929138,7.419607622812729,5.665997549800987
HCC1500,5460769,5.1304942195737935,2.3447175553942796
COR-L95,31703,-3.0462560513884203,-1.182053713238432
HCC1500,46224516,1.0534131743048871,2.370954746557396
Panc 02.03,5328940,2.397017671249583,1.559061663996469
LCLC-97TM1,11404337,-1.4043223473519348,-0.4254091153988029
HCC1500,42642645,1.451455976812008,0.7845058245277501
IGROV-1,51037431,5.669320749085174,3.10082796495436
SW1573,107970,2.0608182724975266,2.3029314718240044
SW948,46191454,4.338482378206047,1.3518500781597358
Granta-519,11455910,0.302072347623865,0.9557745122323711
COR-L105,2113511,6.080993735084838,5.381335299817078
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.5350305453431912
IGROV-1,448949,2.098499309472767,1.9537365892294993
NCI-H1568,107970,1.680617581032042,2.3029314718240044
SK-OV-3,24797083,1.6169926593639932,1.277886491385028
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.0163468544412688
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.456683733824014
IGROV-1,4259181,0.1937358171291443,0.11236669175956715
LS180,135875424,4.384751932486372,3.743891076041643
UACC-812,54765302,2.961863639252158,3.905112278839675
SW1271,49867926,6.0238397416149345,4.110210541110895
SU-DHL-1,3025944,3.851371371046294,4.206240213808089
SW48,9967941,4.423983829284398,3.6034131982542865
SW1573,11609586,3.686627979451031,2.621607380466062
Panc 02.03,16065773,3.1661848504472023,2.3641186374244216
RCC10RGB,135421197,4.393109316582631,1.8199795612290348
IGROV-1,24785538,1.106246320450551,1.3344504348570345
HuP-T3,5278396,4.193223405360703,3.517590475337377
IA-LM,24901704,3.940918836251392,3.1103746959488285
SK-HEP-1,11214940,1.8009666315936252,1.8119431265240042
K-562,11364421,-5.792707438494169,-2.2476185097624475
LS411N,3384730,4.573317632228089,2.4620443610818112
LCLC-97TM1,568763,-0.0784771886342085,0.28862358029973745
HCC1500,9936388,-2.5304598124234365,-1.7988236137529168
HCC15,5311,0.7792586953300233,1.2663000347984639
SU-DHL-1,54686904,3.5039759810509676,3.776063215737675
PaTu 8988t,11626560,2.010870886496287,1.6795489442409048
HuP-T3,2749,2.009482044490881,1.7932893499757152
RKO,60750,-2.2331483998906654,-2.435153852929516
HCC15,5287620,-1.6098111318920385,-1.9697846958841214
HEL,654092,-1.523294365181231,-0.4472857419901597
SK-HEP-1,71304818,1.6350171624170464,2.396178486082573
SU-DHL-1,448949,1.2808073887625644,1.9537365892294993
K-562,5281321,0.5422415972342122,-1.3097742666845045
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.2359123501503817
LCLC-97TM1,5351362,1.316382729979947,1.4604743967139864
MOLP-8,5460769,1.8843864880791628,2.3447175553942796
SaOS-2,56963564,-0.1924881408966614,0.2569389627451253
RKN,446155,3.7628691651204234,2.662752180605146
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-1.261852028375895
NCI-H1568,16038120,0.8714631615296456,0.9090093368534204
Daudi,25102847,1.3031740879242997,2.3366995460793083
LS411N,25154868,4.929077040033465,4.289494395804131
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,1.78247230086659
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,3.7880999548273127
LS411N,9915743,2.8294092926119028,0.5935480801734145
Panc 02.03,BRD-K55473186,4.513191364064351,4.097702021052896
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,0.7705130043498147
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,1.7724503678159762
SU-DHL-6,4917,2.9501994456287792,3.079848880785536
Daudi,16741245,3.410771008602035,3.801678648950925
MOLP-8,3062316,1.3489297980566397,0.9747482048219924
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,2.93841691857644
RERF-LC-MS,25183872,-0.4545636564638026,-0.902802947451298
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,1.3153680794849765
MOLP-8,60700,-2.8082015295780858,-0.4482559328189002
NCI-H2452,637858,1.8545349692582156,1.8880097009592578
LCLC-97TM1,11626560,0.938916298027116,1.6795489442409048
HuP-T3,136227924,2.888640375816574,2.867001064974719
IA-LM,5284329,5.1954673618886655,3.2209771184161022
RKO,104842,-2.5196749638548,-3.040993872013826
SaOS-2,11494412,0.4895123820960489,1.4248282417532188
IA-LM,9926054,3.212619063516659,1.9546333131599372
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-1.261852028375895
MDST8,23635314,-2.200660522590374,-1.8612337831613235
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,0.11065310288154762
RKN,4261,1.529955054772996,1.4288257082744877
SW48,11396600,3.829401994456863,3.4309758536883517
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.4199080872215506
HCC1500,16659841,5.303826701580757,3.7845234388741966
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.1103746959488285
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,0.7705130043498147
MOLP-8,10231331,1.2198029486879254,1.6547412916072393
COR-L95,16725315,5.004914745056217,4.150060666188836
HEL,16115403,-4.756245139541522,-4.875275216600306
WM115,11717001,-1.1241138002933555,3.961276339234443
SaOS-2,11626560,1.1465195781021866,1.6795489442409048
BFTC-909,9907093,4.635414583134371,4.134688957161641
HCC1500,66577038,2.9555971550997935,2.9870697487432882
IA-LM,285033,0.5092837727748464,-2.1791335812392365
IA-LM,4917,4.737499942891754,3.079848880785536
BICR 22,44632017,0.9263322393180023,1.0838611345650022
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-0.8865368208635396
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-3.5071094923394703
SW1573,89928392,2.032641459256584,1.344325138639762
MOLP-8,119607,5.472499710124238,5.129253777214588
COR-L105,46398810,3.2483226376094194,2.510712955745063
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,1.1345509900924162
HCC1500,135999136,4.086589117257826,3.6300382464802663
WM115,11497983,4.51521868458229,2.348631818792911
SK-HEP-1,46926350,-4.110479335135347,-4.429063309555999
RKO,322968,3.8471310775605216,3.4956311613712456
LS180,25262965,-0.0916364033105869,-1.6224193967571534
HCC1500,246676,4.424448695399937,4.505551974581321
COR-L105,104842,-0.9230389281504464,-3.040993872013826
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,1.4554460238042177
SK-CO-1,6610355,4.767157937449789,4.45123297085854
IGROV-1,676352,2.310492141650647,2.088896150621564
SW48,262093,2.726859331273406,2.6275548088442098
HCC15,55508,3.481008151195261,3.1188086218267883
HCC1500,2126,3.801078614960916,4.466606494133751
PaTu 8988t,24951314,3.0808050806085188,1.227614980483031
RKN,11455910,3.815213247766997,0.9557745122323711
SW1573,3062316,2.075650426956439,0.9747482048219924
SK-HEP-1,5287620,-1.0463187584720948,-1.9697846958841214
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.3366995460793083
MOLP-8,24779724,4.381900106399647,4.725601600845458
Panc 02.03,107985,-4.238430695688479,-3.5771139994401464
IA-LM,322968,2.7570489193637018,3.4956311613712456
K-562,448949,1.070656561881704,1.9537365892294993
LS180,54649381,3.823257143411622,3.7880999548273127
IGROV-1,5281321,-1.4962463697398798,-1.3097742666845045
NCI-H1568,42642645,1.4281976900349445,0.7845058245277501
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.2834565267098785
K-562,44185566,1.8580861510177096,2.4057100644299436
SW48,637858,1.3097623359774897,1.8880097009592578
SK-HEP-1,613753,3.3794099216210203,3.1495845971526135
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,2.8341325456747963
COR-L105,11234052,4.539846823478364,3.869960809483736
IGROV-1,72193861,2.0623829231433293,1.3858780169906042
SW1271,3503,3.0280256153278606,2.2426858883255045
NCI-H1568,57330099,4.373464200171548,4.311542343968036
MOLM-13,1750826,-3.2515027143289728,-1.4739669220989267
SW1271,11222830,1.3106603955640226,1.5350294688251391
RERF-LC-MS,445091,4.218142840499499,4.3274252089919045
BICR 31,3062316,-1.406162609577698,0.9747482048219924
HEL,25126798,0.3968700607761156,3.7921789378214816
COR-L95,5738263,2.419040765220329,3.3050405288071003
SK-CO-1,36462,0.7476665664464673,1.5076124324231743
WM115,49766530,-0.6421157759153451,-0.6944377068647134
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.5350305453431912
BFTC-909,46901937,4.445112058189045,3.965127781632745
SW1271,136227331,4.376300443457216,4.306903331742339
COR-L95,25262965,1.4716002732306153,-1.6224193967571534
COR-L105,5281672,4.46136628199001,4.4250678360691875
WM115,73707398,1.178086440828875,1.180307991266282
Granta-519,6852167,2.2648312753409887,2.69961445504738
RERF-LC-MS,46174525,5.020740506928848,4.156087356848057
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,1.5478733404534093
RCC10RGB,44202524,4.922768729279552,1.9639001504219202
BFTC-909,BRD-K27188169,5.152610673434624,4.461608338658225
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,1.715838652040812
IA-LM,439501,-4.16745845294267,-2.2321662354381537
RKN,25262965,-0.5506090189051945,-1.6224193967571534
SW48,3385,1.919145280274203,3.472185389430271
RERF-LC-MS,12001922,2.43602915295576,1.8522788760744173
IGROV-1,568763,0.665047061839467,0.28862358029973745
P31/FUJ,10385095,1.5135865779060806,1.2480392352773622
HuP-T3,12001922,2.3367896101102907,1.8522788760744173
HCC1500,1641662,3.3816027924522487,3.3408828038827
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.08171494739702
P31/FUJ,1242560,3.8275456086274127,3.534393132486151
NCI-H1568,57519531,1.3161148530355309,2.4211376500246136
SW1271,42611257,4.308869978455437,3.0669311087446527
Daudi,10184653,1.026270071695755,1.1325795715302809
K-562,2858523,2.745068324935018,3.0086502241129605
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.78247230086659
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.5866736007906306
BICR 22,12001922,2.2523981699696165,1.8522788760744173
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.37491183386883553
UACC-812,5978,-2.554443854158195,-2.3753204421143224
MOLP-8,753704,3.0200894206550877,4.832125608051433
ALL-SIL,5394,4.4345454375843625,3.9762102103866797
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.5478733404534093
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,1.7724503678159762
NCI-H2452,44137675,2.6709050374584846,3.337336921695599
BICR 31,52912189,2.5113420173615464,1.6723266261402217
WM115,72199292,4.562209520612744,1.1233129488647187
BICR 22,25154868,5.114547534217177,4.289494395804131
SW48,25262965,-0.5589271325062998,-1.6224193967571534
IGROV-1,4705,3.3098412390054603,3.0428654274536564
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.6778195760397165
COR-L95,11955716,-2.3894028875885778,-1.4856643985320634
BICR 31,241158,4.31214680273537,3.598987869990464
RCC10RGB,25062766,2.0619451400109265,2.0522756909743434
HCC1500,25262965,-5.244904140838402,-1.6224193967571534
PaTu 8988t,285033,-2.1993510069972215,-2.1791335812392365
PaTu 8988t,44566777,-0.8532538772982161,0.6972581949653407
SW948,71466445,3.954398511848749,3.3478019143630626
IGROV-1,6610216,4.310938387105607,4.26979744561799
PaTu 8902,11497983,4.394920409770125,2.348631818792911
SW48,11612883,0.3553002535249436,2.6386482274158856
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.37491183386883553
HEL,9868037,2.50949616555346,2.82815333449006
HEL,11178236,-0.8324730036537664,-3.539769866873396
RERF-LC-MS,60750,-4.1612389836176,-2.435153852929516
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,2.3791567205504176
SaOS-2,24901704,3.518814077302041,3.1103746959488285
COR-L95,6914657,-4.192308975603822,-4.170094408243688
COR-L105,262093,2.940873643596252,2.6275548088442098
LS180,44486219,4.325065743764261,4.281343219898981
RKN,10074640,3.313081701902331,3.066922642013836
BFTC-909,5746,0.5111824642409613,0.8084551861824514
K-562,8515,4.039482215632923,3.7716438213452004
PaTu 8988t,31703,0.1373281877500042,-1.182053713238432
MDST8,135984461,4.124255066625015,3.6237408287871284
WM115,107970,1.780812210779262,2.3029314718240044
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.3228542035372683
IGROV-1,327653,3.667792542405671,3.018652636936018
P31/FUJ,89183176,3.539325961528454,3.4938336610308007
RCC10RGB,6438330,2.9900078425794385,2.016737971321332
RKN,5280436,4.161667428331563,3.153394505533252
COR-L105,445455,4.3186388426275535,4.540053644561405
LS411N,24785538,0.7817075732213645,1.3344504348570345
Daudi,11152667,-2.9472151872913104,-0.5866736007906306
P31/FUJ,448949,2.0159916590055067,1.9537365892294993
Daudi,11609586,-0.3532025604686024,2.621607380466062
SW948,46926350,-4.641976408237662,-4.429063309555999
SW1271,72193861,2.914678902909763,1.3858780169906042
PaTu 8902,25126798,4.210533326596683,3.7921789378214816
COR-L105,11955716,-2.257823880116287,-1.4856643985320634
HCC15,46224516,2.679221759698836,2.370954746557396
HCC15,135423438,2.37991378319322,2.1190856698194294
Daudi,421610,1.7509728437935097,3.1278257636093416
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0276770243216165
SaOS-2,11238147,2.85636627636287,2.694366237977623
IGROV-1,374536,0.7022324251593053,1.7732341041149164
SU-DHL-1,51039095,1.7422871999086744,2.682611194240459
IA-LM,72193861,3.820444995189443,1.3858780169906042
HEL,5738263,3.378820716395454,3.3050405288071003
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,1.2160403056527411
SW948,6852167,2.188206161672083,2.69961445504738
K-562,71751553,5.367911183247371,4.504570481353087
BFTC-909,71304818,3.116417285157316,2.396178486082573
SW948,25227462,-0.2382390684396511,-0.4151865926866767
SK-OV-3,637858,3.830307013284548,1.8880097009592578
RKN,49766530,-3.8574490235665584,-0.6944377068647134
NCI-H1568,9933475,1.8521331470520848,1.793439230086884
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,1.1345509900924162
KU-19-19,17759555,3.7275461226555566,3.5392373768677334
LS411N,44589607,3.372730635507476,2.659070263037081
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.9860814461500107
SW1271,5278396,3.101008990901291,3.517590475337377
LCLC-97TM1,46398810,1.8633773855233131,2.510712955745063
SK-CO-1,6852167,2.111498553552754,2.69961445504738
SW1573,5479543,3.675213844165782,3.2992765862159215
COR-L95,12003241,2.921570030601445,-1.0889198012759371
Panc 02.03,9911463,4.953148943637795,3.732908427020576
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,1.78247230086659
RERF-LC-MS,3384730,3.247206310046507,2.4620443610818112
IGROV-1,51039095,1.7163430299301403,2.682611194240459
KU-19-19,89928392,2.8864230284497747,1.344325138639762
SK-CO-1,216468,0.6363757446548435,2.5020743765616316
LCLC-97TM1,3038522,2.979698040139259,2.9847437848386558
BICR 22,6914657,-3.057028291966878,-4.170094408243688
MDST8,3815108,3.655140825789689,2.885036533777781
HEL,11364421,-3.0976744543470067,-2.2476185097624475
SW1573,10074640,3.956421484938757,3.066922642013836
LS180,6610355,3.640469161520063,4.45123297085854
Daudi,2858523,2.224035136584194,3.0086502241129605
BICR 22,135875424,4.925705128316808,3.743891076041643
SK-OV-3,23582824,0.9299959314677436,0.7400136078733197
K-562,5282054,3.5952240521498062,3.5628845676855256
NCI-H2452,44589607,3.0010828964799208,2.659070263037081
LS180,638278,3.5544678930796656,3.209337660705321
MOLP-8,426756,3.5390437920539117,4.301139445753315
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.2382789669868983
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.0276770243216165
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,3.0665232817889554
BICR 31,71466380,5.422644788319504,4.275465599745589
PaTu 8988t,53392493,3.5279637137541524,2.4832542501558077
UACC-812,6610216,4.947422623598504,4.26979744561799
SW1271,16038120,0.5203426502283315,0.9090093368534204
IGROV-1,67156097,0.1763939852409119,-1.0279170724737183
UACC-812,216239,2.3945159107119767,2.1474208097396077
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.0058447943574325
ALL-SIL,36462,-1.376242093473402,1.5076124324231743
BICR 31,1750826,0.6511109819152475,-1.4739669220989267
IGROV-1,56649450,0.515518984822669,2.999158341046921
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,2.9870697487432882
PaTu 8988t,6918837,-0.8891471976747255,-3.046222711611649
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-1.7988236137529168
NCI-H1568,2828334,5.9155051642717,6.082620037824382
MOLP-8,56973724,1.5171827826362807,2.823032655731692
MOLP-8,2729026,2.779201693602774,2.6325975116350393
P31/FUJ,753704,3.2802738483106766,4.832125608051433
SaOS-2,25183872,-0.102413301755783,-0.902802947451298
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,1.1345509900924162
LCLC-97TM1,9825149,1.404394440199107,2.074054954263997
WM115,9929138,6.7694003006369226,5.665997549800987
RERF-LC-MS,2746,3.2731211053052647,2.8579929499469348
COR-L95,5351362,0.837381680047442,1.4604743967139864
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.5350305453431912
RCC10RGB,3101542,4.48788654191394,4.518946219608264
BICR 31,44566777,1.4466588952743178,0.6972581949653407
WM115,5746,-0.962904812763719,0.8084551861824514
HEL,9903786,1.206049982415758,2.756077717004494
NCI-H1568,44486219,3.435494584556288,4.281343219898981
SK-CO-1,124202324,2.795373404058925,2.1784388364790748
MOLM-13,5329102,-5.212236525427112,2.031058842574058
SaOS-2,10427712,4.893681366378875,4.184108330161863
SW48,409805,3.4729287041870127,4.6745070702664995
HCC15,216345,4.3772403070959705,3.7540083674013296
NCI-H2452,46215462,2.291566037713401,1.762132613731386
SU-DHL-1,55283,1.0511806970329092,2.1635123760949786
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,1.133687221210622
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-4.2202975286026225
MDST8,24821094,3.627663013095859,2.7369152351179045
HCC15,9911463,3.642862209488471,3.732908427020576
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-1.57821899028641
SW948,11178236,-0.7120713487548671,-3.539769866873396
HCC1500,5329102,1.6369795361395487,2.031058842574058
SU-DHL-1,11364421,-4.160715855029451,-2.2476185097624475
SU-DHL-1,176870,3.225718242496366,3.0253996189023358
WM115,2742550,3.774256401917875,3.8595787492072238
SW48,12003241,-0.9746028071684796,-1.0889198012759371
NCI-H1568,11494412,0.631822071405162,1.4248282417532188
WM115,25102847,1.9091464851380515,2.3366995460793083
COR-L105,23725625,5.8274909459435165,4.726527081330662
Granta-519,9956119,4.186560294974692,3.4762974507018756
COR-L95,72193861,1.6807669427950571,1.3858780169906042
IA-LM,6917907,0.442667441503668,-4.864372369867458
SW1573,53232,-0.4627324496874346,2.8161144578264046
Panc 02.03,19582717,5.117031119305748,3.9198146524152833
RCC10RGB,227681,3.758665689171896,2.9941233013598234
WM115,24901704,3.629786211252992,3.1103746959488285
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.5570685949048098
K-562,637858,1.3097643671251342,1.8880097009592578
SW948,613753,3.0653891790249617,3.1495845971526135
Granta-519,9926054,1.8135939424605243,1.9546333131599372
SK-CO-1,55508,3.57241133457179,3.1188086218267883
HCC1500,5426,4.174536858194301,4.746710128133936
IGROV-1,4521392,5.131794979216607,4.280943620409205
UACC-812,6918878,3.827620339158657,1.9069091595174383
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.38762532684053896
KU-19-19,72193861,2.401782330602402,1.3858780169906042
WM115,5281321,0.1495893125543727,-1.3097742666845045
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,2.9847437848386558
P31/FUJ,31703,-2.5575864334968976,-1.182053713238432
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,1.1345509900924162
ALL-SIL,44589607,0.5481515481681011,2.659070263037081
PaTu 8988t,11955716,-2.6731660557009267,-1.4856643985320634
IGROV-1,5738263,4.037832478240785,3.3050405288071003
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.8921209077069348
BFTC-909,650361,3.8112149600795706,4.223422874692544
SW948,16725315,5.2631267850751335,4.150060666188836
Panc 02.03,25102847,3.3458680072040603,2.3366995460793083
BICR 31,216239,4.655547148927136,2.1474208097396077
SK-HEP-1,51039095,3.60670356936783,2.682611194240459
IGROV-1,9907093,2.687959785702283,4.134688957161641
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.8921209077069348
LCLC-97TM1,49766530,0.6419783818490065,-0.6944377068647134
Granta-519,2113511,5.634502761977105,5.381335299817078
COR-L95,322968,2.331837213900703,3.4956311613712456
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.5350305453431912
SW48,60700,-1.9747801062936423,-0.4482559328189002
SaOS-2,46907787,1.5905885991562354,1.584957029505121
LS411N,5311,1.0830647686053458,1.2663000347984639
NCI-H1568,5278396,3.684546625455108,3.517590475337377
P31/FUJ,2858523,2.921593087757198,3.0086502241129605
MOLP-8,25102847,1.798391543473315,2.3366995460793083
HCC15,57330099,4.175732386995395,4.311542343968036
LCLC-97TM1,16013152,5.423690206414697,4.119375381760217
SW1271,16065773,2.6188234772001886,2.3641186374244216
RERF-LC-MS,52947716,-5.597592816818683,-1.4012147836358484
MOLM-13,11167602,-1.7638454235436123,2.4705816300476062
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,2.9860814461500107
Granta-519,3038522,1.8764454398289976,2.9847437848386558
SW1573,54626689,3.958399976383255,4.561309020020982
K-562,445455,4.202279962055385,4.540053644561405
SK-CO-1,25262965,-3.291258197582341,-1.6224193967571534
Granta-519,54618771,-0.1786557603441652,0.9253379925205388
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,3.7540083674013296
HuP-T3,42642645,1.566786855324099,0.7845058245277501
MOLM-13,44589607,2.917529465117915,2.659070263037081
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.2480392352773622
SU-DHL-6,753704,4.418086475877281,4.832125608051433
SU-DHL-6,6918837,-4.716152603392634,-3.046222711611649
P31/FUJ,46199207,2.4446101047156215,3.1312366616263048
SaOS-2,156422,4.313289259132858,3.8435202478608215
BFTC-909,5282054,4.21714099973987,3.5628845676855256
RCC10RGB,9803433,4.221770064596342,4.847536831977339
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,1.2047817895412443
RKN,89183176,6.327700475537756,3.4938336610308007
BFTC-909,16038120,1.74161234898449,0.9090093368534204
HCC1500,71466445,3.970736335461394,3.3478019143630626
Granta-519,25062766,1.8322611726564384,2.0522756909743434
SK-OV-3,216345,4.761928129554225,3.7540083674013296
Granta-519,11609586,-2.485330170292811,2.621607380466062
SK-HEP-1,6918878,4.4325993547595655,1.9069091595174383
P31/FUJ,676352,1.6175160353980318,2.088896150621564
UACC-812,25227462,-0.2916299121927669,-0.4151865926866767
RERF-LC-MS,54596558,4.400747096440468,4.397101469450013
Daudi,9911830,-0.0057102646081846,2.4240324657892436
COR-L95,72376,-2.5853838467146493,-2.110114148114304
LCLC-97TM1,135875424,3.9585615026829823,3.743891076041643
P31/FUJ,49850262,2.7073676452568427,3.414452598711333
HEL,10410894,1.686960620182283,3.2189174762180457
LS180,10127622,1.4423864514133429,3.6054187258933235
LS411N,16038120,1.458068935835204,0.9090093368534204
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,2.867001064974719
IGROV-1,11214940,1.360660548899077,1.8119431265240042
Panc 02.03,969516,3.806573436208542,2.7772567284956553
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.4199080872215506
SW48,656346,-0.2718986936332406,0.7582608913284792
SW948,285033,-0.875487938395224,-2.1791335812392365
Panc 02.03,4261,3.516583077320981,1.4288257082744877
SW48,49766530,3.606492941369466,-0.6944377068647134
SW48,16038120,-1.7922421690180796,0.9090093368534204
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.9218131221296273
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.1312366616263048
WM115,2945648,2.5851994154769025,2.7548400693819435
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,2.9860814461500107
BICR 22,25227462,-3.180570489875023,-0.4151865926866767
IGROV-1,5460769,1.6083174601829917,2.3447175553942796
K-562,753704,4.7227938780788525,4.832125608051433
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.5350305453431912
HuP-T3,4788,5.894927949545096,5.493389053048461
SK-OV-3,42642645,1.640931292575566,0.7845058245277501
PaTu 8988t,11222830,1.761666424308375,1.5350294688251391
BFTC-909,448949,2.818327130228084,1.9537365892294993
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,2.0058447943574325
WM115,5281672,6.287836255113029,4.4250678360691875
Daudi,3384730,1.441294292217556,2.4620443610818112
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-0.8865368208635396
LS180,6252,-0.5438897009285958,-0.10942982547788271
SaOS-2,3025944,4.435896212894107,4.206240213808089
SaOS-2,25161177,4.43427627730954,4.097137926934978
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,1.3153680794849765
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,-0.28710840066117727
BFTC-909,11228183,3.298719229946038,1.8712017695678478
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.4539899714896953
Granta-519,135659046,3.900512348834848,3.604307380358917
LS180,126941,-2.6871715133008385,-2.8921209077069348
MOLM-13,3081361,0.9632978577503784,2.3568884936851697
WM115,9936388,-1.175666523167262,-1.7988236137529168
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-1.3340160156368264
IGROV-1,15953870,2.712793598656007,3.4781017448929608
RKN,10410894,1.511663597063748,3.2189174762180457
IA-LM,6918638,0.61198230609435,0.3065957347013626
SW1271,56946209,-4.174123648346971,-4.2202975286026225
BICR 22,67156097,-1.5899611273150889,-1.0279170724737183
SW1271,2749,2.846909316544141,1.7932893499757152
KU-19-19,65628,4.405271017285275,4.026684176415168
MOLM-13,5566,2.591289759721003,3.029152149495273
HCC1500,89928392,1.0051530188155344,1.344325138639762
SW948,25102847,1.6816963863778185,2.3366995460793083
ALL-SIL,10427712,3.5706749567785625,4.184108330161863
IGROV-1,2749,2.0319044408234954,1.7932893499757152
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.8341325456747963
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-1.6778195760397165
SaOS-2,1242560,3.6046854082724034,3.534393132486151
RCC10RGB,123631,3.672101761387351,2.2760265557358337
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.2349426527428076
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.3791567205504176
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.7855881743093749
MOLM-13,23725625,2.3173082013566204,4.726527081330662
SK-CO-1,15547703,3.920131639479481,3.114669509763707
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.8865368208635396
SaOS-2,71729975,2.29546286795302,1.8676365373941402
KU-19-19,12003241,-0.0608702413973226,-1.0889198012759371
SK-CO-1,568763,0.0338205510733868,0.28862358029973745
SU-DHL-1,984333,1.5848171755072842,0.5138000229415411
RERF-LC-MS,49766530,0.7744144603938863,-0.6944377068647134
SU-DHL-6,11152667,-4.5064226702829,-0.5866736007906306
HCC15,2130404,2.6093174666871293,3.195187949563447
RKN,11626560,2.593417875894138,1.6795489442409048
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,0.9218131221296273
Daudi,44137675,1.0044684727898117,3.337336921695599
SW948,54619267,3.654776559833868,3.9342007971372475
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.93841691857644
RCC10RGB,4259181,1.719089746142662,0.11236669175956715
SU-DHL-1,9887053,2.0473441666614156,3.469815136639831
SK-OV-3,9911463,4.2249846626647125,3.732908427020576
HCC15,49766530,0.5190445493569186,-0.6944377068647134
Granta-519,3385,2.090684083959823,3.472185389430271
RKO,54613361,0.2998145946125954,-0.11678183903518824
HEL,3384730,1.593743887858678,2.4620443610818112
NCI-H1568,11977753,-3.4091025242198696,-1.7159558966047241
SK-OV-3,285033,-0.1977879636486448,-2.1791335812392365
Daudi,3385,1.70419989930712,3.472185389430271
NCI-H1568,9825149,1.6639399446813206,2.074054954263997
IGROV-1,654092,-1.340387623873854,-0.4472857419901597
SW1271,126941,-2.215477966101826,-2.8921209077069348
IGROV-1,6852167,1.5305143027352028,2.69961445504738
HEL,11626560,1.0872099702081388,1.6795489442409048
SW948,126941,-3.436390914894009,-2.8921209077069348
RKN,107985,-3.0900461086436404,-3.5771139994401464
P31/FUJ,12001922,1.6134382673725098,1.8522788760744173
Daudi,11404337,-3.064654238522792,-0.4254091153988029
SaOS-2,6438330,2.0981522234577064,2.016737971321332
LS411N,126941,-2.790198017582557,-2.8921209077069348
HCC1500,10302451,3.7658874637842135,3.0143591766147457
BICR 31,4259181,2.3774772051226685,0.11236669175956715
MOLM-13,11656518,1.5202718128538335,1.5480979328089313
COR-L95,148124,-0.3758104123213183,-2.0460232384010055
MOLP-8,53232,1.5052202963885184,2.8161144578264046
NCI-H2452,3038522,3.3601174997652725,2.9847437848386558
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,2.6829735349466532
SW948,16722836,1.2939108289094092,1.5333952667080324
HEL,439501,-2.350875236844296,-2.2321662354381537
NCI-H2452,445091,5.08182727911324,4.3274252089919045
RKO,9840324,5.302067215897717,5.7711165719697215
SaOS-2,44489675,3.960447273667139,3.8856289571074525
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,1.5478733404534093
BICR 22,46901937,4.667354689676901,3.965127781632745
LCLC-97TM1,2746,2.92478275020961,2.8579929499469348
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,1.2359123501503817
Daudi,44491742,3.5549145676591314,4.1566745174283435
BICR 31,374536,2.383890315264743,1.7732341041149164
NCI-H2452,17759555,4.398260875691204,3.5392373768677334
LS411N,25183872,0.0970121311419586,-0.902802947451298
Panc 02.03,23725625,6.172373492037936,4.726527081330662
Granta-519,65064,2.9178387202883735,4.739517756868576
COR-L105,11222830,1.704570553497338,1.5350294688251391
NCI-H1568,5394,4.198509108960074,3.9762102103866797
P31/FUJ,135984461,4.1454221372139894,3.6237408287871284
K-562,49836020,4.414855158615189,2.5464279658175073
HEL,4788,5.03605552733545,5.493389053048461
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,1.2834565267098785
LS411N,6610216,4.962940577428159,4.26979744561799
NCI-H1568,23635314,-3.8228905075414055,-1.8612337831613235
HCC1500,5328940,1.924598719414512,1.559061663996469
BFTC-909,44589607,3.3115887945185496,2.659070263037081
MOLM-13,5281321,-2.338854439084819,-1.3097742666845045
MOLP-8,71466380,3.4619880715079603,4.275465599745589
K-562,439501,-2.3563528898814905,-2.2321662354381537
LCLC-97TM1,44819697,0.4394946813834864,-0.6109288989041974
HCC1500,9956119,4.194319271525248,3.4762974507018756
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.3153680794849765
HCC1500,6505803,-1.3038553273576796,-0.5114413444588124
SK-CO-1,16038120,-1.5377645940979283,0.9090093368534204
MOLP-8,46398810,1.7248083632166018,2.510712955745063
RKN,73707386,3.296207724675486,2.6861216111986805
HuP-T3,6918638,1.0959798369911515,0.3065957347013626
SK-CO-1,72734382,5.327408257337546,4.3578051352274185
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,0.11065310288154762
SU-DHL-1,23725625,3.354193732931358,4.726527081330662
SW948,4378219,2.7444419460246716,2.6822409618839944
Granta-519,6610216,4.381057854502396,4.26979744561799
SaOS-2,25126798,4.16568157244383,3.7921789378214816
MOLP-8,11719255,2.3085103352777057,3.1221102230298534
SU-DHL-1,969516,2.44648475018104,2.7772567284956553
HuP-T3,9884685,1.9355517940144655,0.4230357541133405
SU-DHL-1,54618164,3.660876980117255,4.02740727006158
P31/FUJ,4788,5.1911977113578285,5.493389053048461
IGROV-1,10074640,3.2681490579824426,3.066922642013836
LS180,46224516,3.8200366067107714,2.370954746557396
K-562,24753719,4.107201496626299,4.143618673527016
HCC1500,46926350,-3.99988450675712,-4.429063309555999
LS411N,11175137,2.6624545374598,2.477950770888125
IGROV-1,71466578,4.017291197092763,3.983075654179168
Granta-519,10184653,0.998312657126817,1.1325795715302809
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.0276770243216165
MOLP-8,6918328,-3.583816044173495,-0.28710840066117727
SW948,56649450,1.940604714075546,2.999158341046921
BFTC-909,374536,2.594742723017773,1.7732341041149164
KU-19-19,44185566,3.361767971446376,2.4057100644299436
NCI-H2452,1750826,0.2631697114156899,-1.4739669220989267
LCLC-97TM1,24180719,3.1823264447338837,3.437709308952337
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-3.5071094923394703
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,1.4554460238042177
RKO,675434,4.252493680505022,4.463597576567934
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.0163468544412688
HCC15,25105715,3.3758270019314147,3.410449786117574
HuP-T3,6610216,4.722811341582641,4.26979744561799
MOLP-8,156422,3.6985484587412394,3.8435202478608215
SK-HEP-1,6917907,-0.2672796642005143,-4.864372369867458
SW948,984333,0.954004982504914,0.5138000229415411
PaTu 8988t,51039095,3.672985699080835,2.682611194240459
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.456683733824014
MOLM-13,10385095,0.2048351805935088,1.2480392352773622
WM115,2842253,4.366205978966029,5.203082223374658
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.133687221210622
IGROV-1,135423438,0.764137689665023,2.1190856698194294
RKO,16725315,5.119694523443236,4.150060666188836
MDST8,11609586,4.829072296940778,2.621607380466062
COR-L95,7251185,1.1216187825494426,2.4347287977616
RERF-LC-MS,51039095,3.2453184174795324,2.682611194240459
P31/FUJ,17759555,3.626728737883383,3.5392373768677334
HCC1500,5113032,4.590685122922873,4.970396511864891
P31/FUJ,16741245,4.043144814115882,3.801678648950925
HCC15,5746,0.6503914795852271,0.8084551861824514
RKO,10074640,2.8357111382750646,3.066922642013836
WM115,10322450,3.651827454662003,3.669858075898477
LS180,11404337,-0.0678179476465551,-0.4254091153988029
Daudi,46191454,-0.8094751773550651,1.3518500781597358
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,2.699201704606489
P31/FUJ,44202524,1.0280075167408849,1.9639001504219202
ALL-SIL,44185566,1.0410692737439569,2.4057100644299436
PaTu 8902,54618164,4.284638344065584,4.02740727006158
COR-L95,46224516,1.2687748324677306,2.370954746557396
COR-L105,56949517,4.666554440626914,4.259203439290573
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,1.7691529831259722
BICR 22,45279963,3.757910341256097,3.660133434789582
HEL,9911463,3.4775133545177774,3.732908427020576
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,1.5478733404534093
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.2349426527428076
Granta-519,5287969,-2.420005986832857,-1.9772070858850965
IGROV-1,71466578,4.017291197092763,3.983075654179168
Daudi,1323703,3.9745876209629354,4.646036759655499
COR-L95,9956119,3.960527548011759,3.4762974507018756
SW48,15953870,2.1672009909649415,3.4781017448929608
SW48,5278396,2.530949009900888,3.517590475337377
WM115,10296883,3.9273376390568138,3.795028277273254
NCI-H2452,10302451,4.286596307748033,3.0143591766147457
SW948,9915743,1.1952390119197474,0.5935480801734145
SW1271,9903786,4.005340236032604,2.756077717004494
LS411N,49793307,-3.1894754739686455,-2.848251171596848
Daudi,126941,-4.413815937813151,-2.8921209077069348
SU-DHL-1,89183176,5.662525063156772,3.4938336610308007
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.6778195760397165
SK-CO-1,216239,2.5779715954988656,2.1474208097396077
SaOS-2,24889392,3.914866726590468,3.7858620057203916
LS180,3025944,4.8838055311701805,4.206240213808089
SW48,11626560,-0.4765255311776857,1.6795489442409048
RKN,168313047,2.366456695786382,2.4053217165791536
NCI-H1568,4788,5.820003751306211,5.493389053048461
RKN,65628,4.337575078598336,4.026684176415168
LS411N,5311281,3.759327828108219,2.22503529708604
RKN,23725625,4.172652901782409,4.726527081330662
BFTC-909,168312962,2.436518653578315,1.48933366232238
K-562,56946209,-4.819463057676977,-4.2202975286026225
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,1.4554460238042177
Daudi,11647372,-0.1839602824658907,0.8954839509867156
SW948,5479543,0.3482839273666757,3.2992765862159215
SU-DHL-1,11626560,-1.697644171575415,1.6795489442409048
BICR 22,71466380,4.042212978424107,4.275465599745589
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,2.93841691857644
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,2.344610112805219
MOLP-8,9967941,2.6295638429027206,3.6034131982542865
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.7691529831259722
NCI-H2452,25183872,0.970145395005522,-0.902802947451298
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,0.9218131221296273
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.38762532684053896
HCC15,8515,2.8931769079597767,3.7716438213452004
SK-HEP-1,7251185,3.0945137710223687,2.4347287977616
HuP-T3,3689413,-1.422602865458103,-0.4039154566871359
HCC1500,2113511,4.626117550925971,5.381335299817078
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.3274252089919045
SW1573,5351362,2.395315345585997,1.4604743967139864
SaOS-2,16725315,3.258166087647875,4.150060666188836
SK-HEP-1,44566777,0.1035402456781041,0.6972581949653407
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,3.469815136639831
NCI-H2452,54618771,2.226699645078912,0.9253379925205388
RKN,5329102,3.127163305072316,2.031058842574058
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,0.7705130043498147
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.0276770243216165
NCI-H1568,5287620,-3.0605655272876104,-1.9697846958841214
IGROV-1,5329102,1.2794664511054334,2.031058842574058
SU-DHL-1,71680916,6.473574001994787,4.641848024405652
COR-L105,25262965,-4.3344847799771,-1.6224193967571534
SW48,3503,2.2068347221848605,2.2426858883255045
BICR 31,36462,3.088359748996336,1.5076124324231743
SK-HEP-1,24753719,4.401042857593667,4.143618673527016
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-1.57821899028641
IA-LM,16659841,3.92216274325252,3.7845234388741966
WM115,24771867,3.628628048718056,1.5171458615349627
SK-CO-1,67156097,0.6545128366700663,-1.0279170724737183
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.117207225291035
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.4539899714896953
IGROV-1,71466380,4.863636874274779,4.275465599745589
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,2.8341325456747963
Daudi,5281321,-4.970506938945455,-1.3097742666845045
BFTC-909,12003241,-0.8371396827795129,-1.0889198012759371
SaOS-2,44185566,3.018169617675811,2.4057100644299436
SW48,54619238,4.554849733994691,5.004034610534093
Granta-519,25227462,-6.0432717278136066,-0.4151865926866767
HCC1500,72376,-0.7270592073375387,-2.110114148114304
SK-OV-3,3689413,0.6002437290843657,-0.4039154566871359
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.7007618437932
COR-L105,71466380,4.962997689396809,4.275465599745589
K-562,56649450,4.352548214039191,2.999158341046921
ALL-SIL,2828334,5.780519190951295,6.082620037824382
MOLP-8,5746,-0.9490954024297016,0.8084551861824514
LS411N,9935249,3.5378716054356927,2.8615383619674972
KU-19-19,148198,-3.572091199224797,-3.548509713878981
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,1.4554460238042177
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,0.9218131221296273
RERF-LC-MS,54619267,3.9836959677109354,3.9342007971372475
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.7691529831259722
SK-CO-1,445455,4.388752059403359,4.540053644561405
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.0669311087446527
BFTC-909,6914657,-4.61933610547547,-4.170094408243688
IGROV-1,54619267,3.9701367924453455,3.9342007971372475
NCI-H2452,6918289,-3.5458030779688277,1.9146814118519513
SW48,654092,0.3720639788768654,-0.4472857419901597
LS180,10184653,1.1411409682713576,1.1325795715302809
SW1573,4259181,2.0061423198913766,0.11236669175956715
BICR 22,5978,-3.054007840707858,-2.3753204421143224
SK-CO-1,446155,2.509492168961503,2.662752180605146
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.7691529831259722
MOLP-8,6917907,-6.199761218038622,-4.864372369867458
WM115,6610216,3.675624927368402,4.26979744561799
BICR 22,11964036,1.4111698106068242,1.2382789669868983
IGROV-1,135440466,0.9791523710816318,2.1401473911994366
SU-DHL-1,46224516,1.9664047258697153,2.370954746557396
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,0.7582608913284792
NCI-H2452,156422,4.888821376667332,3.8435202478608215
BICR 22,446155,3.7361559304721106,2.662752180605146
BFTC-909,3038522,3.685618431455981,2.9847437848386558
RKO,46907787,4.104881837237831,1.584957029505121
IGROV-1,123631,1.7694522866439453,2.2760265557358337
LS411N,5280436,4.183720769167266,3.153394505533252
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-1.6396194068861514
HEL,5311,0.0816485968486221,1.2663000347984639
SU-DHL-1,327653,2.51842673185387,3.018652636936018
MOLM-13,8515,0.8268618162227004,3.7716438213452004
MOLP-8,25183872,-1.6811002192977054,-0.902802947451298
Granta-519,11228183,-2.3490545548585335,1.8712017695678478
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.38762532684053896
SaOS-2,5470400,4.204063595869918,-0.3765538821264742
BFTC-909,5738263,3.1091802601858185,3.3050405288071003
SK-CO-1,20959075,-3.269929661945314,-3.173507428051674
SK-OV-3,9956119,5.08600620496794,3.4762974507018756
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.144908880465776
BICR 31,5978,2.6862960741960693,-2.3753204421143224
RERF-LC-MS,375860,-0.2896823379882159,-0.30112130782396007
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,2.8341325456747963
COR-L105,44202524,4.8543272504702895,1.9639001504219202
MOLP-8,44137675,1.775364766844489,3.337336921695599
IGROV-1,9907093,2.687959785702283,4.134688957161641
LCLC-97TM1,10385095,1.2595894653665305,1.2480392352773622
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.0058447943574325
P31/FUJ,3038522,3.230912995410489,2.9847437848386558
PaTu 8988t,5281321,0.6032906637165831,-1.3097742666845045
HEL,9866186,-1.054303819018661,0.7577083020821866
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,2.3791567205504176
SW948,2708,5.7755473109613265,4.591243765137335
PaTu 8988t,3025944,4.261130932115319,4.206240213808089
SK-HEP-1,3689413,-2.4602386660304143,-0.4039154566871359
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.456683733824014
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,1.5171458615349627
RKO,6252,0.5352436981906653,-0.10942982547788271
SU-DHL-1,4521392,5.192178694848648,4.280943620409205
Daudi,72376,-4.854665282210012,-2.110114148114304
RKN,4259181,0.9508926940780028,0.11236669175956715
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,1.856021664538426
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.6109288989041974
SW1271,36314,-4.053350989931705,-1.2422497803043113
COR-L105,1750826,-1.9007119452090728,-1.4739669220989267
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.860017480413567
Granta-519,46215462,0.9491023197189584,1.762132613731386
SW1271,3676137,4.713113076263269,4.517112669127141
IA-LM,5278396,3.9030690758091904,3.517590475337377
NCI-H2452,24775005,5.579264227156813,3.778654827630856
K-562,23635314,-4.3400265171433725,-1.8612337831613235
COR-L105,6852167,2.71981320036177,2.69961445504738
Panc 02.03,16741245,4.354855972582246,3.801678648950925
SU-DHL-1,2733487,6.186604270067288,6.1630813151494985
Granta-519,26596,-3.6955660538224784,-1.5346517263124715
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.3153680794849765
ALL-SIL,176870,2.444675771693443,3.0253996189023358
LCLC-97TM1,19582717,4.783105330370089,3.9198146524152833
HuP-T3,119607,5.841541098284191,5.129253777214588
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,2.93841691857644
P31/FUJ,637858,0.7903103947120294,1.8880097009592578
COR-L95,5329102,1.6379635813529434,2.031058842574058
BICR 31,5291,3.978522058600436,3.5530526201153183
LS180,6852167,2.255231171645259,2.69961445504738
IA-LM,89928392,1.436934436501384,1.344325138639762
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-3.5071094923394703
BICR 22,9903786,3.2901982519836213,2.756077717004494
SK-CO-1,3384730,3.2619898650330272,2.4620443610818112
SW48,17755052,-0.4852421045975616,1.7101929835526413
COR-L105,568763,0.9810834095142736,0.28862358029973745
HCC1500,9866186,3.137309558941867,0.7577083020821866
HCC15,124202324,2.163317754038658,2.1784388364790748
HCC1500,6917907,-5.345696307345718,-4.864372369867458
HCC1500,23635314,-1.1425681705854864,-1.8612337831613235
Granta-519,126941,-4.311277898608593,-2.8921209077069348
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.13551970928241
SW948,24771867,-2.1331828785420166,1.5171458615349627
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.209337660705321
LCLC-97TM1,10410894,3.7243046596553344,3.2189174762180457
COR-L95,11609586,-0.6075050167057128,2.621607380466062
MOLM-13,9952709,2.652499766566874,2.9381980631482683
HCC15,24951314,1.20775234306688,1.227614980483031
BFTC-909,11175137,1.859642091823866,2.477950770888125
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.37491183386883553
SaOS-2,9444,4.299296809659387,4.054048446110465
Daudi,71576739,4.751042411789338,2.9192684489841567
SU-DHL-1,6505803,-0.92520479323989,-0.5114413444588124
SU-DHL-1,11214940,-0.4959690036226346,1.8119431265240042
IA-LM,71466578,5.490140561499378,3.983075654179168
RERF-LC-MS,262093,3.104487938727744,2.6275548088442098
SW1271,71466380,4.990835020791986,4.275465599745589
Panc 02.03,135411,0.8368106867561712,0.5181226666256136
RERF-LC-MS,8515,3.770178660744851,3.7716438213452004
HCC15,45100309,5.717971650422449,6.016171437665366
COR-L95,54618771,1.9587299059916856,0.9253379925205388
LCLC-97TM1,16736978,1.4629436365964008,1.3934160091023764
IGROV-1,9825149,2.5588021380929553,2.074054954263997
IGROV-1,227681,3.5439813498262347,2.9941233013598234
RERF-LC-MS,44489675,3.7548789887197183,3.8856289571074525
MOLP-8,3136844,3.797428854524256,4.214923916993912
COR-L95,5746,-1.1189080553056585,0.8084551861824514
BICR 22,135398516,2.7677082767193117,2.0509021680173207
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-1.1532493383305307
ALL-SIL,57330099,4.126515702027515,4.311542343968036
SW48,135398738,2.3509294796071454,3.3919135064420334
WM115,2113511,5.303490143807845,5.381335299817078
Daudi,2729026,1.2833432455886875,2.6325975116350393
P31/FUJ,100016,5.4217002529902185,5.87798299213578
IGROV-1,71466445,2.3758001916617797,3.3478019143630626
ALL-SIL,6918878,-0.682122479171039,1.9069091595174383
Daudi,73707371,3.866210661620395,5.18278851064184
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,-0.4482559328189002
SW48,11364421,-4.967269122022574,-2.2476185097624475
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.2359123501503817
LS411N,135411,0.7383506227122603,0.5181226666256136
K-562,3634881,3.4419902111623473,3.1576774496130544
KU-19-19,969516,2.8919422545546043,2.7772567284956553
Daudi,135999136,4.063293138043838,3.6300382464802663
SU-DHL-1,12001922,1.0574025128990867,1.8522788760744173
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.3848601780620533
MDST8,11427553,3.108888701151444,2.578035472123966
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-0.8865368208635396
HuP-T3,9840324,6.187364891887578,5.7711165719697215
RERF-LC-MS,5281321,-2.2570738048063257,-1.3097742666845045
UACC-812,16725315,4.601797708491857,4.150060666188836
WM115,53481919,3.625694730030069,3.8547522793737237
WM115,3136844,4.4781621433894925,4.214923916993912
SK-HEP-1,135999136,5.290710201924687,3.6300382464802663
SK-OV-3,72734382,4.397767647147488,4.3578051352274185
SU-DHL-1,4096211,0.0680701310214702,1.856021664538426
SK-CO-1,2749,0.8616454488616467,1.7932893499757152
COR-L105,4477,0.3499366832640422,0.5570685949048098
SW948,24785538,-1.2786696026485709,1.3344504348570345
BICR 22,25161177,4.685384367036766,4.097137926934978
Granta-519,11955716,-3.0537796337487064,-1.4856643985320634
ALL-SIL,10127622,5.469150259822909,3.6054187258933235
SK-CO-1,11238147,1.2924304468719774,2.694366237977623
IGROV-1,11427553,2.926316692603687,2.578035472123966
BICR 22,54618164,4.171441086739322,4.02740727006158
BFTC-909,57519531,3.2286550647211025,2.4211376500246136
SaOS-2,1750826,-1.0374385524430834,-1.4739669220989267
SU-DHL-1,71466445,3.7763473385017994,3.3478019143630626
SW1271,6852167,3.737297660761554,2.69961445504738
SW948,9549297,1.722924191719054,2.3089350530287187
BICR 31,72376,-0.802396523967939,-2.110114148114304
SK-HEP-1,56946209,-4.57873882670014,-4.2202975286026225
RKO,24964624,3.0430796891613903,2.2827362159867324
NCI-H2452,54143018,0.9899128272921088,0.31711465707788644
SU-DHL-6,60750,-4.821248170588626,-2.435153852929516
HEL,44259,1.31343744649104,0.9267255578557378
MDST8,3038522,4.546677862508445,2.9847437848386558
Daudi,72193861,0.2314245956601211,1.3858780169906042
NCI-H2452,4096211,2.487981551988898,1.856021664538426
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.3791567205504176
Daudi,208908,1.616008502166041,1.8663560178908947
LS411N,46191454,1.665967132338862,1.3518500781597358
Panc 02.03,262093,3.467425891303458,2.6275548088442098
COR-L95,462382,0.8255977399878551,0.5714028853239661
IGROV-1,16736978,0.1982875499977011,1.3934160091023764
MDST8,107985,-3.301997074358414,-3.5771139994401464
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-1.57821899028641
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,4.739517756868576
RKO,54618164,4.0326978900214705,4.02740727006158
MOLP-8,5311,0.4432260076750803,1.2663000347984639
SK-HEP-1,5291,4.1108608913621545,3.5530526201153183
SaOS-2,107970,2.235066344736828,2.3029314718240044
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,1.710700657959646
Granta-519,6252,-5.172240666242431,-0.10942982547788271
IGROV-1,285033,-1.3538783590767758,-2.1791335812392365
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,2.0058447943574325
NCI-H1568,46191454,1.7726304550427152,1.3518500781597358
PaTu 8902,24856436,4.585148807200659,0.17994774592918095
WM115,5351362,0.9981168658111552,1.4604743967139864
IA-LM,387447,-4.406032561698067,-4.3765957253648695
MOLM-13,656346,-0.3431029585418202,0.7582608913284792
COR-L105,637858,2.3247583240908405,1.8880097009592578
Daudi,448949,1.1283153338590814,1.9537365892294993
SW948,42642645,-0.386998084672917,0.7845058245277501
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,1.710700657959646
HCC1500,52947716,-7.376885049387286,-1.4012147836358484
MDST8,439501,-2.351670240427255,-2.2321662354381537
RERF-LC-MS,25161177,4.303824118845859,4.097137926934978
SU-DHL-1,3634881,1.9377929493272257,3.1576774496130544
RKO,46398810,2.934390735401444,2.510712955745063
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,2.3791567205504176
HCC15,159324,2.6315252421023536,2.0742938672876736
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.0058447943574325
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.6386482274158856
Daudi,2949965,1.2926680931891954,2.715769249487813
RKO,23725625,3.9986828157613616,4.726527081330662
HEL,16722836,0.561669465799647,1.5333952667080324
Panc 02.03,11175137,3.7353172411310696,2.477950770888125
KU-19-19,6918878,0.8609723302141853,1.9069091595174383
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-3.5071094923394703
SW48,3854666,0.5343434371102147,1.85063491630251
SK-HEP-1,11626560,2.7034566874481745,1.6795489442409048
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.4539899714896953
NCI-H2452,3825829,3.8827569930751937,3.8869840981378028
BFTC-909,126941,-2.0975077483758415,-2.8921209077069348
NCI-H2452,24951314,1.9717681393720747,1.227614980483031
HCC15,54454,0.5186235809490349,2.548844675602096
BICR 31,4096211,1.2121831781068038,1.856021664538426
SK-CO-1,6914657,-1.8836208914019363,-4.170094408243688
SW48,44493528,3.8128145383765992,4.333966846288542
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,2.344610112805219
SW1271,168312962,3.6054980890180746,1.48933366232238
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.029152149495273
Panc 02.03,135440466,3.0724615257354153,2.1401473911994366
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.4554460238042177
BFTC-909,11427553,2.7610941057010754,2.578035472123966
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.5350305453431912
SW1271,44493528,4.286060334293371,4.333966846288542
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,1.2349426527428076
LS180,49836020,0.6204023867713871,2.5464279658175073
HEL,148198,-3.399100076616297,-3.548509713878981
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,3.9198146524152833
Granta-519,3543504,5.0961511485487705,4.269325105068445
HCC1500,3038522,2.0060085934463108,2.9847437848386558
RKO,4917,3.097539294413192,3.079848880785536
RCC10RGB,168312962,4.335962117924443,1.48933366232238
SaOS-2,104842,-4.966916923279438,-3.040993872013826
Panc 02.03,753704,5.09544361232119,4.832125608051433
PaTu 8988t,439501,-3.4446792284706347,-2.2321662354381537
LS180,5282054,4.115839158247494,3.5628845676855256
IA-LM,5287620,-0.8479822353163541,-1.9697846958841214
RCC10RGB,6610216,4.531223922644925,4.26979744561799
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,2.9860814461500107
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,2.699201704606489
SW1271,9911830,2.7072275961126997,2.4240324657892436
WM115,11719255,3.1992621528929166,3.1221102230298534
RCC10RGB,42642645,2.104174802814935,0.7845058245277501
K-562,72376,-2.627875463605781,-2.110114148114304
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.117207225291035
HCC1500,9549297,1.8848953505663728,2.3089350530287187
HCC1500,44241473,4.374636754710865,4.8543955662784395
HuP-T3,2708,5.229598766149438,4.591243765137335
P31/FUJ,9866186,-0.5408158091236333,0.7577083020821866
RERF-LC-MS,11657048,4.330866638894723,4.509467699195642
HEL,119182,-2.1951032337756935,-1.3340160156368264
RCC10RGB,10296883,4.350673741830848,3.795028277273254
MDST8,10385095,1.2575537617816142,1.2480392352773622
SK-CO-1,23635314,-1.3218098525260824,-1.8612337831613235
BICR 22,72199289,4.441607504718354,5.20760114161056
MOLP-8,9911830,1.992368688928045,2.4240324657892436
SW48,24772860,-4.097111396936187,-2.2690769633318126
COR-L105,8515,4.561371818511258,3.7716438213452004
IGROV-1,15547703,3.339928221860449,3.114669509763707
SU-DHL-1,656346,-0.4085927723055031,0.7582608913284792
COR-L105,168313200,3.683873258385797,2.9593589282331023
Daudi,46224516,0.8162026590632436,2.370954746557396
Granta-519,5287620,-2.8216901996678985,-1.9697846958841214
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,0.7705130043498147
UACC-812,11640390,4.086462739167014,3.2466540190485103
K-562,17755052,3.8994339695870326,1.7101929835526413
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.2834565267098785
LS180,656346,-0.0089884994203474,0.7582608913284792
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,2.93841691857644
SU-DHL-1,5311281,2.996662642824561,2.22503529708604
RCC10RGB,25161177,5.612412997721579,4.097137926934978
K-562,3854666,0.2872946014041473,1.85063491630251
P31/FUJ,9825149,2.400010374644864,2.074054954263997
SW1271,11964036,1.1602803966527862,1.2382789669868983
LCLC-97TM1,176870,1.9757247403033509,3.0253996189023358
K-562,168313016,4.482960220744853,4.725757076386842
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,3.0665232817889554
SW1573,285033,-0.3175288260868649,-2.1791335812392365
BICR 31,4788,6.181654669045445,5.493389053048461
LS411N,11404337,-0.9351547419605356,-0.4254091153988029
RERF-LC-MS,9967941,1.5454786965180345,3.6034131982542865
Granta-519,56973724,1.8473061894805545,2.823032655731692
K-562,11507802,0.4095176942133114,1.3590460953824346
SW1271,1750826,-3.093550008900348,-1.4739669220989267
P31/FUJ,135398738,-0.0291234665218711,3.3919135064420334
WM115,5329102,1.7959886386080517,2.031058842574058
MOLM-13,5470400,-0.3466627309634489,-0.3765538821264742
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.5478733404534093
Granta-519,44607531,0.7355881041308102,1.48117322485652
RCC10RGB,5566,3.997570642857795,3.029152149495273
KU-19-19,24964624,3.8522438290321768,2.2827362159867324
WM115,1641662,3.4019570651475557,3.3408828038827
BICR 22,5282054,4.223594396310054,3.5628845676855256
BICR 31,10231331,3.776464743887352,1.6547412916072393
RKO,3825829,4.017808531984142,3.8869840981378028
Daudi,10322450,2.3131627402631905,3.669858075898477
BICR 22,285033,-4.068757657270757,-2.1791335812392365
SU-DHL-1,5281321,-1.7372628502658949,-1.3097742666845045
RKO,5287620,-1.9975210326345276,-1.9697846958841214
Panc 02.03,53232,6.367991743549877,2.8161144578264046
SaOS-2,9826308,0.4955218987390744,0.12580254156308923
HuP-T3,10074640,3.8159838645365807,3.066922642013836
SW948,4259181,0.2292867461834122,0.11236669175956715
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.5350294688251391
IGROV-1,568763,0.665047061839467,0.28862358029973745
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,2.0335760501929605
MOLM-13,322968,2.556875190594409,3.4956311613712456
ALL-SIL,9903786,1.532435199339551,2.756077717004494
SW1573,409805,6.568626512075582,4.6745070702664995
LS180,1750826,1.061711606063746,-1.4739669220989267
HuP-T3,46191454,1.9484889201022677,1.3518500781597358
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.1103746959488285
HEL,216345,3.87635579429504,3.7540083674013296
BICR 31,2749,2.2358137088107033,1.7932893499757152
SaOS-2,3385,7.1536746080698395,3.472185389430271
WM115,11626560,1.643291568999912,1.6795489442409048
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.2834565267098785
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,1.5076124324231743
Granta-519,24964624,2.975569692960617,2.2827362159867324
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,0.9090093368534204
COR-L105,6918638,0.8528151020185122,0.3065957347013626
RCC10RGB,9825149,2.634802111166888,2.074054954263997
HCC1500,44493528,4.240662848371031,4.333966846288542
COR-L105,44489675,3.747818158649104,3.8856289571074525
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,3.456683733824014
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,2.8341325456747963
BICR 31,2746,4.041774334142006,2.8579929499469348
MDST8,51037431,3.453193232905579,3.10082796495436
K-562,676352,1.515837042857868,2.088896150621564
LCLC-97TM1,73707386,3.587652793939767,2.6861216111986805
SK-CO-1,54618164,4.180915062416914,4.02740727006158
SaOS-2,5329102,1.942826181308244,2.031058842574058
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.261852028375895
LCLC-97TM1,151289,0.9235530786043882,0.9562867634504244
BICR 22,400769,0.1100780529561809,-0.7855881743093749
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-3.5071094923394703
SK-CO-1,400769,-0.6897300489229926,-0.7855881743093749
SW1271,56973724,2.58013716529859,2.823032655731692
LCLC-97TM1,2945648,2.6479910997037934,2.7548400693819435
SU-DHL-1,439501,-2.3864560258185916,-2.2321662354381537
NCI-H1568,148198,-4.9953315451672005,-3.548509713878981
RKO,11507802,1.7455765117352984,1.3590460953824346
Panc 02.03,216239,3.7763245170365183,2.1474208097396077
HCC1500,9825149,1.9829642871568696,2.074054954263997
NCI-H2452,53232,3.5381177646863837,2.8161144578264046
MOLP-8,11494412,0.4734092912657368,1.4248282417532188
Granta-519,9911463,3.5000933341892733,3.732908427020576
SK-CO-1,10410894,3.775604170297083,3.2189174762180457
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-0.8865368208635396
MDST8,5328940,2.138158341424683,1.559061663996469
SaOS-2,1716436,3.427239396926117,2.948755251800144
HuP-T3,9887053,4.07990532641299,3.469815136639831
NCI-H1568,24772860,2.3104914540479324,-2.2690769633318126
LCLC-97TM1,135999136,4.356650968290631,3.6300382464802663
IGROV-1,4378219,2.016502068118561,2.6822409618839944
BICR 22,46199207,3.899734747403315,3.1312366616263048
BICR 31,9915743,-0.3251640044425866,0.5935480801734145
NCI-H2452,613753,2.817247196569438,3.1495845971526135
P31/FUJ,46174525,2.51911302821391,4.156087356848057
P31/FUJ,5335621,3.2282922271331613,4.560420742529089
IGROV-1,5278396,3.119031774261392,3.517590475337377
HuP-T3,16038120,1.51216352382263,0.9090093368534204
LCLC-97TM1,17755052,0.1986775459223547,1.7101929835526413
PaTu 8988t,66577038,3.1818565141070625,2.9870697487432882
PaTu 8988t,54618771,0.599962301527202,0.9253379925205388
SK-CO-1,46191454,1.747962727561699,1.3518500781597358
SW48,46907787,-1.5740012638710297,1.584957029505121
ALL-SIL,11485656,1.390704841990788,2.2397291078765758
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,2.8341325456747963
SK-CO-1,4788,5.843658659854095,5.493389053048461
IGROV-1,16725315,4.890680859998698,4.150060666188836
SW1271,24821094,3.627509655063773,2.7369152351179045
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-0.8865368208635396
WM115,216468,3.848857711215856,2.5020743765616316
SaOS-2,24779724,4.377738848523283,4.725601600845458
HCC15,675434,4.852455641097197,4.463597576567934
SK-CO-1,46398810,2.9216967746168625,2.510712955745063
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.7705130043498147
Panc 02.03,123631,3.5560371664842325,2.2760265557358337
SK-CO-1,448949,1.9523830928265349,1.9537365892294993
RKO,285033,-2.0365968290915393,-2.1791335812392365
SW48,2749,0.8385534684858028,1.7932893499757152
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.57821899028641
HCC1500,54618164,3.7944844711277264,4.02740727006158
Panc 02.03,2858523,3.458791746781272,3.0086502241129605
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,1.7691529831259722
COR-L95,4261,0.3666433774913241,1.4288257082744877
HEL,126941,-3.7945695708983664,-2.8921209077069348
HCC1500,54596490,4.413271545106012,4.945697156281648
BFTC-909,375860,-1.1901103647211757,-0.30112130782396007
COR-L95,9866186,0.0204391385842873,0.7577083020821866
BICR 22,66577038,2.5300885228037813,2.9870697487432882
SW948,9826308,0.2428169991227084,0.12580254156308923
MOLM-13,73707440,5.976327057082507,5.0056706494968015
PaTu 8902,5291,3.72219732976082,3.5530526201153183
RERF-LC-MS,5470400,2.5584942331402623,-0.3765538821264742
SW1573,16725315,3.253832365815957,4.150060666188836
SU-DHL-1,3552672,1.9257473882600096,2.8413574589562494
HCC15,60750,0.68669542572171,-2.435153852929516
SW48,5328940,0.1162920415883012,1.559061663996469
PaTu 8988t,4378219,1.99751885903338,2.6822409618839944
HEL,241158,3.370113308144609,3.598987869990464
MOLP-8,53495165,-2.6639864548579535,-0.19108456656304296
LS411N,46943432,5.879073426568822,1.70045196562753
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.5350305453431912
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,2.93841691857644
Panc 02.03,4521392,4.25988041093388,4.280943620409205
SW1271,5951923,6.143368489838077,4.9168889591608265
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.0665232817889554
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.4057100644299436
RERF-LC-MS,11717001,4.567893424272946,3.961276339234443
NCI-H1568,25102847,1.8020479238639409,2.3366995460793083
MOLM-13,44137675,1.768154079183361,3.337336921695599
RKO,10427712,4.823698606341804,4.184108330161863
BICR 22,6852167,2.9570859917106533,2.69961445504738
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,1.0163468544412688
SW1271,124202324,3.327062905972079,2.1784388364790748
WM115,400769,0.2375153529743729,-0.7855881743093749
RKN,3038522,4.332475047921768,2.9847437848386558
SW1271,4096211,3.040458805184357,1.856021664538426
BICR 31,60700,1.4006980690412227,-0.4482559328189002
Granta-519,448949,1.64880276038625,1.9537365892294993
HEL,11964036,0.787171767074348,1.2382789669868983
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.2397291078765758
BICR 22,11485656,1.7887481250962165,2.2397291078765758
HEL,44202524,1.7623585771552046,1.9639001504219202
COR-L105,3503,2.4932686195421625,2.2426858883255045
LS180,4788,5.917574515812926,5.493389053048461
IGROV-1,219104,3.803083685328391,3.5366182443481806
IGROV-1,11152667,-1.4116509977729443,-0.5866736007906306
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.2349426527428076
HuP-T3,11485656,3.0565489144797224,2.2397291078765758
NCI-H1568,9907093,3.7800753982052697,4.134688957161641
LCLC-97TM1,10184653,1.174063194948861,1.1325795715302809
MDST8,16038120,1.9679009346440888,0.9090093368534204
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.5478733404534093
NCI-H1568,216239,1.54277692538335,2.1474208097396077
LCLC-97TM1,5280436,3.0011603005672804,3.153394505533252
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,2.93841691857644
Granta-519,5281321,-3.900138103622144,-1.3097742666845045
NCI-H2452,6917907,-3.4621989648593696,-4.864372369867458
HCC1500,135659046,2.9858139057826905,3.604307380358917
P31/FUJ,3825829,3.1586120375796516,3.8869840981378028
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,2.8341325456747963
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,0.4199080872215506
SK-HEP-1,7326481,2.0213225214426505,2.957630994714242
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,0.4199080872215506
HCC1500,3634881,3.181593200231373,3.1576774496130544
HuP-T3,5311,2.274555641774389,1.2663000347984639
P31/FUJ,969516,2.490551298955204,2.7772567284956553
LCLC-97TM1,25183872,-1.9138026924081315,-0.902802947451298
WM115,54619267,3.5599503094850244,3.9342007971372475
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,2.6829735349466532
SaOS-2,17755052,-0.5339241699834809,1.7101929835526413
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,1.1345509900924162
SaOS-2,19582717,4.316823865856345,3.9198146524152833
COR-L105,25105715,3.731140483220641,3.410449786117574
SK-HEP-1,5278396,4.037206436677834,3.517590475337377
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,2.6829735349466532
COR-L105,6918837,-2.1114263163326177,-3.046222711611649
IGROV-1,25262965,-3.18785020602057,-1.6224193967571534
HuP-T3,6505803,1.3238670991795596,-0.5114413444588124
NCI-H1568,11214940,1.6761106979183067,1.8119431265240042
HCC15,44543605,4.452652862359365,4.160012106477824
SW48,46199207,2.9489751610364405,3.1312366616263048
P31/FUJ,104842,-4.465734156959207,-3.040993872013826
MOLM-13,24180719,3.226510234308061,3.437709308952337
HCC15,12003241,-1.0460858766179792,-1.0889198012759371
IGROV-1,10231331,1.9104831176724932,1.6547412916072393
IGROV-1,107970,2.287061680908213,2.3029314718240044
LCLC-97TM1,46907787,1.8795083111860824,1.584957029505121
IGROV-1,5278396,3.119031774261392,3.517590475337377
SK-CO-1,5329102,2.034917542642271,2.031058842574058
SK-HEP-1,11152667,2.375581084403437,-0.5866736007906306
WM115,2126,3.806678244062894,4.466606494133751
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,2.474523360549852
K-562,6918736,-3.666344542032524,-1.741781295359962
Granta-519,6450551,1.162651959279597,2.361538429265863
NCI-H2452,5479543,3.804245584293823,3.2992765862159215
Daudi,11497983,1.6119133198716458,2.348631818792911
WM115,4521392,4.32247006400087,4.280943620409205
MOLM-13,24901704,-2.733844077576574,3.1103746959488285
Daudi,56973724,1.9677776982823123,2.823032655731692
HCC1500,613753,3.153964202511791,3.1495845971526135
Granta-519,5460769,2.1422187145203897,2.3447175553942796
RCC10RGB,53495165,3.554009618530711,-0.19108456656304296
PaTu 8902,3854666,4.137852419807088,1.85063491630251
Granta-519,151289,0.2062194994497177,0.9562867634504244
MOLP-8,5479543,3.0970965636903327,3.2992765862159215
LCLC-97TM1,4096211,1.6170661636178802,1.856021664538426
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.6778195760397165
SW48,9907093,2.826389946725867,4.134688957161641
MOLP-8,5281672,3.2641398124752063,4.4250678360691875
SW948,6610355,3.913576061403015,4.45123297085854
SU-DHL-1,5746,-2.2023974745237815,0.8084551861824514
MOLM-13,10410894,3.311191932806664,3.2189174762180457
SW1573,3384730,1.5192292760027193,2.4620443610818112
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.4554460238042177
NCI-H2452,54649381,5.966732082850981,3.7880999548273127
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,0.4199080872215506
BFTC-909,9444,3.603329432205708,4.054048446110465
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-1.6778195760397165
SW1271,9952709,3.6093754742197706,2.9381980631482683
IGROV-1,4788,5.801051990484709,5.493389053048461
K-562,3825829,2.9396673791475587,3.8869840981378028
COR-L105,53232,1.738169806280081,2.8161144578264046
Daudi,25195348,1.3194617548918357,3.08171494739702
NCI-H1568,46199207,1.8853593558521984,3.1312366616263048
RCC10RGB,135440466,4.497503570362309,2.1401473911994366
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,1.133687221210622
NCI-H1568,3062316,1.133797551734723,0.9747482048219924
Panc 02.03,56649450,3.905458120664549,2.999158341046921
RKN,44589607,3.09715941328701,2.659070263037081
MOLM-13,568763,-0.9067431163570788,0.28862358029973745
MOLP-8,444795,3.9342801961368417,3.7799917274901733
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.4554460238042177
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.8341325456747963
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.0163468544412688
IGROV-1,6918878,1.6706182189896102,1.9069091595174383
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,1.7691529831259722
BICR 22,5280436,0.2666608642372045,3.153394505533252
BFTC-909,3081361,3.110656330811392,2.3568884936851697
PaTu 8988t,45279963,4.21642269895433,3.660133434789582
MDST8,613753,3.2461287764543085,3.1495845971526135
LS411N,6917907,-5.419583860239815,-4.864372369867458
HCC15,5335621,5.428336568471036,4.560420742529089
SW48,71466380,4.3724837890251935,4.275465599745589
SK-OV-3,66577038,3.416512813520814,2.9870697487432882
RCC10RGB,49766530,-1.6086406954404375,-0.6944377068647134
HuP-T3,16722836,1.72068374216493,1.5333952667080324
MOLM-13,168313016,3.5509192860421592,4.725757076386842
SU-DHL-1,675434,3.83709506639581,4.463597576567934
P31/FUJ,9911463,3.6551866379259743,3.732908427020576
P31/FUJ,445455,5.725867195241275,4.540053644561405
MOLP-8,285033,-4.447286141218139,-2.1791335812392365
RKN,107970,2.600341318615175,2.3029314718240044
IA-LM,4788,5.899787929501101,5.493389053048461
RKO,71680916,5.910552922648844,4.641848024405652
K-562,9825149,1.660902694463834,2.074054954263997
RCC10RGB,4261,3.441062261939301,1.4288257082744877
IGROV-1,387447,-3.9508602289798658,-4.3765957253648695
WM115,54618164,3.776567993994872,4.02740727006158
LS180,44607531,1.744731406430345,1.48117322485652
NCI-H2452,123631,2.1406097245383062,2.2760265557358337
K-562,262093,3.1056763935044813,2.6275548088442098
MDST8,24180719,2.4870372971011374,3.437709308952337
WM115,66577038,2.911239385644133,2.9870697487432882
SU-DHL-1,6918328,-0.7249486298416586,-0.28710840066117727
NCI-H2452,135999136,4.5117873079445205,3.6300382464802663
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,3.7294514785702977
PaTu 8902,11609586,3.6092581559147185,2.621607380466062
IGROV-1,11497983,4.37450324471555,2.348631818792911
RKN,387447,-2.9807645129134066,-4.3765957253648695
LS180,6184667,4.288388758455988,2.901063659317265
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.7705130043498147
NCI-H1568,5460769,1.1324377767406906,2.3447175553942796
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,1.7732341041149164
HuP-T3,3025986,0.0333046209415895,-0.8978770871810051
IGROV-1,11625818,2.877471533668122,4.10791451089978
SaOS-2,122327,5.211292969638739,4.7007618437932
BICR 31,46943432,4.176233154169203,1.70045196562753
HCC1500,10427712,5.196976599700856,4.184108330161863
K-562,9866186,0.7861847855254385,0.7577083020821866
RKO,10231331,2.816804700080647,1.6547412916072393
NCI-H1568,126941,-1.411149621431801,-2.8921209077069348
HCC1500,9933475,1.9677534910437375,1.793439230086884
ALL-SIL,53245473,2.8781179496967666,3.5412534206723127
K-562,135423438,0.8826240773524879,2.1190856698194294
BFTC-909,9956119,4.255413767268681,3.4762974507018756
HCC1500,9884685,1.9086372211674376,0.4230357541133405
P31/FUJ,71304818,2.235751993715144,2.396178486082573
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-1.1532493383305307
MOLP-8,5470400,0.1664110443814662,-0.3765538821264742
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,3.6034131982542865
SW48,44819697,-2.186530212001632,-0.6109288989041974
SW48,12001922,1.4259296039497584,1.8522788760744173
NCI-H1568,24951314,0.6613293075425478,1.227614980483031
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.117207225291035
SW1573,51039095,4.568767182944777,2.682611194240459
BFTC-909,46224516,1.8849058086882595,2.370954746557396
SU-DHL-1,52947716,-4.8688827763192135,-1.4012147836358484
IGROV-1,262093,3.169376516915595,2.6275548088442098
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,3.0665232817889554
WM115,24821094,1.6911725066550027,2.7369152351179045
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,3.456683733824014
SaOS-2,53325874,4.45514535643454,4.753377022200137
SaOS-2,4261,1.4562926555721387,1.4288257082744877
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,3.456683733824014
SK-CO-1,9907093,3.652313916117519,4.134688957161641
SaOS-2,613753,3.192322830330122,3.1495845971526135
BFTC-909,148198,-2.03933057080943,-3.548509713878981
MOLM-13,49793307,-4.691237884437231,-2.848251171596848
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-1.261852028375895
COR-L105,135411,0.974173137304268,0.5181226666256136
RERF-LC-MS,135411,0.496828330774242,0.5181226666256136
SK-OV-3,16725315,5.283554915030345,4.150060666188836
SK-CO-1,3854666,3.8596661393399927,1.85063491630251
LS180,51039095,2.999333495393298,2.682611194240459
RERF-LC-MS,135440466,2.007932851474071,2.1401473911994366
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.6778195760397165
LS411N,446155,3.6642844723827266,2.662752180605146
HCC15,72193861,-0.2523453521741511,1.3858780169906042
BFTC-909,52947716,3.1995758728854224,-1.4012147836358484
SK-HEP-1,9933475,2.440596541444364,1.793439230086884
MOLM-13,702558,4.671896667990455,4.9782351440396395
P31/FUJ,375860,-1.2092771030706315,-0.30112130782396007
Panc 02.03,57519531,5.330694472788803,2.4211376500246136
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,2.474523360549852
HCC1500,11238147,3.2515653100317023,2.694366237977623
RKO,11427553,3.456895276763714,2.578035472123966
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,1.5171458615349627
HCC15,9927531,3.758901572486559,4.578027762171671
Panc 02.03,107970,3.0394503344184214,2.3029314718240044
BICR 22,6917907,-5.724798000333263,-4.864372369867458
P31/FUJ,219104,1.0946129740431632,3.5366182443481806
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,3.456683733824014
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.1278257636093416
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-1.6778195760397165
COR-L105,23582824,0.3539942370445449,0.7400136078733197
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.117207225291035
NCI-H1568,135999136,4.3721543597322405,3.6300382464802663
HuP-T3,11404337,1.0495167124251128,-0.4254091153988029
MOLM-13,2729026,2.3347481789683564,2.6325975116350393
IGROV-1,9935249,3.330117761231163,2.8615383619674972
IGROV-1,16038120,0.2864038103759729,0.9090093368534204
NCI-H2452,11167602,2.565240148317103,2.4705816300476062
Granta-519,4788,5.939837006566146,5.493389053048461
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,2.8615383619674972
Daudi,2842253,3.640131040983124,5.203082223374658
PaTu 8988t,9911463,4.367264855700764,3.732908427020576
IA-LM,613753,3.1957676281974328,3.1495845971526135
HCC1500,168312962,0.9454061370050444,1.48933366232238
Granta-519,52912189,-1.096728840522365,1.6723266261402217
K-562,67291369,1.5957287334193675,1.794812676489941
HuP-T3,1750826,-1.878047057258104,-1.4739669220989267
RCC10RGB,24180125,2.398663234613943,2.888353933707551
SW1271,5566,3.0013167075914344,3.029152149495273
P31/FUJ,126941,-4.476387704672624,-2.8921209077069348
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.2047817895412443
HCC1500,44486219,3.883233561942222,4.281343219898981
SW1573,24964624,5.100144587499453,2.2827362159867324
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.78247230086659
Daudi,42642645,-0.8700738631175318,0.7845058245277501
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,2.3791567205504176
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,0.8084551861824514
SW1271,969516,2.705669665349302,2.7772567284956553
COR-L95,6918837,-4.56092327324237,-3.046222711611649
SK-CO-1,25154868,4.619527339846263,4.289494395804131
RKO,159324,3.5523933893017583,2.0742938672876736
HCC1500,168313200,1.6452616775244175,2.9593589282331023
IGROV-1,4788,5.801051990484709,5.493389053048461
KU-19-19,5746,1.6270456089520258,0.8084551861824514
RERF-LC-MS,46398810,3.3112335021243977,2.510712955745063
IGROV-1,6438330,2.7487580937365683,2.016737971321332
PaTu 8988t,123631,3.803217986992814,2.2760265557358337
LCLC-97TM1,5278396,4.167561166456711,3.517590475337377
WM115,71680916,4.535911767348542,4.641848024405652
NCI-H2452,322968,3.869715934392993,3.4956311613712456
NCI-H1568,2708,3.449118605167301,4.591243765137335
Daudi,5470400,3.6690588756853706,-0.3765538821264742
NCI-H1568,3038522,2.281352774411324,2.9847437848386558
K-562,24951314,0.9405452740645998,1.227614980483031
BICR 31,44137675,3.031084694210408,3.337336921695599
SaOS-2,82146,4.466197629976123,3.596877521367719
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,2.344610112805219
HuP-T3,5738263,4.055810266621769,3.3050405288071003
COR-L95,11494412,1.7619372096243109,1.4248282417532188
Granta-519,11507802,0.4974969144595386,1.3590460953824346
WM115,2949965,2.619280368742809,2.715769249487813
HCC15,613753,3.363668001401703,3.1495845971526135
HCC1500,107985,-3.8501888791364034,-3.5771139994401464
WM115,54678924,1.8194282087981308,1.9473085147454567
Daudi,135398516,-0.2737475793919353,2.0509021680173207
PaTu 8902,5280436,5.000479378124589,3.153394505533252
RKN,439501,-1.5558449248177562,-2.2321662354381537
RCC10RGB,5287620,-0.3857243809023412,-1.9697846958841214
Daudi,5566,2.2518803351891616,3.029152149495273
COR-L105,31703,0.0245204691354453,-1.182053713238432
LS180,44507138,3.917968702075208,2.3228542035372683
Daudi,11964036,0.3747037141940179,1.2382789669868983
K-562,16659841,3.212428083743772,3.7845234388741966
MOLM-13,54618771,-0.6841479707721928,0.9253379925205388
NCI-H1568,49793307,-3.5648882234860895,-2.848251171596848
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.57821899028641
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.0163468544412688
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,2.474523360549852
SW1271,107985,-2.924919788256343,-3.5771139994401464
COR-L95,2746,2.78697970441755,2.8579929499469348
IGROV-1,104842,-1.6690343627553987,-3.040993872013826
COR-L95,16038120,0.5843691628917023,0.9090093368534204
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.180307991266282
HCC1500,123631,1.5682585338280497,2.2760265557358337
PaTu 8902,322968,4.547287257097872,3.4956311613712456
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.0058447943574325
Daudi,11167602,1.0022899570414256,2.4705816300476062
ALL-SIL,10074640,-0.3353589360570669,3.066922642013836
COR-L95,57519531,1.325264870307383,2.4211376500246136
LCLC-97TM1,46191454,0.3820919964810073,1.3518500781597358
ALL-SIL,439501,-2.349752310116714,-2.2321662354381537
IGROV-1,25126798,3.9275606774720817,3.7921789378214816
WM115,24753719,4.6734048968266775,4.143618673527016
HCC15,36314,-6.084589216701663,-1.2422497803043113
HEL,16720766,-1.3120587580234824,0.4291253754884592
SU-DHL-1,11222830,1.179409628644554,1.5350294688251391
HuP-T3,3634881,3.0028113890745707,3.1576774496130544
K-562,5738263,2.3545721599917027,3.3050405288071003
SK-CO-1,16725315,3.5012946679092853,4.150060666188836
RKN,327653,3.2518035953304434,3.018652636936018
RKO,24772860,-3.046302255649564,-2.2690769633318126
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-1.4739669220989267
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,1.7691529831259722
SK-CO-1,15953870,2.1343083972614725,3.4781017448929608
BICR 22,71751553,4.276876209585518,4.504570481353087
K-562,24964624,2.9615918690112717,2.2827362159867324
RKO,11222830,1.6656419736189183,1.5350294688251391
RCC10RGB,25105715,3.76392637454814,3.410449786117574
ALL-SIL,54618164,3.625474128679928,4.02740727006158
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.902802947451298
SU-DHL-1,49793307,-4.256389272054101,-2.848251171596848
SK-HEP-1,9915743,2.4580731883892293,0.5935480801734145
SaOS-2,10410894,2.56650375580144,3.2189174762180457
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,1.9546333131599372
COR-L95,44491742,4.146782751375218,4.1566745174283435
SK-OV-3,44137675,2.687297746540291,3.337336921695599
SU-DHL-1,4477,-0.6876815909262691,0.5570685949048098
RKN,5311,1.8833679583763572,1.2663000347984639
COR-L105,11640390,3.408966388045623,3.2466540190485103
RCC10RGB,637858,2.3286326267725084,1.8880097009592578
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.5333952667080324
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.548844675602096
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.0058447943574325
SU-DHL-1,6852167,2.266746993939426,2.69961445504738
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,2.7548400693819435
HuP-T3,49793307,-5.3581383477853555,-2.848251171596848
SK-CO-1,5282054,3.655593178279643,3.5628845676855256
RKO,2841722,4.522769482159767,4.375424781932207
Granta-519,65628,2.6603144373939154,4.026684176415168
SU-DHL-1,637858,0.6782178889909583,1.8880097009592578
RKN,9911830,3.6623648245681744,2.4240324657892436
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,2.144908880465776
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.5350305453431912
BICR 22,9884685,0.2149660223226223,0.4230357541133405
COR-L105,46907787,0.7742744471044445,1.584957029505121
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.4539899714896953
RKO,54618771,2.3159310195777985,0.9253379925205388
HCC1500,6450551,2.2317386689521816,2.361538429265863
BICR 22,10296883,3.888864516393213,3.795028277273254
Daudi,10302451,1.2926011902861492,3.0143591766147457
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-1.1532493383305307
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,1.710700657959646
Granta-519,216239,2.502983600228736,2.1474208097396077
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.2359123501503817
NCI-H2452,4521392,4.554150979099382,4.280943620409205
IGROV-1,123631,1.7694522866439453,2.2760265557358337
IGROV-1,5566,3.174346862827938,3.029152149495273
MDST8,72193861,1.790495642839322,1.3858780169906042
COR-L95,400769,-0.6446482680437077,-0.7855881743093749
SaOS-2,5287620,-1.8033063725700844,-1.9697846958841214
COR-L95,6917907,-5.619348954097505,-4.864372369867458
WM115,9840324,5.544544164897635,5.7711165719697215
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,2.93841691857644
SW948,10322450,3.138867511839475,3.669858075898477
K-562,25126798,3.746183025237492,3.7921789378214816
LS180,5335621,4.412574333730147,4.560420742529089
SK-CO-1,9911830,2.5560928673864676,2.4240324657892436
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.117207225291035
SK-CO-1,9825149,2.4273154495027147,2.074054954263997
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.144908880465776
KU-19-19,10074640,3.725362653690234,3.066922642013836
NCI-H1568,24901704,3.012455129702266,3.1103746959488285
PaTu 8902,216345,4.855612410794221,3.7540083674013296
LCLC-97TM1,44202524,1.0559659544617075,1.9639001504219202
MOLP-8,9884685,-1.6145757941110517,0.4230357541133405
SaOS-2,11656518,3.53164758658959,1.5480979328089313
ALL-SIL,5280436,2.610850174870569,3.153394505533252
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,1.6547412916072393
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,0.7705130043498147
COR-L105,16659841,4.469572921203622,3.7845234388741966
SW48,11625818,2.5740084903132914,4.10791451089978
COR-L95,135875424,3.0866900102445816,3.743891076041643
NCI-H2452,10074640,3.4255764700713685,3.066922642013836
SK-CO-1,60750,-4.4937571478067495,-2.435153852929516
BICR 22,374536,2.9550889228261386,1.7732341041149164
MOLP-8,2126,5.134995770793403,4.466606494133751
NCI-H2452,5566,2.960608772215372,3.029152149495273
Daudi,54618771,-0.114332288085178,0.9253379925205388
NCI-H1568,44137675,2.485428235347338,3.337336921695599
BICR 31,24771867,6.325583215176513,1.5171458615349627
HCC1500,135875424,3.5744445956281483,3.743891076041643
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,2.9860814461500107
IGROV-1,753704,6.461140333581179,4.832125608051433
SW48,11497983,-4.007853458767396,2.348631818792911
MOLM-13,25195348,1.114215790958376,3.08171494739702
Daudi,441298,1.3514709590925575,2.5423368047098167
SK-OV-3,124202324,3.0713957973247186,2.1784388364790748
BFTC-909,23635314,-1.3241610546701814,-1.8612337831613235
COR-L95,71304818,2.943301589855332,2.396178486082573
SW1271,44607530,2.17277245139498,1.715838652040812
RERF-LC-MS,219104,4.628133490361187,3.5366182443481806
NCI-H2452,31703,-0.2834256058580119,-1.182053713238432
Daudi,462382,-0.0525304302162242,0.5714028853239661
SU-DHL-1,25183872,-2.297532702486321,-0.902802947451298
K-562,54618164,3.946994253297547,4.02740727006158
SK-HEP-1,568763,1.0235069184223942,0.28862358029973745
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-3.5071094923394703
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,2.344610112805219
Panc 02.03,2828334,6.385741192046609,6.082620037824382
HCC15,5702613,2.8473188935914835,3.145942765655066
PaTu 8902,11625818,4.430115392870615,4.10791451089978
COR-L105,53392493,2.0389615313780256,2.4832542501558077
RKN,3062316,2.6330403907451863,0.9747482048219924
UACC-812,6505803,-4.59801553223132,-0.5114413444588124
UACC-812,16736978,0.0217391388778129,1.3934160091023764
BFTC-909,5278396,3.473037688340168,3.517590475337377
SW948,73707398,1.7510146080607218,1.180307991266282
BICR 22,107970,2.71438120007047,2.3029314718240044
SW1271,984333,0.5174855517327741,0.5138000229415411
IGROV-1,9967941,2.9735049794712545,3.6034131982542865
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.37491183386883553
SW948,135984461,4.375312800732864,3.6237408287871284
LS180,5280436,4.14000298943632,3.153394505533252
MOLP-8,219104,2.0853040324344536,3.5366182443481806
MOLP-8,1716436,2.7387406442001287,2.948755251800144
MOLM-13,171352865,4.594115651620468,3.764962937653422
KU-19-19,10127622,1.068304480617998,3.6054187258933235
KU-19-19,5460769,4.3332822587900255,2.3447175553942796
LS180,675434,4.417044491450032,4.463597576567934
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,2.9860814461500107
SK-HEP-1,66577038,3.45712203265648,2.9870697487432882
SW1271,3689413,-1.2412691685690602,-0.4039154566871359
COR-L95,10296883,4.074268886544182,3.795028277273254
HCC1500,5287620,-3.8084705838741306,-1.9697846958841214
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,0.4199080872215506
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,2.0058447943574325
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,1.0163468544412688
SW1271,46843906,3.0036733058278298,2.723521570705241
SW1271,10184653,2.439662406391272,1.1325795715302809
SK-CO-1,31703,-2.259601900898513,-1.182053713238432
COR-L105,10074640,3.626128603914542,3.066922642013836
MOLP-8,11152667,-1.9226575172330305,-0.5866736007906306
SW948,56646779,5.261847054930003,4.506996225444503
MOLP-8,9825149,0.6088991704164435,2.074054954263997
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.7691529831259722
RKN,1641662,3.781184529562369,3.3408828038827
Daudi,1750826,-5.008838903624334,-1.4739669220989267
RERF-LC-MS,24856436,0.2419222597799965,0.17994774592918095
COR-L105,6184667,3.4155069342084916,2.901063659317265
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,0.9562867634504244
MOLP-8,568763,-0.8505432933185847,0.28862358029973745
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.7691529831259722
SK-OV-3,54618771,2.5849230632376923,0.9253379925205388
SW1271,135398516,2.256973153183445,2.0509021680173207
MOLM-13,44819697,-1.7672663076184636,-0.6109288989041974
LCLC-97TM1,24748573,2.1629406196043894,1.9565115912575295
NCI-H1568,10113978,1.8126489257310032,3.010980031724017
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-1.6778195760397165
COR-L95,1566236,1.7351682171374878,2.2263982365179604
PaTu 8988t,54619267,4.243668204976347,3.9342007971372475
BICR 31,73707398,2.635299985295534,1.180307991266282
P31/FUJ,24978538,-1.1674360999825653,0.6273547794147847
HuP-T3,25227462,0.1487181406442073,-0.4151865926866767
Daudi,439501,-2.973914496380735,-2.2321662354381537
NCI-H1568,67156097,-1.7914617240991686,-1.0279170724737183
WM115,36314,3.85550299796777,-1.2422497803043113
MOLP-8,409805,3.552664043240888,4.6745070702664995
SW48,24753719,4.052743892866938,4.143618673527016
SW48,3825829,3.1303188593692854,3.8869840981378028
PaTu 8988t,54613361,0.5051194448617704,-0.11678183903518824
SK-CO-1,44493528,4.973545843770428,4.333966846288542
MOLP-8,44202524,1.1617664844294235,1.9639001504219202
P31/FUJ,11656518,-0.8295634521320199,1.5480979328089313
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.10791451089978
LS180,36314,2.4476112429633403,-1.2422497803043113
SK-CO-1,119182,-2.3548964470523974,-1.3340160156368264
LS411N,72376,-2.6969507034435236,-2.110114148114304
BICR 31,51037431,4.633533363663127,3.10082796495436
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-2.110114148114304
HCC1500,46907787,2.786329845885891,1.584957029505121
MOLP-8,2708,2.5820066460748015,4.591243765137335
HEL,10113978,2.6394190696879662,3.010980031724017
HEL,1641662,3.192273244328466,3.3408828038827
LS411N,12001922,2.0246848718715604,1.8522788760744173
ALL-SIL,56963564,-1.2928564241979046,0.2569389627451253
ALL-SIL,168313047,1.973173862571291,2.4053217165791536
COR-L95,3038522,2.051786867518871,2.9847437848386558
LS411N,25102847,2.9606059837222767,2.3366995460793083
SW48,5566,2.216391660090734,3.029152149495273
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,1.8880097009592578
SW48,6917907,-5.957551707769467,-4.864372369867458
RKN,246676,4.414592383854902,4.505551974581321
IGROV-1,285033,-1.3538783590767758,-2.1791335812392365
PaTu 8988t,11609586,2.9135578891851233,2.621607380466062
P31/FUJ,19582717,2.23583270668625,3.9198146524152833
SK-OV-3,71304818,3.289226671933847,2.396178486082573
SW48,9903786,0.6824641791663469,2.756077717004494
SW48,107985,-4.220376672084107,-3.5771139994401464
ALL-SIL,49836020,-3.56746653346715,2.5464279658175073
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-2.2690769633318126
MOLM-13,7326481,3.309466894819375,2.957630994714242
PaTu 8988t,387447,-4.215036300164339,-4.3765957253648695
IGROV-1,10231331,1.9104831176724932,1.6547412916072393
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,4.860017480413567
WM115,6852167,1.3860811523021286,2.69961445504738
SW48,11175137,0.8049020199472112,2.477950770888125
NCI-H1568,6918837,-3.937828464321892,-3.046222711611649
ALL-SIL,409805,3.511042482554543,4.6745070702664995
BFTC-909,11485656,2.882750602975944,2.2397291078765758
HCC1500,6610216,3.984830656845064,4.26979744561799
MDST8,46191454,-0.3052251724831438,1.3518500781597358
NCI-H2452,52947716,2.3907771066336543,-1.4012147836358484
COR-L95,135411,0.6709946332822974,0.5181226666256136
RERF-LC-MS,11497983,4.204546577264711,2.348631818792911
MDST8,3025986,-2.3601391308628368,-0.8978770871810051
K-562,10113978,1.9599198523990544,3.010980031724017
MDST8,66577038,3.4472401917824387,2.9870697487432882
RCC10RGB,6917907,3.54732574828972,-4.864372369867458
SU-DHL-1,54618305,4.34503505735179,4.084826955496459
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,1.7724503678159762
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,1.4554460238042177
WM115,448949,1.6539360415615445,1.9537365892294993
ALL-SIL,216239,1.0502640873271551,2.1474208097396077
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.5071094923394703
IA-LM,53325874,6.131967715828746,4.753377022200137
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.135611362850641
P31/FUJ,119182,-2.8125390579467244,-1.3340160156368264
SU-DHL-1,11717001,3.585470860794662,3.961276339234443
MOLP-8,168313016,3.7646553629166304,4.725757076386842
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.2397291078765758
SW1271,9823820,4.369434873409536,3.7294514785702977
SK-CO-1,51037431,2.025162533854422,3.10082796495436
SW48,11964036,-0.90016316876993,1.2382789669868983
Granta-519,702558,4.9740995052838874,4.9782351440396395
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,1.2047817895412443
NCI-H1568,6918328,-2.169641972219076,-0.28710840066117727
Daudi,637858,0.7785119720749748,1.8880097009592578
SW948,53495165,0.2015090818079991,-0.19108456656304296
SW1573,46398810,3.5765453048302933,2.510712955745063
MOLP-8,637858,0.6022882265593398,1.8880097009592578
NCI-H1568,3825829,3.749474944576795,3.8869840981378028
MOLM-13,4788,4.00969340257961,5.493389053048461
SU-DHL-1,135398516,1.716785738144405,2.0509021680173207
HCC1500,2945648,3.001490751925554,2.7548400693819435
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.6778195760397165
HEL,46943432,0.8947528664895825,1.70045196562753
RKN,3689413,-4.085525957083088,-0.4039154566871359
COR-L95,45279963,4.007720953160328,3.660133434789582
LS180,11364421,-2.9792456594346945,-2.2476185097624475
SW948,51039095,-2.1737453378627567,2.682611194240459
HEL,135421197,2.810551353794614,1.8199795612290348
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.261852028375895
HuP-T3,5351362,1.4959503226370765,1.4604743967139864
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,2.474523360549852
SU-DHL-1,6623618,1.9512254956144048,2.1468722777789853
BICR 22,31703,-2.104947288409208,-1.182053713238432
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,2.344610112805219
IA-LM,17755052,4.247702528352723,1.7101929835526413
IGROV-1,17755052,-1.0246415273055465,1.7101929835526413
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.133687221210622
IGROV-1,3503,2.453392942972796,2.2426858883255045
BICR 31,10302451,2.0763164615496232,3.0143591766147457
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.7705130043498147
MOLM-13,2841722,4.084965304911922,4.375424781932207
COR-L105,9549297,5.541569761250669,2.3089350530287187
COR-L95,4705,3.007858501345706,3.0428654274536564
SK-HEP-1,54626689,5.252317432323977,4.561309020020982
BICR 22,24964624,2.8366894332481127,2.2827362159867324
K-562,3384730,2.2830550335302555,2.4620443610818112
RKN,46224516,3.695788234754723,2.370954746557396
Panc 02.03,44607531,1.9299895981807216,1.48117322485652
MOLM-13,11317348,-4.1893096196029465,2.3090854497210964
LS411N,60700,1.793788628592944,-0.4482559328189002
ALL-SIL,9967941,3.4348481015027628,3.6034131982542865
SK-HEP-1,46907787,5.1061569205326505,1.584957029505121
RKN,5351362,2.529766574998156,1.4604743967139864
HuP-T3,31703,0.4675615226322689,-1.182053713238432
SaOS-2,6610355,4.596244040557677,4.45123297085854
BICR 31,25195348,4.130650271984148,3.08171494739702
MOLP-8,73707438,3.908454567487333,4.210679418158044
MDST8,3503,3.3556251865549065,2.2426858883255045
COR-L95,439501,-1.1523844892623298,-2.2321662354381537
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,2.8341325456747963
P31/FUJ,5281321,-2.503740446113486,-1.3097742666845045
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,2.8341325456747963
BICR 22,2729026,3.062923067871907,2.6325975116350393
SW1573,51037431,1.8928004764191728,3.10082796495436
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-2.1791335812392365
RERF-LC-MS,16741245,3.282184197465347,3.801678648950925
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.275465599745589
SK-HEP-1,11427553,3.604603983851784,2.578035472123966
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.11065310288154762
SaOS-2,36462,1.0480120523183942,1.5076124324231743
IGROV-1,124202324,2.2563058955522157,2.1784388364790748
P31/FUJ,54618771,-0.1557090961755644,0.9253379925205388
HCC15,6918837,-3.491973763742546,-3.046222711611649
RERF-LC-MS,10302451,4.085913110869725,3.0143591766147457
WM115,9866186,1.4274901944164853,0.7577083020821866
RCC10RGB,3634881,4.1231622503065495,3.1576774496130544
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,4.13551970928241
SK-OV-3,56946209,-2.3996417591607235,-4.2202975286026225
Daudi,9907093,2.3595872536278977,4.134688957161641
UACC-812,135421197,0.8848266315498433,1.8199795612290348
COR-L105,11707110,-2.3960237918310967,-0.02846554242907695
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,1.78247230086659
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.2834565267098785
BICR 22,5287620,-2.2777736835755076,-1.9697846958841214
HEL,135398738,1.3240045179008624,3.3919135064420334
SK-CO-1,3825829,3.015639513793665,3.8869840981378028
BFTC-909,135398516,3.047749913114312,2.0509021680173207
Granta-519,252682,6.242071482699392,6.516263069090082
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.7691529831259722
SU-DHL-1,241158,1.6235055790866513,3.598987869990464
PaTu 8988t,8515,4.36808886077581,3.7716438213452004
NCI-H1568,44489675,3.7863062268563064,3.8856289571074525
MDST8,135875424,6.383148165610491,3.743891076041643
IA-LM,24771867,1.1290385026114922,1.5171458615349627
PaTu 8902,12001922,1.8953174279693872,1.8522788760744173
HCC1500,8515,5.3989297102528715,3.7716438213452004
MDST8,4259181,0.8851574645315519,0.11236669175956715
SK-OV-3,16038120,1.745962946040546,0.9090093368534204
SK-CO-1,25126798,3.6561952188996503,3.7921789378214816
HCC1500,4261,0.9221319619811188,1.4288257082744877
WM115,613753,3.1291419252746877,3.1495845971526135
IGROV-1,6505803,-0.2382223795960626,-0.5114413444588124
KU-19-19,49766530,0.1366302187334878,-0.6944377068647134
BICR 22,11494412,0.8036857209518554,1.4248282417532188
HCC1500,11955716,2.281516197797272,-1.4856643985320634
MOLP-8,71680916,4.479993680298279,4.641848024405652
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.206240213808089
BICR 22,15983966,-4.391384426150851,-1.6396194068861514
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,2.699201704606489
RERF-LC-MS,9866186,0.0636323256725951,0.7577083020821866
IGROV-1,54613361,1.0826132998561049,-0.11678183903518824
K-562,4259181,-0.7813149193344907,0.11236669175956715
SW48,6438330,1.214777505056659,2.016737971321332
LS180,54618305,4.3130332958468385,4.084826955496459
K-562,5746,1.9738407973257048,0.8084551861824514
COR-L95,3081361,3.577896308939448,2.3568884936851697
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.5350305453431912
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,1.4539899714896953
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.381335299817078
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.11065310288154762
K-562,53495165,-1.204911447319433,-0.19108456656304296
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,0.7705130043498147
HCC15,3676137,4.952150033317278,4.517112669127141
PaTu 8988t,46398810,3.220252132938068,2.510712955745063
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.5350305453431912
BFTC-909,9927531,5.31835549136936,4.578027762171671
Panc 02.03,16722836,2.9028860212849565,1.5333952667080324
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-1.261852028375895
Granta-519,3011155,5.044202810550695,3.2201851439403857
IGROV-1,3825829,4.144093606877803,3.8869840981378028
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.4254091153988029
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,0.38762532684053896
WM115,11238147,1.7518250261640556,2.694366237977623
HEL,6610355,4.700351008256091,4.45123297085854
COR-L105,10410894,5.46795970795096,3.2189174762180457
K-562,135421197,2.032823128578147,1.8199795612290348
HuP-T3,25105715,3.756943800954468,3.410449786117574
BICR 22,11717001,4.533318725499836,3.961276339234443
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.4053217165791536
BICR 22,176870,3.0604023761484154,3.0253996189023358
COR-L105,9823820,3.977631180290917,3.7294514785702977
P31/FUJ,66577038,3.0536576112540916,2.9870697487432882
HuP-T3,11612883,3.639610964764467,2.6386482274158856
PaTu 8988t,12001922,2.536714978511883,1.8522788760744173
P31/FUJ,24771867,-2.604308550432203,1.5171458615349627
P31/FUJ,3634881,2.159990781463395,3.1576774496130544
SW1271,11640390,3.706316930576478,3.2466540190485103
Granta-519,984333,0.7513060576966085,0.5138000229415411
COR-L95,46398810,2.3153378536205036,2.510712955745063
NCI-H2452,4259181,1.4154165902225178,0.11236669175956715
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-3.5071094923394703
RERF-LC-MS,3503,1.2198018250646854,2.2426858883255045
BFTC-909,168313047,1.967772312792883,2.4053217165791536
NCI-H1568,49766530,-3.205306991379519,-0.6944377068647134
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,1.2359123501503817
IGROV-1,44491742,4.406671418311328,4.1566745174283435
SaOS-2,54596490,5.687426160237218,4.945697156281648
Granta-519,46843906,0.846372381562089,2.723521570705241
SK-OV-3,46398810,2.6339706660379205,2.510712955745063
WM115,25154868,2.4497388117539773,4.289494395804131
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-1.57821899028641
BICR 31,123631,1.818021308876907,2.2760265557358337
HuP-T3,60750,3.212181181151216,-2.435153852929516
WM115,71304818,2.065667497969779,2.396178486082573
SU-DHL-1,11964036,1.0253922980362349,1.2382789669868983
SW1271,9444,4.046685913234064,4.054048446110465
IA-LM,1716436,3.827820678542469,2.948755251800144
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,1.85063491630251
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,2.474523360549852
SW48,44137675,1.8984167228990951,3.337336921695599
IGROV-1,11364421,-2.1205062036040982,-2.2476185097624475
PaTu 8902,3465537,3.540732953494624,2.5477591829493655
HCC1500,54618771,1.4039271563223086,0.9253379925205388
NCI-H1568,23725625,5.336887169251221,4.726527081330662
BICR 31,9936388,2.7244047649519074,-1.7988236137529168
IGROV-1,49850262,4.068828647042517,3.414452598711333
HCC15,5280436,4.320878094694944,3.153394505533252
COR-L95,46215462,1.6156782364555438,1.762132613731386
SW948,25022340,4.946878477600784,2.219156297475395
P31/FUJ,3025944,3.8644283212627895,4.206240213808089
SK-CO-1,5978,-3.732613512446313,-2.3753204421143224
LS411N,19582717,5.192972758226466,3.9198146524152833
SaOS-2,26596,-1.8442798913702467,-1.5346517263124715
MOLM-13,6610216,4.131122051839403,4.26979744561799
KU-19-19,3025944,4.41555498235696,4.206240213808089
HCC15,11497983,1.686538707374479,2.348631818792911
HCC1500,216468,3.3608861469702735,2.5020743765616316
NCI-H2452,56649450,2.972344092085675,2.999158341046921
SK-OV-3,25262965,0.4953902890441227,-1.6224193967571534
HCC15,10184653,1.3258142209068642,1.1325795715302809
SU-DHL-1,3825829,2.249840075454991,3.8869840981378028
WM115,49867926,3.8689880289876446,4.110210541110895
K-562,285033,-3.792012978388577,-2.1791335812392365
Granta-519,53495165,-2.785106410212646,-0.19108456656304296
SU-DHL-1,5335621,3.5965276677583846,4.560420742529089
NCI-H1568,1566236,1.6523344134899465,2.2263982365179604
HCC15,25195348,3.62058364960133,3.08171494739702
LCLC-97TM1,7326481,3.961997196958484,2.957630994714242
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,1.3153680794849765
LS411N,9887053,4.348393626170801,3.469815136639831
LS180,208908,2.3350670945107783,1.8663560178908947
IA-LM,54454,3.681506421747591,2.548844675602096
RKN,4378219,1.9905206425028277,2.6822409618839944
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.699201704606489
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,2.715769249487813
IGROV-1,216345,3.498629789107092,3.7540083674013296
SW948,5282054,2.5738720751419746,3.5628845676855256
PaTu 8902,66577038,3.2739824602509304,2.9870697487432882
COR-L105,1566236,2.352597865521479,2.2263982365179604
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,2.8341325456747963
MOLM-13,46191454,-2.5774836063329905,1.3518500781597358
HCC15,72734382,4.010055800269774,4.3578051352274185
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.9218131221296273
SaOS-2,53232,1.3253237607162072,2.8161144578264046
KU-19-19,9936388,2.972521935644637,-1.7988236137529168
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.2359123501503817
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.0665232817889554
SU-DHL-6,445643,2.4790626422724107,3.9383569867901693
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,3.4938336610308007
HCC1500,208908,1.6399748300125228,1.8663560178908947
P31/FUJ,4917,2.744589019426067,3.079848880785536
HuP-T3,241158,3.8412641522091144,3.598987869990464
SaOS-2,46224516,2.521923040225463,2.370954746557396
LS180,54618771,0.643112685351952,0.9253379925205388
Daudi,23725625,2.2816125857144978,4.726527081330662
Panc 02.03,25227462,-1.0518848939229315,-0.4151865926866767
WM115,462382,0.0353255606914336,0.5714028853239661
SaOS-2,135875424,3.0421388786055727,3.743891076041643
Granta-519,10113978,3.360346958971763,3.010980031724017
SU-DHL-1,51037431,2.2415500634191763,3.10082796495436
SW1271,135440466,1.7072517695379112,2.1401473911994366
BICR 31,208908,2.9880095911503983,1.8663560178908947
NCI-H1568,11719255,3.5544275615483087,3.1221102230298534
SU-DHL-1,4259181,-1.4222017445817885,0.11236669175956715
NCI-H1568,135984461,4.216726883570129,3.6237408287871284
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,1.4554460238042177
K-562,25195348,2.6278567451650394,3.08171494739702
SW948,6918638,-0.8188756331889222,0.3065957347013626
UACC-812,216345,3.8515167014354152,3.7540083674013296
PaTu 8988t,446155,5.325372031764619,2.662752180605146
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,2.699201704606489
NCI-H1568,54618771,0.8004506686595156,0.9253379925205388
HCC15,9823820,3.975711917882334,3.7294514785702977
RCC10RGB,9935249,3.9754060705766943,2.8615383619674972
SK-OV-3,3854666,3.321518045263264,1.85063491630251
Daudi,135928012,2.6114481479622516,3.8701906312906376
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,2.93841691857644
HCC1500,44491742,3.6723474636183537,4.1566745174283435
K-562,54626689,4.3954029102592145,4.561309020020982
SW948,11152667,-0.307089718187717,-0.5866736007906306
NCI-H1568,984333,0.7198134332239758,0.5138000229415411
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,2.699201704606489
IGROV-1,44507138,2.359177395411688,2.3228542035372683
COR-L105,44566777,0.9614143121394376,0.6972581949653407
HCC1500,25126798,3.9309577641895137,3.7921789378214816
LS411N,5470400,-0.4509258648896809,-0.3765538821264742
PaTu 8902,11427553,3.388107623793881,2.578035472123966
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,1.710700657959646
LS411N,11364421,-0.88941081068058,-2.2476185097624475
Panc 02.03,6918638,1.5939476449475074,0.3065957347013626
IA-LM,73707398,1.4255919606814562,1.180307991266282
Granta-519,54613361,-0.5306815642640709,-0.11678183903518824
IGROV-1,176870,1.8349827429681411,3.0253996189023358
SK-OV-3,24821094,3.4952627197751744,2.7369152351179045
SaOS-2,5566,3.2892304449964125,3.029152149495273
BFTC-909,44486219,4.380685277356905,4.281343219898981
SW1271,52947716,2.875834451056303,-1.4012147836358484
LS180,20959075,-3.038194424999374,-3.173507428051674
BICR 22,2708,5.160276397343071,4.591243765137335
LS411N,24856436,0.7977520405714393,0.17994774592918095
RKO,3062316,2.656751778030552,0.9747482048219924
IGROV-1,2841722,3.834853118277962,4.375424781932207
SW948,9967941,3.223093544556301,3.6034131982542865
WM115,5291,3.6779708977342263,3.5530526201153183
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,2.6275548088442098
NCI-H2452,11152667,-1.2581393219211725,-0.5866736007906306
SK-HEP-1,54454,2.662573207119838,2.548844675602096
PaTu 8902,46398810,2.87785673961289,2.510712955745063
MOLM-13,4096211,0.3628379797080729,1.856021664538426
SaOS-2,31703,-1.4545352226195103,-1.182053713238432
NCI-H2452,89928392,1.3829077368930702,1.344325138639762
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.38762532684053896
SU-DHL-1,216468,2.865615091111303,2.5020743765616316
BFTC-909,5335621,5.263558209813896,4.560420742529089
IGROV-1,984333,0.6618578113050116,0.5138000229415411
SaOS-2,53393127,5.00574224434263,4.234361111099659
LS180,26596,-1.3053249122689552,-1.5346517263124715
PaTu 8902,216239,3.2515461693373946,2.1474208097396077
RERF-LC-MS,216239,1.5111459083459036,2.1474208097396077
IGROV-1,327653,3.667792542405671,3.018652636936018
MDST8,25062766,1.7641764997703038,2.0522756909743434
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.37491183386883553
SW948,9911830,2.1163810502856344,2.4240324657892436
SW948,25262965,-4.786935998048743,-1.6224193967571534
Granta-519,17755052,3.698735089058188,1.7101929835526413
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.7772567284956553
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,0.9218131221296273
BICR 31,65628,4.368112552275168,4.026684176415168
LS411N,1716436,3.6051806229528394,2.948755251800144
HEL,31703,-1.5815868160580933,-1.182053713238432
ALL-SIL,46191454,0.8221974593607395,1.3518500781597358
IGROV-1,46843906,3.392503571349757,2.723521570705241
MDST8,52912189,0.1558018738717314,1.6723266261402217
SK-HEP-1,73707398,1.730256970360003,1.180307991266282
NCI-H2452,969516,2.821538204226011,2.7772567284956553
Daudi,9825149,1.5190393381512124,2.074054954263997
HEL,49766530,-2.395534265113236,-0.6944377068647134
SU-DHL-1,445643,3.1136870030048116,3.9383569867901693
Granta-519,25102847,2.235988678650905,2.3366995460793083
SU-DHL-1,8515,3.677486404661737,3.7716438213452004
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,2.0335760501929605
NCI-H1568,73707398,1.0000031751048108,1.180307991266282
RKN,44607531,3.612700906890815,1.48117322485652
RKO,448949,2.722052887717566,1.9537365892294993
SaOS-2,123631,3.143555798261004,2.2760265557358337
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-3.5071094923394703
HCC15,445455,6.40486213649735,4.540053644561405
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,4.550433807048704
MOLM-13,16720766,-3.0154852550238473,0.4291253754884592
SU-DHL-1,52912189,2.819399061651446,1.6723266261402217
IGROV-1,6918328,-0.5330006254346346,-0.28710840066117727
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-1.0279170724737183
Granta-519,168312962,2.8455100129937447,1.48933366232238
RCC10RGB,24748573,3.544482176439233,1.9565115912575295
NCI-H1568,71576739,4.4464222538448075,2.9192684489841567
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5350305453431912
MOLP-8,3025944,3.977744021049233,4.206240213808089
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.4539899714896953
SW48,3025944,3.8378875325919513,4.206240213808089
P31/FUJ,5460769,2.718083541162644,2.3447175553942796
PaTu 8902,56946209,-3.5225671286307585,-4.2202975286026225
IGROV-1,11964036,-0.1609353030421705,1.2382789669868983
HCC1500,327653,2.623652361439541,3.018652636936018
BICR 22,11640390,3.3009766271386014,3.2466540190485103
IGROV-1,400769,-0.5589612210030486,-0.7855881743093749
HuP-T3,24821094,3.9398095537443023,2.7369152351179045
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.344610112805219
RKN,54618771,1.93479648501244,0.9253379925205388
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,4.4833676274788345
PaTu 8988t,73707398,1.170719580837983,1.180307991266282
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.010980031724017
Panc 02.03,10231331,3.962628244123872,1.6547412916072393
HCC1500,387447,-5.435802195710178,-4.3765957253648695
K-562,25150857,2.2256112733235978,2.336756962918186
COR-L95,135398516,3.161482452438301,2.0509021680173207
MOLP-8,46191454,-2.2442719810217984,1.3518500781597358
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,2.344610112805219
BICR 22,4259181,0.3497439952553443,0.11236669175956715
SU-DHL-1,49836020,5.336381428124731,2.5464279658175073
P31/FUJ,246676,3.344572915959865,4.505551974581321
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,1.2047817895412443
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.2349426527428076
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.3848601780620533
SK-CO-1,135875424,3.678629656731489,3.743891076041643
SW948,3552672,1.903682389315955,2.8413574589562494
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,3.456683733824014
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,0.4199080872215506
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,2.474523360549852
P31/FUJ,6610355,3.438139996915945,4.45123297085854
NCI-H1568,446155,2.3736727750277455,2.662752180605146
HCC15,107985,-2.9906891972859415,-3.5771139994401464
Daudi,6918328,-3.006382851838594,-0.28710840066117727
Daudi,25161177,4.237474374185298,4.097137926934978
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.7724503678159762
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,2.9860814461500107
HCC1500,374536,2.8802619944250765,1.7732341041149164
SU-DHL-1,400769,-1.357151076144479,-0.7855881743093749
MOLP-8,16725315,4.20287759788283,4.150060666188836
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-1.6778195760397165
MDST8,24753719,4.799692184779076,4.143618673527016
Panc 02.03,25195348,3.9334722209588735,3.08171494739702
IA-LM,5328940,2.67230513268953,1.559061663996469
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-4.3765957253648695
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,1.710700657959646
Granta-519,676352,1.633141874861156,2.088896150621564
HCC15,49793307,-2.657858659953827,-2.848251171596848
K-562,16065773,1.923835638804153,2.3641186374244216
RERF-LC-MS,23582824,0.1470987082457378,0.7400136078733197
SW948,9907093,4.923675844906718,4.134688957161641
HuP-T3,374536,4.193584653265312,1.7732341041149164
WM115,11396600,2.8854117577089378,3.4309758536883517
IGROV-1,16722836,0.856484234547582,1.5333952667080324
LS411N,89183176,4.7846004508379085,3.4938336610308007
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,2.0276770243216165
HCC15,6917907,-3.7751611818797897,-4.864372369867458
NCI-H1568,637858,1.7833024505225796,1.8880097009592578
PaTu 8902,5329102,2.5341846500240246,2.031058842574058
Daudi,54765302,2.540510911033338,3.905112278839675
RERF-LC-MS,100016,6.56071523320666,5.87798299213578
NCI-H1568,387447,-3.95080818095812,-4.3765957253648695
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.4053217165791536
SaOS-2,11612883,2.0316436721768087,2.6386482274158856
SK-OV-3,135411,1.6318689765112546,0.5181226666256136
IGROV-1,208908,2.822483792004996,1.8663560178908947
RKN,51037431,2.467401650082352,3.10082796495436
MOLM-13,3025944,3.8428716966726992,4.206240213808089
PaTu 8902,135421197,2.3024316473658004,1.8199795612290348
MDST8,969516,2.598297465814476,2.7772567284956553
MOLM-13,60750,-4.5529472050787545,-2.435153852929516
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,1.2834565267098785
IGROV-1,9915743,-0.4757488934941289,0.5935480801734145
BICR 31,56946209,-4.213875977630207,-4.2202975286026225
MDST8,124202324,2.333625526818204,2.1784388364790748
BFTC-909,46907787,2.3649992203474515,1.584957029505121
Daudi,12003241,-4.903510386182724,-1.0889198012759371
PaTu 8902,969516,4.108056616445131,2.7772567284956553
RKO,24951314,1.467797052763695,1.227614980483031
SW48,439501,-2.266376314928653,-2.2321662354381537
IGROV-1,5311281,3.3250623444804206,2.22503529708604
BFTC-909,9825149,2.463033939289578,2.074054954263997
LS180,2858523,3.002923184305197,3.0086502241129605
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,2.0335760501929605
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,1.7724503678159762
PaTu 8902,10074640,3.6154267469790304,3.066922642013836
LS180,135421197,1.2375553911833763,1.8199795612290348
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.3568884936851697
HuP-T3,4259181,1.3598984416642497,0.11236669175956715
MOLM-13,9840324,5.573129737038137,5.7711165719697215
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-3.5071094923394703
RCC10RGB,7251185,2.312506998895348,2.4347287977616
LCLC-97TM1,23725625,2.954034200595367,4.726527081330662
RKO,24797083,0.8657042008278414,1.277886491385028
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,2.8341325456747963
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,6.016171437665366
ALL-SIL,24951314,0.1921049921473096,1.227614980483031
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.144908880465776
K-562,16725315,4.409558206085648,4.150060666188836
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.074054954263997
SU-DHL-1,9915743,1.482861419138649,0.5935480801734145
SW1271,4917,2.7806051488376293,3.079848880785536
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,2.9860814461500107
COR-L95,3062316,3.2830028596837217,0.9747482048219924
MDST8,10074640,3.541716125988611,3.066922642013836
IGROV-1,44185566,2.2104732991243248,2.4057100644299436
SU-DHL-6,57519531,1.2127003418717253,2.4211376500246136
SK-CO-1,241158,4.831010946536929,3.598987869990464
SW948,46843906,2.6248020109336023,2.723521570705241
RERF-LC-MS,6610216,4.063402980130349,4.26979744561799
RERF-LC-MS,46843906,4.323049782377064,2.723521570705241
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,2.93841691857644
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.7691529831259722
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.117207225291035
HCC15,24180719,4.303391195547382,3.437709308952337
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.7724503678159762
MOLP-8,6505803,0.6382990348001342,-0.5114413444588124
Daudi,5278396,2.816567405543214,3.517590475337377
RKO,66577038,3.1469091340303637,2.9870697487432882
MOLP-8,54143018,0.5860183196437395,0.31711465707788644
SaOS-2,24856436,0.4386880001360848,0.17994774592918095
BICR 31,9866186,1.254760755448308,0.7577083020821866
RCC10RGB,11257553,3.6405008146732434,0.882092451246884
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.4199080872215506
RKO,57330099,4.8516025997257275,4.311542343968036
P31/FUJ,54649500,4.423311343715707,5.83301672271965
SW948,10302451,4.082058519290096,3.0143591766147457
WM115,2746,3.2273654457979957,2.8579929499469348
KU-19-19,654092,0.6096416345891582,-0.4472857419901597
PaTu 8988t,10296883,3.999790485906541,3.795028277273254
BICR 22,54143018,1.1733542553992964,0.31711465707788644
MDST8,71466445,2.0942740576673593,3.3478019143630626
PaTu 8902,36462,3.471634301287976,1.5076124324231743
LS411N,44632017,5.0127460000138,1.0838611345650022
COR-L95,9911830,2.1813921058815553,2.4240324657892436
ALL-SIL,9911830,-2.857836139869332,2.4240324657892436
WM115,3465537,1.2344570371137795,2.5477591829493655
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.133687221210622
SU-DHL-1,54454,0.0220955119836291,2.548844675602096
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.578027762171671
MOLP-8,24821094,3.654707766369703,2.7369152351179045
MOLP-8,6852167,0.8455390099609336,2.69961445504738
Panc 02.03,11222830,1.865607722872823,1.5350294688251391
MDST8,2746,2.514425635914287,2.8579929499469348
Granta-519,1716436,2.7310795448836904,2.948755251800144
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,2.699201704606489
RERF-LC-MS,11625818,4.251014876931036,4.10791451089978
P31/FUJ,4378219,1.2412027933720209,2.6822409618839944
HCC15,3062316,2.729530034687651,0.9747482048219924
LS180,9903786,2.2166672873522857,2.756077717004494
PaTu 8902,16065773,3.37985868216597,2.3641186374244216
LS411N,9911830,3.118029057589745,2.4240324657892436
LCLC-97TM1,6438330,3.0238187505324885,2.016737971321332
KU-19-19,25062766,2.9321374053838807,2.0522756909743434
HCC1500,10074640,2.968051262406446,3.066922642013836
P31/FUJ,6505803,0.2535639265329721,-0.5114413444588124
NCI-H2452,387447,-3.2957708741809975,-4.3765957253648695
MOLM-13,11228183,-2.7074565632423546,1.8712017695678478
SU-DHL-6,5566,0.7122829809928822,3.029152149495273
COR-L95,24785538,1.0654849938174582,1.3344504348570345
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.5350305453431912
WM115,4578,4.221194502857287,4.446937148676336
COR-L105,4578,4.590840204947243,4.446937148676336
K-562,374536,0.780579010414565,1.7732341041149164
COR-L105,60700,0.1425021915553204,-0.4482559328189002
K-562,46926350,-4.162486097405079,-4.429063309555999
SW1573,4705,3.887877577681455,3.0428654274536564
LCLC-97TM1,637858,1.4157632634757724,1.8880097009592578
WM115,46926350,-4.284670953339827,-4.429063309555999
RERF-LC-MS,15547703,2.8085711207925015,3.114669509763707
NCI-H1568,11497983,3.872384435522252,2.348631818792911
MDST8,4788,5.889593740712007,5.493389053048461
IGROV-1,8515,2.1861539315976053,3.7716438213452004
RKN,24772860,-0.333409077824626,-2.2690769633318126
PaTu 8988t,322968,4.849886698333752,3.4956311613712456
RERF-LC-MS,16720766,0.5604118097796991,0.4291253754884592
SW948,6505803,-1.4287073835677784,-0.5114413444588124
BICR 22,462382,1.3729135623232431,0.5714028853239661
LS180,322968,4.435040308321651,3.4956311613712456
SaOS-2,11152667,-0.1732170298835725,-0.5866736007906306
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,0.5554913629931677
HCC1500,227681,1.895909952215359,2.9941233013598234
SU-DHL-1,57330099,3.736750567984075,4.311542343968036
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,1.78247230086659
COR-L95,11977753,-0.4790698517891548,-1.7159558966047241
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.361538429265863
SW1573,11427553,4.057369297610019,2.578035472123966
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,2.474523360549852
LS180,12001922,1.7594619366424422,1.8522788760744173
SaOS-2,12001922,2.1147367002170494,1.8522788760744173
SU-DHL-1,3543504,3.7817510655567625,4.269325105068445
BICR 31,24901704,3.914024172074534,3.1103746959488285
MOLM-13,5287620,-2.884996470216499,-1.9697846958841214
BICR 31,25102847,2.842271629600241,2.3366995460793083
COR-L95,10113978,3.7452762075447104,3.010980031724017
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,1.2834565267098785
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,1.0163468544412688
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.4739669220989267
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,2.0335760501929605
COR-L105,168312962,3.0410731046381065,1.48933366232238
LCLC-97TM1,10322450,3.85878970197106,3.669858075898477
HCC1500,25161177,4.357780519617112,4.097137926934978
SK-CO-1,9967941,1.837567054996146,3.6034131982542865
COR-L95,5311,1.4789786210040632,1.2663000347984639
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.714359432422819
LCLC-97TM1,72193861,0.688846554638978,1.3858780169906042
SW48,4096211,0.1208358665406906,1.856021664538426
LS411N,135875424,4.300305751936665,3.743891076041643
SK-CO-1,42642645,0.466262192383588,0.7845058245277501
IGROV-1,1566236,2.765820903157784,2.2263982365179604
HCC15,10410894,4.508285516741203,3.2189174762180457
IGROV-1,6450551,2.579641476451469,2.361538429265863
IGROV-1,452548,0.0422661560146271,-0.31026393275322106
COR-L95,216345,3.729430833860697,3.7540083674013296
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-1.57821899028641
LS180,2945648,3.723684880750219,2.7548400693819435
RKO,9936388,0.8183869926163714,-1.7988236137529168
HuP-T3,10231331,2.6811135289001236,1.6547412916072393
PaTu 8902,44493528,4.360494725244959,4.333966846288542
Panc 02.03,45279963,4.323488067826322,3.660133434789582
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.102163121425029
BFTC-909,44507138,2.8704731321552734,2.3228542035372683
ALL-SIL,49766530,-2.347000417785464,-0.6944377068647134
SU-DHL-1,6918289,4.3249644726818275,1.9146814118519513
NCI-H2452,54626689,4.879011133008654,4.561309020020982
HCC1500,4917,1.9149154714535184,3.079848880785536
LCLC-97TM1,15547703,3.011827246330581,3.114669509763707
MOLM-13,71304818,2.1544936448447873,2.396178486082573
SU-DHL-1,4917,2.4666047815714154,3.079848880785536
NCI-H2452,56946209,-3.558178980562316,-4.2202975286026225
RKN,1750826,-6.055252220387113,-1.4739669220989267
RKO,25105715,3.388469834531371,3.410449786117574
RCC10RGB,46191454,4.887818963424851,1.3518500781597358
LS411N,3815108,3.549037613932863,2.885036533777781
HEL,56946209,-4.040477533762366,-4.2202975286026225
BICR 22,122327,5.571410232221064,4.7007618437932
BFTC-909,969516,2.723005004244225,2.7772567284956553
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.2359123501503817
RKO,24856436,0.2423564692967549,0.17994774592918095
SU-DHL-6,5746,-1.2123840023346684,0.8084551861824514
SU-DHL-1,135411,-2.10627226052293,0.5181226666256136
SK-OV-3,1716436,3.636442167288748,2.948755251800144
IGROV-1,44543605,3.88270235241076,4.160012106477824
K-562,6914657,-3.91828110768511,-4.170094408243688
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.7577083020821866
NCI-H2452,25262965,-3.6663688304344695,-1.6224193967571534
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,0.9218131221296273
MOLM-13,11404337,-1.791363376051536,-0.4254091153988029
RKO,36462,3.4370564574699185,1.5076124324231743
IGROV-1,446155,3.750396425244744,2.662752180605146
COR-L95,72734382,4.117898969233179,4.3578051352274185
K-562,11396600,3.7562155275673415,3.4309758536883517
LCLC-97TM1,4705,3.0319662392534057,3.0428654274536564
Daudi,2130404,3.4806417402967993,3.195187949563447
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.0163468544412688
MDST8,327653,3.1544218347658375,3.018652636936018
SK-CO-1,11656518,0.968890652064466,1.5480979328089313
K-562,5311281,3.9022564066083967,2.22503529708604
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,2.3791567205504176
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.0665232817889554
RKO,445091,4.342692134156949,4.3274252089919045
MOLM-13,9935249,2.7939558009041283,2.8615383619674972
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.7724503678159762
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.2359123501503817
SU-DHL-1,124202324,2.3695119203399906,2.1784388364790748
COR-L105,9884685,2.6443959528770167,0.4230357541133405
BICR 31,10113978,4.990782635230478,3.010980031724017
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,1.78247230086659
MOLP-8,6610355,3.5622833697709178,4.45123297085854
LCLC-97TM1,2749,2.4194398786749067,1.7932893499757152
Daudi,5311,0.1794409230409946,1.2663000347984639
HuP-T3,2113511,6.036487802507154,5.381335299817078
P31/FUJ,452548,-2.598049093653093,-0.31026393275322106
SaOS-2,16065773,3.691866894593861,2.3641186374244216
RERF-LC-MS,65064,5.274588293813746,4.739517756868576
HuP-T3,89928392,1.747135585577409,1.344325138639762
P31/FUJ,56963564,-0.6738396792941169,0.2569389627451253
LS180,5746,0.8609008276830991,0.8084551861824514
BICR 22,11707110,-2.2145574606059912,-0.02846554242907695
Daudi,9952709,2.2307089742515713,2.9381980631482683
SW48,3543504,4.30466926238752,4.269325105068445
SW48,11427553,0.5193301330840923,2.578035472123966
WM115,56649450,1.7070260970326938,2.999158341046921
IGROV-1,89928392,1.4824233552493276,1.344325138639762
SW1271,72376,-1.909620961604672,-2.110114148114304
SaOS-2,5278396,3.8495121754699686,3.517590475337377
K-562,42642645,-0.9952706094252596,0.7845058245277501
Panc 02.03,446155,2.721578883226381,2.662752180605146
RERF-LC-MS,44462760,4.251912039026111,3.143997930658831
BFTC-909,3503,3.411270469206907,2.2426858883255045
MOLM-13,104842,-5.846939346357726,-3.040993872013826
K-562,11656518,1.1460195934444493,1.5480979328089313
HCC15,76446078,6.244123044550032,4.473999410152771
COR-L95,6438330,1.555078701387849,2.016737971321332
COR-L95,9926054,2.0133423062539726,1.9546333131599372
BICR 31,462382,1.217928478873545,0.5714028853239661
UACC-812,46199207,3.606176782545976,3.1312366616263048
SW1271,16725315,3.214819296898604,4.150060666188836
BICR 22,3385,1.594485383262216,3.472185389430271
HEL,11234052,1.6482548628813194,3.869960809483736
SW1271,49793307,-1.6735159246770874,-2.848251171596848
HEL,3025944,4.107185950107739,4.206240213808089
SK-CO-1,1641662,2.678789461404506,3.3408828038827
RKN,71680916,6.446363106372924,4.641848024405652
IA-LM,25183872,-0.4633226224219731,-0.902802947451298
IGROV-1,6918837,-2.9804518885508635,-3.046222711611649
HEL,252682,5.808471376099282,6.516263069090082
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,0.38762532684053896
MOLM-13,374536,0.9670025892080272,1.7732341041149164
NCI-H2452,168313047,2.588327036215806,2.4053217165791536
Granta-519,4917,3.021022166883331,3.079848880785536
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,1.3153680794849765
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,1.2834565267098785
BICR 31,262093,3.397835562493394,2.6275548088442098
LS411N,12003241,-0.0946051023392001,-1.0889198012759371
HCC1500,5282054,2.2651950194203323,3.5628845676855256
HCC15,322968,4.854333863324092,3.4956311613712456
RCC10RGB,9936388,2.3235560801623465,-1.7988236137529168
NCI-H2452,46199207,3.026577128215497,3.1312366616263048
Granta-519,9444,3.3091580955395146,4.054048446110465
IGROV-1,53392493,2.352084848618059,2.4832542501558077
COR-L95,151289,3.0372683791028705,0.9562867634504244
NCI-H1568,216468,4.700562763036761,2.5020743765616316
WM115,25195348,4.859937697346287,3.08171494739702
SaOS-2,2858523,3.094677154220442,3.0086502241129605
SW1271,421610,4.471416490511734,3.1278257636093416
BICR 31,637858,2.611871003184785,1.8880097009592578
SW948,11175137,1.686043515242534,2.477950770888125
MDST8,11625818,2.7981930885976705,4.10791451089978
Panc 02.03,11609586,3.3931905350155915,2.621607380466062
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.93841691857644
PaTu 8902,9825149,2.767587999144615,2.074054954263997
HCC1500,6918837,-4.362896894201754,-3.046222711611649
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,1.5478733404534093
SaOS-2,5282054,3.07206551989859,3.5628845676855256
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.133687221210622
SK-CO-1,72376,-3.2194985981528808,-2.110114148114304
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.3848601780620533
WM115,10302451,3.6553280898048905,3.0143591766147457
Granta-519,613000,2.2510291651452143,2.227141832343803
SaOS-2,11222830,1.0878926350484104,1.5350294688251391
IA-LM,54678924,1.6007306497128662,1.9473085147454567
HEL,119607,4.922739390517752,5.129253777214588
HCC1500,6918328,-0.2689126411143879,-0.28710840066117727
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,1.78247230086659
LS180,3062316,2.327440880417239,0.9747482048219924
LCLC-97TM1,11317348,1.7152030009838672,2.3090854497210964
SaOS-2,6918736,-1.8799034133096575,-1.741781295359962
SaOS-2,12003241,-0.699813042979073,-1.0889198012759371
LS180,10113978,3.7861477365363383,3.010980031724017
SW48,54618359,4.4319552735559,4.4567336793083925
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.5350305453431912
HEL,387447,-4.961191552031455,-4.3765957253648695
RKN,6610216,4.220445612403551,4.26979744561799
P31/FUJ,656346,-0.3707458386499477,0.7582608913284792
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,1.2359123501503817
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-1.57821899028641
MOLP-8,9952709,2.638563783306324,2.9381980631482683
SaOS-2,11455910,0.8777485884783317,0.9557745122323711
K-562,10184653,1.719293175029272,1.1325795715302809
Granta-519,4259181,-0.7648884727300508,0.11236669175956715
BICR 22,4521392,3.4098909359208625,4.280943620409205
HCC15,2874250,4.519421691404506,4.0377213891771015
SaOS-2,6918638,1.2055090485954645,0.3065957347013626
MOLM-13,9868037,0.9756233042827712,2.82815333449006
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.4539899714896953
MOLP-8,16659841,2.203571056365997,3.7845234388741966
LS411N,656346,4.206497662771029,0.7582608913284792
RKO,5460769,5.660789679983863,2.3447175553942796
BICR 31,6610355,4.797647038745592,4.45123297085854
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,1.7101929835526413
RKO,11964036,1.8153618806471208,1.2382789669868983
NCI-H2452,7326481,3.286880233884326,2.957630994714242
RCC10RGB,44491742,5.1484686760969645,4.1566745174283435
IGROV-1,50905018,6.092412272559071,4.441836356719809
BICR 31,9884685,0.303781088019613,0.4230357541133405
Panc 02.03,3081361,3.1546648300373357,2.3568884936851697
BFTC-909,25126798,3.8219929141120166,3.7921789378214816
MOLM-13,66890843,1.9738756301734208,3.1520074701710383
HCC1500,24180125,3.164669305988548,2.888353933707551
SK-HEP-1,53392493,3.66906541895257,2.4832542501558077
RERF-LC-MS,2945648,2.437954541344266,2.7548400693819435
HEL,25150857,2.447529551071105,2.336756962918186
BICR 22,65064,5.333446499438452,4.739517756868576
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.3848601780620533
P31/FUJ,123631,2.0303759233077017,2.2760265557358337
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-1.1532493383305307
IGROV-1,11175137,1.8411496230681277,2.477950770888125
KU-19-19,44241473,5.030815161961597,4.8543955662784395
SW48,72193861,-0.4534629909928462,1.3858780169906042
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.117207225291035
MOLM-13,5311281,1.6146001182421037,2.22503529708604
HCC1500,9915743,1.9340540182592263,0.5935480801734145
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.37491183386883553
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.78247230086659
LS180,4096211,2.1975503712063604,1.856021664538426
NCI-H2452,66577038,3.355972963473848,2.9870697487432882
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.3153680794849765
HCC15,11175137,3.485795641541794,2.477950770888125
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-0.8865368208635396
HuP-T3,2945648,2.5475895191101197,2.7548400693819435
Panc 02.03,6450551,4.166761052507323,2.361538429265863
K-562,2708,5.362475494708341,4.591243765137335
RKN,219104,3.4277527780329096,3.5366182443481806
RKO,16722836,2.0172870973895085,1.5333952667080324
UACC-812,439501,-1.4243957864326813,-2.2321662354381537
MOLP-8,11222830,0.9410853080031706,1.5350294688251391
WM115,1239801,4.563824386797348,3.981036641317754
Daudi,11717001,4.763561920962392,3.961276339234443
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.3344504348570345
COR-L95,16736978,-0.5228132160938015,1.3934160091023764
IGROV-1,11213558,0.52356811652227,1.4781707184028035
MDST8,44202524,1.4033794041893788,1.9639001504219202
SU-DHL-6,10113978,2.1190356124222194,3.010980031724017
SK-HEP-1,4917,3.764636353681369,3.079848880785536
HCC15,452548,-2.1001752731425727,-0.31026393275322106
SW48,46191454,-0.9829938197758128,1.3518500781597358
MOLM-13,4521392,4.5803067712490115,4.280943620409205
HuP-T3,25062766,2.4453672011464023,2.0522756909743434
COR-L105,107985,-4.244896937866387,-3.5771139994401464
SU-DHL-1,89928392,0.4021872915525221,1.344325138639762
BICR 22,55508,4.44611517999926,3.1188086218267883
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.604307380358917
MOLM-13,675434,3.665195693175508,4.463597576567934
SK-HEP-1,6610216,4.694225049802747,4.26979744561799
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.4554460238042177
SU-DHL-1,49766530,-4.824875359994143,-0.6944377068647134
HEL,12001922,1.658840092002429,1.8522788760744173
HCC15,46398810,2.6134237903958093,2.510712955745063
NCI-H1568,3136844,4.658915015928919,4.214923916993912
NCI-H2452,24821094,3.1123469452418537,2.7369152351179045
LS180,3543504,4.376890558116308,4.269325105068445
ALL-SIL,9927531,4.600523700119875,4.578027762171671
BICR 31,11167602,4.451308398956488,2.4705816300476062
SW1271,16219061,4.25548468975063,3.135611362850641
PaTu 8988t,448949,1.751499890417066,1.9537365892294993
WM115,2858523,2.9957579985597467,3.0086502241129605
RCC10RGB,11364421,1.2845393833467151,-2.2476185097624475
SK-CO-1,984333,1.8899562330111348,0.5138000229415411
COR-L105,72376,-1.002534224494363,-2.110114148114304
NCI-H1568,168312962,2.190321562510239,1.48933366232238
SaOS-2,2746,3.4161371679978436,2.8579929499469348
Panc 02.03,51039095,3.661030142872421,2.682611194240459
SK-CO-1,65628,3.554197618459022,4.026684176415168
COR-L105,16725315,5.297524124299076,4.150060666188836
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.710700657959646
RCC10RGB,46224516,2.231293839634299,2.370954746557396
RKN,9956119,4.4432647969313,3.4762974507018756
RKN,16065773,2.958619348149216,2.3641186374244216
WM115,17755052,0.4002517605741686,1.7101929835526413
WM115,168313200,2.1363369230808593,2.9593589282331023
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.5350305453431912
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,0.9218131221296273
LCLC-97TM1,9903786,1.8016114643921617,2.756077717004494
SaOS-2,49867926,4.146129188416838,4.110210541110895
RKO,25126798,4.002843113400742,3.7921789378214816
ALL-SIL,219104,1.1543769867483644,3.5366182443481806
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,2.144908880465776
SK-OV-3,3062316,0.5292744016150154,0.9747482048219924
SK-OV-3,11178236,-2.424602318267421,-3.539769866873396
LS180,9887053,3.1718141126704618,3.469815136639831
BFTC-909,25183872,0.7872065650622051,-0.902802947451298
NCI-H1568,2945648,2.136721092573253,2.7548400693819435
RKO,1716436,3.795795915163565,2.948755251800144
SW948,65064,5.291153994733523,4.739517756868576
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.860017480413567
SK-CO-1,16115403,-4.417233339728943,-4.875275216600306
SaOS-2,400769,-0.6660591873157414,-0.7855881743093749
SW1271,2733526,3.2893803459487594,3.714359432422819
BICR 31,4521392,4.267019749412992,4.280943620409205
P31/FUJ,25154868,4.728907139536709,4.289494395804131
HEL,676352,2.4086189638079643,2.088896150621564
PaTu 8902,BRD-K27188169,4.434214541500356,4.461608338658225
KU-19-19,44607531,3.044914521934579,1.48117322485652
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.699201704606489
SK-CO-1,72193861,-0.1340038294528125,1.3858780169906042
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,2.93841691857644
WM115,135423438,3.926483426744841,2.1190856698194294
RERF-LC-MS,135875424,2.839581382146162,3.743891076041643
PaTu 8988t,46926350,-4.145321949318386,-4.429063309555999
Daudi,23582824,-0.638376916275564,0.7400136078733197
Panc 02.03,168313200,4.226618217059218,2.9593589282331023
NCI-H1568,11175137,2.3278621292073067,2.477950770888125
COR-L105,11152667,-0.3968124554752262,-0.5866736007906306
IA-LM,5281672,4.428935042775787,4.4250678360691875
IGROV-1,3062316,-2.2361832227909075,0.9747482048219924
SU-DHL-1,5281672,4.30860315799997,4.4250678360691875
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,4.13551970928241
BICR 31,11625818,3.9395546041344858,4.10791451089978
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.22503529708604
NCI-H1568,445643,3.6093957886383814,3.9383569867901693
NCI-H1568,4477,0.3996701755478256,0.5570685949048098
RKO,36314,-4.63858923378885,-1.2422497803043113
Daudi,675434,3.694219652985114,4.463597576567934
MDST8,60750,-4.217127024403589,-2.435153852929516
WM115,9903786,3.894434750277636,2.756077717004494
RCC10RGB,5282054,3.6705963985990993,3.5628845676855256
HCC1500,262093,2.85046563878574,2.6275548088442098
BFTC-909,4259181,-0.0277162117211437,0.11236669175956715
COR-L95,252682,6.347695054422412,6.516263069090082
LS180,9911463,3.681535048080384,3.732908427020576
SK-HEP-1,1566236,1.7725788045776691,2.2263982365179604
LCLC-97TM1,6918736,-2.1743152466595626,-1.741781295359962
SW948,10231331,-0.4116197219649379,1.6547412916072393
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.117207225291035
KU-19-19,52912189,3.155674258646967,1.6723266261402217
PaTu 8988t,44185566,3.1955818251601493,2.4057100644299436
ALL-SIL,31703,-2.84181702758724,-1.182053713238432
MOLP-8,67156097,-2.505693621695456,-1.0279170724737183
P31/FUJ,12003241,-0.93015536828776,-1.0889198012759371
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.48117322485652
HuP-T3,72376,-1.771653200109272,-2.110114148114304
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.9860814461500107
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,0.9747482048219924
SK-CO-1,54649381,3.727346200170898,3.7880999548273127
BICR 31,4578,4.306546690441069,4.446937148676336
HEL,24856436,0.2549549224561803,0.17994774592918095
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,2.117207225291035
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,2.117207225291035
NCI-H1568,568763,0.1547040002068053,0.28862358029973745
SaOS-2,10184653,1.5674189620168135,1.1325795715302809
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,2.3791567205504176
SK-CO-1,10127622,-1.7782095442547816,3.6054187258933235
RKO,6450551,2.9764230599456782,2.361538429265863
RCC10RGB,11222830,2.1708629162803654,1.5350294688251391
MOLM-13,439501,-2.531564352317227,-2.2321662354381537
KU-19-19,5328940,2.592216165266187,1.559061663996469
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.344610112805219
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.8865368208635396
LS411N,46224516,2.772468105753273,2.370954746557396
COR-L95,3465537,1.5360689669151406,2.5477591829493655
NCI-H2452,650361,3.725817753027947,4.223422874692544
MOLP-8,135423438,1.7176055832456645,2.1190856698194294
Daudi,15953870,2.3174310256528017,3.4781017448929608
HEL,25062766,1.0860006913119025,2.0522756909743434
LS411N,9866186,0.9541786681011424,0.7577083020821866
NCI-H2452,72193861,1.1802568558602904,1.3858780169906042
SW1573,104842,-2.57352069349058,-3.040993872013826
SW48,1750826,1.3136286655933227,-1.4739669220989267
HCC15,25262965,-1.0400697166295236,-1.6224193967571534
SW948,156414,1.6424995325300082,1.1062813598863759
HEL,49793307,-3.822273429090704,-2.848251171596848
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.2349426527428076
KU-19-19,15983966,3.017543110767297,-1.6396194068861514
Granta-519,445643,4.101892829369416,3.9383569867901693
WM115,44462760,-6.607584862322745,3.143997930658831
COR-L95,16722836,1.6737270586986386,1.5333952667080324
HuP-T3,19582717,-4.617931701404403,3.9198146524152833
MOLP-8,135984461,3.690365922940533,3.6237408287871284
WM115,25105715,3.143290836206988,3.410449786117574
SU-DHL-1,6610355,4.337111630655639,4.45123297085854
P31/FUJ,107970,2.0437014771117425,2.3029314718240044
BICR 31,9903786,2.10396775229317,2.756077717004494
HCC15,119607,5.6213928119464285,5.129253777214588
K-562,53392493,1.9280012389180945,2.4832542501558077
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.6829735349466532
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.493389053048461
SaOS-2,6184667,2.75971928345779,2.901063659317265
HCC1500,49867930,4.391361036771465,4.9782389619557925
HCC1500,156422,3.756088196252004,3.8435202478608215
LS180,2729026,2.858515315971793,2.6325975116350393
UACC-812,9926054,1.7122964049751828,1.9546333131599372
BFTC-909,2945648,3.347829093032643,2.7548400693819435
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,1.7691529831259722
COR-L95,10427712,3.3507411292398315,4.184108330161863
HCC1500,73707371,6.057238887548947,5.18278851064184
SU-DHL-1,5566,2.363543718324467,3.029152149495273
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.8865368208635396
SW1271,44137675,2.993655891868926,3.337336921695599
PaTu 8988t,10385095,1.1295524511895831,1.2480392352773622
IGROV-1,107970,2.287061680908213,2.3029314718240044
LCLC-97TM1,3081361,3.200154540210029,2.3568884936851697
MDST8,24797083,1.659668465713326,1.277886491385028
MOLM-13,100016,3.967621300341963,5.87798299213578
SW48,6914657,-5.582748420606011,-4.170094408243688
RKN,54454,2.1815674244706407,2.548844675602096
SW1271,54686904,4.077781574312711,3.776063215737675
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,-1.1532493383305307
LCLC-97TM1,11152667,-1.9849905525936635,-0.5866736007906306
RKO,6610355,5.147293026177706,4.45123297085854
HuP-T3,11234052,4.425621489915021,3.869960809483736
BICR 31,11485656,2.9684140094972387,2.2397291078765758
HCC15,445643,3.643779771767104,3.9383569867901693
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.11065310288154762
Granta-519,6918878,0.9437787040623058,1.9069091595174383
SU-DHL-1,16720766,-1.7997333167058054,0.4291253754884592
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.9218131221296273
RKO,11626560,1.596896929931414,1.6795489442409048
IGROV-1,44589607,3.0909001492794377,2.659070263037081
HEL,168313047,1.7739787927154282,2.4053217165791536
IGROV-1,11964036,-0.1609353030421705,1.2382789669868983
SK-HEP-1,969516,2.3030983588134917,2.7772567284956553
LS411N,68056272,3.648680202626129,3.2394422692786446
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.4554460238042177
HEL,2749,1.5352641298417238,1.7932893499757152
MOLM-13,135398516,0.1807695197937267,2.0509021680173207
Daudi,176870,1.9898427065198672,3.0253996189023358
HEL,10427712,4.076538081897971,4.184108330161863
SW948,24772860,-2.2115718578693495,-2.2690769633318126
Granta-519,2729026,1.8472912754822493,2.6325975116350393
COR-L95,5394,4.313147278509764,3.9762102103866797
LS411N,46907787,0.8939335106347707,1.584957029505121
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.375424781932207
KU-19-19,11485656,2.7576201496249264,2.2397291078765758
IGROV-1,2858523,3.196384505087132,3.0086502241129605
SW948,702558,5.163408425848839,4.9782351440396395
RERF-LC-MS,72734382,4.885789692793362,4.3578051352274185
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,0.4199080872215506
RERF-LC-MS,11964036,1.6707185338079893,1.2382789669868983
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.289494395804131
SW48,3038522,2.575519148977434,2.9847437848386558
IGROV-1,11364421,-2.1205062036040982,-2.2476185097624475
Daudi,24753719,1.7041863717102288,4.143618673527016
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,3.456683733824014
SW1271,73707438,3.2742940196229022,4.210679418158044
MOLM-13,44487061,4.373293273870424,4.3789002420433025
SaOS-2,568763,0.7449819257203903,0.28862358029973745
SaOS-2,168313200,1.7182390433527042,2.9593589282331023
K-562,15547703,3.09098547046412,3.114669509763707
BICR 22,24785538,-0.3286106781648999,1.3344504348570345
IGROV-1,9936388,2.10108466287406,-1.7988236137529168
BICR 22,4477,1.559722374810713,0.5570685949048098
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.133687221210622
BICR 22,16038120,1.2563245393113998,0.9090093368534204
PaTu 8988t,56649450,4.324867884259214,2.999158341046921
PaTu 8988t,135411,1.3050507330755643,0.5181226666256136
NCI-H2452,12001922,2.2907278374018296,1.8522788760744173
RKO,44185566,2.4837284923488063,2.4057100644299436
K-562,9826308,0.1842141800186153,0.12580254156308923
RCC10RGB,5311281,4.058856975975892,2.22503529708604
WM115,5460769,2.9023963298546507,2.3447175553942796
HCC15,119182,0.1055567812373319,-1.3340160156368264
BICR 22,44607531,1.5270609291983028,1.48117322485652
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.5346517263124715
NCI-H1568,25262965,-4.225307409424958,-1.6224193967571534
SW948,5328940,1.2304763256018572,1.559061663996469
IA-LM,10296883,4.25848729020474,3.795028277273254
LCLC-97TM1,11964036,0.9095700511944136,1.2382789669868983
SK-OV-3,10074640,3.759507235638381,3.066922642013836
BFTC-909,25062766,1.7422044094415416,2.0522756909743434
MOLM-13,44202524,0.8413416322030352,1.9639001504219202
P31/FUJ,44137675,3.225768708166513,3.337336921695599
PaTu 8902,42642645,2.254917267204718,0.7845058245277501
RKO,53232,4.485666667988006,2.8161144578264046
MDST8,51039095,3.753808380930837,2.682611194240459
ALL-SIL,25150857,1.7729123360103365,2.336756962918186
KU-19-19,136227924,3.1447471190609217,2.867001064974719
BICR 22,9911830,2.5765146499323497,2.4240324657892436
SW48,26596,-2.356334812614481,-1.5346517263124715
WM115,8515,4.149615392892544,3.7716438213452004
SaOS-2,3025986,-1.3703894596366477,-0.8978770871810051
LS411N,6623618,2.410312404439064,2.1468722777789853
RKO,2749,1.3580925102381314,1.7932893499757152
SW1271,9915743,1.6128868969613257,0.5935480801734145
SaOS-2,44589607,3.1014372869468736,2.659070263037081
BICR 31,9908783,4.390198834476992,5.056023266605311
RERF-LC-MS,1641662,3.403538628142178,3.3408828038827
SW948,168313200,2.3052543991742933,2.9593589282331023
BFTC-909,16720766,-0.0189955240044846,0.4291253754884592
HCC1500,46843906,3.5664723036358703,2.723521570705241
BFTC-909,5291,3.495280995080932,3.5530526201153183
PaTu 8902,5287620,-1.817962379422155,-1.9697846958841214
Granta-519,24772860,-2.616849709254195,-2.2690769633318126
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,2.474523360549852
MOLM-13,2858523,2.990787770243497,3.0086502241129605
MOLP-8,73707398,-1.5200522985211378,1.180307991266282
WM115,4788,5.364989483250021,5.493389053048461
KU-19-19,11717001,1.9129980214779312,3.961276339234443
PaTu 8988t,3854666,2.839522644305469,1.85063491630251
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,1.0163468544412688
RKN,11222830,1.5707482267531538,1.5350294688251391
SK-HEP-1,5978,1.689065603838291,-2.3753204421143224
LS180,374536,-1.6764778169414856,1.7732341041149164
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.38762532684053896
RCC10RGB,46199207,3.760684270246491,3.1312366616263048
SW1271,49836020,-1.4027167140646708,2.5464279658175073
BFTC-909,2130404,3.366307483642889,3.195187949563447
SW1271,3384730,3.1846503121443144,2.4620443610818112
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.0276770243216165
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.0665232817889554
SaOS-2,285033,-3.099559966451384,-2.1791335812392365
LS180,71466578,4.68838045718991,3.983075654179168
LCLC-97TM1,2126,5.523539990092585,4.466606494133751
NCI-H1568,9936388,-8.53108348301746,-1.7988236137529168
Panc 02.03,6505803,-1.93196111296706,-0.5114413444588124
BICR 22,9926054,1.8271931211135617,1.9546333131599372
SW1573,54618164,4.339091959582753,4.02740727006158
COR-L95,9907093,4.309721999642839,4.134688957161641
LCLC-97TM1,9911830,3.2250615193472085,2.4240324657892436
K-562,151289,0.3703020531314545,0.9562867634504244
HCC1500,24821094,2.4557115965701257,2.7369152351179045
ALL-SIL,11222830,0.8263932665864424,1.5350294688251391
ALL-SIL,44490293,5.541636788423512,2.7785569635127336
BFTC-909,15547703,3.647732910564925,3.114669509763707
PaTu 8988t,11175137,3.61207596874577,2.477950770888125
COR-L95,44566777,1.612039010223373,0.6972581949653407
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.5478733404534093
SW48,9444,3.3118033011757806,4.054048446110465
COR-L105,52947716,1.1539739817838972,-1.4012147836358484
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,1.8712017695678478
SW1573,16013152,3.6979705228045354,4.119375381760217
SW1573,17759555,4.342323370433329,3.5392373768677334
SW1271,11609586,3.768986685585146,2.621607380466062
K-562,3552672,6.190745251508109,2.8413574589562494
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,0.9562867634504244
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,2.9860814461500107
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,3.456683733824014
IGROV-1,57519531,2.639098862164858,2.4211376500246136
IGROV-1,1716436,3.2816872421007375,2.948755251800144
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.5350294688251391
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.37491183386883553
IGROV-1,2828334,6.070696247039626,6.082620037824382
SW1271,53495165,2.774319130141937,-0.19108456656304296
SW948,67291369,3.8063591597957593,1.794812676489941
Daudi,11507802,0.3815953316544085,1.3590460953824346
RERF-LC-MS,2708,5.106155932743474,4.591243765137335
SW1573,52912189,3.9296893768173065,1.6723266261402217
SU-DHL-1,25154868,3.5324679540942165,4.289494395804131
BICR 31,24772860,-2.497965982707089,-2.2690769633318126
K-562,11719255,4.077642177046201,3.1221102230298534
WM115,5470400,-1.5377493662522326,-0.3765538821264742
KU-19-19,44589607,3.6813877406069246,2.659070263037081
LS180,11626560,1.7567799331145733,1.6795489442409048
Daudi,11427553,0.4642664556868584,2.578035472123966
HCC1500,44607531,1.3781074542184104,1.48117322485652
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.38762532684053896
PaTu 8902,4259181,0.9791956381618654,0.11236669175956715
SaOS-2,216345,4.363902597199754,3.7540083674013296
BFTC-909,100016,5.8134150302243865,5.87798299213578
BICR 22,56963564,0.2615280103832354,0.2569389627451253
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.0276770243216165
LS180,613753,3.1711720082363337,3.1495845971526135
BICR 22,3825829,4.259881935728516,3.8869840981378028
P31/FUJ,25262965,-1.897985536240049,-1.6224193967571534
RKO,15953870,3.3462063589818034,3.4781017448929608
ALL-SIL,26596,-3.0181503922951674,-1.5346517263124715
SW1271,4788,5.888244914590778,5.493389053048461
COR-L105,25150857,2.68968810352953,2.336756962918186
RKO,24753719,3.882573791668401,4.143618673527016
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.1221102230298534
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,3.0665232817889554
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,3.0665232817889554
PaTu 8902,613753,4.768885644214674,3.1495845971526135
PaTu 8902,44589607,3.762990171329796,2.659070263037081
MOLP-8,176870,4.692998654081846,3.0253996189023358
MOLP-8,216468,0.300035377459394,2.5020743765616316
NCI-H1568,1641662,3.419317894706959,3.3408828038827
HCC1500,11626560,1.5792444837322512,1.6795489442409048
HCC1500,3689413,-1.6712109221216571,-0.4039154566871359
RKN,984333,1.094463938199557,0.5138000229415411
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.732908427020576
COR-L105,4788,5.897633886873905,5.493389053048461
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,2.3791567205504176
PaTu 8988t,136227924,2.49705731140334,2.867001064974719
LCLC-97TM1,3634881,2.947438100526324,3.1576774496130544
RCC10RGB,53392493,3.4706572822964072,2.4832542501558077
Panc 02.03,10385095,1.3097039910351371,1.2480392352773622
RERF-LC-MS,445455,4.41080153827665,4.540053644561405
PaTu 8988t,6918638,2.256433939948275,0.3065957347013626
KU-19-19,24951314,1.2793314486163916,1.227614980483031
MDST8,25183872,-0.5549651899708961,-0.902802947451298
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.2349426527428076
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.4539899714896953
COR-L95,9908783,4.358103020890871,5.056023266605311
COR-L105,3552672,2.0991572824292435,2.8413574589562494
SK-CO-1,5566,2.706069596509063,3.029152149495273
RERF-LC-MS,969516,2.2498421794663095,2.7772567284956553
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.3153680794849765
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,1.7724503678159762
NCI-H2452,452548,0.0358025934468,-0.31026393275322106
Daudi,409805,3.686040208403983,4.6745070702664995
BFTC-909,5287620,-2.871557478653834,-1.9697846958841214
UACC-812,25183872,-0.2383295665292847,-0.902802947451298
SW48,36462,-1.5563073788110886,1.5076124324231743
SK-CO-1,327653,3.1822308576162692,3.018652636936018
MOLP-8,11507802,0.9747707839930404,1.3590460953824346
SW48,55508,1.9258231187784565,3.1188086218267883
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.031058842574058
COR-L105,16065773,2.993283969068687,2.3641186374244216
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,-0.19108456656304296
LS180,451668,4.827094473942733,-0.17843514405649885
IGROV-1,36462,2.313632721410001,1.5076124324231743
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,2.8341325456747963
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,1.4554460238042177
MDST8,11719255,3.580824685094748,3.1221102230298534
BICR 22,135984461,4.376718251500639,3.6237408287871284
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.0276770243216165
Granta-519,2871966,-2.0442685638601947,0.29730316799892464
Panc 02.03,136227924,3.0839082623333387,2.867001064974719
IA-LM,10074640,3.892343788144062,3.066922642013836
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.4554460238042177
BICR 22,10231331,2.1949493731732095,1.6547412916072393
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.3848601780620533
NCI-H2452,10127622,4.466077980380041,3.6054187258933235
PaTu 8902,11178236,-2.9840755573739943,-3.539769866873396
MDST8,6918837,-2.3764765121755,-3.046222711611649
HCC15,1716436,2.8917896521916537,2.948755251800144
Daudi,5351362,0.314899635949887,1.4604743967139864
IGROV-1,1750826,-3.124548162001242,-1.4739669220989267
SW1271,24779724,6.290779023739936,4.725601600845458
SW948,216468,0.513065020542466,2.5020743765616316
HCC15,5738263,4.375256926251463,3.3050405288071003
Granta-519,25183872,-2.24080905771406,-0.902802947451298
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,1.7724503678159762
SaOS-2,46926350,-4.2820912559124995,-4.429063309555999
COR-L105,49766530,-0.5480688242609842,-0.6944377068647134
HEL,2874250,-2.245656223692803,4.0377213891771015
K-562,45279963,2.402740503794971,3.660133434789582
SW1271,441298,2.7117876410913073,2.5423368047098167
Daudi,46215462,1.1016280052611975,1.762132613731386
BFTC-909,9915743,2.0959000942543025,0.5935480801734145
Granta-519,55508,1.5366901224911111,3.1188086218267883
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,1.3590460953824346
SU-DHL-1,445455,4.339452591135178,4.540053644561405
Granta-519,11222830,0.944926764715042,1.5350294688251391
SK-HEP-1,135421197,3.339831791709741,1.8199795612290348
COR-L105,11719255,5.177770829400177,3.1221102230298534
SaOS-2,49793307,-3.0698778362667807,-2.848251171596848
SU-DHL-1,54618771,0.3433661921186922,0.9253379925205388
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.5478733404534093
IGROV-1,54618164,4.2184521751950115,4.02740727006158
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.3228542035372683
HCC15,4259181,-0.5021574884501439,0.11236669175956715
PaTu 8902,5311,1.4468060231693458,1.2663000347984639
SaOS-2,11609586,3.464015551213678,2.621607380466062
BFTC-909,26596,-1.7437210940555867,-1.5346517263124715
RKO,3385,4.410917651107157,3.472185389430271
SW48,5282054,3.4229655251352984,3.5628845676855256
HEL,3025986,1.4059985389197358,-0.8978770871810051
HCC15,2749,2.6993987110059456,1.7932893499757152
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.0058447943574325
MOLM-13,2733526,3.3430267495988693,3.714359432422819
HCC1500,71466380,5.203984730888507,4.275465599745589
SK-HEP-1,104842,-1.0887000355540395,-3.040993872013826
SW948,5566,3.1149649258053107,3.029152149495273
Daudi,11234052,2.508646185471885,3.869960809483736
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-1.1532493383305307
SW48,208908,0.7661322887377208,1.8663560178908947
SW48,24978538,0.0148337391131729,0.6273547794147847
P31/FUJ,9926054,1.2698752833949425,1.9546333131599372
Daudi,5287620,-2.5355659158885167,-1.9697846958841214
BICR 31,53325874,4.467091056736401,4.753377022200137
LS411N,400769,-0.3072623933562745,-0.7855881743093749
HCC15,7326481,6.13295321500094,2.957630994714242
LS180,6610216,4.524725364990245,4.26979744561799
BICR 31,11609586,2.804864928293696,2.621607380466062
NCI-H1568,5351362,0.9370615420718584,1.4604743967139864
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.0665232817889554
HCC1500,26596,-0.8174609850015592,-1.5346517263124715
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,1.3153680794849765
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.860017480413567
BICR 31,5311281,1.899563489561116,2.22503529708604
HuP-T3,11964036,1.9148977928601396,1.2382789669868983
HuP-T3,6918328,0.6989696425214073,-0.28710840066117727
IA-LM,56963564,0.8197284064300991,0.2569389627451253
K-562,25227462,-1.535473545694956,-0.4151865926866767
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.2394422692786446
P31/FUJ,6438330,0.60015264799364,2.016737971321332
NCI-H1568,54143018,1.7330311939537375,0.31711465707788644
MOLM-13,10184653,-1.0304513474260102,1.1325795715302809
COR-L105,3081361,0.7591954413754667,2.3568884936851697
SW48,3465537,3.829258919586145,2.5477591829493655
SK-CO-1,135398516,1.0451560562277196,2.0509021680173207
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,2.117207225291035
BICR 31,11222830,2.7999268343872603,1.5350294688251391
P31/FUJ,1750826,-3.787471607079622,-1.4739669220989267
MOLM-13,124202324,0.9453642044256088,2.1784388364790748
LS180,445091,4.461419397707798,4.3274252089919045
K-562,4578,4.401657334703153,4.446937148676336
BFTC-909,31703,-0.9928331583982526,-1.182053713238432
Daudi,54618164,3.154466747848232,4.02740727006158
HCC1500,375860,0.1348683063529126,-0.30112130782396007
MOLM-13,3385,-0.0516453787728095,3.472185389430271
Daudi,123631,1.6174763425926726,2.2760265557358337
SW1573,6610355,4.129027118562099,4.45123297085854
K-562,44589607,2.662527895237601,2.659070263037081
SW948,24964624,1.7910099631647045,2.2827362159867324
LS180,387447,-4.2321913932512185,-4.3765957253648695
SW1271,445091,4.3767610709371025,4.3274252089919045
LS411N,5328940,2.1913370268343324,1.559061663996469
ALL-SIL,46199207,2.4207183231317826,3.1312366616263048
BFTC-909,644241,3.062866082016443,2.1017288356510795
SK-CO-1,5738263,3.1381077819263954,3.3050405288071003
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,3.456683733824014
PaTu 8902,3385,6.504553614083827,3.472185389430271
SW1271,5328940,1.739297434861375,1.559061663996469
Daudi,444795,4.05018196872557,3.7799917274901733
SaOS-2,9887053,4.468769125876902,3.469815136639831
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.45123297085854
MOLP-8,9936388,3.4211096692910052,-1.7988236137529168
SaOS-2,5746,3.648398890023908,0.8084551861824514
PaTu 8988t,135875424,4.8815767191826325,3.743891076041643
SaOS-2,25195348,4.111342507306749,3.08171494739702
NCI-H1568,135398738,4.732110826035958,3.3919135064420334
RKO,5329102,2.192208184281935,2.031058842574058
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.7007618437932
WM115,11612883,3.668907379861532,2.6386482274158856
HCC1500,24785538,2.8337652504333817,1.3344504348570345
ALL-SIL,3854666,-1.067048731148745,1.85063491630251
WM115,11494412,2.975341542339242,1.4248282417532188
Granta-519,9884685,-0.5481626961732873,0.4230357541133405
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,2.117207225291035
KU-19-19,5287620,-2.913600334543538,-1.9697846958841214
HCC1500,25227462,-1.134185511373382,-0.4151865926866767
SK-OV-3,9936388,2.038842599711319,-1.7988236137529168
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.970396511864891
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.3518500781597358
COR-L95,9840324,5.902997789616562,5.7711165719697215
SK-OV-3,159324,5.082712026660022,2.0742938672876736
COR-L105,5426,4.419968019169297,4.746710128133936
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.3848601780620533
HuP-T3,44491742,4.372770131484514,4.1566745174283435
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-1.57821899028641
MOLM-13,5978,-4.923441638627742,-2.3753204421143224
KU-19-19,9911463,4.338553857034003,3.732908427020576
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.6778195760397165
MDST8,9956119,3.20428794924567,3.4762974507018756
IGROV-1,44137675,1.8406125640672395,3.337336921695599
NCI-H1568,24771867,2.7621066837370156,1.5171458615349627
SW1573,3503,1.662872296112478,2.2426858883255045
ALL-SIL,54143018,-1.6646130342073118,0.31711465707788644
KU-19-19,9903786,4.470072542277405,2.756077717004494
Granta-519,67291369,2.669151289874282,1.794812676489941
HuP-T3,126941,-4.07371973001698,-2.8921209077069348
IGROV-1,11175137,1.8411496230681277,2.477950770888125
LCLC-97TM1,3543504,4.4040963352609825,4.269325105068445
PaTu 8988t,10184653,1.9115764380070437,1.1325795715302809
BICR 31,10184653,-1.3652350776002238,1.1325795715302809
PaTu 8988t,4917,3.9515789700022728,3.079848880785536
LS411N,9967941,4.95978669187673,3.6034131982542865
SW948,6918837,-5.2716912634433815,-3.046222711611649
Granta-519,19582717,3.2223711893143796,3.9198146524152833
HuP-T3,753704,5.56041062328625,4.832125608051433
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,2.344610112805219
HuP-T3,44819697,0.7007171788005963,-0.6109288989041974
Daudi,49766530,-5.535187194073846,-0.6944377068647134
RKO,168313047,1.9322709085928884,2.4053217165791536
HEL,451668,-1.9900462993769088,-0.17843514405649885
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.699201704606489
ALL-SIL,637858,0.2842777242368783,1.8880097009592578
SW48,375860,-0.9823609780883206,-0.30112130782396007
Granta-519,426756,3.1337304970475865,4.301139445753315
LS411N,3038522,4.360410119835835,2.9847437848386558
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.6778195760397165
NCI-H2452,11626560,1.8431584922948163,1.6795489442409048
SW48,135398516,1.3232406127849534,2.0509021680173207
SW48,5329102,0.4162536894409948,2.031058842574058
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,3.4956311613712456
BICR 22,11427553,3.133254296040306,2.578035472123966
NCI-H2452,72376,-3.519434001557919,-2.110114148114304
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,2.694366237977623
K-562,135984461,3.2548026411837787,3.6237408287871284
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.344610112805219
Daudi,73707398,-0.7942959168982594,1.180307991266282
NCI-H2452,46398810,2.3683678826725387,2.510712955745063
PaTu 8902,5738263,4.741832860910815,3.3050405288071003
MOLP-8,10322450,4.082153801594249,3.669858075898477
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.02740727006158
SW48,5287620,-2.9796019172473747,-1.9697846958841214
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,1.133687221210622
MOLP-8,56963564,0.2564931281605764,0.2569389627451253
Granta-519,375860,-0.9367901929922506,-0.30112130782396007
SK-CO-1,656346,-0.6691405855346803,0.7582608913284792
RCC10RGB,44607531,1.912198544747903,1.48117322485652
RKO,9823820,5.913042612438718,3.7294514785702977
SW1271,25262965,-0.6695626057691765,-1.6224193967571534
SaOS-2,2742550,4.001711578380083,3.8595787492072238
SW948,44491742,3.910317363967626,4.1566745174283435
K-562,25105715,3.3934107563871088,3.410449786117574
K-562,3689413,1.0071697658281389,-0.4039154566871359
NCI-H1568,9911830,1.3917537385715242,2.4240324657892436
IGROV-1,42642645,0.3750175292659389,0.7845058245277501
MOLP-8,53392493,1.8438027475223988,2.4832542501558077
BICR 22,4788,5.9489186959823845,5.493389053048461
IGROV-1,5287620,-1.5394168430569777,-1.9697846958841214
IGROV-1,446155,3.750396425244744,2.662752180605146
LS180,15983966,-3.417830365026362,-1.6396194068861514
MDST8,5566,3.234550965497495,3.029152149495273
K-562,644241,-4.86229706466587,2.1017288356510795
SU-DHL-1,135421197,1.1384736779813156,1.8199795612290348
KU-19-19,44507138,1.5611189443326865,2.3228542035372683
Panc 02.03,5281321,1.7682996743542674,-1.3097742666845045
SW948,44607531,1.464462944366021,1.48117322485652
KU-19-19,54649381,3.8760376098429616,3.7880999548273127
Daudi,25062766,1.1734245449662122,2.0522756909743434
IGROV-1,56946209,-4.416985130578084,-4.2202975286026225
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.6944377068647134
NCI-H2452,11238147,5.37150149846425,2.694366237977623
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.0163468544412688
HEL,3689413,-2.191477482826257,-0.4039154566871359
WM115,285033,-0.1832916587196474,-2.1791335812392365
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.7691529831259722
SU-DHL-1,426756,3.3694285311129777,4.301139445753315
WM115,135999136,1.8466122948256136,3.6300382464802663
IA-LM,45279963,4.638115534107364,3.660133434789582
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.3153680794849765
SW948,4917,3.7157271581620166,3.079848880785536
Granta-519,119182,-4.107570420442856,-1.3340160156368264
MDST8,56946209,-2.145438357732055,-4.2202975286026225
HuP-T3,9927531,4.952379772704904,4.578027762171671
RCC10RGB,72967,3.7162805539485775,3.749474136437445
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,2.9860814461500107
COR-L105,25126798,3.974391104898093,3.7921789378214816
IGROV-1,676352,2.310492141650647,2.088896150621564
MOLM-13,11640390,3.605079146985929,3.2466540190485103
SW1271,10302451,1.5832525718610488,3.0143591766147457
HEL,123631,2.2046071754004553,2.2760265557358337
Daudi,9887053,0.4273795924431001,3.469815136639831
HCC15,53232,1.2438342439906054,2.8161144578264046
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,1.78247230086659
MOLP-8,107970,1.7976582890286323,2.3029314718240044
COR-L105,12003241,-1.8759508779616432,-1.0889198012759371
SW948,11222830,1.2602033369542562,1.5350294688251391
LS411N,60750,3.4958773713368725,-2.435153852929516
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,2.474523360549852
COR-L95,11152667,-1.0192155235937173,-0.5866736007906306
RCC10RGB,136227924,3.611686331312014,2.867001064974719
Granta-519,46398810,1.929291860170987,2.510712955745063
SW1271,135999136,4.614562085611917,3.6300382464802663
IGROV-1,53232,2.4872106086763393,2.8161144578264046
SW1271,5329102,1.7502689549650896,2.031058842574058
Granta-519,136227924,1.3333863896282263,2.867001064974719
HCC15,11213558,1.313690011959325,1.4781707184028035
BICR 22,54619267,3.924840101579574,3.9342007971372475
MDST8,9907093,2.778674083883115,4.134688957161641
P31/FUJ,11175137,-0.7372235608093404,2.477950770888125
MDST8,36314,1.6029219233562175,-1.2422497803043113
PaTu 8902,2746,3.932313359375791,2.8579929499469348
P31/FUJ,3543504,4.167476980253382,4.269325105068445
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,2.474523360549852
HCC1500,2749,1.6972528944159595,1.7932893499757152
HCC1500,2858523,2.9580940168196372,3.0086502241129605
P31/FUJ,241158,2.9181679480161997,3.598987869990464
IGROV-1,44202524,1.8303703172382677,1.9639001504219202
COR-L95,24856436,0.3013384579313291,0.17994774592918095
Daudi,15983966,-4.480185591931726,-1.6396194068861514
MDST8,9903786,2.958137426904596,2.756077717004494
SU-DHL-1,57519531,0.9649766396601452,2.4211376500246136
IGROV-1,25262965,-3.18785020602057,-1.6224193967571534
MOLM-13,135411,-0.7080955458923358,0.5181226666256136
HCC15,24901704,2.315976175325417,3.1103746959488285
SW1573,656346,0.5263129478884733,0.7582608913284792
SW1573,11238147,3.4967804964098517,2.694366237977623
MOLM-13,6918837,-5.322581124261525,-3.046222711611649
MOLM-13,444795,-0.8871401586886155,3.7799917274901733
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.714359432422819
SW948,44486219,4.202726475674803,4.281343219898981
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.0143591766147457
SK-HEP-1,4259181,0.3926762831937545,0.11236669175956715
MOLM-13,11152667,-8.249378694414048,-0.5866736007906306
HCC15,46199207,3.454904957256138,3.1312366616263048
COR-L95,BRD-K55473186,4.076833088818027,4.097702021052896
SK-HEP-1,11612883,3.763210558313423,2.6386482274158856
SW48,54619267,2.8192087316830587,3.9342007971372475
COR-L95,448949,2.666065821382702,1.9537365892294993
SW1271,31703,-2.541706035799043,-1.182053713238432
SW48,374536,2.9137455711630365,1.7732341041149164
HuP-T3,25183872,-1.5149537087973208,-0.902802947451298
BICR 31,71466578,6.11729815776394,3.983075654179168
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.3153680794849765
SW48,135440466,-0.9616456131279733,2.1401473911994366
Granta-519,322968,2.3569390760499234,3.4956311613712456
RCC10RGB,25227462,3.0929907596871646,-0.4151865926866767
P31/FUJ,6917907,-6.201167718101803,-4.864372369867458
PaTu 8988t,49793307,-2.0749757720441164,-2.848251171596848
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.4230357541133405
Granta-519,12001922,1.093482575381039,1.8522788760744173
SaOS-2,54649381,4.670802712896813,3.7880999548273127
BICR 31,11213558,1.307666782243681,1.4781707184028035
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,1.78247230086659
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.93841691857644
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.37491183386883553
SW1573,216468,2.7570678542174294,2.5020743765616316
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.93841691857644
LCLC-97TM1,441298,2.906797889353979,2.5423368047098167
LS180,24753719,4.21554861148433,4.143618673527016
ALL-SIL,65064,2.797289094590348,4.739517756868576
BICR 22,67291369,2.228219380635809,1.794812676489941
RERF-LC-MS,168313200,3.896073258981905,2.9593589282331023
SK-HEP-1,9444,4.343802313850578,4.054048446110465
PaTu 8988t,5328940,1.37213408852796,1.559061663996469
BICR 22,5311,1.9321946929787237,1.2663000347984639
BICR 31,219104,4.339385963743166,3.5366182443481806
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.133687221210622
ALL-SIL,4477,0.1906678465210559,0.5570685949048098
K-562,25154868,2.7747166739598264,4.289494395804131
SK-HEP-1,16065773,3.000790971898234,2.3641186374244216
PaTu 8902,11364421,1.1100050491651887,-2.2476185097624475
NCI-H1568,3081361,2.134244125445247,2.3568884936851697
HCC1500,11640390,3.4842141291887234,3.2466540190485103
BFTC-909,11626560,2.2197507332783735,1.6795489442409048
SW948,107970,1.650733689507072,2.3029314718240044
RKN,15983966,-2.847635435689191,-1.6396194068861514
P31/FUJ,11455910,0.7543092217738059,0.9557745122323711
MDST8,71466380,4.4925072325945825,4.275465599745589
HuP-T3,44185566,3.047929926499308,2.4057100644299436
WM115,24772860,-3.130789858430774,-2.2690769633318126
COR-L95,327653,2.664763845896721,3.018652636936018
BICR 31,46398810,2.284799792972812,2.510712955745063
MDST8,46199207,3.2831338438462545,3.1312366616263048
P31/FUJ,54143018,-1.089453758548118,0.31711465707788644
RKN,119607,5.106543735080002,5.129253777214588
COR-L105,5746,2.3338049438674933,0.8084551861824514
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,0.11065310288154762
MOLM-13,5738263,2.9100103684660237,3.3050405288071003
RERF-LC-MS,216345,4.25766275770173,3.7540083674013296
P31/FUJ,10322450,3.023071845081992,3.669858075898477
BICR 22,16065773,3.2562595111068933,2.3641186374244216
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.214923916993912
RCC10RGB,2858523,3.1824977664847833,3.0086502241129605
HEL,3634881,2.3660153954756,3.1576774496130544
BICR 31,4705,2.7587837218207194,3.0428654274536564
Daudi,16736978,-0.1290294552432643,1.3934160091023764
HCC1500,409805,3.5957056987066407,4.6745070702664995
COR-L95,11497983,3.7904455836505977,2.348631818792911
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,2.6829735349466532
HuP-T3,123631,3.4682236131630213,2.2760265557358337
MOLM-13,6918736,-1.7098661921605196,-1.741781295359962
MOLM-13,46943432,-0.154947866345158,1.70045196562753
HCC1500,219104,2.0821347677363473,3.5366182443481806
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.860017480413567
NCI-H1568,65064,3.2204713254113373,4.739517756868576
SW1271,16720766,0.8044088826386648,0.4291253754884592
Daudi,119607,3.8512151262400978,5.129253777214588
HCC1500,72193861,2.243893882523798,1.3858780169906042
K-562,5328940,0.7651330448756731,1.559061663996469
SaOS-2,644241,2.5011234622868415,2.1017288356510795
HEL,60700,-1.2821695146150829,-0.4482559328189002
RERF-LC-MS,25227462,0.8140348385016122,-0.4151865926866767
COR-L95,4521392,4.944619543772989,4.280943620409205
KU-19-19,16720766,1.6427063989874335,0.4291253754884592
SK-OV-3,3025944,4.375754256809385,4.206240213808089
P31/FUJ,36314,-5.221113398603202,-1.2422497803043113
Panc 02.03,568763,0.7660787595735656,0.28862358029973745
PaTu 8988t,60700,1.4149082605005396,-0.4482559328189002
BFTC-909,421610,2.763760389372973,3.1278257636093416
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.8341325456747963
RERF-LC-MS,123631,2.7610356359897104,2.2760265557358337
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,2.474523360549852
RKN,10385095,1.0188882527918253,1.2480392352773622
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,2.3791567205504176
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.117207225291035
Daudi,44486219,3.679556481815833,4.281343219898981
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,1.710700657959646
P31/FUJ,159324,1.227532336429348,2.0742938672876736
SK-CO-1,6252,-1.3434891204218062,-0.10942982547788271
LCLC-97TM1,656346,0.6605690440583806,0.7582608913284792
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.6778195760397165
RERF-LC-MS,675434,4.646232548137413,4.463597576567934
KU-19-19,123631,3.236221278135049,2.2760265557358337
MOLM-13,15983966,-4.417403089755366,-1.6396194068861514
HuP-T3,4917,3.663340719397695,3.079848880785536
LS180,44185566,1.7571027497277631,2.4057100644299436
P31/FUJ,11228183,-0.9086595542209992,1.8712017695678478
WM115,9933475,1.7795579913266513,1.793439230086884
RCC10RGB,445643,3.986839371383198,3.9383569867901693
LS180,11238147,1.5426585727528574,2.694366237977623
SK-OV-3,6918328,0.3966751205296329,-0.28710840066117727
SU-DHL-1,71466578,4.395132834723917,3.983075654179168
ALL-SIL,135421197,0.8278001934093618,1.8199795612290348
BICR 31,2858523,3.440938149330432,3.0086502241129605
NCI-H1568,72734382,4.159676082420196,4.3578051352274185
BICR 31,10427712,4.26091650049326,4.184108330161863
K-562,5351362,1.2059406782397044,1.4604743967139864
HEL,44589607,2.8579344181758164,2.659070263037081
RERF-LC-MS,89928392,3.2509495975064193,1.344325138639762
K-562,4705,3.481256778033869,3.0428654274536564
SW948,400769,-0.4902020150535968,-0.7855881743093749
RKO,46199207,3.448070090368443,3.1312366616263048
HuP-T3,10410894,4.484643398072658,3.2189174762180457
BICR 31,969516,3.644181632779252,2.7772567284956553
WM115,54618771,0.9043395114740442,0.9253379925205388
MDST8,2749,2.5181508528519365,1.7932893499757152
SW1271,4378219,1.9495591217614856,2.6822409618839944
RERF-LC-MS,12003241,-0.3897829713203344,-1.0889198012759371
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.769580038308904
PaTu 8902,44620216,3.796821774118314,4.02734353170299
MOLP-8,4378219,3.751203523477959,2.6822409618839944
PaTu 8988t,11152667,-0.7220641758089987,-0.5866736007906306
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.57821899028641
SK-OV-3,60700,0.4435128165358443,-0.4482559328189002
LS180,168313047,2.515878081381246,2.4053217165791536
K-562,400769,-0.7978860959413716,-0.7855881743093749
Panc 02.03,126941,-0.7071805078882285,-2.8921209077069348
NCI-H1568,3634881,3.2529386900783024,3.1576774496130544
LCLC-97TM1,24821094,3.5658031163211996,2.7369152351179045
LS411N,11485656,1.6093796612349578,2.2397291078765758
HCC15,16736978,2.153897232237977,1.3934160091023764
LCLC-97TM1,6610355,3.6494140877324273,4.45123297085854
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,2.0058447943574325
IGROV-1,9911830,1.9130562323799436,2.4240324657892436
LS411N,159324,3.2133975478450005,2.0742938672876736
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.0665232817889554
SaOS-2,322968,3.970591848140582,3.4956311613712456
BICR 31,216345,4.54975912567895,3.7540083674013296
HEL,3825829,3.033394475732853,3.8869840981378028
COR-L105,46191454,3.4168297701439223,1.3518500781597358
K-562,5113032,4.649240406472478,4.970396511864891
BICR 22,156414,1.4774483319728589,1.1062813598863759
SW1573,135875424,1.8143158468632437,3.743891076041643
WM115,12003241,-3.303596686294694,-1.0889198012759371
RKN,11640390,3.613472996393559,3.2466540190485103
HEL,23725625,2.914554844202699,4.726527081330662
COR-L95,36462,-0.8944975018350346,1.5076124324231743
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.8161144578264046
HuP-T3,11977753,3.281021154274905,-1.7159558966047241
SK-HEP-1,400769,0.2777482831309371,-0.7855881743093749
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,2.9860814461500107
SU-DHL-1,246676,5.693727803678488,4.505551974581321
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,1.6795489442409048
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.2359123501503817
RCC10RGB,44507138,4.147954700367582,2.3228542035372683
LS411N,123631,3.048490743589503,2.2760265557358337
MOLM-13,11213558,-2.3442824820578347,1.4781707184028035
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,2.699201704606489
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.37491183386883553
PaTu 8988t,444795,4.288290341819835,3.7799917274901733
SK-CO-1,66577038,1.9378658470267984,2.9870697487432882
SW48,24771867,-3.897611921368264,1.5171458615349627
NCI-H2452,9907093,3.826391051371518,4.134688957161641
SW1271,171352865,2.2565348875691624,3.764962937653422
SU-DHL-1,11152667,-1.9410189761528236,-0.5866736007906306
SK-HEP-1,148124,3.734435411699081,-2.0460232384010055
RERF-LC-MS,107985,-3.0933260647006215,-3.5771139994401464
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,2.659070263037081
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-1.2422497803043113
RCC10RGB,10184653,2.2305820416370965,1.1325795715302809
LS411N,17755052,2.4732315703899226,1.7101929835526413
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,1.1345509900924162
KU-19-19,24753719,4.40371401160258,4.143618673527016
PaTu 8902,72376,-1.694582331183855,-2.110114148114304
HEL,72376,-3.0304513894944933,-2.110114148114304
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.336756962918186
SW948,9884685,3.1398548031465525,0.4230357541133405
Daudi,24748573,1.578133478161721,1.9565115912575295
COR-L95,4917,3.3160135329409406,3.079848880785536
SK-CO-1,2708,2.7526164010571152,4.591243765137335
Daudi,5479543,1.606221989903471,3.2992765862159215
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.0163468544412688
MOLP-8,44632017,0.8356757219547752,1.0838611345650022
SW1271,9868037,2.9396003878324857,2.82815333449006
COR-L95,11455910,1.0154509596480157,0.9557745122323711
IGROV-1,445091,5.8777802446160825,4.3274252089919045
IA-LM,107970,1.9308025720075177,2.3029314718240044
BICR 31,15953870,5.115358479555731,3.4781017448929608
HEL,135984461,1.7610482730169696,3.6237408287871284
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,2.9860814461500107
PaTu 8988t,5311,3.6038975682992422,1.2663000347984639
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-0.8865368208635396
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.344610112805219
SK-CO-1,11228183,0.9546983133897222,1.8712017695678478
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.2349426527428076
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.117207225291035
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.5423368047098167
BICR 22,42642645,1.569820729256039,0.7845058245277501
RERF-LC-MS,387447,-4.351660250848144,-4.3765957253648695
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,2.3791567205504176
RKO,676352,2.3070338313311547,2.088896150621564
HEL,66577038,3.4935326109734217,2.9870697487432882
RERF-LC-MS,25062766,1.7296886540377192,2.0522756909743434
RKN,52947716,-5.912196482956353,-1.4012147836358484
SW48,56973724,0.919295357428288,2.823032655731692
LS180,66577038,2.8527700320727725,2.9870697487432882
K-562,7251185,2.894408284149289,2.4347287977616
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,0.38762532684053896
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.8978770871810051
MOLM-13,6918878,-0.6248914400619264,1.9069091595174383
IGROV-1,135421197,1.96820638017286,1.8199795612290348
RKN,11404337,0.6786980557761386,-0.4254091153988029
SU-DHL-1,6918878,1.5556600104975795,1.9069091595174383
MOLM-13,176870,1.4073018577806429,3.0253996189023358
SaOS-2,44566777,0.9896093397626105,0.6972581949653407
COR-L105,5470400,0.2171168006478052,-0.3765538821264742
LS180,44632017,0.4358481157568056,1.0838611345650022
RCC10RGB,16065773,4.176477311044804,2.3641186374244216
BICR 31,156414,0.5699919561712937,1.1062813598863759
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-1.1532493383305307
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,0.4199080872215506
Daudi,54596490,4.948926549609605,4.945697156281648
NCI-H2452,11317348,1.7824301660124695,2.3090854497210964
IGROV-1,60700,0.4424479122017752,-0.4482559328189002
IA-LM,135421197,2.370501142960713,1.8199795612290348
NCI-H2452,135423438,1.816833708086427,2.1190856698194294
NCI-H2452,6918837,-2.3246752526945413,-3.046222711611649
HuP-T3,409805,5.703463345532586,4.6745070702664995
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,1.2047817895412443
WM115,3025944,4.015069634557516,4.206240213808089
BICR 22,10127622,2.812639951672956,3.6054187258933235
RCC10RGB,16741245,4.755009504271123,3.801678648950925
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,1.2359123501503817
BFTC-909,1641662,3.805506520632872,3.3408828038827
SK-HEP-1,3136844,5.506062707172487,4.214923916993912
MOLM-13,5335621,3.915836728943439,4.560420742529089
ALL-SIL,6918736,-2.784980550106597,-1.741781295359962
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,1.7724503678159762
SK-OV-3,5311,1.582209129738937,1.2663000347984639
NCI-H1568,4378219,1.8995328874154,2.6822409618839944
PaTu 8988t,135440466,2.5529183901912456,2.1401473911994366
P31/FUJ,208908,3.0114989034455415,1.8663560178908947
MOLM-13,55508,1.530825081139479,3.1188086218267883
ALL-SIL,15983966,-4.919474478826657,-1.6396194068861514
ALL-SIL,72193861,-0.8088702984298154,1.3858780169906042
Granta-519,135875424,2.983761714085865,3.743891076041643
Panc 02.03,25062766,3.7424097220448207,2.0522756909743434
LS411N,5282054,4.11513360382112,3.5628845676855256
WM115,9956119,3.8110537513046423,3.4762974507018756
Daudi,10077130,1.7104594990439606,3.2681369737435437
PaTu 8902,54618771,-1.3103145579416535,0.9253379925205388
LS411N,6610355,5.174673905344729,4.45123297085854
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.662752180605146
Daudi,11364421,-5.814557541528941,-2.2476185097624475
SW48,10090485,5.377611493091081,4.776418823086279
RERF-LC-MS,252682,6.464777279315186,6.516263069090082
RERF-LC-MS,25195348,2.310586589861769,3.08171494739702
LS411N,57330099,4.386912904802011,4.311542343968036
RERF-LC-MS,5351362,3.2669953777859493,1.4604743967139864
SaOS-2,5281321,-2.1045144226453134,-1.3097742666845045
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-1.57821899028641
HCC1500,15953870,3.698430879415157,3.4781017448929608
BICR 31,107985,-2.559614665868775,-3.5771139994401464
SU-DHL-1,5978,-4.006589870739168,-2.3753204421143224
SK-HEP-1,387447,-3.995016034956776,-4.3765957253648695
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,2.621607380466062
BICR 22,44491742,3.912327775797625,4.1566745174283435
NCI-H2452,10113978,2.1292579793865167,3.010980031724017
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,2.0276770243216165
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,0.7705130043498147
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,0.7705130043498147
PaTu 8988t,10074640,3.912219918984309,3.066922642013836
RKO,25102847,3.0524897378806033,2.3366995460793083
K-562,446155,2.553560117982406,2.662752180605146
HuP-T3,3062316,-3.5835263694309862,0.9747482048219924
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,2.8341325456747963
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.0276770243216165
COR-L105,9915743,-1.8659407955600968,0.5935480801734145
SU-DHL-1,676352,1.6127382742380425,2.088896150621564
SK-CO-1,15983966,-2.8914318783251733,-1.6396194068861514
BFTC-909,6450551,3.0302116860685886,2.361538429265863
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.860017480413567
LCLC-97TM1,6852167,1.822160840349085,2.69961445504738
K-562,1716436,3.607306146681396,2.948755251800144
ALL-SIL,6917907,-6.413711962559719,-4.864372369867458
SW48,44505237,4.455085659285412,4.339301557123993
MOLP-8,4788,5.509648062033256,5.493389053048461
KU-19-19,49793307,-2.3409308252506777,-2.848251171596848
IGROV-1,46843906,3.392503571349757,2.723521570705241
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.7724503678159762
NCI-H1568,23582824,0.2708211860244319,0.7400136078733197
P31/FUJ,156414,0.8249508749632878,1.1062813598863759
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.9860814461500107
Panc 02.03,24951314,2.3006835537528585,1.227614980483031
RERF-LC-MS,46199207,3.61094494328213,3.1312366616263048
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-3.5071094923394703
IGROV-1,25102847,1.7007012555618253,2.3366995460793083
COR-L95,9884685,1.274087436172542,0.4230357541133405
RKO,5738263,3.4166283525852523,3.3050405288071003
BICR 31,446155,3.004688823756655,2.662752180605146
MOLP-8,3081361,3.002632255231731,2.3568884936851697
KU-19-19,124202324,2.2262797687523266,2.1784388364790748
COR-L95,241158,4.468160037389037,3.598987869990464
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,2.93841691857644
SK-OV-3,9926054,2.1800400954819716,1.9546333131599372
NCI-H2452,285033,-1.1649166052412432,-2.1791335812392365
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-1.6778195760397165
SaOS-2,3136844,3.967600163436525,4.214923916993912
Granta-519,36462,-1.2340392932323463,1.5076124324231743
Granta-519,24785538,0.1958729752370936,1.3344504348570345
WM115,5566,2.8846390038255127,3.029152149495273
IGROV-1,31703,-1.792518264692263,-1.182053713238432
HCC1500,3025986,-0.5847488606379614,-0.8978770871810051
K-562,2828334,5.968313970587813,6.082620037824382
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-1.57821899028641
LS411N,72193861,2.8187845663214848,1.3858780169906042
SU-DHL-6,11964036,-0.1529025297927845,1.2382789669868983
LS180,6918837,-2.789669873343886,-3.046222711611649
Granta-519,445455,5.050402748491994,4.540053644561405
LS411N,9926054,1.9376785020428349,1.9546333131599372
MOLM-13,135398738,2.371405234005272,3.3919135064420334
BICR 22,53392493,3.288173891171126,2.4832542501558077
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.78247230086659
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.466606494133751
MOLP-8,9823820,3.862667538801475,3.7294514785702977
SW948,219104,3.4463785749905886,3.5366182443481806
Daudi,56649450,2.7731175257265757,2.999158341046921
RKO,446155,4.170579555483674,2.662752180605146
COR-L95,2708,4.088828930735336,4.591243765137335
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.578035472123966
SW948,6610216,4.184431800680971,4.26979744561799
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,1.0163468544412688
MDST8,24978538,-1.5034064763640302,0.6273547794147847
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.8865368208635396
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,1.0163468544412688
RERF-LC-MS,44607531,1.5104561529736475,1.48117322485652
MDST8,16065773,2.461320056751215,2.3641186374244216
Daudi,11955716,-2.451420398730992,-1.4856643985320634
Daudi,44566777,-1.3909109996970672,0.6972581949653407
WM115,53495165,2.3633352174150155,-0.19108456656304296
MOLM-13,10077130,2.656845569256352,3.2681369737435437
LCLC-97TM1,11364421,-5.841421445385269,-2.2476185097624475
MOLM-13,9887053,0.5396890830211841,3.469815136639831
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0058447943574325
IGROV-1,46191454,1.3777495915525844,1.3518500781597358
Granta-519,5328940,0.7430401080732436,1.559061663996469
SW1271,54618305,4.440463475812739,4.084826955496459
COR-L95,23725625,3.551891881441416,4.726527081330662
RCC10RGB,46843906,4.246883034106686,2.723521570705241
Granta-519,2945648,2.528276278220214,2.7548400693819435
Granta-519,11977753,-6.302388202708452,-1.7159558966047241
SU-DHL-6,15953870,2.4587311871536315,3.4781017448929608
MOLM-13,10322450,2.9930800125873045,3.669858075898477
LCLC-97TM1,6505803,0.2281876141434561,-0.5114413444588124
WM115,9967941,2.88500943866673,3.6034131982542865
K-562,44202524,1.302888790519651,1.9639001504219202
K-562,252682,6.220409267483573,6.516263069090082
HCC15,49867926,4.259454552862098,4.110210541110895
BICR 22,25183872,-0.1596442578279089,-0.902802947451298
RKO,17755052,3.988455753476612,1.7101929835526413
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.8341325456747963
PaTu 8988t,5566,2.9380975134161553,3.029152149495273
K-562,219104,3.3686951285077273,3.5366182443481806
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,4.4833676274788345
WM115,100016,7.477930972064711,5.87798299213578
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,2.0058447943574325
SU-DHL-6,46191454,-0.3846699961999978,1.3518500781597358
LS180,124202324,2.088899784140079,2.1784388364790748
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,0.9218131221296273
K-562,4261,1.1039684536741017,1.4288257082744877
NCI-H2452,5282054,2.993265650723398,3.5628845676855256
MOLP-8,168312962,1.5743557083321402,1.48933366232238
Granta-519,969516,1.9567849087702365,2.7772567284956553
NCI-H1568,25062766,1.9660972036535989,2.0522756909743434
MOLM-13,448949,-0.3738099635599754,1.9537365892294993
SW48,11647372,-0.0986138935854908,0.8954839509867156
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,2.8341325456747963
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.117207225291035
RERF-LC-MS,11977753,-0.575574044510787,-1.7159558966047241
LS180,49793307,-3.6014942577594415,-2.848251171596848
SW948,3854666,3.050289300885683,1.85063491630251
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.079848880785536
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,1.5478733404534093
WM115,5278396,3.4301399168519153,3.517590475337377
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,1.710700657959646
HCC1500,11485656,2.6610961572019103,2.2397291078765758
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,0.38762532684053896
Daudi,2945648,2.1407869976239087,2.7548400693819435
MOLM-13,3689413,-2.8005667715254017,-0.4039154566871359
RKN,3543504,4.234888347098623,4.269325105068445
IGROV-1,24964624,0.5052308994941754,2.2827362159867324
PaTu 8988t,676352,1.787056590779638,2.088896150621564
RERF-LC-MS,10385095,0.7812016081678173,1.2480392352773622
WM115,4259181,1.0090630393378868,0.11236669175956715
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-1.57821899028641
SaOS-2,1239801,5.3522865443092575,3.981036641317754
Granta-519,44137675,2.975150065736677,3.337336921695599
Daudi,11455910,-1.173613913103254,0.9557745122323711
UACC-812,11152667,2.562952126743398,-0.5866736007906306
SaOS-2,16219061,3.147835700454569,3.135611362850641
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.6829735349466532
SaOS-2,71304818,3.198114510015862,2.396178486082573
IGROV-1,57330099,4.391385744785918,4.311542343968036
LCLC-97TM1,2729026,2.4668071198749555,2.6325975116350393
HCC1500,5281672,4.190998095776345,4.4250678360691875
NCI-H1568,9884685,-0.6579514975056241,0.4230357541133405
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.4832542501558077
LS411N,107985,-2.091782559178726,-3.5771139994401464
COR-L95,42642645,0.7279572059378924,0.7845058245277501
LS180,5566,2.7460265721966897,3.029152149495273
COR-L95,104842,-6.859012992539376,-3.040993872013826
K-562,702558,5.364922414830515,4.9782351440396395
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.0163468544412688
LCLC-97TM1,9929138,5.774162864206733,5.665997549800987
LS411N,31703,0.7183186901084707,-1.182053713238432
WM115,23725625,4.964211357698685,4.726527081330662
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.7691529831259722
SaOS-2,24978538,2.44958290959275,0.6273547794147847
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.2047817895412443
PaTu 8902,2858523,3.3217981805434196,3.0086502241129605
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.0509021680173207
SW48,65628,3.988389614478155,4.026684176415168
Granta-519,9903786,1.2937892753152922,2.756077717004494
IGROV-1,71304818,2.4878074097553378,2.396178486082573
COR-L95,25105715,3.673741872436949,3.410449786117574
HuP-T3,6918837,-1.8626358392084263,-3.046222711611649
PaTu 8988t,72376,-1.956580109455481,-2.110114148114304
NCI-H2452,46907787,3.091101876271566,1.584957029505121
SW948,23725625,5.544404993552476,4.726527081330662
K-562,25062766,2.5223735702376753,2.0522756909743434
SaOS-2,753704,5.53840358060444,4.832125608051433
NCI-H2452,56973724,2.8465784993073564,2.823032655731692
Granta-519,71466578,4.383489061930637,3.983075654179168
SW948,11609586,2.9863433458317714,2.621607380466062
HEL,71466445,1.5745300131733593,3.3478019143630626
Daudi,5329102,1.2784768117884069,2.031058842574058
HCC15,409805,6.461768980239098,4.6745070702664995
Daudi,2871966,-2.2343916463272873,0.29730316799892464
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,2.8341325456747963
RERF-LC-MS,135421197,1.554065103888189,1.8199795612290348
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,2.699201704606489
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.0058447943574325
PaTu 8988t,25150857,2.5954794764360343,2.336756962918186
P31/FUJ,11152667,-2.5755274762926095,-0.5866736007906306
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.5350305453431912
BICR 31,2828334,6.263113325647995,6.082620037824382
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.2834565267098785
IGROV-1,11507802,1.5049911819213722,1.3590460953824346
Daudi,11485656,1.7254760898020216,2.2397291078765758
Granta-519,11152667,-3.975154363660797,-0.5866736007906306
SW48,11640390,-0.422464249163724,3.2466540190485103
IA-LM,2828334,6.3387056990337705,6.082620037824382
HEL,36462,0.8349109175120154,1.5076124324231743
LS411N,4477,1.0450277541726452,0.5570685949048098
NCI-H2452,16219061,3.733701707144141,3.135611362850641
RKO,16741245,1.399079485469943,3.801678648950925
NCI-H1568,445455,4.330931204553833,4.540053644561405
K-562,15983966,-4.450185495623787,-1.6396194068861514
HCC1500,4096211,2.7054358198440345,1.856021664538426
SU-DHL-1,46191454,-0.3713761809994262,1.3518500781597358
IGROV-1,387447,-3.9508602289798658,-4.3765957253648695
NCI-H1568,71751553,3.6437596116554887,4.504570481353087
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.117207225291035
WM115,46199207,3.650123600055899,3.1312366616263048
SaOS-2,71680916,4.865393442781168,4.641848024405652
COR-L95,9823820,4.611798945344124,3.7294514785702977
HuP-T3,44589607,2.433680498088492,2.659070263037081
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.0163468544412688
IGROV-1,3634881,2.769147818550815,3.1576774496130544
COR-L105,54626689,5.0742986339862926,4.561309020020982
HEL,176870,2.3693727744318887,3.0253996189023358
LCLC-97TM1,9549297,2.332709006301325,2.3089350530287187
COR-L105,24180125,3.5925931777332676,2.888353933707551
MOLP-8,89928392,0.1045876418070581,1.344325138639762
BICR 22,3025986,-2.8899356497226756,-0.8978770871810051
ALL-SIL,400769,-0.758162988868875,-0.7855881743093749
BFTC-909,71466380,5.267829049221599,4.275465599745589
MOLM-13,24951314,-0.2336633009541456,1.227614980483031
MOLP-8,3038522,2.029025514425164,2.9847437848386558
RKN,16741245,1.555254881894904,3.801678648950925
COR-L105,71751553,4.255827287979035,4.504570481353087
MOLP-8,60750,-8.573260651984995,-2.435153852929516
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.133687221210622
BICR 22,24772860,-1.3590035600374548,-2.2690769633318126
LCLC-97TM1,5470400,0.2889153362640624,-0.3765538821264742
BICR 31,53232,3.653430995715962,2.8161144578264046
BICR 31,8515,4.104799625743522,3.7716438213452004
COR-L105,10127622,2.236200578684094,3.6054187258933235
NCI-H1568,5328940,0.3466597705312412,1.559061663996469
MOLP-8,135421197,1.7506124789909805,1.8199795612290348
SW1573,54454,1.176648172779268,2.548844675602096
NCI-H2452,11964036,2.1879069513719087,1.2382789669868983
MOLM-13,44493528,3.9608078939228175,4.333966846288542
SK-HEP-1,11396600,5.84824704867975,3.4309758536883517
WM115,46215462,1.6800224060395437,1.762132613731386
Granta-519,23939,5.101725753715152,4.316990186905579
BICR 22,46907787,3.4905986586009843,1.584957029505121
HEL,10184653,1.0835446596032057,1.1325795715302809
LS411N,9903786,3.6806866285220017,2.756077717004494
SW48,9840324,6.311735261945371,5.7711165719697215
HCC15,24753719,5.171121417544096,4.143618673527016
SW948,11507802,1.163064588903486,1.3590460953824346
COR-L105,2733487,7.427108299628283,6.1630813151494985
SaOS-2,439501,-2.8243657156627724,-2.2321662354381537
UACC-812,5287969,-2.4803922230812527,-1.9772070858850965
Granta-519,66577038,2.6663435544296346,2.9870697487432882
RERF-LC-MS,6918837,-3.051376318733669,-3.046222711611649
NCI-H1568,11152667,-1.392140833696634,-0.5866736007906306
KU-19-19,49850262,4.263742487880845,3.414452598711333
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,1.7724503678159762
SaOS-2,156414,1.509432711545826,1.1062813598863759
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-1.57821899028641
Granta-519,216468,0.2159572219264565,2.5020743765616316
P31/FUJ,3136844,4.357504973194935,4.214923916993912
MOLP-8,6918638,-1.572747132532541,0.3065957347013626
LS411N,445643,4.311506480272609,3.9383569867901693
MOLM-13,25126798,1.909946064109967,3.7921789378214816
BICR 22,9927531,5.395078942533075,4.578027762171671
SU-DHL-6,3385,2.96945431954736,3.472185389430271
SW948,49766530,-0.6875988061214425,-0.6944377068647134
MOLP-8,5287620,-5.023262566828496,-1.9697846958841214
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.2359123501503817
SW1271,5746,1.8306286254207629,0.8084551861824514
SU-DHL-1,4788,5.095368657375766,5.493389053048461
UACC-812,44607531,-0.3950460021726514,1.48117322485652
SK-CO-1,10074640,3.0297361304753143,3.066922642013836
IGROV-1,65064,4.920352624378345,4.739517756868576
P31/FUJ,9444,3.558733501871851,4.054048446110465
MOLP-8,16722836,0.6223558214261112,1.5333952667080324
LCLC-97TM1,11647372,-0.3650454903758569,0.8954839509867156
COR-L95,9911463,4.18924595414168,3.732908427020576
MOLM-13,3634881,2.324290549736021,3.1576774496130544
IGROV-1,1242560,3.902441161940491,3.534393132486151
LS411N,702558,5.325144902608101,4.9782351440396395
MOLM-13,969516,1.839627080728713,2.7772567284956553
IGROV-1,50905018,6.092412272559071,4.441836356719809
SaOS-2,5311,1.6246857228566176,1.2663000347984639
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-1.9697846958841214
BICR 31,11178236,-3.7191700347439176,-3.539769866873396
IGROV-1,16736978,0.1982875499977011,1.3934160091023764
HEL,54613361,-1.063581606127445,-0.11678183903518824
LS411N,409805,5.900990799691521,4.6745070702664995
RKN,44819697,0.8547407464301948,-0.6109288989041974
SaOS-2,7326481,3.920515261577408,2.957630994714242
HCC15,135411,0.5020362424433897,0.5181226666256136
SW1271,135875424,3.8663800475620542,3.743891076041643
SW948,5281321,-2.986965028390854,-1.3097742666845045
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,-1.4012147836358484
ALL-SIL,16722836,0.4684239096852854,1.5333952667080324
BICR 22,3384730,2.588423009806214,2.4620443610818112
SU-DHL-1,5282054,2.781862093779865,3.5628845676855256
COR-L105,10385095,2.1444085139831643,1.2480392352773622
Panc 02.03,409805,5.9877775932277615,4.6745070702664995
RERF-LC-MS,11707110,3.327368501952155,-0.02846554242907695
Daudi,46199207,1.9328464692742409,3.1312366616263048
SK-HEP-1,9907093,4.5474965014619455,4.134688957161641
NCI-H2452,6918736,-2.096990091914002,-1.741781295359962
SW948,25062766,2.473025838261029,2.0522756909743434
SW1573,73707398,2.4757839790774123,1.180307991266282
WM115,19582717,5.070140237856123,3.9198146524152833
LCLC-97TM1,9926054,1.7367616025320842,1.9546333131599372
Granta-519,46907787,0.1510211143130647,1.584957029505121
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.2349426527428076
Daudi,9866186,0.2429325896096028,0.7577083020821866
HCC15,19582717,3.4575202036464665,3.9198146524152833
BICR 22,3136844,4.306912771504561,4.214923916993912
PaTu 8988t,15983966,3.5024124287376477,-1.6396194068861514
WM115,24964624,1.5810045411950775,2.2827362159867324
Daudi,5335621,3.7832010435602568,4.560420742529089
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.0665232817889554
HCC1500,67156097,1.177976655162538,-1.0279170724737183
LS180,6918878,3.4964027843545775,1.9069091595174383
MOLP-8,4096211,1.580191863417666,1.856021664538426
P31/FUJ,6252,0.489412050489878,-0.10942982547788271
RERF-LC-MS,6505803,-0.6931241555509828,-0.5114413444588124
IGROV-1,24821094,1.720998716331183,2.7369152351179045
BICR 31,5311,2.2783252682939876,1.2663000347984639
K-562,6438330,2.2742899368871123,2.016737971321332
HCC15,71466578,3.4480874510133708,3.983075654179168
RKO,5566,3.2270609816668308,3.029152149495273
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,2.344610112805219
Panc 02.03,24785538,2.724480470289088,1.3344504348570345
Granta-519,3025986,-4.58955813375105,-0.8978770871810051
BICR 22,6918837,-3.531862368916405,-3.046222711611649
MDST8,25262965,-2.668035259531665,-1.6224193967571534
IA-LM,5329102,2.7310604185474654,2.031058842574058
SK-HEP-1,3385,5.476337571299632,3.472185389430271
LS180,16722836,2.063998190370722,1.5333952667080324
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-1.1532493383305307
LS180,2749,2.025296960861402,1.7932893499757152
WM115,25262965,-0.2525217612691299,-1.6224193967571534
PaTu 8988t,5287620,-2.232870102756846,-1.9697846958841214
BICR 22,1641662,3.554805763515046,3.3408828038827
HEL,11152667,-1.5416892011653274,-0.5866736007906306
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-1.261852028375895
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,3.5366182443481806
Granta-519,9907093,4.568904425758597,4.134688957161641
HuP-T3,56946209,-4.563482636842077,-4.2202975286026225
COR-L95,2126,5.99033959567007,4.466606494133751
WM115,216239,1.6966934324307903,2.1474208097396077
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,2.867001064974719
BICR 31,6918837,-2.993188010662521,-3.046222711611649
WM115,3676137,5.1484929308777225,4.517112669127141
COR-L105,5113032,4.587192003158758,4.970396511864891
NCI-H2452,23635314,-2.1133256000938596,-1.8612337831613235
RKN,9887053,4.324470541002337,3.469815136639831
RCC10RGB,11427553,3.4421917630858387,2.578035472123966
SK-HEP-1,3025944,4.243935374614092,4.206240213808089
HEL,613753,3.431831043675297,3.1495845971526135
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.133687221210622
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,0.5181226666256136
WM115,6450551,3.3231751041078086,2.361538429265863
LS180,11178236,-2.7486494175863703,-3.539769866873396
SU-DHL-1,53232,0.8595699071174782,2.8161144578264046
LCLC-97TM1,2742550,3.525188493197443,3.8595787492072238
Daudi,1716436,1.8661291896859675,2.948755251800144
SK-OV-3,11964036,1.753508425012185,1.2382789669868983
LS411N,10385095,1.4098978051841675,1.2480392352773622
P31/FUJ,54613361,-1.6350280742113157,-0.11678183903518824
SU-DHL-1,638278,2.888532213305057,3.209337660705321
SW48,11228183,0.7765992306729816,1.8712017695678478
Daudi,54596558,3.73872893191344,4.397101469450013
IGROV-1,44543605,3.88270235241076,4.160012106477824
SK-OV-3,16722836,0.9083609759186712,1.5333952667080324
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,2.144908880465776
P31/FUJ,168313047,1.7496121138347704,2.4053217165791536
RCC10RGB,969516,5.025939213907113,2.7772567284956553
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.1532493383305307
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,2.0276770243216165
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,1.78247230086659
LS180,11507802,1.428529607587261,1.3590460953824346
SW1271,2746,3.8382249001906814,2.8579929499469348
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.8865368208635396
SW48,6918328,-0.3603149144304291,-0.28710840066117727
RKN,11214940,-1.342915177510304,1.8119431265240042
NCI-H1568,24180719,2.911739165396745,3.437709308952337
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.2359123501503817
K-562,11234052,2.2960989815513013,3.869960809483736
SU-DHL-1,107970,1.234326472603969,2.3029314718240044
RERF-LC-MS,5280436,-0.2566098032119844,3.153394505533252
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.066922642013836
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.2834565267098785
WM115,6184667,1.9705044508079528,2.901063659317265
P31/FUJ,26596,-2.2448149587984836,-1.5346517263124715
RCC10RGB,216345,4.504390062805713,3.7540083674013296
WM115,3634881,2.5774509186458183,3.1576774496130544
COR-L105,5328940,1.3778120925573558,1.559061663996469
NCI-H2452,135440466,3.051805385291023,2.1401473911994366
P31/FUJ,51039095,1.7212337572708742,2.682611194240459
Daudi,135398738,3.444692827115736,3.3919135064420334
MDST8,753704,4.923832713886697,4.832125608051433
Granta-519,23725625,1.8582588361990624,4.726527081330662
IGROV-1,6438330,2.7487580937365683,2.016737971321332
BFTC-909,51037431,4.63288955594681,3.10082796495436
LS411N,262093,3.2594677855419456,2.6275548088442098
Daudi,12001922,0.8334324910861088,1.8522788760744173
LS411N,10074640,3.3220574057236876,3.066922642013836
COR-L105,6438330,3.2365890454650867,2.016737971321332
LS180,3689413,1.3392854552239355,-0.4039154566871359
IGROV-1,53495165,1.3981720287668329,-0.19108456656304296
RKO,10296883,4.075814636405189,3.795028277273254
MOLP-8,24951314,0.5243645664323562,1.227614980483031
IGROV-1,25126798,3.9275606774720817,3.7921789378214816
BFTC-909,5281321,-1.6266730162675118,-1.3097742666845045
MOLP-8,123631,3.0356710048833446,2.2760265557358337
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,2.0276770243216165
PaTu 8988t,72193861,1.5880501840541692,1.3858780169906042
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,1.2349426527428076
MOLP-8,2742550,3.824247044326815,3.8595787492072238
BICR 31,10074640,3.67367044204876,3.066922642013836
UACC-812,1750826,-1.5614417963348088,-1.4739669220989267
LS180,9907093,4.718701288752834,4.134688957161641
BICR 22,25062766,1.615874512669176,2.0522756909743434
NCI-H2452,6852167,1.5258165813873172,2.69961445504738
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.559061663996469
PaTu 8988t,52912189,2.515835026596807,1.6723266261402217
KU-19-19,9935249,4.318045076797651,2.8615383619674972
KU-19-19,57330099,3.159149106170822,4.311542343968036
SK-OV-3,17755052,2.097752569372091,1.7101929835526413
SK-OV-3,73707386,3.7899266428434233,2.6861216111986805
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,1.5478733404534093
SK-HEP-1,216239,1.5998975447874937,2.1474208097396077
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-4.3765957253648695
RKO,3689413,3.093382349703003,-0.4039154566871359
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,0.8954839509867156
K-562,44819697,-0.9868024060185686,-0.6109288989041974
LS411N,322968,4.732979049951269,3.4956311613712456
RCC10RGB,3689413,-2.0864832427963336,-0.4039154566871359
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,4.4833676274788345
COR-L105,409805,5.8843358134901775,4.6745070702664995
ALL-SIL,11404337,-1.8413362349398936,-0.4254091153988029
Granta-519,135398738,2.4818536310203587,3.3919135064420334
IGROV-1,10385095,1.0670946713416192,1.2480392352773622
KU-19-19,5311,0.9327005340349652,1.2663000347984639
MOLP-8,6438330,1.5207659246126146,2.016737971321332
SW948,5351362,1.282672018702937,1.4604743967139864
HuP-T3,54626689,4.821166418142214,4.561309020020982
HuP-T3,16013152,4.473149012747972,4.119375381760217
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.38762532684053896
RKN,67156097,-0.5718675734992968,-1.0279170724737183
IA-LM,241158,3.7495123409873528,3.598987869990464
LCLC-97TM1,644241,3.02487415997038,2.1017288356510795
NCI-H2452,9823820,3.552631474664052,3.7294514785702977
BFTC-909,2749,2.0212973698927184,1.7932893499757152
Daudi,9956119,3.1347708383856827,3.4762974507018756
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.11065310288154762
ALL-SIL,136227924,2.439460537978413,2.867001064974719
HEL,44507138,3.4784823626806296,2.3228542035372683
Panc 02.03,3634881,5.203302993958793,3.1576774496130544
HCC15,3038522,3.407637609998807,2.9847437848386558
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,0.7705130043498147
SU-DHL-1,5311,0.6388765020007606,1.2663000347984639
RKN,16038120,2.2721636156695357,0.9090093368534204
Daudi,6917907,-7.619939635694887,-4.864372369867458
MOLP-8,3385,2.1758430637220334,3.472185389430271
COR-L95,2749,1.0184502693195283,1.7932893499757152
BICR 22,56946209,-6.158851096198738,-4.2202975286026225
SU-DHL-6,72193861,0.720057034069739,1.3858780169906042
RCC10RGB,122327,5.581829763733156,4.7007618437932
Daudi,5284329,2.65655795986699,3.2209771184161022
WM115,72376,-0.2019485443349478,-2.110114148114304
HCC1500,4378219,1.8377088226049565,2.6822409618839944
SK-CO-1,246676,3.87632071272349,4.505551974581321
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-3.5071094923394703
IGROV-1,57519531,2.639098862164858,2.4211376500246136
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,2.0058447943574325
MOLM-13,1714884,4.557672503718371,2.7385495072683548
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,0.7705130043498147
Granta-519,72193861,-0.9369484536210768,1.3858780169906042
RKO,5311,2.326095881991792,1.2663000347984639
SK-HEP-1,4521392,4.36382839215776,4.280943620409205
COR-L105,3062316,-0.8702764318143076,0.9747482048219924
COR-L95,387447,-4.370301659619954,-4.3765957253648695
COR-L105,10231331,1.4114577114599935,1.6547412916072393
SK-CO-1,637858,1.8597515079418403,1.8880097009592578
SW1573,5282054,2.2636648441362417,3.5628845676855256
K-562,66577038,2.461713560075674,2.9870697487432882
Panc 02.03,984333,0.8671961837803726,0.5138000229415411
HCC1500,9967941,2.192170342398577,3.6034131982542865
NCI-H1568,5281672,4.0091617833462125,4.4250678360691875
K-562,11640390,3.4084234644631244,3.2466540190485103
SW1271,60750,-2.442139934484719,-2.435153852929516
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.153394505533252
MOLM-13,24889392,-6.717782140097413,3.7858620057203916
Granta-519,11364421,-8.40665244505035,-2.2476185097624475
LCLC-97TM1,11612883,2.215690343731866,2.6386482274158856
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,2.0058447943574325
PaTu 8902,1566236,3.6887913704860535,2.2263982365179604
MOLM-13,16741245,4.189200129622084,3.801678648950925
SW48,6184667,4.015043076320991,2.901063659317265
RERF-LC-MS,66577038,3.051572744120707,2.9870697487432882
K-562,71304818,1.450074212827562,2.396178486082573
RCC10RGB,44489675,4.041451654117508,3.8856289571074525
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.133687221210622
SW1271,10074640,2.938380325815859,3.066922642013836
RERF-LC-MS,11626560,1.1998891680987491,1.6795489442409048
PaTu 8988t,81146,4.470184859000855,4.85414860513934
HCC15,11178236,-3.9629964965138584,-3.539769866873396
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.8865368208635396
HCC15,11317348,1.1767586352696475,2.3090854497210964
P31/FUJ,9903786,1.0734919883099745,2.756077717004494
IGROV-1,23582824,0.3287266354391525,0.7400136078733197
Granta-519,3465537,1.1430845598370274,2.5477591829493655
PaTu 8988t,984333,0.9294993195358888,0.5138000229415411
HCC1500,11396600,2.707080690171913,3.4309758536883517
NCI-H1568,6252,-1.964470857288188,-0.10942982547788271
NCI-H1568,7251185,1.379011815458227,2.4347287977616
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.2047817895412443
LCLC-97TM1,55508,4.820744956173848,3.1188086218267883
PaTu 8902,9903786,4.041497343746548,2.756077717004494
SW1271,12001922,2.1604198968714754,1.8522788760744173
HEL,6505803,1.212867497705534,-0.5114413444588124
SK-HEP-1,216345,4.108495190728752,3.7540083674013296
WM115,4705,2.3860154683324897,3.0428654274536564
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,0.7705130043498147
COR-L105,126941,-1.5036718028706904,-2.8921209077069348
PaTu 8988t,9926054,1.9241127892750265,1.9546333131599372
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,4.13551970928241
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,0.9218131221296273
SK-HEP-1,374536,4.396616434658188,1.7732341041149164
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.3791567205504176
NCI-H2452,208908,2.397298909776284,1.8663560178908947
SW948,24821094,3.757524617053942,2.7369152351179045
K-562,44491742,3.373435641850853,4.1566745174283435
RKO,24180719,5.308193040989237,3.437709308952337
MOLM-13,56946209,-5.150374128805616,-4.2202975286026225
MDST8,54454,0.3151053774213321,2.548844675602096
Daudi,969516,2.18084937908482,2.7772567284956553
COR-L105,44607531,0.2442604090297878,1.48117322485652
SaOS-2,54619267,4.116373312960232,3.9342007971372475
MOLP-8,44607531,1.2227606502433142,1.48117322485652
ALL-SIL,11427553,-0.6859128537837271,2.578035472123966
NCI-H1568,11427553,2.9296384487881166,2.578035472123966
SK-HEP-1,6918638,1.490993863020431,0.3065957347013626
K-562,11175137,2.6421325977097663,2.477950770888125
MOLP-8,25126798,3.554030345273679,3.7921789378214816
MOLP-8,10427712,3.937375048887725,4.184108330161863
BFTC-909,11404337,0.4468911705694049,-0.4254091153988029
Daudi,19582717,2.1579117268337975,3.9198146524152833
SW1573,9936388,3.0507391751654698,-1.7988236137529168
SW1271,156414,2.097129180606755,1.1062813598863759
Daudi,11213558,0.7122197709980888,1.4781707184028035
MOLM-13,135875424,3.721528356214304,3.743891076041643
LS411N,3062316,3.313525141236135,0.9747482048219924
Panc 02.03,6438330,3.381062774421129,2.016737971321332
MOLP-8,4705,2.7848528520877727,3.0428654274536564
SW48,675434,5.164587034175743,4.463597576567934
NCI-H1568,46215462,1.5662565779678703,1.762132613731386
BICR 22,23635314,-3.9149935419765423,-1.8612337831613235
NCI-H1568,44607530,0.8979533446197012,1.715838652040812
BFTC-909,89928392,2.1120581393996116,1.344325138639762
NCI-H2452,8515,2.9816658051225344,3.7716438213452004
WM115,252682,5.883677253194902,6.516263069090082
SaOS-2,11507802,0.9759404440699744,1.3590460953824346
NCI-H1568,9935249,0.3822057580098375,2.8615383619674972
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,2.117207225291035
SW1271,65628,4.408026608161547,4.026684176415168
MOLM-13,2742550,3.0943449980031845,3.8595787492072238
HuP-T3,56973724,4.820716068374067,2.823032655731692
P31/FUJ,5328940,0.1000739186855886,1.559061663996469
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.38762532684053896
KU-19-19,9967941,2.4242338826427794,3.6034131982542865
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,2.474523360549852
SK-CO-1,5328940,2.280320557186381,1.559061663996469
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,2.901063659317265
COR-L95,1716436,2.176954941746147,2.948755251800144
MDST8,46398810,3.011862004714757,2.510712955745063
SK-OV-3,654092,-0.1739817534251795,-0.4472857419901597
SW948,54613361,-2.2535675944820084,-0.11678183903518824
HuP-T3,25154868,5.141210696949765,4.289494395804131
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,3.0665232817889554
RKO,124202324,3.4391315101947386,2.1784388364790748
RCC10RGB,9444,4.509247284467684,4.054048446110465
P31/FUJ,135421197,1.0144502005310674,1.8199795612290348
MOLP-8,44487872,4.385798937588512,4.868560883407912
PaTu 8902,448949,2.6032868845304606,1.9537365892294993
MOLM-13,11427553,-2.505370137631637,2.578035472123966
IA-LM,60750,4.549488262081028,-2.435153852929516
MDST8,3825829,4.752817875520721,3.8869840981378028
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,0.4199080872215506
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,0.9218131221296273
COR-L105,51037431,3.876010066295024,3.10082796495436
RKO,31703,-1.8438289452025527,-1.182053713238432
HEL,5978,-0.5240559956879017,-2.3753204421143224
SW948,168312962,3.6749765666335903,1.48933366232238
IGROV-1,72734382,4.633226130326536,4.3578051352274185
SW48,216468,-0.1130169029097753,2.5020743765616316
HuP-T3,216345,4.480282764347718,3.7540083674013296
HCC15,439501,0.3030845703669018,-2.2321662354381537
P31/FUJ,638278,2.9129004591727057,3.209337660705321
BFTC-909,676352,2.5282943369079818,2.088896150621564
SK-HEP-1,60750,5.759979022694095,-2.435153852929516
PaTu 8988t,4788,6.262210396704686,5.493389053048461
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,0.4199080872215506
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-1.261852028375895
HEL,24951314,0.022330385445513,1.227614980483031
MOLM-13,46907787,-1.536709398859376,1.584957029505121
SaOS-2,54626689,4.533352391847383,4.561309020020982
RERF-LC-MS,10410894,3.034247655874134,3.2189174762180457
RERF-LC-MS,9903786,2.6182355767545213,2.756077717004494
IGROV-1,107985,-2.8971910842184516,-3.5771139994401464
WM115,10231331,-3.458943295987183,1.6547412916072393
Daudi,71466578,1.924283792281082,3.983075654179168
KU-19-19,6610216,4.876021689690227,4.26979744561799
COR-L95,6918736,-0.04136223528326,-1.741781295359962
MOLM-13,11625818,3.232701320691832,4.10791451089978
Granta-519,16038120,-0.1772437220791911,0.9090093368534204
BICR 31,46907787,2.190433361645711,1.584957029505121
Daudi,702558,3.2750017094913657,4.9782351440396395
MOLP-8,24856436,-0.8263886484359759,0.17994774592918095
MOLP-8,135440466,1.6989907480456066,2.1401473911994366
SK-HEP-1,46843906,3.844316747572769,2.723521570705241
RKO,54626689,4.750442055573677,4.561309020020982
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-1.57821899028641
IGROV-1,11717001,4.394306548697183,3.961276339234443
Granta-519,5291,3.886616753428741,3.5530526201153183
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,2.9860814461500107
SW1271,262093,2.7991981503454495,2.6275548088442098
Granta-519,1566236,1.1036082649410253,2.2263982365179604
BICR 22,24753719,4.1427183131543615,4.143618673527016
Panc 02.03,9926054,1.881153725115377,1.9546333131599372
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,2.93841691857644
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,1.9146814118519513
LS180,54619267,4.074522434074431,3.9342007971372475
SK-OV-3,5281321,-0.7098099698865428,-1.3097742666845045
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,2.0276770243216165
SK-CO-1,2729026,2.8886798476744246,2.6325975116350393
Granta-519,23582824,0.9303240666722092,0.7400136078733197
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,0.4199080872215506
WM115,24978538,1.155471911978994,0.6273547794147847
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-1.57821899028641
NCI-H1568,11238147,2.925799577076833,2.694366237977623
ALL-SIL,135398516,1.5622324093538014,2.0509021680173207
COR-L95,135659046,3.614564650544248,3.604307380358917
SW1271,1285940,4.280510054640018,4.0494196828548
SW1271,6505803,0.8186340021888412,-0.5114413444588124
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-1.6778195760397165
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.2047817895412443
IGROV-1,11626560,1.7276653519578558,1.6795489442409048
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,1.9565115912575295
P31/FUJ,3552672,1.950832295752278,2.8413574589562494
P31/FUJ,67291369,0.7371006748241407,1.794812676489941
LCLC-97TM1,107970,2.3018486004849907,2.3029314718240044
SK-OV-3,44607531,1.947967745365508,1.48117322485652
BFTC-909,9936388,1.702123766125507,-1.7988236137529168
ALL-SIL,8515,1.9161675301812888,3.7716438213452004
LCLC-97TM1,25262965,-1.937189863749451,-1.6224193967571534
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.5350305453431912
MDST8,6914657,-1.2463021469195388,-4.170094408243688
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.6778195760397165
HCC1500,53392493,1.8683885031226253,2.4832542501558077
MDST8,135411,0.5541309628089411,0.5181226666256136
RERF-LC-MS,1750826,-0.5689233588179538,-1.4739669220989267
LCLC-97TM1,5328940,1.525932870405189,1.559061663996469
NCI-H2452,25195348,3.541594611208225,3.08171494739702
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.396178486082573
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.78247230086659
SaOS-2,53495165,-0.9847313398251484,-0.19108456656304296
SW948,11626560,1.2721393744446543,1.6795489442409048
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.1532493383305307
HEL,25183872,-2.1054192111007657,-0.902802947451298
RCC10RGB,89928392,1.8749323034057075,1.344325138639762
Panc 02.03,10074640,3.562403354758929,3.066922642013836
PaTu 8988t,57519531,4.351537289113079,2.4211376500246136
SK-CO-1,5281321,-2.128194299198524,-1.3097742666845045
RERF-LC-MS,5311,1.7201713868016182,1.2663000347984639
HuP-T3,11427553,3.1840600229712037,2.578035472123966
ALL-SIL,4259181,-1.3200126273341632,0.11236669175956715
HCC1500,11214940,3.550811671890936,1.8119431265240042
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,1.5478733404534093
HCC1500,25195348,3.452030504957034,3.08171494739702
SW1271,52912189,0.6284206808713965,1.6723266261402217
MOLP-8,984333,1.0413549547234568,0.5138000229415411
SW948,72734382,3.6940713099503473,4.3578051352274185
IGROV-1,46943432,4.105714883822214,1.70045196562753
BICR 31,25227462,0.4256700478941367,-0.4151865926866767
SaOS-2,2126,4.6809882623674905,4.466606494133751
SaOS-2,11427553,2.020035940690151,2.578035472123966
MOLM-13,6914657,-6.22505002098335,-4.170094408243688
NCI-H1568,24964624,2.125017418877952,2.2827362159867324
HCC1500,11497983,4.502799578122533,2.348631818792911
K-562,23725625,5.2530061405843975,4.726527081330662
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.860017480413567
RKO,136227924,3.256787131627037,2.867001064974719
IGROV-1,31703,-1.792518264692263,-1.182053713238432
HEL,6438330,1.7062913765539824,2.016737971321332
RERF-LC-MS,25126798,3.475546322259903,3.7921789378214816
LCLC-97TM1,409805,4.11204743963536,4.6745070702664995
Daudi,2708,2.1654486353587266,4.591243765137335
SK-HEP-1,6914657,-2.911576812343612,-4.170094408243688
MOLM-13,36462,-3.0478349617512466,1.5076124324231743
COR-L105,208908,1.1794902635628597,1.8663560178908947
MOLP-8,44491742,4.067907034019371,4.1566745174283435
Panc 02.03,89183176,4.957506748320777,3.4938336610308007
Daudi,3025986,-1.684737909075286,-0.8978770871810051
PaTu 8902,10302451,3.9687769441396608,3.0143591766147457
PaTu 8988t,9933475,2.2874108911255693,1.793439230086884
SW1573,5281321,-2.072955292880288,-1.3097742666845045
IA-LM,2733526,5.6911514373146135,3.714359432422819
Panc 02.03,6918837,-1.2317043962492993,-3.046222711611649
NCI-H1568,19582717,3.4209569673427342,3.9198146524152833
WM115,55508,6.132181701054794,3.1188086218267883
MOLP-8,2871966,-0.632569947519592,0.29730316799892464
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,1.1345509900924162
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,1.1345509900924162
HEL,6918837,-4.248380638359999,-3.046222711611649
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.11065310288154762
BICR 22,136227924,2.105383482893856,2.867001064974719
SW48,135875424,3.469184081134181,3.743891076041643
COR-L95,10127622,5.649647064343883,3.6054187258933235
SU-DHL-1,60750,-4.603947913298721,-2.435153852929516
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.3641186374244216
SaOS-2,446155,1.978878402700164,2.662752180605146
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,4.13551970928241
SK-CO-1,11625818,4.187860927408271,4.10791451089978
COR-L95,676352,2.06388279354012,2.088896150621564
RKO,11719255,3.406006587740275,3.1221102230298534
NCI-H1568,135875424,3.0063280878885967,3.743891076041643
IGROV-1,25195348,3.0698662305180275,3.08171494739702
RERF-LC-MS,16659841,3.453543705685564,3.7845234388741966
SW948,1641662,3.2658822910658905,3.3408828038827
BFTC-909,5351362,0.3148685714677321,1.4604743967139864
COR-L95,24771867,5.320672645408192,1.5171458615349627
NCI-H2452,16725315,3.1677771909290184,4.150060666188836
WM115,9926054,3.0880179510914454,1.9546333131599372
IGROV-1,135875424,3.3275053166921347,3.743891076041643
LS411N,4259181,-1.386635238211632,0.11236669175956715
SK-HEP-1,24821094,3.809459846332286,2.7369152351179045
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-1.1532493383305307
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.5392373768677334
HCC1500,11364421,1.8102576985092016,-2.2476185097624475
WM115,11647372,-0.748702419415335,0.8954839509867156
IGROV-1,374536,0.7022324251593053,1.7732341041149164
K-562,5311,0.9288629076778604,1.2663000347984639
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.4554460238042177
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.30112130782396007
Daudi,44607531,0.7322116783883826,1.48117322485652
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.7711165719697215
SW1271,448949,2.9810988383972084,1.9537365892294993
SU-DHL-1,42642645,0.6641769458510169,0.7845058245277501
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,1.48933366232238
SW48,53232,2.98078944705874,2.8161144578264046
K-562,4096211,1.5585244853649294,1.856021664538426
LS180,89183176,4.9114720653238315,3.4938336610308007
SW1271,10427712,4.007366682408904,4.184108330161863
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.3153680794849765
SK-OV-3,72193861,3.227068856168802,1.3858780169906042
K-562,148198,-4.073315546446919,-3.548509713878981
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-1.6224193967571534
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.37491183386883553
SW948,2729026,3.020599067804879,2.6325975116350393
SaOS-2,3552672,2.445112397338648,2.8413574589562494
K-562,6918638,0.0740833242167517,0.3065957347013626
HCC15,67291369,1.6613409933263477,1.794812676489941
LCLC-97TM1,11396600,3.6456493290211425,3.4309758536883517
HCC15,6438330,2.907250953014235,2.016737971321332
SW48,123631,-2.3971553119638553,2.2760265557358337
RERF-LC-MS,6918638,0.4520678244574614,0.3065957347013626
HCC15,54619238,5.509074276782743,5.004034610534093
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,2.93841691857644
Granta-519,5351362,0.2173676915670352,1.4604743967139864
SW1271,219104,3.9142621703193625,3.5366182443481806
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.2359123501503817
SW948,11497983,1.2110688984787443,2.348631818792911
Panc 02.03,11404337,1.528571500956484,-0.4254091153988029
SK-OV-3,107985,-2.353051363092625,-3.5771139994401464
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.2834565267098785
HCC1500,56649450,4.199956636233384,2.999158341046921
MDST8,54649381,4.2434412709491385,3.7880999548273127
SK-CO-1,24772860,-2.764468608226056,-2.2690769633318126
SW1271,2708,3.697662973501111,4.591243765137335
COR-L105,25062766,2.3512127388642865,2.0522756909743434
BICR 22,9826308,0.9832071992526458,0.12580254156308923
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.4554460238042177
KU-19-19,11404337,0.0275069311149896,-0.4254091153988029
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.1345509900924162
LS411N,452548,1.178688753001054,-0.31026393275322106
COR-L105,3025986,2.299444367217184,-0.8978770871810051
IGROV-1,25102847,1.7007012555618253,2.3366995460793083
PaTu 8988t,24797083,1.3448554408655904,1.277886491385028
IGROV-1,46398810,2.003787621940583,2.510712955745063
SaOS-2,2749,2.484303950908632,1.7932893499757152
WM115,7251185,2.999080033015298,2.4347287977616
IA-LM,151289,3.753931026261757,0.9562867634504244
SW48,60168763,3.2354609354554924,1.9998178357438696
IGROV-1,168313016,4.807199318661473,4.725757076386842
MDST8,5351362,2.4401541198795726,1.4604743967139864
RKO,5291,3.391339544898264,3.5530526201153183
LCLC-97TM1,23582824,0.7435680585464137,0.7400136078733197
BICR 22,16725315,5.207801943730372,4.150060666188836
HCC1500,44632017,4.723480031494906,1.0838611345650022
MOLM-13,219104,1.3929442819191806,3.5366182443481806
SaOS-2,44202524,1.4210473732360835,1.9639001504219202
COR-L105,753704,5.105702577689745,4.832125608051433
BICR 22,216468,1.2752332856392885,2.5020743765616316
RERF-LC-MS,445643,4.345437949323675,3.9383569867901693
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.93841691857644
HuP-T3,44607531,1.7591062122540748,1.48117322485652
NCI-H1568,9915743,-0.8427224057935273,0.5935480801734145
ALL-SIL,126941,-2.455728969669062,-2.8921209077069348
IGROV-1,168313047,1.93821625738322,2.4053217165791536
LS180,100016,6.005443229591697,5.87798299213578
SaOS-2,60700,-2.625519230364934,-0.4482559328189002
KU-19-19,9907093,4.38040739031281,4.134688957161641
SaOS-2,9935249,3.097116977919543,2.8615383619674972
COR-L95,24821094,3.5692160345671335,2.7369152351179045
Daudi,327653,2.694862581871668,3.018652636936018
SaOS-2,65628,4.208345318362158,4.026684176415168
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.4554460238042177
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-1.3340160156368264
LS411N,24772860,-2.6286287692739587,-2.2690769633318126
HCC1500,15983966,1.4595203856942676,-1.6396194068861514
COR-L95,46907787,3.807595772412777,1.584957029505121
BICR 22,24821094,3.82687279949815,2.7369152351179045
RERF-LC-MS,56946209,-3.4945734927118552,-4.2202975286026225
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.9218131221296273
MDST8,49793307,-1.5088082080905487,-2.848251171596848
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-1.1532493383305307
SW1271,159324,2.241950485620868,2.0742938672876736
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-1.261852028375895
HCC1500,135398516,0.4161092034804287,2.0509021680173207
Granta-519,46901937,3.6488183223471022,3.965127781632745
RERF-LC-MS,5328940,2.240356815676024,1.559061663996469
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.4539899714896953
Granta-519,400769,-1.7592122365530554,-0.7855881743093749
BICR 22,135421197,2.0438055763788556,1.8199795612290348
BICR 31,9967941,4.3746614656618865,3.6034131982542865
Daudi,89928392,0.010222000273875,1.344325138639762
MOLM-13,151289,-0.2275053531847663,0.9562867634504244
IGROV-1,2874250,4.893662837169153,4.0377213891771015
MOLM-13,4261,-0.2853779042398361,1.4288257082744877
MOLP-8,5280436,2.785612173209183,3.153394505533252
RKN,11427553,3.6372919842764424,2.578035472123966
LCLC-97TM1,2828334,6.057082646440782,6.082620037824382
Daudi,11640390,2.7767455060282873,3.2466540190485103
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,2.0276770243216165
RKN,51039095,3.7797830340785694,2.682611194240459
HuP-T3,46398810,2.968900053185397,2.510712955745063
SW948,60700,1.1260701186231294,-0.4482559328189002
LCLC-97TM1,168313047,1.50715487575417,2.4053217165791536
Panc 02.03,46174525,6.272327915554807,4.156087356848057
SW948,72193861,0.8788999866892542,1.3858780169906042
HCC1500,6918638,0.5709126385335386,0.3065957347013626
RERF-LC-MS,42642645,-0.4358765804877467,0.7845058245277501
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.117207225291035
ALL-SIL,12001922,1.676377280214729,1.8522788760744173
NCI-H2452,441298,2.247705741320954,2.5423368047098167
BICR 22,46191454,1.6809351488377804,1.3518500781597358
COR-L95,16013152,4.05038947229277,4.119375381760217
BFTC-909,72376,-1.4314875177558029,-2.110114148114304
SU-DHL-6,15983966,-6.405792257227171,-1.6396194068861514
K-562,11497983,3.839483588328175,2.348631818792911
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.1325795715302809
IGROV-1,4477,1.1767656777594142,0.5570685949048098
SK-CO-1,9444,4.465837668270579,4.054048446110465
SU-DHL-1,135999136,4.730243036337901,3.6300382464802663
IGROV-1,54619267,3.9701367924453455,3.9342007971372475
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.69961445504738
SW948,31703,0.6983000463207195,-1.182053713238432
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,0.38762532684053896
SU-DHL-1,BRD-K03911514,2.3803066372148742,4.4100188539115495
HCC1500,46398810,2.5427546617930905,2.510712955745063
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.1532493383305307
WM115,51039095,2.786212621210589,2.682611194240459
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,1.710700657959646
HCC1500,24772860,0.2838196702204312,-2.2690769633318126
SU-DHL-1,71304818,1.6958772786188914,2.396178486082573
WM115,16736978,2.885535594388376,1.3934160091023764
NCI-H1568,54618305,4.1006341963066255,4.084826955496459
RCC10RGB,11404337,1.763382313076518,-0.4254091153988029
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,0.9218131221296273
HCC15,17755052,4.876160174226561,1.7101929835526413
COR-L95,6610216,4.601423414679649,4.26979744561799
LCLC-97TM1,10296883,3.762301074740285,3.795028277273254
Granta-519,753704,4.381381177541046,4.832125608051433
COR-L95,3825829,4.2210058836960265,3.8869840981378028
HCC15,51039095,2.370618956781999,2.682611194240459
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.6829735349466532
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,1.78247230086659
K-562,9915743,1.457381054045144,0.5935480801734145
Daudi,644241,1.4114598324864769,2.1017288356510795
COR-L105,6610355,4.615259996363044,4.45123297085854
NCI-H1568,400769,-0.2296701698466811,-0.7855881743093749
PaTu 8902,4096211,3.3878786245174917,1.856021664538426
IGROV-1,6610355,3.969940996770339,4.45123297085854
NCI-H1568,15547703,3.0519937502167744,3.114669509763707
BICR 22,11609586,1.2076158919216122,2.621607380466062
NCI-H1568,6918736,-3.5744965026463893,-1.741781295359962
Panc 02.03,2729026,3.1511226959620715,2.6325975116350393
RCC10RGB,73707438,4.14323951901879,4.210679418158044
SK-HEP-1,11609586,4.257559552037769,2.621607380466062
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,1.7691529831259722
WM115,9935249,2.3950107716018465,2.8615383619674972
ALL-SIL,9929138,4.286241964174987,5.665997549800987
SU-DHL-1,452548,-2.7499107831448257,-0.31026393275322106
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,1.2349426527428076
COR-L95,262093,1.2094317801688714,2.6275548088442098
LCLC-97TM1,4788,5.877974617736734,5.493389053048461
LCLC-97TM1,11455910,0.6647050862050086,0.9557745122323711
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-2.3753204421143224
IGROV-1,3025944,3.9702787396819503,4.206240213808089
COR-L105,44486219,4.2268301570583,4.281343219898981
HEL,6852167,2.7971477189216207,2.69961445504738
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-3.046222711611649
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.6778195760397165
MOLP-8,24753719,3.861578571306771,4.143618673527016
RKN,54649381,4.194319964969153,3.7880999548273127
NCI-H2452,5738263,2.391583749104638,3.3050405288071003
RERF-LC-MS,11612883,2.474683430971872,2.6386482274158856
LS180,67156097,-0.3004464994297747,-1.0279170724737183
ALL-SIL,638278,2.4844738615144797,3.209337660705321
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,1.4539899714896953
WM115,89928392,1.4475546317176564,1.344325138639762
NCI-H1568,4917,1.9457015565482707,3.079848880785536
Daudi,2746,0.9195319579001202,2.8579929499469348
RERF-LC-MS,136227924,4.560045704487339,2.867001064974719
SK-OV-3,400769,-0.3757443057400228,-0.7855881743093749
Daudi,2742550,2.6022450411597764,3.8595787492072238
SU-DHL-1,1242560,3.2887270842989285,3.534393132486151
IGROV-1,1750826,-3.124548162001242,-1.4739669220989267
IGROV-1,3025986,-1.046010021597061,-0.8978770871810051
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,2.0058447943574325
COR-L95,11178236,-1.511835887926392,-3.539769866873396
MDST8,15953870,3.886262261351445,3.4781017448929608
P31/FUJ,71466578,3.434376258750051,3.983075654179168
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.8865368208635396
HCC15,16038120,-0.3287102193479797,0.9090093368534204
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,1.2359123501503817
WM115,44607531,1.8052962391610108,1.48117322485652
SK-CO-1,322968,3.708989182542924,3.4956311613712456
IGROV-1,1716436,3.2816872421007375,2.948755251800144
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.456683733824014
SK-HEP-1,15953870,5.227718988850451,3.4781017448929608
SW1271,10231331,-0.1974856956768426,1.6547412916072393
HuP-T3,168312962,3.781886601468438,1.48933366232238
Granta-519,11238147,3.49055902156802,2.694366237977623
SW1271,54678924,4.1367056407476595,1.9473085147454567
Panc 02.03,89928392,1.630028817710481,1.344325138639762
BICR 31,148198,-3.2373882564770513,-3.548509713878981
IGROV-1,104842,-1.6690343627553987,-3.040993872013826
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,2.6829735349466532
HCC1500,10184653,1.0749855490236058,1.1325795715302809
HCC15,44202524,2.021204517823952,1.9639001504219202
COR-L105,9866186,1.0648092573013754,0.7577083020821866
COR-L95,285033,-2.430535969260308,-2.1791335812392365
COR-L95,23635314,-1.8010937940640896,-1.8612337831613235
SaOS-2,11364421,-5.8107581348158,-2.2476185097624475
BFTC-909,122327,4.590877432942681,4.7007618437932
IGROV-1,54618771,1.2456991772210466,0.9253379925205388
P31/FUJ,675434,4.075878142833804,4.463597576567934
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,2.144908880465776
NCI-H2452,5328940,1.966899609603824,1.559061663996469
RCC10RGB,72376,3.207429090732714,-2.110114148114304
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.699201704606489
NCI-H2452,4917,2.7944300449003907,3.079848880785536
BICR 31,1716436,3.7157300626912617,2.948755251800144
MOLM-13,1239801,3.478439984806631,3.981036641317754
HuP-T3,10296883,4.266239948990751,3.795028277273254
PaTu 8988t,107970,2.530920724052233,2.3029314718240044
ALL-SIL,675434,4.0400251875066715,4.463597576567934
PaTu 8988t,16736978,1.6582336139520693,1.3934160091023764
LS180,5460769,0.3293841533128088,2.3447175553942796
MDST8,11612883,2.4942536836786635,2.6386482274158856
COR-L95,46191454,2.009346014708409,1.3518500781597358
MOLM-13,451668,-3.798095624109847,-0.17843514405649885
Daudi,168313016,3.9002026806644734,4.725757076386842
ALL-SIL,135411,-0.5620485907345016,0.5181226666256136
RCC10RGB,46215462,3.684591481140594,1.762132613731386
KU-19-19,4917,3.607977283390518,3.079848880785536
Panc 02.03,71751553,4.925944110140211,4.504570481353087
HCC1500,5281321,-4.561246998431513,-1.3097742666845045
LS411N,44202524,4.412838675121289,1.9639001504219202
LS411N,637858,2.7012095970179635,1.8880097009592578
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,1.3518500781597358
SK-HEP-1,24797083,1.0035545042427043,1.277886491385028
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-1.57821899028641
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.227614980483031
BICR 31,387447,-3.4745770631768553,-4.3765957253648695
SK-CO-1,452548,-1.5551413224098238,-0.31026393275322106
SW948,6914657,-4.288216532991124,-4.170094408243688
SK-HEP-1,216468,4.223762462623231,2.5020743765616316
ALL-SIL,71466380,3.7861137397034255,4.275465599745589
ALL-SIL,66577038,2.592918053791083,2.9870697487432882
K-562,46174525,4.631327159993839,4.156087356848057
SK-HEP-1,11404337,1.0852289139958715,-0.4254091153988029
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.1532493383305307
COR-L105,156414,4.037454349539868,1.1062813598863759
P31/FUJ,5351362,0.932451869978648,1.4604743967139864
BICR 22,57519531,2.122776388957543,2.4211376500246136
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,1.78247230086659
SW48,156414,-3.5613148313114293,1.1062813598863759
BICR 31,24180719,3.9564262696237096,3.437709308952337
KU-19-19,11222830,1.7129831318158657,1.5350294688251391
HuP-T3,9911463,3.677427040789425,3.732908427020576
Granta-519,56649450,2.820913380280981,2.999158341046921
BICR 31,5328940,1.2878315189706533,1.559061663996469
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.133687221210622
IGROV-1,19582717,6.764352444432722,3.9198146524152833
IGROV-1,24951314,0.9075718706849548,1.227614980483031
Granta-519,9911830,2.3469616146388033,2.4240324657892436
RKO,3038522,3.342495330103654,2.9847437848386558
P31/FUJ,135440466,3.423250795887436,2.1401473911994366
IGROV-1,6918878,1.6706182189896102,1.9069091595174383
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.37491183386883553
SW1271,136227924,3.2074421772411372,2.867001064974719
IGROV-1,16722836,0.856484234547582,1.5333952667080324
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.7691529831259722
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.8978770871810051
IGROV-1,168313016,4.807199318661473,4.725757076386842
Panc 02.03,9935249,3.920507280118285,2.8615383619674972
UACC-812,19582717,5.3439559865445245,3.9198146524152833
SK-CO-1,54619267,3.100073010472608,3.9342007971372475
LCLC-97TM1,56973724,2.3842885859021985,2.823032655731692
P31/FUJ,44185566,1.65624467652309,2.4057100644299436
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,2.6829735349466532
LS180,568763,0.2796957344404436,0.28862358029973745
HEL,5281321,0.1504430999261452,-1.3097742666845045
COR-L95,168313200,1.9910859109269063,2.9593589282331023
NCI-H2452,100016,6.6405878618594985,5.87798299213578
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.0163468544412688
SK-HEP-1,71751553,4.559763777433237,4.504570481353087
COR-L105,6450551,3.13458936271996,2.361538429265863
MOLP-8,227681,1.7901539797099055,2.9941233013598234
LCLC-97TM1,24951314,1.6929873886763296,1.227614980483031
LCLC-97TM1,20959075,-3.5903877814282836,-3.173507428051674
Panc 02.03,11964036,1.263021853424522,1.2382789669868983
Granta-519,54596558,4.099782953798094,4.397101469450013
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,1.5478733404534093
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-1.57821899028641
IGROV-1,246676,4.485924799339535,4.505551974581321
HCC15,25126798,3.760529318413009,3.7921789378214816
P31/FUJ,67156097,-2.27730723064269,-1.0279170724737183
KU-19-19,4788,5.856744699338042,5.493389053048461
MOLM-13,44507138,0.4726740823031857,2.3228542035372683
COR-L95,5281672,3.930459616892441,4.4250678360691875
HEL,46191454,2.0114602406157487,1.3518500781597358
SaOS-2,25227462,1.0053365829052552,-0.4151865926866767
NCI-H1568,327653,2.9538763640308403,3.018652636936018
MOLM-13,126941,-4.1996343959718665,-2.8921209077069348
SW1573,23582824,0.5044187481506299,0.7400136078733197
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,2.93841691857644
RKN,46199207,3.372714950884571,3.1312366616263048
MOLP-8,2113511,4.489524818659998,5.381335299817078
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,2.474523360549852
MOLM-13,9907093,2.467705892800055,4.134688957161641
BICR 31,135398516,1.997761003126595,2.0509021680173207
SW1271,216345,3.992520329028928,3.7540083674013296
SW1271,49766530,-1.8216621121390524,-0.6944377068647134
BFTC-909,44819697,-0.8003395289407239,-0.6109288989041974
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,2.144908880465776
COR-L95,24951314,1.2848618182948477,1.227614980483031
Panc 02.03,11427553,3.85172253134883,2.578035472123966
RERF-LC-MS,11955716,-2.426679724944883,-1.4856643985320634
LCLC-97TM1,168312962,4.14705930417905,1.48933366232238
LCLC-97TM1,984333,1.7706091320352773,0.5138000229415411
RERF-LC-MS,3689413,0.4263782886644774,-0.4039154566871359
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.1495845971526135
HEL,72734382,4.138558929268269,4.3578051352274185
Daudi,5281672,3.0556000328651267,4.4250678360691875
Granta-519,73707438,4.294812737502366,4.210679418158044
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.8612337831613235
BFTC-909,3465537,1.8561429441463555,2.5477591829493655
MDST8,53232,0.2243602329572143,2.8161144578264046
PaTu 8988t,54618164,4.622822732421989,4.02740727006158
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,1.1345509900924162
BICR 22,241158,4.423333712203234,3.598987869990464
IGROV-1,25150857,3.031865110078871,2.336756962918186
MDST8,2729026,2.783400494590182,2.6325975116350393
IA-LM,56649450,5.159895082661475,2.999158341046921
RERF-LC-MS,44137675,3.373454428855253,3.337336921695599
HCC1500,11612883,3.8728122953700113,2.6386482274158856
COR-L105,44491742,4.003695029376484,4.1566745174283435
SU-DHL-1,17759555,3.5507610454949177,3.5392373768677334
PaTu 8988t,2828334,6.317024230854033,6.082620037824382
PaTu 8988t,168312962,3.961414669504744,1.48933366232238
NCI-H2452,15953870,1.9726746369071917,3.4781017448929608
LCLC-97TM1,54626689,4.751501808909531,4.561309020020982
PaTu 8902,136227331,5.567107594748722,4.306903331742339
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,3.9383569867901693
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.5350305453431912
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,2.93841691857644
Daudi,11317348,0.8828508555827204,2.3090854497210964
IGROV-1,26596,2.910298792762654,-1.5346517263124715
K-562,2742550,1.8061055262772656,3.8595787492072238
IGROV-1,25062766,2.144848161581278,2.0522756909743434
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-2.2321662354381537
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.9218131221296273
SW948,123631,3.5700289871060327,2.2760265557358337
COR-L95,168312962,1.6965693753889812,1.48933366232238
IGROV-1,9956119,3.7231415872817024,3.4762974507018756
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.261852028375895
HCC15,23725625,4.984445415553906,4.726527081330662
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,0.7705130043498147
RKO,2708,5.0364138660049935,4.591243765137335
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,1.4554460238042177
IA-LM,148198,-11.384967135346804,-3.548509713878981
PaTu 8902,44202524,5.539571067533291,1.9639001504219202
SK-OV-3,10127622,6.3662035368843535,3.6054187258933235
PaTu 8988t,16038120,1.6913300198770496,0.9090093368534204
HCC1500,6610355,5.5539350619643395,4.45123297085854
RKO,9956119,3.3077949428120195,3.4762974507018756
MDST8,8515,5.547245054967808,3.7716438213452004
HCC1500,5978,-3.1049031694332183,-2.3753204421143224
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.57821899028641
BFTC-909,262093,3.5924629632259792,2.6275548088442098
RKO,23635314,-2.140231911981244,-1.8612337831613235
MDST8,11626560,2.2403804115384207,1.6795489442409048
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,1.2047817895412443
COR-L95,44819697,-0.3616253875757693,-0.6109288989041974
BICR 22,5351362,1.2051272382141311,1.4604743967139864
K-562,9967941,4.015535149970178,3.6034131982542865
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,2.8341325456747963
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.7845058245277501
UACC-812,25102847,4.053875686762356,2.3366995460793083
SK-OV-3,6610355,6.222226160480143,4.45123297085854
IA-LM,11152667,1.0642318645878492,-0.5866736007906306
BFTC-909,6918289,3.427790661189136,1.9146814118519513
Granta-519,11167602,4.36712443545526,2.4705816300476062
BICR 22,60700,-0.4008092990404712,-0.4482559328189002
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,4.4833676274788345
RERF-LC-MS,241158,4.36087401910034,3.598987869990464
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,1.3153680794849765
HCC1500,24951314,1.2674136228128516,1.227614980483031
K-562,65064,5.606410384518605,4.739517756868576
PaTu 8988t,6852167,4.186106645973286,2.69961445504738
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.344610112805219
RERF-LC-MS,25154868,3.293982375318642,4.289494395804131
Daudi,11719255,1.9605498566152704,3.1221102230298534
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.8341325456747963
P31/FUJ,9907093,4.323796399268767,4.134688957161641
SK-HEP-1,56649450,4.110961369423777,2.999158341046921
SW948,11238147,1.5812364597614252,2.694366237977623
MOLM-13,60700,-3.6931560077615337,-0.4482559328189002
SK-OV-3,54618164,4.236989567252486,4.02740727006158
WM115,53232,2.2909547616931243,2.8161144578264046
Granta-519,11213558,2.214733921051264,1.4781707184028035
HCC1500,12001922,1.110118640671234,1.8522788760744173
MDST8,12003241,0.3559193403256231,-1.0889198012759371
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,-0.31026393275322106
MOLP-8,44819697,-0.0313402586892576,-0.6109288989041974
COR-L95,136227924,2.879022500990784,2.867001064974719
Granta-519,135421197,0.2234065586927925,1.8199795612290348
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-1.6778195760397165
SW48,6505803,-3.5264924347891897,-0.5114413444588124
IGROV-1,8515,2.1861539315976053,3.7716438213452004
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.2189174762180457
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-1.261852028375895
MOLM-13,25102847,-4.845176201807707,2.3366995460793083
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.2359123501503817
SW1271,53481919,3.611390941951582,3.8547522793737237
RERF-LC-MS,24964624,3.0594292113466515,2.2827362159867324
LCLC-97TM1,969516,2.175595213634207,2.7772567284956553
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,1.710700657959646
RKN,49793307,-1.2643121180608,-2.848251171596848
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.699201704606489
SU-DHL-1,15547703,1.7605543364675147,3.114669509763707
COR-L95,11625818,4.182153411947424,4.10791451089978
BICR 22,12003241,-0.4808187565312439,-1.0889198012759371
LCLC-97TM1,124202324,2.4863882679536133,2.1784388364790748
BICR 22,24797083,1.5794716057353129,1.277886491385028
WM115,136227331,3.7917327546536983,4.306903331742339
MOLP-8,23725625,3.090240324780466,4.726527081330662
NCI-H1568,3552672,1.826953477138791,2.8413574589562494
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.7724503678159762
IA-LM,51039095,2.817946248906647,2.682611194240459
K-562,11964036,1.6077176524784418,1.2382789669868983
HCC1500,5470400,-1.7385310235308598,-0.3765538821264742
SU-DHL-1,11396600,2.533401176626175,3.4309758536883517
BFTC-909,216345,4.226804426652683,3.7540083674013296
Panc 02.03,71304818,4.256945507775637,2.396178486082573
Panc 02.03,219104,4.2068478561753375,3.5366182443481806
SW948,23582824,0.2041553679799947,0.7400136078733197
NCI-H2452,5287620,-2.107035322199283,-1.9697846958841214
SW1271,15953870,2.918493523161381,3.4781017448929608
IGROV-1,119182,0.2112476135388779,-1.3340160156368264
SW1271,11656518,1.475105479065936,1.5480979328089313
Panc 02.03,49766530,0.9655059796360064,-0.6944377068647134
LS180,89928392,1.7442798189695845,1.344325138639762
SW1573,53495165,2.229023421141798,-0.19108456656304296
WM115,16659841,5.127619480623103,3.7845234388741966
SW1271,3552672,3.981050843991283,2.8413574589562494
SW948,9926054,1.8406028662949705,1.9546333131599372
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,1.2349426527428076
RCC10RGB,71466445,4.397911896340776,3.3478019143630626
WM115,7326481,2.374260909001927,2.957630994714242
SW948,44202524,1.7116279237548724,1.9639001504219202
RCC10RGB,46907787,5.224507823938942,1.584957029505121
LS411N,9936388,1.997277136132151,-1.7988236137529168
SW1271,135423438,1.1699634662635283,2.1190856698194294
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.5350305453431912
COR-L105,123631,-0.3749766708664047,2.2760265557358337
MOLM-13,52947716,-3.8827491455655694,-1.4012147836358484
HEL,36314,-3.7348038354216593,-1.2422497803043113
KU-19-19,54454,2.6957608866389866,2.548844675602096
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,2.344610112805219
MOLM-13,71680916,4.890723285268907,4.641848024405652
SW1573,65628,4.136448104244246,4.026684176415168
HuP-T3,11178236,-4.0067645508863174,-3.539769866873396
WM115,11364421,-5.628114250516673,-2.2476185097624475
K-562,613753,3.252228295501032,3.1495845971526135
IGROV-1,24771867,1.9944882740161016,1.5171458615349627
ALL-SIL,11152667,-2.075218964097288,-0.5866736007906306
BICR 31,3081361,0.7844567898788304,2.3568884936851697
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,1.7691529831259722
RCC10RGB,4788,6.17872638158586,5.493389053048461
Panc 02.03,11626560,2.1710424521283427,1.6795489442409048
IA-LM,11175137,3.357915620650256,2.477950770888125
RCC10RGB,11626560,2.6825909392900376,1.6795489442409048
SW1573,168313200,1.7327341920391253,2.9593589282331023
Granta-519,2828334,6.191507302277889,6.082620037824382
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.8341325456747963
MOLM-13,5460769,1.2989705913507943,2.3447175553942796
SU-DHL-1,216345,3.4378126257341406,3.7540083674013296
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.0163468544412688
MDST8,9926054,1.8075400364112937,1.9546333131599372
WM115,676352,1.7628184284101875,2.088896150621564
BFTC-909,55508,3.078625314561866,3.1188086218267883
RKO,100016,5.817852214634293,5.87798299213578
MDST8,46943432,3.6174081091701886,1.70045196562753
SW48,5978,-4.7084088584036525,-2.3753204421143224
ALL-SIL,44491742,3.700418914769662,4.1566745174283435
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,1.4554460238042177
SU-DHL-1,11178236,-5.1175240313736845,-3.539769866873396
BICR 31,11955716,-3.162575487986667,-1.4856643985320634
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-2.2476185097624475
MOLP-8,374536,-0.3332412159105151,1.7732341041149164
BICR 31,66577038,3.1838871840280745,2.9870697487432882
MDST8,409805,3.941558883413243,4.6745070702664995
K-562,6918878,0.8571724386049573,1.9069091595174383
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,2.823032655731692
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.78247230086659
NCI-H1568,5281321,-2.717480517336961,-1.3097742666845045
LCLC-97TM1,374536,2.574075324433214,1.7732341041149164
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-3.5071094923394703
HCC15,66577038,3.417660968254761,2.9870697487432882
IA-LM,9911463,2.6703246121465436,3.732908427020576
SW1271,1566236,1.9677070098040983,2.2263982365179604
IGROV-1,11238147,2.1723642292765084,2.694366237977623
SK-OV-3,11364421,-1.984047807336832,-2.2476185097624475
SU-DHL-1,54613361,-0.1121754666598921,-0.11678183903518824
COR-L105,119182,0.6226208228567816,-1.3340160156368264
WM115,3384730,6.229532895174781,2.4620443610818112
COR-L105,9967941,2.071649254258539,3.6034131982542865
RKO,72193861,0.7735395045157347,1.3858780169906042
COR-L95,753704,4.781559661696253,4.832125608051433
IGROV-1,49766530,-0.195540678413639,-0.6944377068647134
BFTC-909,8515,4.73152093133166,3.7716438213452004
Granta-519,31703,-4.611611754102639,-1.182053713238432
SW48,19582717,4.381046957550593,3.9198146524152833
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,1.2834565267098785
HCC15,15547703,3.515422457694346,3.114669509763707
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-1.2422497803043113
SU-DHL-1,BRD-K58730230,4.384837032763104,4.39496051692984
HuP-T3,2858523,3.211348955084378,3.0086502241129605
LCLC-97TM1,24901704,3.846855123751057,3.1103746959488285
NCI-H2452,44607530,1.9759156929339727,1.715838652040812
HCC15,9936388,-3.3305479025951783,-1.7988236137529168
RKO,46191454,0.9841477576830012,1.3518500781597358
SW1271,3081361,2.248142117307072,2.3568884936851697
HEL,100016,4.260371486080393,5.87798299213578
Panc 02.03,327653,3.634511095206161,3.018652636936018
NCI-H2452,25062766,2.439590704022921,2.0522756909743434
SaOS-2,44607530,1.05170222821091,1.715838652040812
HEL,5335621,4.9483155198907225,4.560420742529089
BFTC-909,6852167,2.133526407129769,2.69961445504738
MOLM-13,638278,1.880317910461832,3.209337660705321
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.2834565267098785
SK-CO-1,387447,-5.86001644251988,-4.3765957253648695
MOLP-8,10113978,2.697897563265303,3.010980031724017
MOLP-8,216239,2.6519870661660803,2.1474208097396077
NCI-H1568,46174525,4.305444868539079,4.156087356848057
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.8865368208635396
LCLC-97TM1,44607530,2.097748917507136,1.715838652040812
SaOS-2,9911463,4.168030006572111,3.732908427020576
Daudi,24889392,0.6157424479011876,3.7858620057203916
PaTu 8902,51039095,3.3801139171258976,2.682611194240459
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.4554460238042177
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.3153680794849765
Daudi,387447,-5.635352264179238,-4.3765957253648695
IGROV-1,5702613,4.420745339537274,3.145942765655066
LS180,375860,-0.0541765269880971,-0.30112130782396007
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.37491183386883553
MOLP-8,241158,1.846975252387852,3.598987869990464
SW948,44819697,-1.5719383449848416,-0.6109288989041974
NCI-H2452,5951923,4.988154330604512,4.9168889591608265
MOLM-13,54613361,-1.833470941599732,-0.11678183903518824
SW948,148198,-4.802987893737634,-3.548509713878981
BFTC-909,4261,3.835594401773327,1.4288257082744877
Daudi,45100481,4.914271492759253,4.430120472879877
MOLM-13,3384730,-1.9717967977442377,2.4620443610818112
IGROV-1,5566,3.174346862827938,3.029152149495273
SU-DHL-1,10302451,2.2731723403274535,3.0143591766147457
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-1.6778195760397165
RKN,24797083,0.944322820476056,1.277886491385028
SK-HEP-1,148198,-3.434194259121147,-3.548509713878981
SW48,16736978,1.8227831775957584,1.3934160091023764
HCC15,2708,6.122532058448304,4.591243765137335
SW48,5335621,4.0461877603353855,4.560420742529089
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.2349426527428076
NCI-H1568,71304818,2.2110745175145876,2.396178486082573
COR-L105,5311,1.9211659995219237,1.2663000347984639
SK-OV-3,5328940,3.4311724872159903,1.559061663996469
RCC10RGB,1716436,3.489109378341682,2.948755251800144
MDST8,6918878,1.145593411739036,1.9069091595174383
RKO,11364421,1.233720517884939,-2.2476185097624475
P31/FUJ,65064,5.109694638799521,4.739517756868576
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.102163121425029
PaTu 8902,3025944,5.120505038776715,4.206240213808089
Panc 02.03,12001922,2.5444953584324193,1.8522788760744173
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.8199795612290348
ALL-SIL,54454,2.130103786841792,2.548844675602096
Daudi,11238147,1.1945947480643642,2.694366237977623
WM115,148124,-1.9357807696466565,-2.0460232384010055
PaTu 8988t,25262965,-2.4539636298097376,-1.6224193967571534
IA-LM,49766530,-3.412847117105243,-0.6944377068647134
Granta-519,44185566,0.7632366174102183,2.4057100644299436
MOLP-8,44607530,1.0628729381864028,1.715838652040812
K-562,409805,3.7514940654800064,4.6745070702664995
BICR 31,89928392,2.942196417475874,1.344325138639762
SW48,23725625,4.606874242451815,4.726527081330662
RCC10RGB,16038120,1.536821218292656,0.9090093368534204
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.2047817895412443
RKO,148198,-2.1467795088860875,-3.548509713878981
SK-CO-1,409805,5.790109243945559,4.6745070702664995
HuP-T3,7251185,1.9415241444855404,2.4347287977616
LS180,11612883,2.759028826688456,2.6386482274158856
WM115,11507802,3.278245549501506,1.3590460953824346
IA-LM,168313016,4.257474229118996,4.725757076386842
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.029152149495273
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,1.78247230086659
SW48,10302451,2.1638159560649157,3.0143591766147457
Daudi,65064,2.8809848507042095,4.739517756868576
LS411N,11612883,3.0472980958623705,2.6386482274158856
NCI-H2452,11214940,1.2392722713501154,1.8119431265240042
ALL-SIL,984333,-1.3370961884574026,0.5138000229415411
P31/FUJ,1641662,2.802136916275355,3.3408828038827
MOLM-13,25183872,-2.142456248879295,-0.902802947451298
K-562,969516,2.7986550178028216,2.7772567284956553
Granta-519,54143018,0.4327684951223574,0.31711465707788644
SU-DHL-1,44819697,-0.3444138900100821,-0.6109288989041974
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,2.117207225291035
Daudi,9933475,1.2993243126142855,1.793439230086884
SK-CO-1,10427712,4.208191107568486,4.184108330161863
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,2.474523360549852
HEL,2841722,4.805306475973069,4.375424781932207
COR-L105,9926054,1.7310748902984938,1.9546333131599372
RCC10RGB,15983966,2.263334704673794,-1.6396194068861514
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,1.710700657959646
IGROV-1,46174525,4.5083762186279595,4.156087356848057
BICR 31,11175137,2.7548462189262817,2.477950770888125
COR-L105,11609586,4.426382611322312,2.621607380466062
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,4.13551970928241
IGROV-1,107985,-2.8971910842184516,-3.5771139994401464
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,2.699201704606489
IA-LM,71466380,4.547922152882383,4.275465599745589
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,1.4539899714896953
K-562,11612883,3.292128537791773,2.6386482274158856
HuP-T3,15953870,4.533958601099395,3.4781017448929608
NCI-H1568,219104,4.078417481216408,3.5366182443481806
RKO,65064,4.5178366082525,4.739517756868576
NCI-H1568,9911463,2.564901149372131,3.732908427020576
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.37491183386883553
ALL-SIL,6852167,2.025737624061405,2.69961445504738
Daudi,16065773,1.627011760718674,2.3641186374244216
MOLP-8,10410894,2.1334782114390425,3.2189174762180457
RERF-LC-MS,73707371,5.9060077591992375,5.18278851064184
RKN,1566236,1.687441004968786,2.2263982365179604
IGROV-1,439501,-2.1510551928674557,-2.2321662354381537
MOLM-13,57519531,1.2030375936335158,2.4211376500246136
Granta-519,11625818,4.458439944218401,4.10791451089978
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.4199080872215506
MOLP-8,3689413,-2.303477592076259,-0.4039154566871359
SK-HEP-1,54596558,4.485352352092043,4.397101469450013
SW1271,4705,3.86061099620112,3.0428654274536564
Granta-519,9927531,4.885085469625254,4.578027762171671
SU-DHL-1,11427553,0.3775832797434548,2.578035472123966
ALL-SIL,15953870,2.429039509996585,3.4781017448929608
COR-L105,4259181,2.2372065992854133,0.11236669175956715
HCC15,17759555,4.480266922784899,3.5392373768677334
COR-L105,10184653,-3.6529884694455608,1.1325795715302809
RKO,72376,-2.4980018930037673,-2.110114148114304
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,2.9860814461500107
RKO,613753,3.427719504210608,3.1495845971526135
LCLC-97TM1,10302451,3.3699574981481217,3.0143591766147457
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.3153680794849765
MOLP-8,3634881,2.730356562919761,3.1576774496130544
SW948,11612883,1.2539645440532456,2.6386482274158856
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.3791567205504176
BFTC-909,10074640,3.0053798884123837,3.066922642013836
LS411N,24901704,3.828527152917887,3.1103746959488285
SW1271,51039095,2.010271277744507,2.682611194240459
K-562,9935249,0.8993678101188762,2.8615383619674972
COR-L105,462382,1.111643181026989,0.5714028853239661
Granta-519,10385095,0.7144131323279258,1.2480392352773622
COR-L105,5281321,-2.635307184860664,-1.3097742666845045
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,2.8341325456747963
LS180,11234052,4.148077533652898,3.869960809483736
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,0.38762532684053896
COR-L95,25154868,4.601001468087818,4.289494395804131
Daudi,3025944,3.5610963405625267,4.206240213808089
SW48,24180125,2.6937498240420457,2.888353933707551
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.133687221210622
PaTu 8902,168312962,5.583922762984923,1.48933366232238
COR-L105,5280436,1.8180108392693488,3.153394505533252
SU-DHL-1,44507138,1.5242294298964132,2.3228542035372683
MOLM-13,10302451,1.7245492330691454,3.0143591766147457
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-2.110114148114304
SK-HEP-1,44607531,1.6636821475505756,1.48117322485652
IA-LM,15983966,2.169762444969255,-1.6396194068861514
IGROV-1,56946209,-4.416985130578084,-4.2202975286026225
P31/FUJ,25126798,3.55669651950966,3.7921789378214816
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.7691529831259722
BICR 31,15983966,1.7355748159582445,-1.6396194068861514
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.3848601780620533
NCI-H1568,135421197,1.29303587511011,1.8199795612290348
HEL,374536,0.3200488785786777,1.7732341041149164
NCI-H1568,25161177,4.305259269080427,4.097137926934978
Granta-519,24951314,0.3336244464551668,1.227614980483031
LS180,400769,-0.7559227838025858,-0.7855881743093749
MDST8,44607531,3.32682409463767,1.48117322485652
WM115,46843906,3.7194943725295992,2.723521570705241
RKN,24771867,0.8860225124393014,1.5171458615349627
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-1.1532493383305307
MDST8,72734382,4.130038178532864,4.3578051352274185
SK-CO-1,1750826,-0.0283504159212216,-1.4739669220989267
MOLP-8,10184653,1.0374255182903005,1.1325795715302809
NCI-H1568,46398810,2.1853633940590966,2.510712955745063
PaTu 8902,6438330,3.32865710338655,2.016737971321332
K-562,60700,0.041873955903415,-0.4482559328189002
KU-19-19,23725625,4.865374475902274,4.726527081330662
BFTC-909,6438330,3.0201113942824436,2.016737971321332
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,0.7705130043498147
HCC15,65064,4.883028365063005,4.739517756868576
HCC1500,285033,-0.4229420433590342,-2.1791335812392365
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.8865368208635396
LCLC-97TM1,5479543,3.538440111241957,3.2992765862159215
PaTu 8988t,613753,3.3970334474933495,3.1495845971526135
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.37491183386883553
SW1271,2949965,2.7362256869687895,2.715769249487813
SaOS-2,4705,3.668938036329027,3.0428654274536564
KU-19-19,11364421,2.01242470272022,-2.2476185097624475
SW1271,676352,2.2943086949623885,2.088896150621564
RKN,24856436,1.2279395925477072,0.17994774592918095
SW48,159324,-1.9628962598081805,2.0742938672876736
ALL-SIL,568763,-1.7129740739789223,0.28862358029973745
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.180307991266282
WM115,9907093,3.0763750955907883,4.134688957161641
SW948,637858,1.5262532123254355,1.8880097009592578
PaTu 8988t,24901704,4.232615528659116,3.1103746959488285
SU-DHL-1,11238147,0.4308170484254632,2.694366237977623
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.11065310288154762
COR-L105,3634881,3.59150153069964,3.1576774496130544
BICR 31,49766530,2.6564815829329236,-0.6944377068647134
SU-DHL-6,439501,-2.4303946334698057,-2.2321662354381537
SK-CO-1,6438330,2.884853035173295,2.016737971321332
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.37491183386883553
SW948,23635314,-3.685869994463448,-1.8612337831613235
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.227614980483031
RCC10RGB,24753719,5.18895385781671,4.143618673527016
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-1.1532493383305307
HCC15,53481919,4.945944641956239,3.8547522793737237
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-1.4012147836358484
BICR 31,11612883,2.9886930364048387,2.6386482274158856
HEL,20959075,-3.3486318540939535,-3.173507428051674
SU-DHL-1,24964624,1.891650824203322,2.2827362159867324
K-562,11609586,2.0906528510972775,2.621607380466062
KU-19-19,89183176,4.239044338938638,3.4938336610308007
MOLM-13,9927531,3.44947203831576,4.578027762171671
COR-L95,10302451,3.773437494355592,3.0143591766147457
SW1271,10385095,1.244878723840673,1.2480392352773622
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.9218131221296273
IGROV-1,17755052,-1.0246415273055465,1.7101929835526413
Daudi,3634881,1.264969339465191,3.1576774496130544
MDST8,46224516,2.508010817025431,2.370954746557396
SK-OV-3,65064,5.055886881526936,4.739517756868576
IA-LM,11364421,2.389092199855664,-2.2476185097624475
P31/FUJ,6918878,-0.2487475841908946,1.9069091595174383
SaOS-2,426756,5.396474834861055,4.301139445753315
MOLP-8,25150857,0.9011737742745826,2.336756962918186
BFTC-909,11167602,2.8757137848929006,2.4705816300476062
RKO,10302451,3.926970734642152,3.0143591766147457
HCC15,6252,2.2097348223357396,-0.10942982547788271
PaTu 8988t,135421197,1.788370067257354,1.8199795612290348
SW48,42642645,-1.378549292450493,0.7845058245277501
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-3.5071094923394703
COR-L105,73707398,2.56355231698926,1.180307991266282
Panc 02.03,3854666,5.373190444337423,1.85063491630251
WM115,11404337,-2.7813606850874595,-0.4254091153988029
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,3.456683733824014
K-562,9803433,4.389269041756261,4.847536831977339
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,0.7705130043498147
SW48,11152667,-1.5089069748808788,-0.5866736007906306
MOLP-8,BRD-K55473186,4.200306440270822,4.097702021052896
MOLP-8,3854666,0.8063321236158104,1.85063491630251
WM115,156422,4.742483160763306,3.8435202478608215
BICR 22,10302451,3.218470138701286,3.0143591766147457
P31/FUJ,3815108,3.712799909664185,2.885036533777781
SK-CO-1,5280436,3.963354946284049,3.153394505533252
SaOS-2,11625818,4.3669462586555055,4.10791451089978
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,2.0058447943574325
NCI-H1568,24856436,-0.7402646666066086,0.17994774592918095
MOLM-13,19582717,1.836192229041244,3.9198146524152833
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.117207225291035
LS411N,65064,5.143309491248943,4.739517756868576
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.0665232817889554
SW948,1716436,3.337695569228523,2.948755251800144
HEL,60750,-4.342121097179363,-2.435153852929516
SW48,5738263,2.8832489904283207,3.3050405288071003
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,2.5020743765616316
LS180,135984461,4.839780886141452,3.6237408287871284
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.2760265557358337
SW48,3634881,4.093042888484318,3.1576774496130544
WM115,82146,3.7974591517158,3.596877521367719
MOLP-8,24901704,2.731912612856625,3.1103746959488285
SU-DHL-1,9826308,0.1808938529022712,0.12580254156308923
SK-HEP-1,60700,1.3088528574816594,-0.4482559328189002
SW948,49793307,-5.1176222473357775,-2.848251171596848
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,2.474523360549852
P31/FUJ,15953870,2.7000087530897776,3.4781017448929608
SK-CO-1,24901704,3.265743022928408,3.1103746959488285
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.93841691857644
Panc 02.03,100016,6.582809568040202,5.87798299213578
RKO,168312962,-2.5117583451491012,1.48933366232238
RCC10RGB,25126798,4.759098567819552,3.7921789378214816
SW1271,24964624,2.7126751219569147,2.2827362159867324
ALL-SIL,9444,2.1167841583667277,4.054048446110465
SW1271,1641662,3.842487885295187,3.3408828038827
BICR 22,676352,2.452861704781308,2.088896150621564
K-562,54596558,4.166105900128149,4.397101469450013
Panc 02.03,9933475,2.3025810529048205,1.793439230086884
NCI-H2452,374536,-3.751500666928139,1.7732341041149164
SW48,9825149,0.0451584979105152,2.074054954263997
MDST8,3634881,2.8722303311625006,3.1576774496130544
SW1573,24180125,4.83914798243841,2.888353933707551
WM115,42642645,1.5932691238490415,0.7845058245277501
SaOS-2,24753719,4.762341084721446,4.143618673527016
SK-CO-1,25062766,1.7088187930933407,2.0522756909743434
Daudi,71466445,1.7957550148901065,3.3478019143630626
K-562,9903786,3.6050720376028105,2.756077717004494
MDST8,5281321,-0.743993786053836,-1.3097742666845045
WM115,216345,2.152490626678771,3.7540083674013296
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.860017480413567
Panc 02.03,44566777,1.8066319547984584,0.6972581949653407
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,2.3791567205504176
SW48,1716436,3.2732206570492512,2.948755251800144
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.0058447943574325
COR-L95,5281321,-5.086788267908354,-1.3097742666845045
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.466606494133751
LS180,5287620,-2.159393408078438,-1.9697846958841214
HCC15,24856436,0.7194572205096856,0.17994774592918095
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.3153680794849765
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,4.4833676274788345
K-562,54613361,-1.429503199294265,-0.11678183903518824
PaTu 8988t,5311281,3.776140248734943,2.22503529708604
HCC15,10090485,4.457627969814505,4.776418823086279
LS411N,1242560,3.5784744482633526,3.534393132486151
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,1.710700657959646
MDST8,3854666,1.4298592595361392,1.85063491630251
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,2.3791567205504176
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-1.261852028375895
SaOS-2,448949,2.4147534872316916,1.9537365892294993
K-562,44607531,1.5533391017282614,1.48117322485652
RKO,656346,1.2468664563159324,0.7582608913284792
SW1271,54619267,4.215254166837184,3.9342007971372475
PaTu 8988t,107985,-3.7439330143768106,-3.5771139994401464
Daudi,107985,-4.311158471957254,-3.5771139994401464
K-562,89928392,1.1726799483120014,1.344325138639762
BICR 22,2828334,6.182973514514405,6.082620037824382
PaTu 8988t,462382,0.0850922030405946,0.5714028853239661
COR-L95,54619267,4.025082196689936,3.9342007971372475
SW48,44486219,4.521255071137468,4.281343219898981
MOLP-8,136227924,1.5113872866650588,2.867001064974719
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.9860814461500107
LS180,176870,3.0513508415646644,3.0253996189023358
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,4.6745070702664995
NCI-H2452,60700,-2.076184021255351,-0.4482559328189002
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.5477591829493655
Daudi,2749,-0.7661278600765006,1.7932893499757152
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-1.6778195760397165
HCC15,11364421,-3.377820549130246,-2.2476185097624475
ALL-SIL,135984461,1.7193250250744925,3.6237408287871284
HCC1500,1750826,-2.1124887265082255,-1.4739669220989267
RKN,53392493,3.005817826052642,2.4832542501558077
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,1.3153680794849765
BICR 22,5287969,-2.619429839358568,-1.9772070858850965
BFTC-909,24978538,2.589526114093726,0.6273547794147847
SK-HEP-1,2828334,6.264472809398218,6.082620037824382
Daudi,4705,2.565440722309658,3.0428654274536564
HEL,11485656,1.96241131365886,2.2397291078765758
BICR 22,23582824,1.0399288647056628,0.7400136078733197
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-1.261852028375895
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-1.57821899028641
MOLP-8,11364421,-5.744944118703229,-2.2476185097624475
COR-L105,374536,-3.312479831607182,1.7732341041149164
SK-CO-1,56973724,0.9140094173628892,2.823032655731692
HCC1500,135440466,3.12374064827048,2.1401473911994366
COR-L105,24978538,1.189273057385404,0.6273547794147847
SK-HEP-1,45279963,4.052806603396004,3.660133434789582
K-562,11317348,0.8853213314815674,2.3090854497210964
RKN,6918837,-0.6134153399361431,-3.046222711611649
LCLC-97TM1,285033,-3.3608842191269104,-2.1791335812392365
HCC15,11455910,-0.3399110905288865,0.9557745122323711
SK-HEP-1,176870,5.630942733934813,3.0253996189023358
RKN,23635314,-1.997093039658799,-1.8612337831613235
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.456683733824014
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.0058447943574325
SW948,969516,2.384481795832599,2.7772567284956553
WM115,24180125,3.7433275341391057,2.888353933707551
SK-HEP-1,135440466,3.4774178685499324,2.1401473911994366
KU-19-19,11626560,2.7733848967135017,1.6795489442409048
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.463597576567934
LCLC-97TM1,44507138,1.7278080476353117,2.3228542035372683
SK-OV-3,25150857,2.8200349544845045,2.336756962918186
HCC15,44491742,4.47716804785037,4.1566745174283435
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,2.3791567205504176
LCLC-97TM1,25150857,2.1625900659079296,2.336756962918186
P31/FUJ,124202324,0.9428129005296164,2.1784388364790748
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,2.344610112805219
COR-L95,6505803,0.0712785503404296,-0.5114413444588124
HCC15,24964624,3.0755429715166063,2.2827362159867324
MOLP-8,11647372,0.2904161448795228,0.8954839509867156
BICR 31,11977753,-1.0341786941527915,-1.7159558966047241
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,3.7540083674013296
HuP-T3,5282054,2.779269170716028,3.5628845676855256
SW948,54618771,1.4567685239775812,0.9253379925205388
Granta-519,24797083,0.9051026865971544,1.277886491385028
SW48,73707398,0.6331221198690845,1.180307991266282
BFTC-909,135411,0.8518885281649031,0.5181226666256136
HCC1500,675434,3.977739266447536,4.463597576567934
SK-HEP-1,6918328,0.8938731782790444,-0.28710840066117727
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.381335299817078
LS180,159324,3.258862193159196,2.0742938672876736
HEL,168312962,0.5016152377841688,1.48933366232238
SaOS-2,44607531,1.4975746891341548,1.48117322485652
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,1.0163468544412688
MOLP-8,6610216,4.187822370904977,4.26979744561799
HCC1500,5278396,3.6802956879537856,3.517590475337377
K-562,445643,4.07029800941494,3.9383569867901693
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.539769866873396
Panc 02.03,5351362,2.6810485074832,1.4604743967139864
BFTC-909,23725625,7.000464253417552,4.726527081330662
SK-OV-3,8515,5.143916520422132,3.7716438213452004
RKO,24779724,5.847036108864024,4.725601600845458
MOLM-13,65064,3.286890258414819,4.739517756868576
P31/FUJ,9868037,1.2869642230829814,2.82815333449006
MOLP-8,52912189,-0.8757353744499203,1.6723266261402217
HCC15,2113511,6.327015395869061,5.381335299817078
IGROV-1,25183872,-0.4560099928976716,-0.902802947451298
MOLM-13,44259,-1.8425758706378912,0.9267255578557378
P31/FUJ,9911830,2.020541196825024,2.4240324657892436
NCI-H1568,11455910,-0.0792581795853734,0.9557745122323711
Granta-519,409805,2.9966967612339417,4.6745070702664995
IA-LM,7251185,3.003277248553597,2.4347287977616
LCLC-97TM1,24771867,-3.13973757551719,1.5171458615349627
SaOS-2,387447,-3.480142635313653,-4.3765957253648695
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,1.710700657959646
HCC15,71466380,4.492977556176778,4.275465599745589
KU-19-19,11178236,-2.578122805273377,-3.539769866873396
SK-HEP-1,107970,2.7276242080982405,2.3029314718240044
SW948,3503,2.019264798250741,2.2426858883255045
MOLM-13,11455910,-0.3133362084586128,0.9557745122323711
COR-L95,216239,1.9606601522489808,2.1474208097396077
MOLM-13,20959075,-3.627453597088981,-3.173507428051674
SW1573,3543504,3.864321270652805,4.269325105068445
NCI-H2452,16722836,1.367876124233394,1.5333952667080324
LCLC-97TM1,2949965,2.4577774402858203,2.715769249487813
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.2992765862159215
SK-HEP-1,9911463,4.3683168964450125,3.732908427020576
P31/FUJ,11404337,-0.879305702132212,-0.4254091153988029
RERF-LC-MS,23725625,5.011639185934848,4.726527081330662
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.11065310288154762
SW48,126941,-4.535727103151088,-2.8921209077069348
BFTC-909,6184667,3.207156937684644,2.901063659317265
KU-19-19,2945648,2.475372674219151,2.7548400693819435
HuP-T3,387447,-4.787053098216054,-4.3765957253648695
Panc 02.03,44493528,4.298055948100647,4.333966846288542
Daudi,4788,4.597613323137637,5.493389053048461
K-562,46907787,1.0881737362577,1.584957029505121
HCC15,6505803,-2.813846830430111,-0.5114413444588124
MOLM-13,3503,1.2246558483585983,2.2426858883255045
NCI-H1568,136227924,3.032081072579533,2.867001064974719
RKO,9444,4.448790979485227,4.054048446110465
Daudi,107970,1.216737596928884,2.3029314718240044
Daudi,5311037,3.4563783042396015,3.9433489656963694
SW948,10184653,-0.1197105127119604,1.1325795715302809
HEL,89928392,0.5480178499310975,1.344325138639762
SK-HEP-1,5566,3.210365271342881,3.029152149495273
NCI-H2452,44493528,4.324080951064212,4.333966846288542
SW948,24753719,4.222068008445673,4.143618673527016
K-562,11717001,4.3318290739670555,3.961276339234443
HCC15,11647372,2.6612404016221824,0.8954839509867156
COR-L95,11214940,4.129361910595318,1.8119431265240042
P31/FUJ,57330099,4.216278217816623,4.311542343968036
COR-L95,24889392,4.336996294263524,3.7858620057203916
ALL-SIL,16725315,3.2612856597636064,4.150060666188836
SU-DHL-1,2749,0.1348057545057474,1.7932893499757152
IGROV-1,6918736,-0.950858733923241,-1.741781295359962
HEL,46398810,0.908204113249262,2.510712955745063
COR-L105,969516,2.680370673187369,2.7772567284956553
MOLP-8,613000,0.7667530859484226,2.227141832343803
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,-0.10942982547788271
SW948,375860,-0.5776308885037049,-0.30112130782396007
Granta-519,6438330,1.446800550416973,2.016737971321332
SaOS-2,3384730,0.9471099210722488,2.4620443610818112
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.8865368208635396
SW948,10127622,1.0689347689119728,3.6054187258933235
SK-OV-3,104842,-0.359869843998673,-3.040993872013826
HCC15,2733526,3.237047771361035,3.714359432422819
ALL-SIL,9884685,1.523019065964201,0.4230357541133405
HCC1500,31703,-0.1591983874970776,-1.182053713238432
MOLP-8,24785538,-1.5077289265748457,1.3344504348570345
COR-L95,6918328,0.296514622397876,-0.28710840066117727
LS180,24964624,2.8898766327054153,2.2827362159867324
PaTu 8902,2945648,2.947030382730425,2.7548400693819435
IA-LM,16038120,1.0865848932778794,0.9090093368534204
Daudi,54619267,3.035333918034676,3.9342007971372475
Daudi,5284373,1.725683673378691,2.7079346453511217
SW948,56946209,-4.45606402023299,-4.2202975286026225
SU-DHL-1,9956119,2.7884192993685666,3.4762974507018756
PaTu 8988t,3689413,2.4784022576221836,-0.4039154566871359
WM115,44241473,4.443917717257507,4.8543955662784395
HEL,11507802,0.749942791895586,1.3590460953824346
LS180,25150857,2.6595729662678846,2.336756962918186
ALL-SIL,11964036,0.9057184864624424,1.2382789669868983
SW1271,5351362,2.529410314371741,1.4604743967139864
KU-19-19,151289,4.45756440863607,0.9562867634504244
MDST8,24785538,2.8042557252914597,1.3344504348570345
LCLC-97TM1,11228183,2.6499520646531254,1.8712017695678478
NCI-H1568,10127622,5.078058454742808,3.6054187258933235
RKN,676352,2.5860960344205175,2.088896150621564
WM115,6505803,-4.475953396274594,-0.5114413444588124
MOLM-13,5278396,2.870927952465231,3.517590475337377
SW48,1641662,2.4016053281737544,3.3408828038827
Panc 02.03,5329102,3.1751218779490404,2.031058842574058
P31/FUJ,136227924,2.3905530687579497,2.867001064974719
LCLC-97TM1,5281321,-1.0764177966981967,-1.3097742666845045
SU-DHL-1,23635314,-2.2508595154996844,-1.8612337831613235
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.8865368208635396
MOLM-13,44494015,-5.247330257185634,-5.3692657980463965
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.3848601780620533
HCC1500,46199207,3.053954841618667,3.1312366616263048
NCI-H1568,6610355,3.436001375430949,4.45123297085854
HCC15,54618164,4.329878027642837,4.02740727006158
RKN,969516,2.6409066030454804,2.7772567284956553
COR-L105,71680916,4.738410817171978,4.641848024405652
SU-DHL-6,3634881,2.3700422517918653,3.1576774496130544
Daudi,374536,1.069903440531545,1.7732341041149164
K-562,322968,4.0833948777840225,3.4956311613712456
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,2.144908880465776
K-562,136227924,2.737847329779252,2.867001064974719
HCC15,15953870,3.1000423449826275,3.4781017448929608
BICR 22,6505803,-0.8504421983690468,-0.5114413444588124
BICR 31,409805,3.7719372874267982,4.6745070702664995
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-0.8865368208635396
KU-19-19,71304818,1.8280747292346609,2.396178486082573
SW1271,6917907,-6.616351101315701,-4.864372369867458
SW48,44589607,2.4172125993075335,2.659070263037081
KU-19-19,3854666,3.1161318305167995,1.85063491630251
MOLP-8,11404337,-0.9705317414577028,-0.4254091153988029
SK-OV-3,11152667,-0.6824217491873509,-0.5866736007906306
LCLC-97TM1,72199292,1.0139745528188595,1.1233129488647187
SK-OV-3,5566,3.179406871626594,3.029152149495273
SU-DHL-1,11683005,2.624367478757415,3.769580038308904
PaTu 8902,71466380,4.078142681912824,4.275465599745589
Daudi,56963564,0.012925039709307,0.2569389627451253
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,0.7582608913284792
SU-DHL-1,25195348,1.1859308431356896,3.08171494739702
RERF-LC-MS,11494412,1.0302757077826894,1.4248282417532188
IGROV-1,3634881,2.769147818550815,3.1576774496130544
SW48,445643,3.7110082204631545,3.9383569867901693
IGROV-1,3854666,2.3355254440561137,1.85063491630251
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-1.1532493383305307
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.110210541110895
PaTu 8902,387447,-3.44390255134181,-4.3765957253648695
BICR 22,25150857,2.1797682691439233,2.336756962918186
SK-HEP-1,54618164,4.274964046269975,4.02740727006158
BICR 22,44493528,4.288893884195869,4.333966846288542
NCI-H1568,969516,2.3539842482072353,2.7772567284956553
HEL,52912189,-0.3930066433927971,1.6723266261402217
BICR 31,53392493,3.0187901836288824,2.4832542501558077
Panc 02.03,6610216,4.56797737488032,4.26979744561799
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,2.93841691857644
SaOS-2,445643,3.906030165734591,3.9383569867901693
SU-DHL-1,9967941,3.123701665105139,3.6034131982542865
P31/FUJ,10113978,2.718593007254544,3.010980031724017
K-562,54618771,1.1969173800987956,0.9253379925205388
SW1271,445643,4.255849699563793,3.9383569867901693
SU-DHL-1,16741245,1.9818901112506189,3.801678648950925
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,1.2834565267098785
SU-DHL-1,9935249,2.376788737359572,2.8615383619674972
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-1.261852028375895
Daudi,11625818,2.088957631704298,4.10791451089978
IGROV-1,11213558,0.52356811652227,1.4781707184028035
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.0276770243216165
SaOS-2,9907093,3.731287417721421,4.134688957161641
COR-L105,54618771,2.0419110046350135,0.9253379925205388
RKO,9935249,5.020114551473781,2.8615383619674972
RCC10RGB,54649381,5.891551456540707,3.7880999548273127
RCC10RGB,11228183,3.0224846047699288,1.8712017695678478
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,1.7724503678159762
ALL-SIL,11683005,2.0727325774258794,3.769580038308904
RKN,9935249,4.428036529076262,2.8615383619674972
SK-HEP-1,6918837,-2.2229066751457345,-3.046222711611649
Panc 02.03,36462,3.4500230117265933,1.5076124324231743
SU-DHL-1,9866186,-0.7631869517914462,0.7577083020821866
LCLC-97TM1,448949,2.0046135576158637,1.9537365892294993
SW1271,2858523,3.03244629786768,3.0086502241129605
SaOS-2,46398810,2.449640817433895,2.510712955745063
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,1.4554460238042177
COR-L105,16013152,4.074366111138725,4.119375381760217
SW1271,10127622,0.8769341404821704,3.6054187258933235
PaTu 8902,24951314,1.6215809376037376,1.227614980483031
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,1.133687221210622
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,0.38762532684053896
Daudi,72199292,0.1565760694605324,1.1233129488647187
PaTu 8902,409805,5.142449436796194,4.6745070702664995
BFTC-909,16115403,-3.993091010962378,-4.875275216600306
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,2.0058447943574325
NCI-H2452,6505803,0.3706171048891257,-0.5114413444588124
K-562,123631,1.7867714727142892,2.2760265557358337
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,2.117207225291035
SW948,56963564,0.1376223024943695,0.2569389627451253
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-1.261852028375895
KU-19-19,25183872,1.353604037781074,-0.902802947451298
K-562,462382,0.6666012292356907,0.5714028853239661
BICR 22,216239,3.622359576149126,2.1474208097396077
SW948,72376,-2.235310823117723,-2.110114148114304
SK-HEP-1,16736978,1.840110323821058,1.3934160091023764
LS411N,135440466,2.8415058675889,2.1401473911994366
BICR 31,2871966,0.8542621552894032,0.29730316799892464
NCI-H2452,5311281,2.597680352332147,2.22503529708604
HEL,25195348,3.2451646073619416,3.08171494739702
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.9218131221296273
SW48,24856436,-0.3608375787119608,0.17994774592918095
COR-L95,23582824,1.713723586402061,0.7400136078733197
NCI-H2452,400769,-0.2625889565980605,-0.7855881743093749
Granta-519,6610355,5.056177796240837,4.45123297085854
RKN,135984461,0.6080422026652917,3.6237408287871284
IGROV-1,9956119,3.7231415872817024,3.4762974507018756
SU-DHL-1,24856436,-0.2626900450765423,0.17994774592918095
BICR 31,9911463,4.617619725588035,3.732908427020576
BICR 31,2742550,4.742856926113666,3.8595787492072238
Daudi,6450551,1.0042642679666238,2.361538429265863
HEL,57519531,1.593967479342305,2.4211376500246136
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.38762532684053896
RKN,216345,4.602972623005823,3.7540083674013296
SW48,46224516,2.362473255058207,2.370954746557396
RKN,10184653,1.939164173873933,1.1325795715302809
MOLP-8,31703,-3.4249459011432912,-1.182053713238432
HCC15,9911830,1.9028880277746671,2.4240324657892436
P31/FUJ,24180125,3.650250525491935,2.888353933707551
HCC1500,11427553,3.400784702269924,2.578035472123966
WM115,4378219,1.986798403927216,2.6822409618839944
MOLM-13,445643,3.334033231716822,3.9383569867901693
HuP-T3,135440466,1.565116417651368,2.1401473911994366
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.1566745174283435
SaOS-2,5284616,3.138246393599145,1.1658534217096055
LCLC-97TM1,156422,4.251965697410575,3.8435202478608215
Granta-519,71680916,3.9040498639791226,4.641848024405652
SU-DHL-1,16725315,3.3729799888412257,4.150060666188836
P31/FUJ,20959075,-3.3972839651855207,-3.173507428051674
K-562,16720766,1.059873963232806,0.4291253754884592
WM115,9915743,2.6223908273409515,0.5935480801734145
COR-L105,11238147,3.8255779395664065,2.694366237977623
HCC15,6918878,1.2461206152093485,1.9069091595174383
SK-OV-3,11427553,3.3243369937323877,2.578035472123966
RKN,6918736,-2.1202784612128416,-1.741781295359962
NCI-H1568,10385095,0.5241849666466598,1.2480392352773622
LS180,6623618,2.712323731600185,2.1468722777789853
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.344610112805219
COR-L95,5287620,-3.7742892062529183,-1.9697846958841214
Daudi,11977753,-5.803293235753203,-1.7159558966047241
NCI-H1568,375860,-0.3746562160702436,-0.30112130782396007
Daudi,1242560,2.7879344365615633,3.534393132486151
RKN,2729026,3.0549768432694377,2.6325975116350393
SU-DHL-1,56963564,-1.155496663147979,0.2569389627451253
SK-HEP-1,42642645,1.5394057036271682,0.7845058245277501
COR-L105,9935249,3.5389604716579175,2.8615383619674972
SK-CO-1,107970,2.4721550322855843,2.3029314718240044
RKO,5113032,5.90165838842917,4.970396511864891
SW1573,135411,2.599466343128946,0.5181226666256136
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.2834565267098785
RCC10RGB,6610355,5.214940260192328,4.45123297085854
BICR 31,5287620,-1.513974949921974,-1.9697846958841214
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.184108330161863
RERF-LC-MS,72376,-2.3536044208150644,-2.110114148114304
UACC-812,7326481,2.606201441290427,2.957630994714242
MOLP-8,11717001,3.6554432811683824,3.961276339234443
P31/FUJ,1317464,4.709019850634407,4.148586664919221
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.4762974507018756
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.559061663996469
SaOS-2,44507138,2.054017263478066,2.3228542035372683
IGROV-1,445091,5.8777802446160825,4.3274252089919045
RERF-LC-MS,54613361,-1.445874788963763,-0.11678183903518824
RERF-LC-MS,72193861,1.0218744083195843,1.3858780169906042
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.0163468544412688
HEL,56963564,-0.4081404928481738,0.2569389627451253
PaTu 8902,136227924,3.2072125986231117,2.867001064974719
SW1271,25183872,-0.9123448839798644,-0.902802947451298
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.9218131221296273
IGROV-1,25154868,4.833387840688245,4.289494395804131
LS180,107970,2.4480125060803077,2.3029314718240044
RERF-LC-MS,9840324,5.508232790936476,5.7711165719697215
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.1188086218267883
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.741781295359962
COR-L95,60700,-2.695152938475503,-0.4482559328189002
HCC15,24785538,0.0662714662573936,1.3344504348570345
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,2.93841691857644
ALL-SIL,73707398,-0.324762560862376,1.180307991266282
HuP-T3,23725625,5.187021863055133,4.726527081330662
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,2.8341325456747963
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.8547522793737237
MDST8,6505803,-0.0816923181525763,-0.5114413444588124
SK-OV-3,5351362,2.7626479495985765,1.4604743967139864
IGROV-1,36462,2.313632721410001,1.5076124324231743
BICR 22,54618305,4.315554591509874,4.084826955496459
MDST8,5311281,0.3396864368094036,2.22503529708604
MDST8,9866186,0.4787443726889831,0.7577083020821866
COR-L105,9840324,5.89386509883338,5.7711165719697215
SU-DHL-6,9887053,3.723065049771557,3.469815136639831
SU-DHL-1,10113978,2.4232665022526154,3.010980031724017
K-562,6610216,3.734328570580528,4.26979744561799
MOLM-13,9936388,-7.059788369591511,-1.7988236137529168
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.0163468544412688
WM115,135659046,3.4373276092449667,3.604307380358917
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.3934160091023764
RCC10RGB,2708,5.228545547030361,4.591243765137335
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,0.4199080872215506
HuP-T3,969516,2.913535439683091,2.7772567284956553
P31/FUJ,135398744,5.7727848933678,6.625444078703129
SaOS-2,168312962,3.518591614256865,1.48933366232238
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-3.5071094923394703
Panc 02.03,11364421,0.2085573081853932,-2.2476185097624475
SU-DHL-1,3385,0.1709309619587451,3.472185389430271
COR-L105,3854666,3.5309487733662923,1.85063491630251
K-562,3025986,-1.372296763308674,-0.8978770871810051
PaTu 8902,25183872,-0.4459453921876214,-0.902802947451298
BICR 22,25022340,5.75714905141274,2.219156297475395
SK-CO-1,71466445,5.862416915369376,3.3478019143630626
HEL,159324,1.7687894675630291,2.0742938672876736
P31/FUJ,135411,-0.6620772647112111,0.5181226666256136
K-562,11455910,-0.068399521398108,0.9557745122323711
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-1.261852028375895
SaOS-2,135421197,3.6760992974277817,1.8199795612290348
RKO,54678924,1.753529637740366,1.9473085147454567
LS180,9926054,2.059729849775666,1.9546333131599372
PaTu 8902,3081361,4.091517551590367,2.3568884936851697
HCC15,54618305,4.644823264977023,4.084826955496459
SK-CO-1,135421197,1.070123520764916,1.8199795612290348
MOLP-8,5282054,2.3704039128819603,3.5628845676855256
Granta-519,2874250,5.483813332492178,4.0377213891771015
SW948,15547703,2.460178853059974,3.114669509763707
RKN,11175137,3.1657803092866224,2.477950770888125
HCC1500,15547703,2.6330912213710693,3.114669509763707
PaTu 8988t,3503,2.8268609009838706,2.2426858883255045
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,0.4199080872215506
NCI-H2452,409805,5.262030999116563,4.6745070702664995
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.578027762171671
K-562,107985,-3.1543528536618175,-3.5771139994401464
RCC10RGB,6918837,-1.099435459858538,-3.046222711611649
HuP-T3,2746,4.662800576379415,2.8579929499469348
Granta-519,135928012,3.1328015926823065,3.8701906312906376
HEL,2733487,3.1527152778808794,6.1630813151494985
RCC10RGB,11175137,3.603105896683611,2.477950770888125
RKO,51039095,3.7257826703811014,2.682611194240459
WM115,3689413,-0.1044392328624619,-0.4039154566871359
SaOS-2,25154868,5.397428200613107,4.289494395804131
RKO,25195348,3.4491832635970585,3.08171494739702
BFTC-909,49850262,4.237463012213885,3.414452598711333
SW48,168313047,2.500888470511616,2.4053217165791536
WM115,444795,4.375682835505768,3.7799917274901733
IGROV-1,5738263,4.037832478240785,3.3050405288071003
MOLM-13,24748573,1.5626639761830592,1.9565115912575295
UACC-812,6917907,-5.293133909322777,-4.864372369867458
IGROV-1,168313200,3.9938362637732983,2.9593589282331023
PaTu 8988t,262093,3.2462588578894587,2.6275548088442098
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,1.7724503678159762
WM115,3543504,4.159835009416132,4.269325105068445
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.0276770243216165
SU-DHL-1,9903786,2.5464454731205777,2.756077717004494
ALL-SIL,6438330,0.5772640537372373,2.016737971321332
SK-HEP-1,322968,4.726859452680793,3.4956311613712456
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,2.948755251800144
WM115,2874250,4.6839306454467975,4.0377213891771015
HEL,327653,2.969363674974165,3.018652636936018
SU-DHL-1,11625818,3.655247454502854,4.10791451089978
UACC-812,49766530,0.2629782697340875,-0.6944377068647134
SU-DHL-1,3815108,2.229733806447586,2.885036533777781
IA-LM,71466445,4.189377103287156,3.3478019143630626
HuP-T3,1716436,3.1901993610711092,2.948755251800144
SW948,44566777,0.0218128389697893,0.6972581949653407
SaOS-2,24821094,3.1556587771151117,2.7369152351179045
Panc 02.03,135875424,4.996461687769912,3.743891076041643
COR-L95,3136844,6.4544258549997675,4.214923916993912
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,1.3858780169906042
LCLC-97TM1,3385,2.7516430893834696,3.472185389430271
K-562,135875424,2.7247406179323055,3.743891076041643
LS411N,5329102,2.797825403975713,2.031058842574058
MDST8,24964624,1.7196440159479949,2.2827362159867324
KU-19-19,10090485,5.355458016675434,4.776418823086279
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.0163468544412688
RKO,89183176,-5.254565057669901,3.4938336610308007
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,1.1345509900924162
Daudi,24775005,2.5651956502981093,3.778654827630856
SW948,46215462,1.7533079238953375,1.762132613731386
BICR 31,6610216,4.499990209090508,4.26979744561799
ALL-SIL,89928392,-0.8842785165403505,1.344325138639762
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,3.3848601780620533
SaOS-2,9933475,1.7767718055197024,1.793439230086884
LCLC-97TM1,16722836,1.3652485758433368,1.5333952667080324
LCLC-97TM1,49793307,-2.6941720612695814,-2.848251171596848
SW48,10127622,-3.686333454689576,3.6054187258933235
Daudi,451668,-1.5751627659840317,-0.17843514405649885
NCI-H1568,135398516,0.1447365774963497,2.0509021680173207
MOLP-8,11178236,-5.22072808334844,-3.539769866873396
NCI-H1568,46907787,2.5747387573296425,1.584957029505121
PaTu 8988t,6914657,-5.535111189097384,-4.170094408243688
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,1.0163468544412688
SW948,3025986,-0.0730103520402185,-0.8978770871810051
IGROV-1,11612883,1.8715405446213529,2.6386482274158856
RCC10RGB,3081361,3.5981013353753464,2.3568884936851697
MOLM-13,73707398,-1.293008226929777,1.180307991266282
RCC10RGB,9915743,0.9759946846108524,0.5935480801734145
HCC1500,24771867,4.066345817331682,1.5171458615349627
K-562,44137675,5.346911467461658,3.337336921695599
BICR 22,89183176,4.4276408454646,3.4938336610308007
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.37491183386883553
BFTC-909,54619267,3.991913685478571,3.9342007971372475
RKO,71304818,0.9175289508752972,2.396178486082573
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,1.7724503678159762
BICR 31,25161177,4.144120396566418,4.097137926934978
SK-CO-1,6918328,0.4731277879927994,-0.28710840066117727
RERF-LC-MS,6914657,-3.1593675222943896,-4.170094408243688
NCI-H1568,44185566,2.743919877007031,2.4057100644299436
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-0.8865368208635396
COR-L95,6852167,3.112371536345172,2.69961445504738
P31/FUJ,5113032,4.875284905433655,4.970396511864891
BFTC-909,24180125,2.699370118217823,2.888353933707551
SU-DHL-1,6252,0.3334498529847555,-0.10942982547788271
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-1.1532493383305307
LCLC-97TM1,322968,2.924684365208183,3.4956311613712456
Daudi,60750,-4.624244800464318,-2.435153852929516
NCI-H1568,3385,5.30334090203815,3.472185389430271
COR-L95,5978,-2.5997235685562026,-2.3753204421143224
Daudi,24856436,-0.3602858360333429,0.17994774592918095
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,0.9253379925205388
MOLM-13,445455,3.1473640199222386,4.540053644561405
SW1573,135421197,1.3915330004591782,1.8199795612290348
HCC1500,16065773,1.504426355167742,2.3641186374244216
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.548844675602096
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.7691529831259722
Daudi,9826308,0.3207715704810925,0.12580254156308923
RKN,17759555,4.047966260499275,3.5392373768677334
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.4554460238042177
PaTu 8902,9911463,4.390925153080421,3.732908427020576
LS180,54613361,-0.777399447336216,-0.11678183903518824
COR-L95,11396600,3.695258257335492,3.4309758536883517
SU-DHL-1,9911463,3.067527187401269,3.732908427020576
COR-L95,4477,0.8356196347588036,0.5570685949048098
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,4.4833676274788345
COR-L105,12001922,2.476912212032941,1.8522788760744173
NCI-H1568,25154868,2.392234118098981,4.289494395804131
P31/FUJ,24964624,0.604485461730223,2.2827362159867324
RKN,11507802,1.1392194525963166,1.3590460953824346
Granta-519,2746,3.996696473436098,2.8579929499469348
BICR 22,6918736,-3.590209831667407,-1.741781295359962
IGROV-1,135423438,0.764137689665023,2.1190856698194294
SaOS-2,5460769,2.263492155098724,2.3447175553942796
MDST8,3025944,3.984610722170807,4.206240213808089
HuP-T3,9935249,3.692881062494191,2.8615383619674972
BICR 31,54618164,5.999146696375086,4.02740727006158
MOLM-13,3552672,1.8354180523958712,2.8413574589562494
ALL-SIL,24889392,1.2675997647257198,3.7858620057203916
P31/FUJ,5470400,3.6840145170482383,-0.3765538821264742
RCC10RGB,68056272,3.770230744947895,3.2394422692786446
K-562,135440466,2.878154323162211,2.1401473911994366
KU-19-19,16038120,2.2784541929956563,0.9090093368534204
IGROV-1,969516,2.460805405371151,2.7772567284956553
RCC10RGB,54596490,4.957303932772775,4.945697156281648
SW48,54618771,0.2213541125267267,0.9253379925205388
SK-CO-1,56963564,-1.3743653333208103,0.2569389627451253
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,2.957630994714242
SaOS-2,4096211,1.593922478920674,1.856021664538426
WM115,11317348,4.689716075377342,2.3090854497210964
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.5350305453431912
LS411N,387447,-3.952629374311597,-4.3765957253648695
SK-CO-1,11396600,4.255124433433546,3.4309758536883517
RKO,2828334,5.934464187728916,6.082620037824382
NCI-H2452,6184667,2.981030320075281,2.901063659317265
MDST8,119182,-3.087899770061731,-1.3340160156368264
NCI-H1568,5282054,2.3545727551586744,3.5628845676855256
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,2.93841691857644
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.4539899714896953
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.2569389627451253
MOLM-13,5311,-0.2452037316548625,1.2663000347984639
Panc 02.03,119607,6.223236877281167,5.129253777214588
P31/FUJ,5566,2.621678413077409,3.029152149495273
RKN,5311281,3.300248210659573,2.22503529708604
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.344610112805219
K-562,11152667,-1.0937594737206502,-0.5866736007906306
WM115,241158,3.4880777915567496,3.598987869990464
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.0253996189023358
SW948,11707110,-5.12001559624384,-0.02846554242907695
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,-0.37491183386883553
RKO,3503,2.683687073265507,2.2426858883255045
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.144908880465776
HCC15,3081361,2.87617011057776,2.3568884936851697
SW1573,25102847,2.4268351657646874,2.3366995460793083
SW48,24785538,-2.175303706573729,1.3344504348570345
NCI-H2452,5329102,1.9284891088724192,2.031058842574058
NCI-H1568,56946209,-4.312547212322036,-4.2202975286026225
SU-DHL-1,23939,4.934189555353841,4.316990186905579
IGROV-1,2708,4.438419625543199,4.591243765137335
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.3153680794849765
K-562,44489675,3.6585617881709585,3.8856289571074525
SaOS-2,23582824,0.6839328831098858,0.7400136078733197
WM115,1242560,3.734530534800184,3.534393132486151
BICR 22,89928392,1.801349914013067,1.344325138639762
MDST8,375860,-0.0509298762434446,-0.30112130782396007
WM115,387447,-5.543981096917634,-4.3765957253648695
PaTu 8988t,46215462,1.6929329300119484,1.762132613731386
SK-CO-1,25150857,2.4521914239487965,2.336756962918186
RKO,46843906,3.289277038806309,2.723521570705241
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.38762532684053896
SU-DHL-1,3062316,2.138301047480956,0.9747482048219924
LS180,31703,-0.5385699496513472,-1.182053713238432
NCI-H1568,54619267,3.44714412714971,3.9342007971372475
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,2.344610112805219
SK-HEP-1,5351362,3.433378240202124,1.4604743967139864
Granta-519,119607,5.75770191278477,5.129253777214588
HCC15,2729026,2.745990777117554,2.6325975116350393
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,0.8084551861824514
MOLP-8,24797083,1.4809895165463562,1.277886491385028
MDST8,446155,3.7715450651151854,2.662752180605146
SaOS-2,11317348,2.7618337203443377,2.3090854497210964
SW948,67156097,-1.6378764151549952,-1.0279170724737183
ALL-SIL,448949,0.3821166271144734,1.9537365892294993
SW948,5287620,-5.231918659547503,-1.9697846958841214
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,2.474523360549852
RKN,159324,4.081844329649501,2.0742938672876736
SU-DHL-1,6917907,-5.829381256855267,-4.864372369867458
BFTC-909,3825829,4.25128930140834,3.8869840981378028
SK-CO-1,119607,5.49560679798916,5.129253777214588
LCLC-97TM1,6450551,2.230680139016655,2.361538429265863
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.38762532684053896
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.1017288356510795
HCC1500,54626689,4.657243866783195,4.561309020020982
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.0665232817889554
IGROV-1,9866186,0.4571266497661056,0.7577083020821866
K-562,24772860,-2.920105669473321,-2.2690769633318126
SW1573,9956119,4.0915863238100645,3.4762974507018756
BFTC-909,5280436,4.2143472852581025,3.153394505533252
SK-OV-3,5282054,5.04615494272688,3.5628845676855256
SW1271,24180125,2.511417012575286,2.888353933707551
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-1.261852028375895
LS180,46398810,2.878388522539818,2.510712955745063
P31/FUJ,2749,0.384854271149864,1.7932893499757152
NCI-H2452,5281321,-2.0767365956379944,-1.3097742666845045
SaOS-2,9927531,5.410264314347966,4.578027762171671
WM115,156414,1.595819692541897,1.1062813598863759
COR-L95,15983966,3.7167583960216897,-1.6396194068861514
SU-DHL-1,10322450,2.9485372728674473,3.669858075898477
HuP-T3,66577038,3.287519898796673,2.9870697487432882
Daudi,6505803,0.7229387165377155,-0.5114413444588124
COR-L105,46926350,-4.1614749205792565,-4.429063309555999
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,1.5076124324231743
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,4.13551970928241
MDST8,24901704,2.355370692316459,3.1103746959488285
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.4554460238042177
NCI-H2452,25126798,3.2665335299764298,3.7921789378214816
ALL-SIL,107985,-3.6188373708521495,-3.5771139994401464
P31/FUJ,5738263,2.6277017246063252,3.3050405288071003
HCC1500,2742550,3.2494473825713026,3.8595787492072238
LCLC-97TM1,54618771,0.7707104681824843,0.9253379925205388
MDST8,3062316,2.63216781392049,0.9747482048219924
K-562,100016,4.034095210213227,5.87798299213578
NCI-H2452,136227924,3.4253193575490695,2.867001064974719
IGROV-1,3025986,-1.046010021597061,-0.8978770871810051
IGROV-1,135875424,3.3275053166921347,3.743891076041643
RCC10RGB,400769,0.8506758933165035,-0.7855881743093749
HCC15,44241473,5.510013950441446,4.8543955662784395
SK-CO-1,26596,-2.200264316257102,-1.5346517263124715
HCC15,613000,1.6197134073445976,2.227141832343803
Granta-519,10427712,3.8202730219655496,4.184108330161863
HCC15,5479543,3.813478020040636,3.2992765862159215
PaTu 8902,135423438,1.708930423466824,2.1190856698194294
Panc 02.03,24964624,3.328827283539013,2.2827362159867324
LCLC-97TM1,25154868,4.98783448400422,4.289494395804131
RERF-LC-MS,5113032,4.48589538963195,4.970396511864891
SK-CO-1,168313016,6.229837204453753,4.725757076386842
SW1573,9926054,3.1618263718643513,1.9546333131599372
MOLP-8,451668,-1.0880279758209197,-0.17843514405649885
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-1.261852028375895
SW1271,46191454,0.8015154670027128,1.3518500781597358
IGROV-1,156414,1.4212019235656712,1.1062813598863759
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.9860814461500107
NCI-H1568,11647372,0.9090690740398496,0.8954839509867156
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,1.710700657959646
HEL,5394,4.33544579006292,3.9762102103866797
Daudi,23635314,-4.750280690911186,-1.8612337831613235
SK-OV-3,3543504,4.529917197725731,4.269325105068445
NCI-H1568,51037431,4.33384460889792,3.10082796495436
SU-DHL-1,2708,2.612747958759665,4.591243765137335
SW48,151289,-0.0884278513227002,0.9562867634504244
SW1271,24772860,-2.1080107772753607,-2.2690769633318126
SW1271,675434,4.352597318848774,4.463597576567934
Granta-519,44632017,0.2326960109936577,1.0838611345650022
SaOS-2,11955716,-1.373693500458253,-1.4856643985320634
KU-19-19,159324,4.255883770522122,2.0742938672876736
SU-DHL-1,4261,-0.6665613942828803,1.4288257082744877
COR-L105,10302451,1.2881684147693646,3.0143591766147457
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.9218131221296273
ALL-SIL,4096211,-0.2650943934034739,1.856021664538426
IGROV-1,216468,0.5330864756407336,2.5020743765616316
Daudi,46907787,-0.707382985228944,1.584957029505121
ALL-SIL,11175137,2.2895463411974597,2.477950770888125
HuP-T3,7326481,3.4338903427833674,2.957630994714242
SK-OV-3,11626560,2.736987670099794,1.6795489442409048
NCI-H1568,5978,-3.194054905017319,-2.3753204421143224
P31/FUJ,25062766,0.5108470478058419,2.0522756909743434
LS180,4261,0.8191216854939201,1.4288257082744877
HEL,71304818,2.1837189642761645,2.396178486082573
NCI-H1568,71466445,4.632148673172368,3.3478019143630626
PaTu 8988t,5282054,4.412677005920707,3.5628845676855256
SW1573,54686904,4.039437320121271,3.776063215737675
RKO,53392493,2.7606647137416616,2.4832542501558077
PaTu 8902,156422,4.606541116596145,3.8435202478608215
COR-L105,54454,1.772071227552003,2.548844675602096
KU-19-19,9926054,2.3371072555508445,1.9546333131599372
IA-LM,3136844,4.47285753340146,4.214923916993912
Daudi,3854666,0.3283534306514684,1.85063491630251
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.37491183386883553
SU-DHL-1,72193861,-0.6645199564816581,1.3858780169906042
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-1.57821899028641
SK-CO-1,44202524,0.5946445627983161,1.9639001504219202
K-562,1750826,1.7671131923879069,-1.4739669220989267
LCLC-97TM1,3854666,0.8191923722369518,1.85063491630251
SK-HEP-1,4477,0.3599343153867445,0.5570685949048098
BICR 31,5282054,4.622453961920413,3.5628845676855256
ALL-SIL,3025986,-1.187507928097146,-0.8978770871810051
BFTC-909,3062316,2.03384364484094,0.9747482048219924
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,3.743891076041643
Granta-519,444795,4.599812836973149,3.7799917274901733
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.7691529831259722
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,1.2359123501503817
RKO,1566236,3.4833841973625725,2.2263982365179604
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.4554460238042177
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.3848601780620533
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,1.710700657959646
NCI-H1568,8515,2.0721444777555327,3.7716438213452004
MOLM-13,24978538,-1.2743594434772367,0.6273547794147847
SW1573,23725625,4.357604161446221,4.726527081330662
HEL,15953870,2.2428109686656295,3.4781017448929608
Daudi,52947716,0.9938257746380776,-1.4012147836358484
BFTC-909,44259,1.3269924163099676,0.9267255578557378
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,2.93841691857644
SaOS-2,6918328,0.1895131607356872,-0.28710840066117727
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.0665232817889554
NCI-H1568,3503,1.1278876480867208,2.2426858883255045
IGROV-1,72376,-2.111352545322758,-2.110114148114304
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,2.8341325456747963
SK-CO-1,654092,0.6285789884023978,-0.4472857419901597
SU-DHL-1,44589607,1.246014317818898,2.659070263037081
PaTu 8988t,3552672,2.097731757890035,2.8413574589562494
HCC15,5282054,3.6050373222028815,3.5628845676855256
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.3408828038827
WM115,16013152,3.8161355323039,4.119375381760217
ALL-SIL,54618305,4.365324809283883,4.084826955496459
SK-CO-1,25195348,3.743308569883415,3.08171494739702
BFTC-909,123631,2.8792987518934403,2.2760265557358337
NCI-H2452,25022340,5.0430378131248785,2.219156297475395
BICR 31,11719255,5.311316415457661,3.1221102230298534
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,0.7705130043498147
HuP-T3,568763,0.3762081962980199,0.28862358029973745
Panc 02.03,71680916,5.6819891784443595,4.641848024405652
SK-CO-1,44484440,3.788843022204708,3.4463009263421043
HCC1500,60750,4.75355506285403,-2.435153852929516
SK-CO-1,44607531,1.475264767684201,1.48117322485652
MOLP-8,1317464,4.425962710369034,4.148586664919221
BFTC-909,107985,-3.700699007813787,-3.5771139994401464
SK-CO-1,3025986,-0.6416687634539443,-0.8978770871810051
BFTC-909,44493528,4.370300807083883,4.333966846288542
SW48,49850262,3.202043440642355,3.414452598711333
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,0.38762532684053896
MOLM-13,5746,-2.6320399073484633,0.8084551861824514
NCI-H1568,36462,0.6787379731584755,1.5076124324231743
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,1.0163468544412688
LCLC-97TM1,31703,-1.7062756219896058,-1.182053713238432
BFTC-909,54454,2.6967031082973527,2.548844675602096
BICR 31,5351362,2.0722735669158876,1.4604743967139864
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-3.173507428051674
HEL,3543504,3.6690825601144064,4.269325105068445
IGROV-1,11178236,-2.8618715106425725,-3.539769866873396
SW48,176870,1.305545107688616,3.0253996189023358
LCLC-97TM1,3062316,0.5973926668956511,0.9747482048219924
HCC1500,6852167,3.541859976914812,2.69961445504738
MOLM-13,54626689,4.673711949381485,4.561309020020982
RKO,11175137,2.9264569639519906,2.477950770888125
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.3791567205504176
BFTC-909,73707398,1.325657316242966,1.180307991266282
SK-HEP-1,11485656,3.3898088020096324,2.2397291078765758
SW1271,637858,1.8302889918552376,1.8880097009592578
P31/FUJ,151289,0.3376751835645198,0.9562867634504244
MOLM-13,6918289,0.5846893448973186,1.9146814118519513
RKO,4096211,2.0568907070726397,1.856021664538426
HCC15,42611257,3.545791426903468,3.0669311087446527
RKO,51037431,1.443783779144223,3.10082796495436
RKN,1716436,3.648262431092988,2.948755251800144
RKO,216345,4.0768365061219525,3.7540083674013296
MOLP-8,54454,2.3030156333842533,2.548844675602096
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,1.710700657959646
SW1271,11719255,2.0964009449704335,3.1221102230298534
SK-HEP-1,5328940,3.1706915881362097,1.559061663996469
HEL,6914657,-6.908409772348001,-4.170094408243688
LCLC-97TM1,6918878,3.384977217975284,1.9069091595174383
HuP-T3,46943432,3.2592232125577665,1.70045196562753
KU-19-19,11152667,0.8748891502312,-0.5866736007906306
MOLP-8,5278396,3.6007551773478093,3.517590475337377
MOLP-8,71304818,1.8062780808091792,2.396178486082573
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,1.7724503678159762
SaOS-2,5280436,3.62212536353362,3.153394505533252
IA-LM,71751553,4.579394980470846,4.504570481353087
COR-L95,374536,2.031472802797221,1.7732341041149164
HCC1500,1716436,1.6304357372897462,2.948755251800144
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.2480392352773622
SW1271,9967941,4.951865473173475,3.6034131982542865
KU-19-19,6918837,-3.3861016705907203,-3.046222711611649
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,3.456683733824014
RCC10RGB,54626689,5.11978438920743,4.561309020020982
COR-L105,24964624,2.7213287093015848,2.2827362159867324
RERF-LC-MS,10184653,1.661334722418144,1.1325795715302809
COR-L105,9907093,4.049740181744662,4.134688957161641
WM115,4917,1.7802954819592542,3.079848880785536
Daudi,25262965,-3.918146889356354,-1.6224193967571534
RKN,9926054,2.8101544562472056,1.9546333131599372
COR-L95,969516,2.641832541585458,2.7772567284956553
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,2.82815333449006
LS180,60700,-0.831384616867798,-0.4482559328189002
HCC1500,25062766,2.7449885477672136,2.0522756909743434
COR-L95,11640390,2.478695805138082,3.2466540190485103
HuP-T3,54618164,3.3933985234085755,4.02740727006158
SaOS-2,25105715,3.6317688538247968,3.410449786117574
SW1271,5335621,2.365445027841909,4.560420742529089
NCI-H1568,72193861,1.9818580959671683,1.3858780169906042
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.3153680794849765
SW1573,10385095,0.5068001344623563,1.2480392352773622
ALL-SIL,2841722,3.706104916487932,4.375424781932207
P31/FUJ,71466445,3.0287439983851225,3.3478019143630626
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.3153680794849765
COR-L105,4917,3.658916006838,3.079848880785536
RCC10RGB,9903786,5.708919982977709,2.756077717004494
HuP-T3,25161177,3.646148401953212,4.097137926934978
K-562,71466445,2.3693775657442373,3.3478019143630626
K-562,11977753,-1.2336845020581693,-1.7159558966047241
LS180,16725315,4.563180557999628,4.150060666188836
NCI-H1568,66577038,1.9593359628641709,2.9870697487432882
SaOS-2,3465537,1.5281169625539155,2.5477591829493655
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.2466540190485103
MOLM-13,17755052,0.2343645648969551,1.7101929835526413
RERF-LC-MS,67156097,-1.006688958645714,-1.0279170724737183
SW948,5470400,-3.941225454290086,-0.3765538821264742
HEL,44185566,1.408371464536178,2.4057100644299436
RCC10RGB,3503,3.522457107356278,2.2426858883255045
BICR 22,9866186,0.6641273098552615,0.7577083020821866
K-562,52947716,-5.609155633475852,-1.4012147836358484
SaOS-2,1641662,3.0320316508312883,3.3408828038827
SW48,5460769,-0.8804369809799648,2.3447175553942796
MOLP-8,11625818,3.354870459420626,4.10791451089978
KU-19-19,3025986,-0.2897675094370045,-0.8978770871810051
K-562,9444,4.095192274458736,4.054048446110465
IGROV-1,5329102,1.2794664511054334,2.031058842574058
LS411N,11427553,2.839596649209722,2.578035472123966
SU-DHL-1,10385095,0.4695713178913991,1.2480392352773622
SW1573,124202324,3.209850220678193,2.1784388364790748
BFTC-909,2949965,3.0294119536880197,2.715769249487813
Panc 02.03,44589607,4.606435993835204,2.659070263037081
LS411N,25126798,4.124739072985443,3.7921789378214816
RKN,24785538,4.869460471506453,1.3344504348570345
SU-DHL-1,31703,-2.5255735182995203,-1.182053713238432
KU-19-19,6505803,0.0199416611110358,-0.5114413444588124
MDST8,5281672,5.754114909876849,4.4250678360691875
PaTu 8988t,9903786,4.140175125497243,2.756077717004494
SK-CO-1,11717001,2.027201802005241,3.961276339234443
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,1.4539899714896953
HuP-T3,54454,3.567661200928428,2.548844675602096
MOLP-8,262093,0.615798330418347,2.6275548088442098
SW1573,6918328,0.8267852089643692,-0.28710840066117727
LCLC-97TM1,73707398,0.638027637531153,1.180307991266282
SaOS-2,11719255,3.097989779485228,3.1221102230298534
SU-DHL-1,73707386,2.8817783064824773,2.6861216111986805
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.375424781932207
LS180,9915743,2.834892961755663,0.5935480801734145
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.31711465707788644
BICR 22,4578,4.285603675470092,4.446937148676336
SaOS-2,24951314,1.4499530102948022,1.227614980483031
RKN,6918328,0.5495182279950256,-0.28710840066117727
IGROV-1,66577038,3.2148239132520455,2.9870697487432882
COR-L105,15547703,4.316721747481802,3.114669509763707
HCC1500,753704,5.032412058463686,4.832125608051433
RKO,44819697,-0.2126149769206573,-0.6109288989041974
HCC1500,16013152,3.952751911590144,4.119375381760217
SW948,89183176,3.757757719513151,3.4938336610308007
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.4199080872215506
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.344610112805219
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,2.578035472123966
IA-LM,44819697,3.529669119404179,-0.6109288989041974
PaTu 8988t,148198,-4.283282973565046,-3.548509713878981
HCC1500,5287969,-0.1960949732639439,-1.9772070858850965
RERF-LC-MS,5460769,5.094680634820597,2.3447175553942796
BICR 22,10113978,3.5652875556244923,3.010980031724017
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2834565267098785
LCLC-97TM1,6184667,3.4160200622822736,2.901063659317265
SK-OV-3,44507138,1.930427516054787,2.3228542035372683
SW1271,54626689,4.884226988721356,4.561309020020982
COR-L105,25195348,2.918205578273492,3.08171494739702
MOLM-13,49850262,2.0503909100702873,3.414452598711333
LS180,104842,-3.608354535822108,-3.040993872013826
Granta-519,6184667,3.6411271735359207,2.901063659317265
IGROV-1,49836020,5.658436828096057,2.5464279658175073
HuP-T3,54619267,3.893027602521098,3.9342007971372475
SW1271,409805,4.993473873943069,4.6745070702664995
NCI-H2452,2749,1.5209092727807076,1.7932893499757152
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,1.710700657959646
SK-OV-3,119607,5.6958068077620405,5.129253777214588
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,0.4199080872215506
SU-DHL-1,6184667,2.253300303827536,2.901063659317265
WM115,2871966,2.231269661110087,0.29730316799892464
SK-HEP-1,219104,4.349330089087446,3.5366182443481806
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.8341325456747963
SW48,8515,2.6507036204950256,3.7716438213452004
MOLM-13,241158,1.7093626682651633,3.598987869990464
RCC10RGB,71576739,5.1028364410536735,2.9192684489841567
LS411N,54619267,4.196494516067777,3.9342007971372475
Panc 02.03,637858,2.766769284687194,1.8880097009592578
P31/FUJ,25150857,2.053516150415863,2.336756962918186
P31/FUJ,24951314,0.294555023880993,1.227614980483031
SU-DHL-6,16736978,-0.092754907722646,1.3934160091023764
RKO,151289,1.190219151105647,0.9562867634504244
NCI-H1568,1716436,2.664872339798973,2.948755251800144
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-1.261852028375895
LCLC-97TM1,49836020,1.9924259842665932,2.5464279658175073
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,1.5478733404534093
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.337336921695599
SW948,11647372,1.3621251009964823,0.8954839509867156
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.93841691857644
LCLC-97TM1,56963564,-0.6229750501206363,0.2569389627451253
IGROV-1,11427553,2.926316692603687,2.578035472123966
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.084826955496459
SW48,24951314,0.6660870475429757,1.227614980483031
RCC10RGB,46398810,2.467266718263722,2.510712955745063
NCI-H1568,16720766,0.7309820541773976,0.4291253754884592
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,2.0335760501929605
HCC1500,6918878,3.8452122267855544,1.9069091595174383
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,0.4199080872215506
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.102163121425029
NCI-H1568,9840324,5.648333485386012,5.7711165719697215
SaOS-2,24772860,-2.2454069761524416,-2.2690769633318126
NCI-H1568,12003241,-1.4870303892505918,-1.0889198012759371
IGROV-1,135411,0.626702113064729,0.5181226666256136
SU-DHL-1,123631,2.2104669936854817,2.2760265557358337
BICR 31,676352,2.5344425849235472,2.088896150621564
WM115,2828334,5.840169576442124,6.082620037824382
BICR 31,16722836,0.993439631718574,1.5333952667080324
LS180,71304818,2.5144465721497573,2.396178486082573
HCC15,176870,4.3801450304989835,3.0253996189023358
SaOS-2,44137675,2.8908105588075537,3.337336921695599
SW48,57519531,1.1891467216952898,2.4211376500246136
LCLC-97TM1,46943432,0.977611384475134,1.70045196562753
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,2.699201704606489
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,0.11065310288154762
UACC-812,52912189,-0.0403441295384107,1.6723266261402217
HEL,638278,3.1804055556137394,3.209337660705321
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.1401473911994366
UACC-812,45279963,4.1756281682233185,3.660133434789582
MDST8,12001922,2.1068751805520423,1.8522788760744173
HuP-T3,11626560,2.4663043755994094,1.6795489442409048
HCC15,9884685,1.2743229964902805,0.4230357541133405
Daudi,82146,3.751797413920901,3.596877521367719
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,2.9860814461500107
BICR 22,969516,2.807563254821311,2.7772567284956553
RKO,6917907,-7.36544436443182,-4.864372369867458
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.4833676274788345
P31/FUJ,54649381,3.661627004097492,3.7880999548273127
P31/FUJ,15983966,-4.570279214878008,-1.6396194068861514
COR-L105,49793307,-0.7736136433109717,-2.848251171596848
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.3029314718240044
SK-CO-1,57330099,5.774767561552264,4.311542343968036
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-1.57821899028641
Daudi,36462,-1.782907247885185,1.5076124324231743
SW1271,10077130,5.262255440725952,3.2681369737435437
PaTu 8902,124202324,2.5191853508509823,2.1784388364790748
SW1271,4261,2.1417567232825157,1.4288257082744877
SW1271,568763,-0.4148311333850545,0.28862358029973745
IGROV-1,44185566,2.2104732991243248,2.4057100644299436
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,1.7691529831259722
RERF-LC-MS,54678924,1.4734481784853186,1.9473085147454567
SW1271,17759555,2.4829827438054104,3.5392373768677334
HCC1500,2871966,-1.8945265193529464,0.29730316799892464
RCC10RGB,119607,6.074674808773517,5.129253777214588
MOLP-8,5566,2.8349074996791295,3.029152149495273
K-562,24901704,1.0460453676907424,3.1103746959488285
SK-OV-3,44607530,2.4027946355264507,1.715838652040812
IGROV-1,44589607,3.0909001492794377,2.659070263037081
SU-DHL-1,44185566,1.07324922266726,2.4057100644299436
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-1.57821899028641
SaOS-2,42642645,-0.01972406793895,0.7845058245277501
SaOS-2,327653,4.165382989627235,3.018652636936018
RERF-LC-MS,44491742,4.380479941679622,4.1566745174283435
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-1.57821899028641
K-562,3038522,1.918387146447148,2.9847437848386558
HuP-T3,702558,5.633624519144866,4.9782351440396395
ALL-SIL,2858523,2.9846374491002376,3.0086502241129605
WM115,44589607,3.0632481185375933,2.659070263037081
LCLC-97TM1,11977753,-2.2409153175434953,-1.7159558966047241
Granta-519,7251185,1.138949301849667,2.4347287977616
MOLM-13,446155,1.5984418257641329,2.662752180605146
SW1271,11455910,0.4702460968788743,0.9557745122323711
WM115,10184653,1.7306018843706388,1.1325795715302809
SW1271,12003241,-1.4062779923685875,-1.0889198012759371
SU-DHL-1,3038522,3.3518104703058467,2.9847437848386558
RERF-LC-MS,44819697,-0.3406635094896507,-0.6109288989041974
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,2.144908880465776
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.7691529831259722
RERF-LC-MS,3825829,3.876424055067748,3.8869840981378028
SU-DHL-1,208908,2.168834483257838,1.8663560178908947
COR-L105,4378219,1.9356703916494296,2.6822409618839944
SU-DHL-1,44489675,4.002710700308593,3.8856289571074525
BICR 31,5329102,1.5123342757929257,2.031058842574058
BICR 22,72193861,1.1787223619968317,1.3858780169906042
SK-CO-1,4259181,-0.2853622975740302,0.11236669175956715
RKN,5278396,4.050807510430523,3.517590475337377
LS411N,3543504,6.407278726964401,4.269325105068445
Granta-519,2749,-0.6711865738648753,1.7932893499757152
LCLC-97TM1,11222830,0.9756157307321038,1.5350294688251391
HCC1500,49766530,0.4188049276678212,-0.6944377068647134
BICR 31,24821094,2.272776200428542,2.7369152351179045
LS411N,15953870,3.79326986504028,3.4781017448929608
KU-19-19,15547703,3.5460273004695364,3.114669509763707
IGROV-1,10410894,3.2660402181528263,3.2189174762180457
SK-HEP-1,9936388,2.725726666175631,-1.7988236137529168
SU-DHL-1,68056272,2.8441937668208297,3.2394422692786446
BICR 31,107970,2.625018410874988,2.3029314718240044
RCC10RGB,24978538,2.2083570886635258,0.6273547794147847
MOLP-8,42642645,0.4027543307161444,0.7845058245277501
IA-LM,6438330,0.5920782597943414,2.016737971321332
HCC1500,25102847,3.871994319987046,2.3366995460793083
SK-CO-1,9903786,1.8148473241522671,2.756077717004494
SK-HEP-1,51037431,1.9503987957256583,3.10082796495436
SU-DHL-6,15547703,1.663295720719241,3.114669509763707
PaTu 8988t,42642645,1.5127014290808742,0.7845058245277501
Daudi,4578,4.14840859618435,4.446937148676336
HEL,73707398,1.0006953763352662,1.180307991266282
RERF-LC-MS,3634881,4.923247717838372,3.1576774496130544
HCC15,9907093,4.55737056946543,4.134688957161641
IGROV-1,16725315,4.890680859998698,4.150060666188836
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,1.5478733404534093
COR-L105,107970,2.936160881286492,2.3029314718240044
PaTu 8902,11485656,3.4031855994132663,2.2397291078765758
BICR 31,5287969,-2.0848564793948423,-1.9772070858850965
SU-DHL-1,3503,1.2104794697541517,2.2426858883255045
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,2.0276770243216165
RCC10RGB,107970,3.009214725762471,2.3029314718240044
KU-19-19,51039095,3.4730458815699743,2.682611194240459
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.0276770243216165
IGROV-1,16038120,0.2864038103759729,0.9090093368534204
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.93841691857644
SK-OV-3,1323703,3.751791158325908,4.646036759655499
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,1.2349426527428076
LS180,56946209,-4.291807545115399,-4.2202975286026225
BICR 22,16741245,4.124711805224883,3.801678648950925
Granta-519,11396600,3.399615682634249,3.4309758536883517
LCLC-97TM1,4378219,2.0431586025336332,2.6822409618839944
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.7691529831259722
PaTu 8902,3062316,3.1999770976977966,0.9747482048219924
MOLM-13,9825149,-0.4975121245832732,2.074054954263997
PaTu 8988t,36462,2.8739750906545263,1.5076124324231743
WM115,4261,1.0617223830766982,1.4288257082744877
BICR 31,54618771,0.3365869204450262,0.9253379925205388
IGROV-1,6918837,-2.9804518885508635,-3.046222711611649
SK-CO-1,49850262,4.729060483840123,3.414452598711333
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.0276770243216165
SK-CO-1,49793307,-2.625714785229563,-2.848251171596848
ALL-SIL,159324,0.7144692186053382,2.0742938672876736
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.37491183386883553
RERF-LC-MS,24821094,3.899392046553833,2.7369152351179045
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,2.474523360549852
ALL-SIL,54613361,-1.2150310590443698,-0.11678183903518824
MDST8,54618771,1.2096098448968695,0.9253379925205388
MOLP-8,26596,-2.4791577040777812,-1.5346517263124715
RKO,4788,5.372325515812119,5.493389053048461
P31/FUJ,44589607,2.3901798108348533,2.659070263037081
SK-OV-3,613753,3.56222269809742,3.1495845971526135
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.4539899714896953
SW1573,2858523,3.1892649395611556,3.0086502241129605
LS180,72193861,-0.0461725132802377,1.3858780169906042
RKN,25126798,3.956068538327861,3.7921789378214816
MOLM-13,6917907,-6.412365954060792,-4.864372369867458
WM115,50905018,4.954075896774319,4.441836356719809
HCC1500,54619267,3.954111090910006,3.9342007971372475
IGROV-1,6252,1.1284141516966473,-0.10942982547788271
Granta-519,49766530,-2.591856607816134,-0.6944377068647134
RKO,400769,-0.364727826621167,-0.7855881743093749
SaOS-2,5113032,4.015669070835574,4.970396511864891
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,1.710700657959646
BICR 31,400769,0.3553213589698107,-0.7855881743093749
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.4291253754884592
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,0.4199080872215506
RKO,24901704,3.90150667551114,3.1103746959488285
K-562,675434,4.134192231732703,4.463597576567934
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,2.9860814461500107
IGROV-1,60700,0.4424479122017752,-0.4482559328189002
RERF-LC-MS,439501,-1.3704502050640626,-2.2321662354381537
PaTu 8988t,3081361,3.3861147832051004,2.3568884936851697
PaTu 8988t,11507802,1.1782523393568187,1.3590460953824346
RKN,25154868,3.091821445991922,4.289494395804131
SK-HEP-1,3384730,4.617019540739567,2.4620443610818112
IGROV-1,135411,0.626702113064729,0.5181226666256136
RKN,44202524,1.6880658914716755,1.9639001504219202
MDST8,10127622,1.4568360900186117,3.6054187258933235
ALL-SIL,5978,-4.2912860791141725,-2.3753204421143224
LCLC-97TM1,25195348,3.14182472834864,3.08171494739702
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.4554460238042177
MOLP-8,2949965,2.304667717892232,2.715769249487813
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.11065310288154762
NCI-H2452,11485656,2.991875358712002,2.2397291078765758
Panc 02.03,2708,5.654354843286421,4.591243765137335
SaOS-2,15953870,3.7774839542606617,3.4781017448929608
LS411N,11238147,4.220683195687341,2.694366237977623
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,2.117207225291035
COR-L105,11404337,0.9270352493146456,-0.4254091153988029
RKO,20959075,-2.9107192765247536,-3.173507428051674
IGROV-1,452548,0.0422661560146271,-0.31026393275322106
SW1271,25062766,1.8071163488926476,2.0522756909743434
SK-OV-3,24180719,3.148638094054939,3.437709308952337
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-1.261852028375895
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.38762532684053896
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.0665232817889554
NCI-H2452,25150857,3.315566378385427,2.336756962918186
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,3.3848601780620533
LS411N,216239,2.6090534487015953,2.1474208097396077
SW948,2828334,6.27053385486612,6.082620037824382
HEL,25262965,-1.9607005706581808,-1.6224193967571534
SK-HEP-1,46398810,3.2056962377986333,2.510712955745063
P31/FUJ,46191454,0.7861082656977861,1.3518500781597358
SaOS-2,11404337,-0.7935370479535776,-0.4254091153988029
LS411N,6918878,3.507421995092854,1.9069091595174383
COR-L95,5566,3.0030322186541754,3.029152149495273
NCI-H1568,2729026,2.4592472427928795,2.6325975116350393
Granta-519,5566,3.1418180472473023,3.029152149495273
SW948,15953870,3.980690301912255,3.4781017448929608
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,1.7724503678159762
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-1.1532493383305307
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,1.1345509900924162
PaTu 8988t,4096211,4.042256121680771,1.856021664538426
HCC15,638278,3.5096393014384346,3.209337660705321
LS411N,44185566,2.59688005994845,2.4057100644299436
WM115,15547703,2.53174585982074,3.114669509763707
RERF-LC-MS,46907787,3.883745984979501,1.584957029505121
RERF-LC-MS,49793307,-1.4864117200972382,-2.848251171596848
LS411N,6918837,-3.511331359252859,-3.046222711611649
HEL,2729026,2.9938268289747394,2.6325975116350393
SU-DHL-1,9911830,2.4926956672938543,2.4240324657892436
RKO,6505803,-0.9276151073099124,-0.5114413444588124
HEL,5351362,1.012542471793317,1.4604743967139864
SW48,448949,2.118847083295334,1.9537365892294993
LS411N,3854666,3.592971008902542,1.85063491630251
Daudi,55283,2.1333092426313143,2.1635123760949786
WM115,568763,0.4176363376103466,0.28862358029973745
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,0.4199080872215506
K-562,54143018,0.8143265967368298,0.31711465707788644
WM115,6914657,-1.139050920215431,-4.170094408243688
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,0.4199080872215506
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,2.7369152351179045
Daudi,57519531,1.0816397392331083,2.4211376500246136
MDST8,9840324,7.1320098113776185,5.7711165719697215
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,1.7724503678159762
NCI-H2452,67156097,-0.4931697978204585,-1.0279170724737183
ALL-SIL,11507802,-0.6218585688390301,1.3590460953824346
MOLM-13,9926054,0.378361077880871,1.9546333131599372
LCLC-97TM1,676352,2.332754642745106,2.088896150621564
SW48,6450551,-0.0066484474606689,2.361538429265863
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.37491183386883553
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,2.9860814461500107
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.8161144578264046
KU-19-19,46191454,1.4474607873871597,1.3518500781597358
BICR 31,135440466,1.3506373291640237,2.1401473911994366
SW948,44632017,0.8619787858061628,1.0838611345650022
NCI-H2452,159324,4.677055932941875,2.0742938672876736
WM115,60700,0.0008203329731028,-0.4482559328189002
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,1.7724503678159762
RKN,9936388,2.306220468641662,-1.7988236137529168
MOLM-13,2945648,3.0282797197343374,2.7548400693819435
P31/FUJ,135875424,3.622681212031297,3.743891076041643
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-1.57821899028641
BFTC-909,24964624,2.4776408698208003,2.2827362159867324
HCC1500,3825829,4.205963950909598,3.8869840981378028
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,2.0276770243216165
SU-DHL-1,135984461,1.9491307161872016,3.6237408287871284
NCI-H1568,409805,3.8387714265583592,4.6745070702664995
COR-L95,2945648,2.3261820103406183,2.7548400693819435
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.699201704606489
IGROV-1,5746,1.9055212643377857,0.8084551861824514
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,2.474523360549852
HCC1500,104842,-2.1208898309536073,-3.040993872013826
IGROV-1,148198,-2.659972993252853,-3.548509713878981
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.11236669175956715
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.78247230086659
IA-LM,5746,4.310443233142937,0.8084551861824514
WM115,10427712,3.357641117907952,4.184108330161863
WM115,31703,-1.493876478932265,-1.182053713238432
K-562,10296883,3.719487542859837,3.795028277273254
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.4199080872215506
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,3.456683733824014
IGROV-1,10184653,0.79276129336756,1.1325795715302809
K-562,5287969,-0.8630520858269013,-1.9772070858850965
MOLP-8,148198,-4.437033387624053,-3.548509713878981
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-1.57821899028641
BICR 31,24951314,2.26082148142024,1.227614980483031
COR-L95,9887053,2.0711365362831193,3.469815136639831
SK-CO-1,2841722,4.495379043063509,4.375424781932207
COR-L95,54618164,3.8157010413732406,4.02740727006158
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.3029314718240044
SaOS-2,25262965,1.6840235781335875,-1.6224193967571534
MDST8,25150857,2.921484336528134,2.336756962918186
SK-HEP-1,984333,0.8474815446030621,0.5138000229415411
COR-L105,5311037,4.270584574919318,3.9433489656963694
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,1.7724503678159762
LCLC-97TM1,3825829,3.858617243526108,3.8869840981378028
SK-OV-3,24951314,1.413681041410239,1.227614980483031
NCI-H2452,9903786,2.1501841215173396,2.756077717004494
PaTu 8902,56963564,4.5637436248697565,0.2569389627451253
SaOS-2,262093,2.7398792490382244,2.6275548088442098
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.493389053048461
BICR 31,3854666,2.26793763186435,1.85063491630251
SK-OV-3,15953870,4.452396287203901,3.4781017448929608
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.0058447943574325
BICR 31,24785538,2.8976650742045127,1.3344504348570345
HuP-T3,9903786,4.0743016574038915,2.756077717004494
Granta-519,11175137,2.0306520437568767,2.477950770888125
Granta-519,25105715,3.663648488967505,3.410449786117574
NCI-H1568,49867930,4.553956635433513,4.9782389619557925
HCC1500,16038120,1.5738549040879308,0.9090093368534204
LCLC-97TM1,227681,3.759896348853487,2.9941233013598234
BFTC-909,49867926,6.076136735210805,4.110210541110895
ALL-SIL,5278396,3.0589186731365814,3.517590475337377
HCC15,2742550,3.2685764522673972,3.8595787492072238
RERF-LC-MS,44486219,4.018485879154908,4.281343219898981
RERF-LC-MS,462382,0.9319597157341816,0.5714028853239661
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.93841691857644
SW1573,3854666,2.927116287337192,1.85063491630251
Daudi,9935249,-0.0031627785077317,2.8615383619674972
MOLM-13,10231331,1.9024628033326092,1.6547412916072393
SaOS-2,6918837,-2.9214939411920593,-3.046222711611649
HCC1500,11507802,0.960722132601806,1.3590460953824346
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.261852028375895
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.133687221210622
LS180,9911830,2.83226076921101,2.4240324657892436
RERF-LC-MS,11222830,1.7620759794741472,1.5350294688251391
MOLP-8,6252,-2.041702184925406,-0.10942982547788271
SW1271,5978,4.916909360273371,-2.3753204421143224
MOLM-13,5479543,2.5400848053862264,3.2992765862159215
NCI-H2452,11612883,2.7546488169018963,2.6386482274158856
NCI-H1568,44493528,4.1542795967274175,4.333966846288542
RKN,46398810,3.1612721401313792,2.510712955745063
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.088896150621564
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,0.5350305453431912
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-1.182053713238432
SW1573,31703,0.7694714266266048,-1.182053713238432
BFTC-909,11238147,5.503103761619835,2.694366237977623
SK-HEP-1,637858,2.866868896175592,1.8880097009592578
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,1.8522788760744173
KU-19-19,2828334,6.071698785304069,6.082620037824382
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,1.710700657959646
RERF-LC-MS,2828334,5.9123201087220325,6.082620037824382
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,2.9860814461500107
PaTu 8902,54649381,5.340946431274584,3.7880999548273127
RCC10RGB,11214940,1.429625683961422,1.8119431265240042
NCI-H1568,25195348,2.211268152441431,3.08171494739702
COR-L95,10184653,1.5221413196357014,1.1325795715302809
BFTC-909,3634881,3.6308731463535704,3.1576774496130544
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.8865368208635396
SaOS-2,24785538,-0.4134197784310965,1.3344504348570345
RERF-LC-MS,4705,3.292681011259135,3.0428654274536564
MOLP-8,10127622,1.9499981558353492,3.6054187258933235
Daudi,11626560,0.3779689739853294,1.6795489442409048
MDST8,168312962,1.677679532849221,1.48933366232238
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.117207225291035
MOLM-13,10113978,0.7724135376915046,3.010980031724017
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,2.0276770243216165
HCC1500,216239,1.4805608336728902,2.1474208097396077
RKN,5281321,-0.4803497212669658,-1.3097742666845045
PaTu 8902,11175137,3.538788964844938,2.477950770888125
Daudi,10113978,1.6179427120332186,3.010980031724017
K-562,26596,-3.6076758496321832,-1.5346517263124715
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.37491183386883553
Daudi,5291,1.8632614405000685,3.5530526201153183
NCI-H1568,2874250,4.364133169191667,4.0377213891771015
LS411N,984333,1.2324204412799928,0.5138000229415411
PaTu 8902,11222830,2.39915227633331,1.5350294688251391
MOLP-8,54678924,1.6307832002497362,1.9473085147454567
COR-L95,49793307,-5.549400502924621,-2.848251171596848
HCC1500,45279963,3.5713917460093434,3.660133434789582
WM115,54765302,3.574934655958074,3.905112278839675
SaOS-2,136227924,4.496792726095474,2.867001064974719
NCI-H2452,107970,2.3345640718356364,2.3029314718240044
LS411N,16720766,1.2713952174238143,0.4291253754884592
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,1.5478733404534093
MOLM-13,216239,-5.069803023561943,2.1474208097396077
RERF-LC-MS,44241473,4.536869636330491,4.8543955662784395
LCLC-97TM1,10074640,3.2021543880531156,3.066922642013836
Panc 02.03,10296883,4.297264305827386,3.795028277273254
IA-LM,3689413,-4.432004355370191,-0.4039154566871359
RKO,375860,-0.2095842697906711,-0.30112130782396007
HuP-T3,676352,1.9029965224961456,2.088896150621564
SW1271,5470400,4.349220092525355,-0.3765538821264742
NCI-H2452,656346,1.056906556032961,0.7582608913284792
BICR 31,56649450,1.7574149169243078,2.999158341046921
RERF-LC-MS,24785538,0.8057743011820994,1.3344504348570345
SaOS-2,9825149,0.8893885919981879,2.074054954263997
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.682611194240459
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.3791567205504176
SK-CO-1,638278,3.4780853527987854,3.209337660705321
WM115,4096211,3.685037910266886,1.856021664538426
RKO,126941,-5.081226966265268,-2.8921209077069348
RERF-LC-MS,54618771,0.9955970244631366,0.9253379925205388
Daudi,50905018,3.9297282000687312,4.441836356719809
WM115,11609586,3.058244435077658,2.621607380466062
BICR 31,9926054,1.721382648019371,1.9546333131599372
RKO,24821094,3.7157598247146977,2.7369152351179045
IGROV-1,135440466,0.9791523710816318,2.1401473911994366
NCI-H1568,44202524,1.0522971592210668,1.9639001504219202
HuP-T3,9933475,3.0776536859408807,1.793439230086884
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.3848601780620533
BICR 22,11612883,2.729453217725868,2.6386482274158856
MDST8,25154868,3.4078840547236333,4.289494395804131
WM115,12001922,1.1273981641266086,1.8522788760744173
SW48,2742550,3.28553671385033,3.8595787492072238
WM115,445091,3.8598878691820886,4.3274252089919045
RKN,135875424,3.6230459419726526,3.743891076041643
BFTC-909,2708,5.254338200716292,4.591243765137335
SaOS-2,2871966,1.7918423486815835,0.29730316799892464
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.0058447943574325
HCC15,44632017,0.3758817607479284,1.0838611345650022
COR-L95,2729026,2.664378744829576,2.6325975116350393
SaOS-2,1566236,1.7620742085681662,2.2263982365179604
BICR 22,11955716,-1.4294009955010087,-1.4856643985320634
BICR 31,2729026,2.966794528433677,2.6325975116350393
COR-L95,119182,-1.6347192148686482,-1.3340160156368264
LS180,5328940,1.742567210928755,1.559061663996469
Panc 02.03,46398810,3.420081587494409,2.510712955745063
RCC10RGB,60700,3.171193268028763,-0.4482559328189002
SU-DHL-6,451668,-1.4332734905345434,-0.17843514405649885
Granta-519,16219061,2.116318709414125,3.135611362850641
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,0.7845058245277501
HEL,53232,2.5038982548529747,2.8161144578264046
RKO,44507138,3.480554434186059,2.3228542035372683
NCI-H2452,3081361,2.98247650375621,2.3568884936851697
RERF-LC-MS,44202524,1.2785968032229695,1.9639001504219202
RERF-LC-MS,16722836,2.4162442447682193,1.5333952667080324
HCC15,637858,3.032734575357801,1.8880097009592578
IGROV-1,11396600,3.99372654279783,3.4309758536883517
BICR 22,44202524,1.658152527320416,1.9639001504219202
MOLP-8,54618771,0.2679151571300236,0.9253379925205388
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-1.57821899028641
LCLC-97TM1,54678924,1.535359034662644,1.9473085147454567
BFTC-909,49793307,-2.946331542038894,-2.848251171596848
KU-19-19,5738263,3.812580710038467,3.3050405288071003
PaTu 8988t,24821094,3.93253598055128,2.7369152351179045
LS180,148198,-2.644013472885731,-3.548509713878981
HEL,409805,5.92709656224454,4.6745070702664995
RKO,11612883,3.106052261550285,2.6386482274158856
SW1271,122327,4.37632222345113,4.7007618437932
MOLM-13,44241473,6.124350775268443,4.8543955662784395
HuP-T3,2126,5.715410620657667,4.466606494133751
K-562,5291,-1.1872539047134878,3.5530526201153183
RKN,5282054,3.624299707956654,3.5628845676855256
BICR 22,613000,2.6534426018316277,2.227141832343803
HCC15,49850262,3.6300454046422774,3.414452598711333
SW948,613000,2.5939391420023212,2.227141832343803
COR-L95,135440466,3.0574476104836914,2.1401473911994366
SK-HEP-1,262093,3.158620019748703,2.6275548088442098
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.38762532684053896
MOLM-13,123631,1.0914116119684203,2.2760265557358337
BICR 31,4378219,2.049792351388142,2.6822409618839944
LS411N,16722836,1.825979837410603,1.5333952667080324
SU-DHL-1,10074640,2.3568880289385654,3.066922642013836
ALL-SIL,6918328,-1.7903684912223865,-0.28710840066117727
SU-DHL-6,3384730,1.0298608560692932,2.4620443610818112
SU-DHL-6,11485656,1.7981230616770194,2.2397291078765758
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.3344504348570345
NCI-H1568,176870,1.641159934282528,3.0253996189023358
HEL,5280436,3.9989145330348896,3.153394505533252
BFTC-909,5328940,1.2290524134113243,1.559061663996469
SK-CO-1,151289,0.7492352886663923,0.9562867634504244
RERF-LC-MS,104842,-3.024577047260716,-3.040993872013826
PaTu 8988t,46843906,4.444995617536364,2.723521570705241
BICR 22,24856436,-0.0251718817877118,0.17994774592918095
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,1.8663560178908947
IA-LM,67156097,4.3159050642226,-1.0279170724737183
HuP-T3,6438330,2.3942211080747837,2.016737971321332
HCC1500,10296883,3.843895309810077,3.795028277273254
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,0.9747482048219924
SK-CO-1,56946209,-3.7989193199280016,-4.2202975286026225
Granta-519,148198,-4.763660659469611,-3.548509713878981
HEL,4917,2.9031193377759603,3.079848880785536
RCC10RGB,66577038,3.312011612499516,2.9870697487432882
Panc 02.03,3689413,0.2165954212360822,-0.4039154566871359
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.344325138639762
SW48,241158,3.5185545260205364,3.598987869990464
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.2834565267098785
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.133687221210622
K-562,11167602,1.4540526159902811,2.4705816300476062
HEL,9911830,3.2406370139452134,2.4240324657892436
SW948,25150857,2.687963392787196,2.336756962918186
WM115,44137675,0.4260207876885596,3.337336921695599
SaOS-2,4917,3.064827494863108,3.079848880785536
SaOS-2,3503,1.987605483793098,2.2426858883255045
LCLC-97TM1,9840324,5.858053248657865,5.7711165719697215
RKN,11178236,-3.061903912386503,-3.539769866873396
COR-L95,46843906,2.16387123849571,2.723521570705241
K-562,46191454,1.7723208241237427,1.3518500781597358
LCLC-97TM1,5746,2.627938158922912,0.8084551861824514
RERF-LC-MS,613753,3.34976336152667,3.1495845971526135
HCC1500,9823820,4.617789125102065,3.7294514785702977
PaTu 8902,49793307,-1.5016152541437175,-2.848251171596848
LS411N,24964624,2.837560916730962,2.2827362159867324
Granta-519,42642645,-0.7384711962533689,0.7845058245277501
Daudi,156414,0.7854974484116999,1.1062813598863759
HCC1500,9840324,5.570797833564005,5.7711165719697215
HuP-T3,6914657,-2.995276103152913,-4.170094408243688
SW48,11178236,-2.976969958039468,-3.539769866873396
Granta-519,11214940,1.149911870185247,1.8119431265240042
Granta-519,72734382,4.317814968690637,4.3578051352274185
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.2359123501503817
SK-HEP-1,15983966,0.8278271069258164,-1.6396194068861514
BICR 22,6610355,3.5129220888937622,4.45123297085854
HCC1500,44489675,3.6836892776405854,3.8856289571074525
IA-LM,3634881,3.385658224323674,3.1576774496130544
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,0.7705130043498147
COR-L95,4788,5.892645370038274,5.493389053048461
NCI-H1568,11717001,4.19629869858104,3.961276339234443
RKO,46224516,2.430810450928805,2.370954746557396
LS411N,6505803,-0.6536233604701492,-0.5114413444588124
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.1190856698194294
HCC1500,16725315,3.090868252599208,4.150060666188836
Panc 02.03,5287620,-2.132468814908427,-1.9697846958841214
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,-0.3765538821264742
LS411N,5351362,1.130738510814583,1.4604743967139864
IA-LM,168312962,3.008218706470952,1.48933366232238
SW48,9887053,1.6385742110161594,3.469815136639831
HCC15,2945648,3.8992008266513305,2.7548400693819435
WM115,10385095,0.3137764342063494,1.2480392352773622
SW48,11213558,0.38171338020492,1.4781707184028035
IGROV-1,9911830,1.9130562323799436,2.4240324657892436
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.741781295359962
LCLC-97TM1,5284616,3.038958191933125,1.1658534217096055
SW948,5311,0.5245292911924586,1.2663000347984639
PaTu 8902,2949965,3.498586647815041,2.715769249487813
PaTu 8988t,53232,5.050646647161413,2.8161144578264046
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.8865368208635396
P31/FUJ,2729026,1.895106624580685,2.6325975116350393
SW48,568763,-0.0201118962331156,0.28862358029973745
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.2834565267098785
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-3.5071094923394703
SK-CO-1,54454,2.352526453014332,2.548844675602096
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,2.144908880465776
SW948,151289,0.9927868711009586,0.9562867634504244
RCC10RGB,676352,2.417271143726191,2.088896150621564
LCLC-97TM1,15953870,3.316413299321368,3.4781017448929608
HCC1500,252682,6.335850466863892,6.516263069090082
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-1.261852028375895
SW1271,702558,5.67814751001827,4.9782351440396395
HEL,3503,1.2339935625044716,2.2426858883255045
SW948,6918328,0.2458443826474451,-0.28710840066117727
ALL-SIL,124202324,0.3755400921280209,2.1784388364790748
SW1573,2729026,2.4001203305493397,2.6325975116350393
SW948,57330099,4.403961221202979,4.311542343968036
UACC-812,42642645,2.375397400257474,0.7845058245277501
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.1532493383305307
PaTu 8902,984333,1.3011106079808883,0.5138000229415411
P31/FUJ,135398516,1.7387657861081838,2.0509021680173207
WM115,46224516,3.0669076127990276,2.370954746557396
SW1271,24771867,3.777194428597206,1.5171458615349627
HEL,73707438,4.0836720937600175,4.210679418158044
MOLM-13,16038120,-1.7825288578452578,0.9090093368534204
IGROV-1,10427712,3.944243047938238,4.184108330161863
LS180,3815108,3.93048377981505,2.885036533777781
HCC15,1750826,-0.4775912601104041,-1.4739669220989267
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,2.699201704606489
P31/FUJ,42642645,-1.1469220315427042,0.7845058245277501
HEL,1750826,-3.7677259179114047,-1.4739669220989267
NCI-H1568,25183872,-0.3156837582718859,-0.902802947451298
SW48,54143018,-1.2192841502688678,0.31711465707788644
SaOS-2,441298,1.6833347099113902,2.5423368047098167
SU-DHL-1,119607,3.7964753700545546,5.129253777214588
LS180,654092,0.275565618798522,-0.4472857419901597
RKO,6918736,-1.762610939534952,-1.741781295359962
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-3.046222711611649
SK-OV-3,168312962,4.003119281373622,1.48933366232238
PaTu 8988t,3062316,1.6786738127042626,0.9747482048219924
P31/FUJ,5746,-1.0128835373821496,0.8084551861824514
ALL-SIL,46943432,1.7359798293614472,1.70045196562753
IGROV-1,119607,5.004384040905396,5.129253777214588
LS180,135440466,2.758543039731734,2.1401473911994366
HEL,15983966,-4.130179752932702,-1.6396194068861514
SW948,11228183,2.319596035574442,1.8712017695678478
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.133687221210622
NCI-H2452,219104,4.089454197150707,3.5366182443481806
LCLC-97TM1,24856436,-0.9719468010392746,0.17994774592918095
WM115,1716436,2.084402062067542,2.948755251800144
WM115,54596558,3.929397107249587,4.397101469450013
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.2834565267098785
SW48,2828334,6.103861625006206,6.082620037824382
Granta-519,5335621,4.386788840750005,4.560420742529089
NCI-H2452,25105715,3.487348959516136,3.410449786117574
LS411N,11152667,-0.1489697958567156,-0.5866736007906306
HCC1500,4259181,0.9827468065480526,0.11236669175956715
SW1271,1716436,3.164329770032204,2.948755251800144
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.37491183386883553
KU-19-19,637858,2.3404288739792314,1.8880097009592578
SK-OV-3,3081361,2.5908903164469317,2.3568884936851697
BICR 22,10322450,4.612637955736889,3.669858075898477
ALL-SIL,44819697,-2.9345943950607136,-0.6109288989041974
LS180,4259181,0.5796574720850999,0.11236669175956715
IGROV-1,6918328,-0.5330006254346346,-0.28710840066117727
RERF-LC-MS,11178236,-5.98494163410248,-3.539769866873396
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-1.6778195760397165
IGROV-1,11485656,1.900409616013456,2.2397291078765758
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-1.3097742666845045
BICR 31,16065773,3.973194001978765,2.3641186374244216
IGROV-1,6252,1.1284141516966473,-0.10942982547788271
SaOS-2,135398516,5.990406168261382,2.0509021680173207
RCC10RGB,11485656,3.364959979667133,2.2397291078765758
NCI-H1568,46926350,-5.085925204635643,-4.429063309555999
LCLC-97TM1,123631,2.4246211789463445,2.2760265557358337
BFTC-909,44185566,2.75887016136311,2.4057100644299436
BFTC-909,124202324,2.9321657702899295,2.1784388364790748
LS411N,4917,3.429074291339912,3.079848880785536
BICR 22,135440466,2.8663984884678513,2.1401473911994366
HCC1500,10127622,5.201205269222406,3.6054187258933235
WM115,24748573,1.2650334763374356,1.9565115912575295
LS180,17755052,1.7669119525953814,1.7101929835526413
HEL,5278396,2.941082820113368,3.517590475337377
K-562,6917907,-5.621792844351372,-4.864372369867458
WM115,11175137,1.8074191527620995,2.477950770888125
ALL-SIL,6610216,3.679901693613009,4.26979744561799
IGROV-1,3815108,1.915722485757852,2.885036533777781
IGROV-1,44491742,4.406671418311328,4.1566745174283435
NCI-H2452,11647372,3.7610160121318055,0.8954839509867156
Granta-519,25262965,-5.6090339200635375,-1.6224193967571534
HuP-T3,5287969,-2.0305885584054693,-1.9772070858850965
Panc 02.03,4578,4.394890119629889,4.446937148676336
PaTu 8902,46199207,3.581196343990194,3.1312366616263048
MOLP-8,5329102,1.1360795478534944,2.031058842574058
SW1573,24797083,0.9725439959134782,1.277886491385028
COR-L105,11507802,4.378208095645504,1.3590460953824346
SK-HEP-1,10385095,2.0924930980552148,1.2480392352773622
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.4057100644299436
MOLM-13,54618164,3.841266236609366,4.02740727006158
SW1573,5287620,-0.7347028317725576,-1.9697846958841214
Panc 02.03,24821094,4.183998590604807,2.7369152351179045
NCI-H2452,11977753,-3.0535753971711617,-1.7159558966047241
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,2.699201704606489
K-562,5278396,3.2143611477277325,3.517590475337377
MDST8,46907787,1.4338285439483007,1.584957029505121
MOLM-13,16219061,2.363003680724254,3.135611362850641
IGROV-1,3854666,2.3355254440561137,1.85063491630251
LS180,11175137,3.0855574956004506,2.477950770888125
PaTu 8902,24180125,3.5735575491444505,2.888353933707551
Granta-519,135440466,3.2501433765769097,2.1401473911994366
Granta-519,3634881,2.8250958488191533,3.1576774496130544
BFTC-909,24785538,3.0409365635840433,1.3344504348570345
Daudi,9903786,1.3988461789185107,2.756077717004494
IGROV-1,126941,-2.246216453812328,-2.8921209077069348
HuP-T3,327653,2.4979616286385573,3.018652636936018
KU-19-19,24785538,4.6207321752497545,1.3344504348570345
PaTu 8902,11238147,5.651020754323713,2.694366237977623
P31/FUJ,24772860,-2.926152167827307,-2.2690769633318126
SW48,969516,2.6010409472277303,2.7772567284956553
NCI-H2452,11656518,-0.3763326461825258,1.5480979328089313
LS180,156422,4.137124258725139,3.8435202478608215
K-562,16038120,0.8140588279430221,0.9090093368534204
HEL,9956119,2.2634866876643924,3.4762974507018756
MOLP-8,16013152,3.9032026583920656,4.119375381760217
SaOS-2,7251185,2.1177882155213488,2.4347287977616
SW1271,16722836,1.1489272284540188,1.5333952667080324
SW1573,1750826,-4.895155026964416,-1.4739669220989267
COR-L105,6918878,5.053406021852451,1.9069091595174383
HuP-T3,44566777,1.596285673654969,0.6972581949653407
RCC10RGB,11167602,3.5267453541831695,2.4705816300476062
KU-19-19,3689413,0.155027117273248,-0.4039154566871359
LS180,262093,3.1953995116592826,2.6275548088442098
HEL,168313016,4.358661125075543,4.725757076386842
LS411N,448949,2.5849168666236273,1.9537365892294993
RERF-LC-MS,11507802,1.168612691302407,1.3590460953824346
RKN,3025986,-0.1432368238740909,-0.8978770871810051
LS411N,5566,3.1552423609786153,3.029152149495273
MOLM-13,168312962,1.173226591058953,1.48933366232238
KU-19-19,16741245,1.8623441782077492,3.801678648950925
BICR 31,5746,2.9612823230829592,0.8084551861824514
RERF-LC-MS,448949,1.7883798522328354,1.9537365892294993
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,1.7691529831259722
K-562,135411,0.731253239019591,0.5181226666256136
WM115,3825829,3.803690072721518,3.8869840981378028
PaTu 8988t,1566236,2.792784501487116,2.2263982365179604
SK-HEP-1,25102847,3.375423501622406,2.3366995460793083
RCC10RGB,4378219,3.5112219508307017,2.6822409618839944
IGROV-1,46907787,2.182756719431072,1.584957029505121
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.0253996189023358
COR-L105,9903786,2.948812050867326,2.756077717004494
SK-HEP-1,5287969,-1.6185163943497696,-1.9772070858850965
LS411N,66577038,3.114674219164565,2.9870697487432882
LS180,11152667,-1.0678137233062412,-0.5866736007906306
SW1573,10322450,3.835483834832597,3.669858075898477
ALL-SIL,4369359,5.632204520937589,4.533951190652583
P31/FUJ,6918289,5.395091759648689,1.9146814118519513
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,2.3791567205504176
BICR 22,54626689,4.975060177279609,4.561309020020982
RKO,11455910,0.1271196393609195,0.9557745122323711
NCI-H1568,2749,1.8950065449811435,1.7932893499757152
SK-HEP-1,2858523,3.173409588420467,3.0086502241129605
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,1.584957029505121
NCI-H1568,16736978,1.0202421307584555,1.3934160091023764
NCI-H1568,11640390,2.883529605834316,3.2466540190485103
SaOS-2,375860,-0.2844076074043694,-0.30112130782396007
Granta-519,9549297,1.4990763156673828,2.3089350530287187
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-2.2690769633318126
MDST8,9915743,3.1722151191536607,0.5935480801734145
HCC1500,7251185,1.592161448601532,2.4347287977616
PaTu 8902,654092,0.4014878659730266,-0.4472857419901597
HCC15,36462,0.276886424919507,1.5076124324231743
HEL,11222830,1.7664464656365049,1.5350294688251391
LCLC-97TM1,6918328,0.5489211755624944,-0.28710840066117727
SW1271,11427553,2.280233400826346,2.578035472123966
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.37491183386883553
SW1271,216239,2.3992651597700805,2.1474208097396077
LS411N,52912189,2.124177170278397,1.6723266261402217
RKO,262093,2.7220373961576834,2.6275548088442098
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,2.8341325456747963
SU-DHL-1,24180125,2.3898229933344193,2.888353933707551
P31/FUJ,10231331,0.360402840185862,1.6547412916072393
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,1.5478733404534093
HCC1500,4705,3.1720127097688073,3.0428654274536564
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.5333952667080324
ALL-SIL,49793307,-3.5976005593324607,-2.848251171596848
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,2.0335760501929605
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.0665232817889554
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.6745070702664995
ALL-SIL,44489675,3.868517697091687,3.8856289571074525
COR-L95,9825149,1.4009706639997015,2.074054954263997
SK-CO-1,25102847,2.4259034566713087,2.3366995460793083
COR-L95,36314,-2.5383774872687743,-1.2422497803043113
IGROV-1,1641662,3.5854177848263675,3.3408828038827
BICR 31,16720766,0.8786813091838682,0.4291253754884592
BICR 22,51037431,2.6213243445689254,3.10082796495436
BICR 22,2742550,3.9616050819266326,3.8595787492072238
Panc 02.03,46843906,3.852893526574364,2.723521570705241
NCI-H2452,2708,3.4614923437122704,4.591243765137335
RCC10RGB,15547703,6.556615668020641,3.114669509763707
RCC10RGB,5311,2.218274000934613,1.2663000347984639
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.6829735349466532
LCLC-97TM1,24964624,2.5877637900313384,2.2827362159867324
KU-19-19,107985,-2.420790531142743,-3.5771139994401464
PaTu 8902,67156097,4.866613623772486,-1.0279170724737183
KU-19-19,676352,2.681008284282423,2.088896150621564
NCI-H1568,67291369,4.628091486396258,1.794812676489941
BFTC-909,54143018,0.6300785047889099,0.31711465707788644
BICR 22,5329102,1.9183442886017033,2.031058842574058
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,1.710700657959646
SU-DHL-1,1641662,2.0867851207635044,3.3408828038827
SU-DHL-1,54143018,-1.2287450259829942,0.31711465707788644
WM115,3552672,1.460151745141153,2.8413574589562494
Granta-519,6505803,0.3707466177802866,-0.5114413444588124
BFTC-909,2733526,3.41724914482818,3.714359432422819
COR-L105,445643,5.447871607768224,3.9383569867901693
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.344610112805219
COR-L95,135421197,1.4504202802892363,1.8199795612290348
BICR 22,4096211,1.2113689067872688,1.856021664538426
Daudi,241158,1.9180708700138325,3.598987869990464
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.5071094923394703
COR-L105,44543605,3.798835657012519,4.160012106477824
NCI-H2452,1641662,5.47511848960003,3.3408828038827
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.6778195760397165
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.12580254156308923
MOLM-13,44489367,5.70063080501961,4.726130190399563
MDST8,9936388,-2.5080849755955485,-1.7988236137529168
Panc 02.03,5311281,4.827416145020449,2.22503529708604
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,2.3791567205504176
Panc 02.03,71466380,5.929652601038649,4.275465599745589
BICR 22,148198,-3.168643556299537,-3.548509713878981
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.860017480413567
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.0058447943574325
MOLP-8,36462,-1.3356090090333852,1.5076124324231743
RKO,168313200,3.1169425006108455,2.9593589282331023
SK-HEP-1,24951314,2.4991128927954063,1.227614980483031
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,-0.4472857419901597
COR-L105,71304818,2.509036292239667,2.396178486082573
LS180,11485656,2.0322073649322716,2.2397291078765758
SW1271,44185566,2.531281599529394,2.4057100644299436
P31/FUJ,49836020,4.674155414221834,2.5464279658175073
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.3791567205504176
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.8341325456747963
RERF-LC-MS,9933475,2.253072026550434,1.793439230086884
SK-CO-1,24964624,3.1718881088721735,2.2827362159867324
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,2.0058447943574325
LCLC-97TM1,54619267,4.094508182091097,3.9342007971372475
SW1271,53232,2.609582991635379,2.8161144578264046
COR-L95,5282054,2.7623794331923293,3.5628845676855256
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,0.9218131221296273
ALL-SIL,2749,0.4174204822378836,1.7932893499757152
MOLP-8,11455910,0.4759456923848041,0.9557745122323711
SK-OV-3,5329102,2.1848030817162427,2.031058842574058
IGROV-1,5978,-1.5618214380165825,-2.3753204421143224
BICR 22,135411,0.5903998872112299,0.5181226666256136
NCI-H1568,6610216,3.52063980115584,4.26979744561799
SK-CO-1,176870,3.965368978694832,3.0253996189023358
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.2834565267098785
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-1.261852028375895
IA-LM,9936388,2.150111055311291,-1.7988236137529168
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.456683733824014
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.0665232817889554
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,0.9218131221296273
P31/FUJ,11214940,0.6332731592867608,1.8119431265240042
WM115,421610,3.513747492259629,3.1278257636093416
SaOS-2,227681,4.210698048028356,2.9941233013598234
BICR 22,25102847,3.5270600092516444,2.3366995460793083
BFTC-909,46199207,3.2760821272908753,3.1312366616263048
IA-LM,25154868,2.8804249714329537,4.289494395804131
SaOS-2,5738263,2.656867973667437,3.3050405288071003
BICR 22,5738263,3.828959854789421,3.3050405288071003
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.4539899714896953
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.6778195760397165
Daudi,24771867,-1.2539165255857252,1.5171458615349627
Daudi,446155,1.8075236258569949,2.662752180605146
LCLC-97TM1,56946209,-4.83981355951691,-4.2202975286026225
BFTC-909,702558,5.601571619782522,4.9782351440396395
LCLC-97TM1,24797083,1.6672233423539589,1.277886491385028
IA-LM,2945648,2.6647419367463794,2.7548400693819435
LS180,11717001,4.39666521822979,3.961276339234443
LS411N,42642645,1.4293896003043414,0.7845058245277501
SaOS-2,16038120,-0.4228492368909831,0.9090093368534204
HCC15,387447,-3.5284625014182556,-4.3765957253648695
K-562,24785538,3.0712560410264436,1.3344504348570345
PaTu 8902,6918289,3.1585202712855196,1.9146814118519513
BICR 31,11404337,-0.6318210319309021,-0.4254091153988029
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,1.5478733404534093
LCLC-97TM1,5460769,-2.8089441547625067,2.3447175553942796
IA-LM,25150857,2.846024040084871,2.336756962918186
HCC15,56973724,1.575466068691269,2.823032655731692
ALL-SIL,3384730,0.9130815120154347,2.4620443610818112
Daudi,426756,2.2442144831253383,4.301139445753315
NCI-H2452,6918328,0.3371182351616307,-0.28710840066117727
SW1271,11364421,-1.228057709924225,-2.2476185097624475
HCC1500,9911830,2.253316240952314,2.4240324657892436
COR-L95,60750,-4.239654973449372,-2.435153852929516
COR-L105,675434,4.897128449999278,4.463597576567934
RKN,5978,-1.5379865785523688,-2.3753204421143224
BICR 31,1641662,4.3069637553272715,3.3408828038827
SW48,5281321,-2.141746406212142,-1.3097742666845045
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.57821899028641
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.0163468544412688
K-562,12003241,-5.632155645383806,-1.0889198012759371
IGROV-1,11455910,-0.2792640061206097,0.9557745122323711
COR-L95,10410894,3.9632969340699735,3.2189174762180457
SW48,5351362,1.0988845715277948,1.4604743967139864
HuP-T3,9907093,4.467626530245781,4.134688957161641
IGROV-1,16065773,3.3717508464278585,2.3641186374244216
Panc 02.03,439501,0.4668648826805023,-2.2321662354381537
COR-L105,11427553,3.315123926488956,2.578035472123966
IGROV-1,119607,5.004384040905396,5.129253777214588
BICR 31,151289,1.9519908762907336,0.9562867634504244
SK-CO-1,60700,-2.5556595153787915,-0.4482559328189002
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.082620037824382
BICR 31,3825829,4.543850483279072,3.8869840981378028
SK-CO-1,65064,5.377201033407044,4.739517756868576
HuP-T3,613753,3.2946831222357233,3.1495845971526135
SK-HEP-1,89928392,1.6602086186634375,1.344325138639762
NCI-H2452,5291,3.747673065274588,3.5530526201153183
NCI-H2452,24964624,2.8171716992687967,2.2827362159867324
SU-DHL-1,654092,-1.6609972231677514,-0.4472857419901597
LCLC-97TM1,327653,3.202975625508304,3.018652636936018
LCLC-97TM1,11507802,1.3666879232460134,1.3590460953824346
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,0.38762532684053896
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,2.93841691857644
SK-CO-1,11222830,1.7982943188317977,1.5350294688251391
WM115,24951314,1.781657055553587,1.227614980483031
WM115,135421197,2.9135607351561883,1.8199795612290348
LCLC-97TM1,136227331,4.3740550996774745,4.306903331742339
BICR 22,24951314,1.8959621159637303,1.227614980483031
HCC15,15983966,-4.250826265389746,-1.6396194068861514
Daudi,24964624,0.5895170730703193,2.2827362159867324
SaOS-2,11257553,0.2323229130258903,0.882092451246884
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-1.261852028375895
RKN,46191454,2.1430961760764897,1.3518500781597358
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,1.4539899714896953
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,2.888353933707551
BICR 22,10410894,2.962619033825151,3.2189174762180457
NCI-H2452,168312962,2.634597095527088,1.48933366232238
MOLM-13,452548,-4.1979459883625045,-0.31026393275322106
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-1.261852028375895
SW1573,44185566,2.872643000979188,2.4057100644299436
SK-CO-1,5470400,-5.490738264790885,-0.3765538821264742
BICR 22,9933475,1.970614134756263,1.793439230086884
BICR 31,24753719,4.233476426959058,4.143618673527016
HuP-T3,4261,3.8165819220848767,1.4288257082744877
COR-L105,7251185,3.034502689275401,2.4347287977616
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,2.0276770243216165
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.78247230086659
SK-OV-3,49793307,0.1269396758315965,-2.848251171596848
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,0.8954839509867156
KU-19-19,216345,3.688803948438149,3.7540083674013296
LS411N,638278,3.5631537252490917,3.209337660705321
SK-CO-1,374536,2.850215581982446,1.7732341041149164
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.7921789378214816
P31/FUJ,11178236,-2.454576103037029,-3.539769866873396
SW948,439501,-2.1692174321648174,-2.2321662354381537
NCI-H2452,9911830,3.1691750432917645,2.4240324657892436
IGROV-1,9911463,4.195269991960018,3.732908427020576
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,0.7705130043498147
KU-19-19,46199207,3.5920417522591723,3.1312366616263048
IA-LM,25102847,3.5065737869109017,2.3366995460793083
SaOS-2,10385095,0.9171223668306429,1.2480392352773622
SK-HEP-1,285033,-0.6546577384402199,-2.1791335812392365
WM115,1566236,3.8332358430398847,2.2263982365179604
LS180,3025986,-0.3657173630682503,-0.8978770871810051
HCC1500,11625818,4.269459310239442,4.10791451089978
HCC15,44259,1.006506996100477,0.9267255578557378
RERF-LC-MS,285033,-2.0574538896256587,-2.1791335812392365
IGROV-1,241158,3.288496474515495,3.598987869990464
BFTC-909,6917907,-4.2174557642594035,-4.864372369867458
BICR 22,375860,-0.6251605141105395,-0.30112130782396007
BICR 22,119607,5.438520616053313,5.129253777214588
RERF-LC-MS,676352,1.6328584527608256,2.088896150621564
HCC15,6918289,2.816502870816243,1.9146814118519513
RKN,241158,3.8611150596916577,3.598987869990464
COR-L95,3634881,3.005165393659793,3.1576774496130544
IGROV-1,11626560,1.7276653519578558,1.6795489442409048
LS180,3385,1.8718372753364907,3.472185389430271
SU-DHL-1,56946209,-5.3778659012875325,-4.2202975286026225
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.456683733824014
NCI-H2452,448949,2.771204919609998,1.9537365892294993
SW1573,5113032,6.532830278238065,4.970396511864891
SK-OV-3,11485656,3.3782074628341894,2.2397291078765758
BICR 22,81146,6.036644504914818,4.85414860513934
P31/FUJ,76446078,4.256026108364254,4.473999410152771
Daudi,2113511,3.606563716227827,5.381335299817078
HuP-T3,5328940,2.3682781464336147,1.559061663996469
RKO,6852167,3.601912647929868,2.69961445504738
SK-HEP-1,1750826,-4.478019715406424,-1.4739669220989267
SU-DHL-1,25102847,1.7846654255237482,2.3366995460793083
KU-19-19,2749,1.0704171129437314,1.7932893499757152
COR-L105,136227924,2.729950058152846,2.867001064974719
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,1.78247230086659
RKO,25154868,3.654559992823761,4.289494395804131
HCC15,5113032,5.023051877119823,4.970396511864891
LCLC-97TM1,3815108,3.2576294300862867,2.885036533777781
SU-DHL-1,6610216,4.061950863639378,4.26979744561799
LS411N,136227924,3.1900427132689724,2.867001064974719
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,2.8341325456747963
KU-19-19,51037431,1.6044173216619535,3.10082796495436
MOLM-13,637858,0.5048034575879493,1.8880097009592578
SW948,5329102,1.476566645762777,2.031058842574058
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,4.13551970928241
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,2.0058447943574325
SW1573,1566236,3.3872191513469025,2.2263982365179604
IGROV-1,46174525,4.5083762186279595,4.156087356848057
SW948,9956119,4.230492181635778,3.4762974507018756
SaOS-2,100016,6.565789067704999,5.87798299213578
WM115,11152667,0.9737214532192616,-0.5866736007906306
HCC1500,439501,-1.4156205398968564,-2.2321662354381537
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.93841691857644
NCI-H2452,49793307,-1.217787389832333,-2.848251171596848
BICR 22,208908,1.938925459708866,1.8663560178908947
KU-19-19,675434,4.307992798559183,4.463597576567934
SU-DHL-6,168312962,-0.817402334599034,1.48933366232238
RKO,4705,3.750134101835121,3.0428654274536564
MOLM-13,72193861,-0.3301410770598842,1.3858780169906042
SU-DHL-6,11497983,-4.838706392617486,2.348631818792911
IA-LM,6610355,7.432350505906943,4.45123297085854
SU-DHL-1,100016,4.0163007651424945,5.87798299213578
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-1.1532493383305307
BICR 31,11717001,4.942461846011657,3.961276339234443
MDST8,452548,1.517979290481689,-0.31026393275322106
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,2.9860814461500107
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,2.144908880465776
HCC15,216239,2.699139377969599,2.1474208097396077
SW948,54143018,1.1269042701713536,0.31711465707788644
PaTu 8988t,2871966,0.7913795837456433,0.29730316799892464
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,3.7858620057203916
MOLP-8,702558,5.64086941386953,4.9782351440396395
SK-CO-1,9926054,2.0008566323964576,1.9546333131599372
NCI-H1568,208908,1.6425276108518176,1.8663560178908947
BICR 31,11364421,0.6668909809197356,-2.2476185097624475
RKO,6438330,2.4839059464581785,2.016737971321332
HCC1500,11717001,5.16685929391629,3.961276339234443
NCI-H2452,5335621,2.361346054519045,4.560420742529089
SK-HEP-1,168313200,3.8713243832650335,2.9593589282331023
MOLP-8,5281321,-3.090542457479921,-1.3097742666845045
LS411N,5287620,-2.7795044954925423,-1.9697846958841214
BFTC-909,42611257,4.384387627976705,3.0669311087446527
MDST8,135421197,2.23565927197073,1.8199795612290348
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,0.9218131221296273
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.4288257082744877
SU-DHL-1,136227924,2.1802521862386395,2.867001064974719
HEL,9929138,6.278460484472286,5.665997549800987
BICR 22,100016,6.157225392196351,5.87798299213578
BFTC-909,6610216,4.898578232775107,4.26979744561799
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.018652636936018
P31/FUJ,2708,3.1798246734444535,4.591243765137335
SK-HEP-1,11222830,2.864448489509693,1.5350294688251391
SW948,6450551,1.190778779915613,2.361538429265863
P31/FUJ,3503,1.1912257572322915,2.2426858883255045
SU-DHL-6,11214940,-0.480666123434414,1.8119431265240042
Granta-519,3101542,4.848909880356854,4.518946219608264
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,0.7705130043498147
SK-OV-3,54613361,2.1799599530092597,-0.11678183903518824
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.9218131221296273
PaTu 8902,9866186,4.760639543290191,0.7577083020821866
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,2.93841691857644
MOLP-8,445455,4.348825488954634,4.540053644561405
LS180,327653,3.1909584751660973,3.018652636936018
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,1.2359123501503817
WM115,24889392,3.868386170167097,3.7858620057203916
SK-CO-1,54618771,-0.118181134306818,0.9253379925205388
SaOS-2,9868037,3.691858985861763,2.82815333449006
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,1.5478733404534093
HCC15,10385095,2.335943691067567,1.2480392352773622
MOLP-8,2874250,4.289349020932475,4.0377213891771015
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.0665232817889554
SU-DHL-1,44137675,2.905771721153928,3.337336921695599
SW948,16038120,-0.173493225813213,0.9090093368534204
SW1271,387447,-4.431171658059158,-4.3765957253648695
HCC15,71304818,2.608087345638841,2.396178486082573
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.8865368208635396
SW48,44259,-0.1330653223053438,0.9267255578557378
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.699201704606489
BFTC-909,216239,2.6603594422751136,2.1474208097396077
MDST8,9825149,2.535214047656483,2.074054954263997
BICR 22,11625818,4.758067302616356,4.10791451089978
LS411N,6852167,3.3651093558735035,2.69961445504738
BICR 31,7251185,3.1852875333924415,2.4347287977616
ALL-SIL,25195348,0.8279476297727174,3.08171494739702
SaOS-2,73707438,3.8840228628110336,4.210679418158044
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,2.0276770243216165
BFTC-909,17755052,1.7621152527207813,1.7101929835526413
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.9860814461500107
SK-CO-1,3815108,2.810447278858876,2.885036533777781
COR-L95,3025944,4.2211844332657344,4.206240213808089
RERF-LC-MS,9825149,2.3136516136403595,2.074054954263997
KU-19-19,72376,-1.7461965003174784,-2.110114148114304
K-562,568763,0.3044566284292496,0.28862358029973745
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.280943620409205
Granta-519,6917907,-6.07944377191165,-4.864372369867458
SK-OV-3,4788,6.178998906779571,5.493389053048461
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.3568884936851697
RERF-LC-MS,6852167,1.8897499878184068,2.69961445504738
RCC10RGB,2746,4.042085650474663,2.8579929499469348
SaOS-2,54143018,-0.9786223984268784,0.31711465707788644
HCC15,451668,4.7728580097586635,-0.17843514405649885
RKN,135999136,4.319110081529012,3.6300382464802663
ALL-SIL,11228183,-1.4217334963731665,1.8712017695678478
RKO,568763,0.6942409100068829,0.28862358029973745
SK-CO-1,71304818,2.179260281615582,2.396178486082573
SaOS-2,151289,0.9278405880660672,0.9562867634504244
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-1.1532493383305307
MDST8,241158,1.799926141571129,3.598987869990464
BICR 22,11214940,1.8032425349242045,1.8119431265240042
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.133687221210622
LS411N,9825149,1.7370452341191267,2.074054954263997
K-562,72193861,0.1570904811456113,1.3858780169906042
RKN,89928392,1.2442310560485252,1.344325138639762
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.336756962918186
RERF-LC-MS,44493528,4.358183394704722,4.333966846288542
COR-L105,5738263,4.054674337055045,3.3050405288071003
P31/FUJ,5280436,3.1830796623136832,3.153394505533252
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,0.4199080872215506
LCLC-97TM1,135398516,2.1563049020997593,2.0509021680173207
COR-L95,25102847,2.826830714185171,2.3366995460793083
BICR 31,11427553,1.8414471938085448,2.578035472123966
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,0.9218131221296273
IGROV-1,15547703,3.339928221860449,3.114669509763707
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.5478733404534093
LS411N,6918328,-0.170211770014818,-0.28710840066117727
Daudi,3136844,3.4483363469146098,4.214923916993912
MOLP-8,10302451,3.559537910744256,3.0143591766147457
LCLC-97TM1,24772860,-2.203105978452304,-2.2690769633318126
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.2834565267098785
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,1.8880097009592578
SW1271,119182,-0.4023310904747799,-1.3340160156368264
RERF-LC-MS,135398516,2.452363199699896,2.0509021680173207
SK-CO-1,44495899,4.504236306700641,4.541868125737901
IGROV-1,10127622,3.2581804056600165,3.6054187258933235
SK-CO-1,44491742,5.1736211152382285,4.1566745174283435
MOLM-13,4477,0.1750371811238646,0.5570685949048098
WM115,25183872,-1.8696572442850008,-0.902802947451298
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.4199080872215506
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.2349426527428076
HCC1500,5335621,4.362965892261437,4.560420742529089
P31/FUJ,1716436,3.053886593694114,2.948755251800144
Daudi,9915743,0.3665260221427978,0.5935480801734145
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,2.0276770243216165
SK-CO-1,5311281,1.7217135985324663,2.22503529708604
IGROV-1,3503,2.453392942972796,2.2426858883255045
SW948,17755052,0.6738246482480579,1.7101929835526413
Granta-519,5329102,1.3717145166802862,2.031058842574058
HCC15,25183872,1.7330298559310635,-0.902802947451298
IGROV-1,23635314,-0.611739968448912,-1.8612337831613235
HuP-T3,46174525,5.4457837824532245,4.156087356848057
IGROV-1,46199207,3.293579955374855,3.1312366616263048
NCI-H1568,11656518,0.902462789439692,1.5480979328089313
SW1573,12001922,2.294011710402099,1.8522788760744173
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.4539899714896953
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,1.9146814118519513
SW948,2871966,1.833559506117821,0.29730316799892464
RKO,42642645,1.3055497818976145,0.7845058245277501
NCI-H2452,6450551,2.947106204512916,2.361538429265863
P31/FUJ,10302451,4.186780329312711,3.0143591766147457
P31/FUJ,6918837,-4.676526715032863,-3.046222711611649
HuP-T3,3552672,1.4793505278318,2.8413574589562494
BFTC-909,25105715,3.3944682152224455,3.410449786117574
HEL,44197249,3.8651368484410056,3.652871643911023
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.2349426527428076
BICR 31,46215462,1.6669957894505008,1.762132613731386
HuP-T3,9866186,1.729562359157257,0.7577083020821866
HuP-T3,11717001,4.25253085122872,3.961276339234443
NCI-H1568,54618164,3.652866089784218,4.02740727006158
WM115,441298,3.225500618866892,2.5423368047098167
LS411N,71304818,3.0616651991102697,2.396178486082573
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.4539899714896953
SK-HEP-1,10184653,3.249474772070569,1.1325795715302809
BICR 31,12003241,-1.4237270953299652,-1.0889198012759371
RERF-LC-MS,25150857,3.1332692975488934,2.336756962918186
COR-L95,24964624,2.1587115359420994,2.2827362159867324
SU-DHL-1,44241473,4.633491620971472,4.8543955662784395
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.3858780169906042
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.5866736007906306
MOLP-8,6918878,0.495059053850733,1.9069091595174383
RCC10RGB,448949,3.406339167429426,1.9537365892294993
HCC1500,148124,1.3380754252474834,-2.0460232384010055
HCC1500,5280436,1.8565158203383687,3.153394505533252
IGROV-1,10302451,0.4135234554742116,3.0143591766147457
Granta-519,285033,-4.09305161448312,-2.1791335812392365
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,0.4199080872215506
Granta-519,71304818,1.7993370678919798,2.396178486082573
NCI-H2452,3689413,1.184555113675537,-0.4039154566871359
IGROV-1,2708,4.438419625543199,4.591243765137335
SW1271,49850262,4.063818012025616,3.414452598711333
LS180,6918736,-2.1262365465987907,-1.741781295359962
PaTu 8902,10127622,6.3250626499292295,3.6054187258933235
SW1271,57519531,1.4534695216386555,2.4211376500246136
HCC15,57519531,1.9577451103636032,2.4211376500246136
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,1.5478733404534093
SW48,44185566,0.7812235367324193,2.4057100644299436
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,1.133687221210622
KU-19-19,241158,4.34083218708613,3.598987869990464
NCI-H1568,11404337,-0.63897934294681,-0.4254091153988029
Granta-519,219104,2.15431657191886,3.5366182443481806
SK-CO-1,5746,-2.8271360432483035,0.8084551861824514
WM115,6918837,-2.450050091846588,-3.046222711611649
SK-CO-1,11152667,-1.1935109806009474,-0.5866736007906306
SW1271,9825149,2.2012182796133084,2.074054954263997
SaOS-2,208908,2.5337103611164893,1.8663560178908947
SW48,5470400,-1.7303817372543355,-0.3765538821264742
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.3153680794849765
SW48,15547703,3.0370188863847414,3.114669509763707
SW948,46907787,2.3709287142369555,1.584957029505121
Daudi,5113032,4.739966647777949,4.970396511864891
SaOS-2,135984461,4.8186429168984475,3.6237408287871284
MDST8,168313047,3.800021027786958,2.4053217165791536
RCC10RGB,11964036,2.4986740771219673,1.2382789669868983
SW1271,24785538,1.505278847517323,1.3344504348570345
BFTC-909,3676137,5.055523871435828,4.517112669127141
SW48,9868037,2.459515994210572,2.82815333449006
KU-19-19,10231331,0.2937024112037242,1.6547412916072393
ALL-SIL,54619267,3.6744484896003713,3.9342007971372475
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.456683733824014
RCC10RGB,24951314,2.138755705452886,1.227614980483031
SU-DHL-6,26596,-1.882707371112463,-1.5346517263124715
COR-L105,46843906,1.9821208299636863,2.723521570705241
RERF-LC-MS,4477,-0.1141702320643991,0.5570685949048098
MOLM-13,49766530,-2.4914272268054107,-0.6944377068647134
SK-CO-1,4917,2.9299888563447163,3.079848880785536
Daudi,72734382,3.17690285998388,4.3578051352274185
LCLC-97TM1,11625818,5.063433550011292,4.10791451089978
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,1.0163468544412688
ALL-SIL,451668,-1.1904263441284522,-0.17843514405649885
SK-CO-1,219104,3.537047767593632,3.5366182443481806
NCI-H2452,65064,5.258935158123576,4.739517756868576
BICR 31,25062766,2.0025728701089904,2.0522756909743434
LCLC-97TM1,4261,1.8883571230172835,1.4288257082744877
BFTC-909,54618164,4.281231487810877,4.02740727006158
NCI-H2452,16736978,0.9447398024439234,1.3934160091023764
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,3.456683733824014
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,2.474523360549852
WM115,6917907,-5.049795628811172,-4.864372369867458
HuP-T3,5746,1.6464242063318688,0.8084551861824514
MOLP-8,327653,2.384727852533787,3.018652636936018
SW48,72376,-3.1415011638088144,-2.110114148114304
SK-HEP-1,23582824,1.0257570544783106,0.7400136078733197
K-562,12001922,1.1213264373636214,1.8522788760744173
WM115,10410894,3.2188686198907743,3.2189174762180457
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2834565267098785
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.414452598711333
KU-19-19,44819697,-2.543386759740491,-0.6109288989041974
LS180,46199207,2.9384583216685023,3.1312366616263048
LS411N,56946209,-3.80128700519076,-4.2202975286026225
LCLC-97TM1,6918289,3.014261251605047,1.9146814118519513
KU-19-19,107970,3.004209688555129,2.3029314718240044
MOLP-8,72376,-3.958595065171294,-2.110114148114304
IGROV-1,5291,3.6852809555447985,3.5530526201153183
Granta-519,46191454,0.5060764897707477,1.3518500781597358
COR-L105,24901704,3.8942422617258714,3.1103746959488285
NCI-H2452,24797083,2.030715286150645,1.277886491385028
NCI-H2452,124202324,3.032884210730814,2.1784388364790748
LCLC-97TM1,4259181,-0.2611730486969081,0.11236669175956715
KU-19-19,73707440,5.592820593626321,5.0056706494968015
RKN,5460769,5.79272629497122,2.3447175553942796
RKO,10184653,1.6814092199651305,1.1325795715302809
PaTu 8988t,24180125,3.300808715406375,2.888353933707551
COR-L105,2858523,3.082532365215724,3.0086502241129605
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.1345509900924162
LCLC-97TM1,16065773,3.044024356255971,2.3641186374244216
MOLM-13,16115403,-5.622868208190141,-4.875275216600306
Daudi,104842,-7.567274671559235,-3.040993872013826
PaTu 8988t,3825829,4.270364787448243,3.8869840981378028
HuP-T3,227681,2.514870644267688,2.9941233013598234
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.2834565267098785
COR-L105,11964036,1.2117851204645589,1.2382789669868983
SW1271,135659046,3.922158232881772,3.604307380358917
IGROV-1,4917,2.985904350427039,3.079848880785536
HCC15,9826308,1.2579647962340863,0.12580254156308923
SK-OV-3,46199207,3.479599233509405,3.1312366616263048
KU-19-19,2729026,3.069520174525383,2.6325975116350393
COR-L105,25102847,1.810865395215699,2.3366995460793083
SW1573,9935249,2.8664920450292852,2.8615383619674972
COR-L95,1714884,3.7968274989469992,2.7385495072683548
PaTu 8988t,7251185,3.286029674356028,2.4347287977616
SK-CO-1,24856436,0.7128954142297991,0.17994774592918095
HCC1500,5738263,2.955373895930653,3.3050405288071003
SU-DHL-1,6914657,-4.020831804674196,-4.170094408243688
SW48,638278,3.16751315896482,3.209337660705321
LCLC-97TM1,135421197,1.517750954289076,1.8199795612290348
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,-0.4254091153988029
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,2.474523360549852
NCI-H1568,6914657,-5.120590256929669,-4.170094408243688
NCI-H2452,3676137,5.703513737309888,4.517112669127141
PaTu 8988t,11238147,3.9795465318298526,2.694366237977623
RCC10RGB,5113032,2.807854627845623,4.970396511864891
IA-LM,44607531,1.5934898700442923,1.48117322485652
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,4.4833676274788345
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-3.5071094923394703
RKN,3815108,2.827407220517517,2.885036533777781
IGROV-1,448949,2.098499309472767,1.9537365892294993
BICR 31,5426,4.483861121335425,4.746710128133936
SK-OV-3,322968,3.987773865251791,3.4956311613712456
BFTC-909,15953870,3.192835350037467,3.4781017448929608
BFTC-909,4378219,4.497242068417329,2.6822409618839944
COR-L95,54143018,1.379812266453913,0.31711465707788644
SU-DHL-1,11612883,2.467580560997241,2.6386482274158856
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,0.11065310288154762
LS180,5978,-1.0800938866172374,-2.3753204421143224
NCI-H1568,44566777,1.438409258191859,0.6972581949653407
BICR 31,42642645,1.5553576315566706,0.7845058245277501
MOLM-13,654092,-2.113392174262404,-0.4472857419901597
LS411N,124202324,2.3656166654970137,2.1784388364790748
SU-DHL-1,5329102,0.4187283879213827,2.031058842574058
Daudi,51037431,1.7669670215364446,3.10082796495436
RERF-LC-MS,45279963,3.7797867340420215,3.660133434789582
IGROV-1,49850262,4.068828647042517,3.414452598711333
BICR 31,12001922,2.662375748901725,1.8522788760744173
IGROV-1,49793307,-2.5291790820063538,-2.848251171596848
PaTu 8902,2828334,6.440933390339598,6.082620037824382
SU-DHL-1,24951314,0.6018835624310062,1.227614980483031
MDST8,676352,2.6149374435458643,2.088896150621564
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.2426858883255045
MOLP-8,44185566,2.3020252385384747,2.4057100644299436
RKN,44137675,5.459450119186335,3.337336921695599
SU-DHL-1,216239,2.4334915471860064,2.1474208097396077
RCC10RGB,5328940,2.5920229504771264,1.559061663996469
MOLP-8,5351362,0.578803181676615,1.4604743967139864
KU-19-19,4521392,6.281175440463305,4.280943620409205
HuP-T3,219104,4.090562015064086,3.5366182443481806
BICR 22,16722836,2.37465920140225,1.5333952667080324
Granta-519,54678924,3.4908303220152512,1.9473085147454567
SW948,5738263,3.889172676108031,3.3050405288071003
SW1271,9549297,2.1335240165820606,2.3089350530287187
MOLM-13,5280436,3.611781786093365,3.153394505533252
BICR 22,3062316,1.4778056821676904,0.9747482048219924
HCC1500,46191454,2.281809335685502,1.3518500781597358
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.540053644561405
SW48,9549297,0.4487326680785643,2.3089350530287187
SK-OV-3,46843906,3.785109660734252,2.723521570705241
NCI-H2452,5351362,1.571040634520482,1.4604743967139864
RKO,56946209,-3.445993729976747,-4.2202975286026225
SaOS-2,56649450,2.657103116813459,2.999158341046921
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-1.261852028375895
LS411N,23725625,5.218761480016774,4.726527081330662
RERF-LC-MS,4578,4.625372786711685,4.446937148676336
MOLM-13,11507802,1.0337656748409854,1.3590460953824346
SW48,65064,5.106206142410259,4.739517756868576
HCC15,2828334,6.579413009448801,6.082620037824382
SaOS-2,4378219,3.572923749570723,2.6822409618839944
BFTC-909,23939,4.493588141952023,4.316990186905579
RCC10RGB,439501,-2.548266242367821,-2.2321662354381537
SW1271,3815108,3.2377532103389832,2.885036533777781
P31/FUJ,5287620,-2.889875327880449,-1.9697846958841214
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,1.9537365892294993
LS411N,5281321,2.872375461605106,-1.3097742666845045
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.079848880785536
MOLM-13,16736978,-0.7178102164081313,1.3934160091023764
HuP-T3,24964624,2.5347495437600753,2.2827362159867324
SW1271,3038522,2.6397404309625574,2.9847437848386558
SK-OV-3,6852167,3.0870556066687076,2.69961445504738
PaTu 8902,25262965,1.559985123462204,-1.6224193967571534
PaTu 8988t,89928392,1.7442497788257625,1.344325138639762
RCC10RGB,5494449,5.764110819730859,2.624769648445017
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,1.710700657959646
Daudi,5282054,2.334684985175564,3.5628845676855256
SW1573,9866186,2.2605214925080035,0.7577083020821866
SK-HEP-1,16013152,4.2454363352103925,4.119375381760217
IGROV-1,11647372,-0.6595372928368528,0.8954839509867156
RKO,60700,-0.2024014556335324,-0.4482559328189002
SaOS-2,66577038,3.461550546017496,2.9870697487432882
BICR 22,6918638,0.0558003797401064,0.3065957347013626
NCI-H1568,6918878,3.5715267618547832,1.9069091595174383
RKN,17755052,4.615024850417848,1.7101929835526413
RKO,10385095,1.2981289243482117,1.2480392352773622
NCI-H1568,25227462,1.3523005990409367,-0.4151865926866767
IGROV-1,168313200,3.9938362637732983,2.9593589282331023
LS180,52912189,2.5201251776162454,1.6723266261402217
SK-OV-3,446155,4.068831864004445,2.662752180605146
SaOS-2,2729026,3.0079080963172573,2.6325975116350393
COR-L105,24785538,1.9787344511962284,1.3344504348570345
WM115,9549297,1.875565618317202,2.3089350530287187
COR-L95,53392493,1.7864953470488698,2.4832542501558077
SaOS-2,219104,3.933074432676362,3.5366182443481806
WM115,3854666,2.6196721416111024,1.85063491630251
PaTu 8902,11626560,1.9806688551606229,1.6795489442409048
P31/FUJ,24901704,1.8625310117446785,3.1103746959488285
IGROV-1,9911463,4.195269991960018,3.732908427020576
LCLC-97TM1,216468,0.7418366776466117,2.5020743765616316
MOLP-8,387447,-5.214034261316855,-4.3765957253648695
RCC10RGB,16722836,2.017391543442539,1.5333952667080324
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.7705130043498147
SW48,5311281,1.5627745937535438,2.22503529708604
MOLM-13,11497983,-4.003769607545663,2.348631818792911
KU-19-19,2858523,2.990442019675252,3.0086502241129605
COR-L95,11626560,1.5180153972734145,1.6795489442409048
WM115,123631,1.7981952102566006,2.2760265557358337
RERF-LC-MS,2874250,4.628157945253743,4.0377213891771015
MOLP-8,65064,3.020382379730844,4.739517756868576
RERF-LC-MS,3854666,0.8294073497518095,1.85063491630251
HCC15,3689413,0.3467742153458734,-0.4039154566871359
HCC15,25150857,2.8177810894811786,2.336756962918186
LCLC-97TM1,46174525,4.403281113181967,4.156087356848057
SK-HEP-1,31703,0.3185055118054912,-1.182053713238432
BICR 22,123631,2.0553358195001383,2.2760265557358337
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.0665232817889554
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,0.7705130043498147
COR-L105,11213558,1.6245415685033464,1.4781707184028035
COR-L105,3689413,-2.1605707630353708,-0.4039154566871359
MOLP-8,4917,1.932746630984224,3.079848880785536
HEL,11238147,1.9261110470981635,2.694366237977623
HCC15,46907787,1.7788170946404287,1.584957029505121
HCC1500,3062316,2.994925150114549,0.9747482048219924
MOLP-8,9935249,-5.983061984872936,2.8615383619674972
IA-LM,135398516,1.3190430503048431,2.0509021680173207
NCI-H1568,6917907,-6.013699668749745,-4.864372369867458
PaTu 8988t,25062766,2.121196656552597,2.0522756909743434
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.848251171596848
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,1.710700657959646
HCC15,3825829,3.261310602619802,3.8869840981378028
SaOS-2,36314,-6.649536011740597,-1.2422497803043113
BFTC-909,54613361,0.5481358040879688,-0.11678183903518824
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.9218131221296273
KU-19-19,135999136,4.912207411852192,3.6300382464802663
HCC15,126941,-2.714458984381298,-2.8921209077069348
K-562,387447,-4.172741798582805,-4.3765957253648695
BFTC-909,400769,-0.3884900564724624,-0.7855881743093749
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,2.0058447943574325
K-562,19582717,3.29667086675107,3.9198146524152833
LS180,676352,2.815097827506973,2.088896150621564
SK-CO-1,5278396,2.886619996042885,3.517590475337377
SW1271,654092,-0.6724961197062129,-0.4472857419901597
BICR 31,984333,1.688597902845401,0.5138000229415411
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,1.85063491630251
PaTu 8902,6918328,0.0837665640709721,-0.28710840066117727
KU-19-19,25126798,3.8528221502524262,3.7921789378214816
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,2.102163121425029
K-562,984333,1.160515473081413,0.5138000229415411
BICR 22,4261,1.6582900308021409,1.4288257082744877
P31/FUJ,24753719,3.279397605233023,4.143618673527016
RKO,89928392,1.6264666324972337,1.344325138639762
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-2.2476185097624475
MOLP-8,2746,0.9128995235322724,2.8579929499469348
PaTu 8988t,44589607,3.069724280166482,2.659070263037081
Daudi,55508,3.074140286884227,3.1188086218267883
IGROV-1,53232,2.4872106086763393,2.8161144578264046
HCC1500,11178236,-0.8618797474299623,-3.539769866873396
SW1573,11228183,1.3544411199442492,1.8712017695678478
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-3.5071094923394703
HCC15,151289,0.5818248951012718,0.9562867634504244
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.4539899714896953
LCLC-97TM1,9956119,3.701469228999412,3.4762974507018756
LS180,65064,5.333283055182179,4.739517756868576
Panc 02.03,1566236,1.9322803720882225,2.2263982365179604
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.2047817895412443
COR-L105,5311281,2.5909348271223833,2.22503529708604
COR-L105,4261,1.037866526492344,1.4288257082744877
MOLM-13,6505803,-3.0527041000310255,-0.5114413444588124
SaOS-2,24797083,1.1743557883271736,1.277886491385028
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.2834565267098785
PaTu 8988t,44819697,-1.4855632158782932,-0.6109288989041974
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.7705130043498147
MOLM-13,136227924,1.704251401840426,2.867001064974719
K-562,11955716,-2.44804051648688,-1.4856643985320634
PaTu 8988t,119607,6.161307312166748,5.129253777214588
COR-L95,71466380,4.385390307812106,4.275465599745589
SW48,400769,-1.161678790289576,-0.7855881743093749
SK-HEP-1,54618771,0.9570801540222316,0.9253379925205388
Daudi,10410894,2.7348964142664096,3.2189174762180457
P31/FUJ,8515,2.4023085754769133,3.7716438213452004
MOLP-8,12001922,1.340541943266141,1.8522788760744173
SaOS-2,24180125,2.5037581025896896,2.888353933707551
LCLC-97TM1,11497983,-3.4928977535107872,2.348631818792911
KU-19-19,54618771,0.4920305765445359,0.9253379925205388
BFTC-909,9826308,0.9467806471528852,0.12580254156308923
HEL,6252,-2.3526628041976547,-0.10942982547788271
PaTu 8902,1750826,3.002378182351502,-1.4739669220989267
HEL,375860,-0.4243086466742362,-0.30112130782396007
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.6829735349466532
LCLC-97TM1,44137675,2.6535109564984403,3.337336921695599
BFTC-909,4096211,2.208598833058293,1.856021664538426
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.7691529831259722
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,2.0058447943574325
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,1.762132613731386
SK-CO-1,10231331,-0.7210930575000714,1.6547412916072393
RERF-LC-MS,9908783,5.63449812951243,5.056023266605311
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,2.344610112805219
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.133687221210622
SaOS-2,54618795,3.185724709117328,3.2898168258752616
PaTu 8988t,637858,2.5993481939897314,1.8880097009592578
HEL,984333,-1.1600295079037413,0.5138000229415411
HCC15,2841722,4.4106331963661285,4.375424781932207
SW948,676352,1.6772543111300298,2.088896150621564
BICR 31,24964624,2.1782924417506235,2.2827362159867324
MDST8,984333,1.6302493723588198,0.5138000229415411
SaOS-2,25102847,2.0054521503393956,2.3366995460793083
NCI-H1568,11396600,3.496587037401377,3.4309758536883517
SU-DHL-1,25126798,1.813712960287442,3.7921789378214816
MOLM-13,445091,4.269392983422825,4.3274252089919045
IA-LM,6918328,0.468629569752011,-0.28710840066117727
RKO,16038120,2.1201165412688385,0.9090093368534204
Daudi,3689413,-4.376822515219121,-0.4039154566871359
LS411N,1750826,2.0365622567800985,-1.4739669220989267
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,1.2834565267098785
LS411N,11640390,3.2208706785393972,3.2466540190485103
SK-OV-3,2729026,2.529477515357917,2.6325975116350393
BICR 22,1317464,3.72634745746102,4.148586664919221
PaTu 8988t,6917907,-5.027469783550181,-4.864372369867458
BICR 22,168313200,4.032164885313491,2.9593589282331023
WM115,24180719,-0.1236916700903925,3.437709308952337
WM115,2708,4.839353437835411,4.591243765137335
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.6829735349466532
SW948,135398516,1.5329637117305952,2.0509021680173207
SK-HEP-1,15547703,3.182423809990023,3.114669509763707
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.7101929835526413
SW1271,400769,-0.393739366900267,-0.7855881743093749
COR-L95,11657048,4.451680892653422,4.509467699195642
KU-19-19,5470400,0.4514058362673593,-0.3765538821264742
SU-DHL-1,46199207,2.2603615990150803,3.1312366616263048
LCLC-97TM1,452548,-0.620032222833134,-0.31026393275322106
COR-L105,216345,3.681753487249753,3.7540083674013296
SK-CO-1,6918736,-2.135863333000623,-1.741781295359962
SK-CO-1,5351362,1.1244803572081656,1.4604743967139864
Granta-519,451668,1.0102660805443675,-0.17843514405649885
RCC10RGB,71751553,5.18764953581067,4.504570481353087
SW948,44137675,3.8395253943289553,3.337336921695599
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.4199080872215506
LS411N,654092,0.6196619744838121,-0.4472857419901597
HCC15,11222830,1.5967166138936082,1.5350294688251391
RERF-LC-MS,54143018,1.1379926617289184,0.31711465707788644
HuP-T3,107970,2.2315719384591133,2.3029314718240044
MOLP-8,462382,0.932516774133838,0.5714028853239661
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,3.7858620057203916
COR-L105,448949,1.923777772079977,1.9537365892294993
SU-DHL-6,5311,0.0847535344452709,1.2663000347984639
COR-L105,65064,5.250674314711081,4.739517756868576
RKO,9908783,5.5436232623995805,5.056023266605311
BICR 22,1566236,3.7080344976190434,2.2263982365179604
SK-OV-3,2708,5.531711784720637,4.591243765137335
RERF-LC-MS,148198,-3.5927713028936834,-3.548509713878981
K-562,10127622,4.587499993681003,3.6054187258933235
MDST8,3543504,4.366917593553272,4.269325105068445
NCI-H2452,675434,4.57874791360699,4.463597576567934
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,2.9860814461500107
K-562,73707398,1.1020172598138147,1.180307991266282
BICR 22,11178236,-2.3138277354389176,-3.539769866873396
KU-19-19,53232,3.650570649303299,2.8161144578264046
COR-L105,2126,5.6436039579971045,4.466606494133751
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,0.11065310288154762
WM115,984333,1.7219326558446977,0.5138000229415411
Daudi,6918878,-0.3078198284611306,1.9069091595174383
HCC15,16725315,4.804384009366738,4.150060666188836
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.37491183386883553
ALL-SIL,56946209,-4.755076906810128,-4.2202975286026225
P31/FUJ,25195348,1.3039046822632598,3.08171494739702
NCI-H1568,4261,1.7177455985107426,1.4288257082744877
BICR 22,11238147,2.160553784520482,2.694366237977623
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,1.1345509900924162
LCLC-97TM1,25126798,4.007107372760091,3.7921789378214816
PaTu 8988t,11612883,3.2937262662044424,2.6386482274158856
SW48,44507138,1.5733509414979852,2.3228542035372683
SU-DHL-1,66577038,2.452346655400699,2.9870697487432882
ALL-SIL,60168763,4.204461937910143,1.9998178357438696
Daudi,25227462,-5.495402710114509,-0.4151865926866767
LCLC-97TM1,613000,2.0466318432711708,2.227141832343803
LS411N,2828334,6.327786282136184,6.082620037824382
IGROV-1,9866186,0.4571266497661056,0.7577083020821866
SU-DHL-6,72376,-4.568822946856545,-2.110114148114304
P31/FUJ,984333,-0.8646677641211812,0.5138000229415411
COR-L95,123631,2.8240072692867915,2.2760265557358337
IGROV-1,11497983,4.37450324471555,2.348631818792911
BFTC-909,5281672,4.401358042981416,4.4250678360691875
PaTu 8902,44607530,2.9609228636650826,1.715838652040812
HuP-T3,5566,3.0002994658008935,3.029152149495273
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.3153680794849765
IGROV-1,2729026,2.3541792737160296,2.6325975116350393
COR-L95,11222830,1.53452681839189,1.5350294688251391
LCLC-97TM1,66577038,1.6013450181273698,2.9870697487432882
IGROV-1,24772860,-3.2892316801587835,-2.2690769633318126
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.57821899028641
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.8865368208635396
NCI-H1568,54678924,1.274078635657008,1.9473085147454567
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,0.9218131221296273
RCC10RGB,9908783,5.908182650801537,5.056023266605311
IA-LM,66577038,3.3956332242260765,2.9870697487432882
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,1.2359123501503817
COR-L95,9935249,2.976260244275784,2.8615383619674972
SU-DHL-6,9868037,3.231553190440303,2.82815333449006
RCC10RGB,11640390,5.2605770793622275,3.2466540190485103
Daudi,285033,-6.062056136351362,-2.1791335812392365
BICR 22,11626560,2.057582050988773,1.6795489442409048
NCI-H1568,60750,-4.838669884752028,-2.435153852929516
MOLM-13,2708,1.6215518677504634,4.591243765137335
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.78247230086659
K-562,10385095,0.5975872383647969,1.2480392352773622
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,2.144908880465776
ALL-SIL,9887053,2.3955838154567703,3.469815136639831
RERF-LC-MS,151289,1.06337646711186,0.9562867634504244
LCLC-97TM1,71466445,2.7974721848465025,3.3478019143630626
RKO,15983966,1.976330033309676,-1.6396194068861514
SU-DHL-6,54143018,-0.9166021499884252,0.31711465707788644
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.38762532684053896
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,2.9860814461500107
IGROV-1,49793307,-2.5291790820063538,-2.848251171596848
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,1.78247230086659
SW48,9866186,-0.0602537260044697,0.7577083020821866
ALL-SIL,24753719,3.3195109491118635,4.143618673527016
PaTu 8988t,409805,3.676693079768219,4.6745070702664995
BICR 22,11175137,1.6412636442827269,2.477950770888125
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.0163468544412688
MOLP-8,9887053,1.3364969406129874,3.469815136639831
Daudi,81146,4.468898659357518,4.85414860513934
NCI-H2452,6438330,4.066979701794873,2.016737971321332
SU-DHL-6,73707438,4.161722925172636,4.210679418158044
SU-DHL-1,9825149,2.3972801394012415,2.074054954263997
LCLC-97TM1,1242560,3.1698209685240832,3.534393132486151
RKO,44632017,0.9673312213076444,1.0838611345650022
ALL-SIL,10184653,0.3156525087572682,1.1325795715302809
MOLM-13,15953870,2.45012914744678,3.4781017448929608
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-3.5071094923394703
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,2.9847437848386558
Daudi,9908783,4.64363842559646,5.056023266605311
BICR 22,2746,3.5358057095338404,2.8579929499469348
SK-OV-3,9903786,2.611217845094376,2.756077717004494
Granta-519,446155,3.3236756015859266,2.662752180605146
HuP-T3,46843906,1.6260119885378777,2.723521570705241
RCC10RGB,25102847,4.4790627708666255,2.3366995460793083
SW1573,119607,3.675967979424282,5.129253777214588
NCI-H2452,36462,2.3648017756260327,1.5076124324231743
RKO,9926054,1.883626680074333,1.9546333131599372
UACC-812,11396600,4.679415745859403,3.4309758536883517
LCLC-97TM1,67291369,2.1623476689900527,1.794812676489941
SaOS-2,9926054,1.5065280757428428,1.9546333131599372
SW1271,11485656,2.5257448561020053,2.2397291078765758
SU-DHL-1,65628,3.0805404655500843,4.026684176415168
RERF-LC-MS,24889392,5.73600211591012,3.7858620057203916
IGROV-1,16720766,-0.0562020789376145,0.4291253754884592
SaOS-2,53392493,1.7453499080757628,2.4832542501558077
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.2349426527428076
LCLC-97TM1,71466578,4.4967812415195025,3.983075654179168
MOLM-13,135440466,-1.1165614244178856,2.1401473911994366
IA-LM,1566236,2.064855820915055,2.2263982365179604
SW948,3825829,4.076553662425885,3.8869840981378028
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.1566745174283435
WM115,322968,4.566671406107956,3.4956311613712456
RKN,637858,2.0099352926359533,1.8880097009592578
COR-L105,135398516,1.4567379833558207,2.0509021680173207
LS411N,15547703,3.407600768992332,3.114669509763707
SW948,6918878,-0.2941800388813576,1.9069091595174383
SK-OV-3,31703,-0.6007067740148971,-1.182053713238432
BICR 31,16038120,0.7865824758597759,0.9090093368534204
SW1271,46943432,0.8939870827443378,1.70045196562753
Daudi,67291369,0.2775886597323658,1.794812676489941
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-1.6778195760397165
BICR 31,11455910,2.0785566961581186,0.9557745122323711
MOLM-13,25150857,2.0975264071969075,2.336756962918186
COR-L105,46174525,5.553907170062061,4.156087356848057
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,1.7691529831259722
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,2.0058447943574325
IGROV-1,135398516,1.9751898057484376,2.0509021680173207
PaTu 8902,3689413,3.662647678116459,-0.4039154566871359
Daudi,31703,-5.42156315939604,-1.182053713238432
IGROV-1,24785538,1.106246320450551,1.3344504348570345
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.9218131221296273
PaTu 8902,676352,2.5672836386659625,2.088896150621564
MOLM-13,426756,3.5583078181784504,4.301139445753315
WM115,64971,1.594754361798162,2.5328398474495826
SW1271,4521392,3.9428497415690713,4.280943620409205
HCC1500,19582717,3.689290387765622,3.9198146524152833
BICR 22,71680916,5.5411632888305755,4.641848024405652
IA-LM,462382,0.6444148679919928,0.5714028853239661
P31/FUJ,24856436,-2.072993507389728,0.17994774592918095
LS180,135411,0.2951252953722391,0.5181226666256136
MOLM-13,72376,-3.7215877343251456,-2.110114148114304
RKO,6610216,3.958403220086871,4.26979744561799
RKN,452548,0.7515073582009456,-0.31026393275322106
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,1.4539899714896953
SaOS-2,3038522,3.0360203721983257,2.9847437848386558
SK-HEP-1,409805,5.808157500863876,4.6745070702664995
BFTC-909,44137675,3.23817368119839,3.337336921695599
SW1573,25183872,-2.56928333929943,-0.902802947451298
HCC1500,23582824,1.5666293035108128,0.7400136078733197
MOLM-13,11612883,-1.8374573083034769,2.6386482274158856
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,1.2834565267098785
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,3.9383569867901693
KU-19-19,135421197,1.2163789616721166,1.8199795612290348
SK-HEP-1,49766530,-2.8567737760804324,-0.6944377068647134
Daudi,46843906,1.1534141628569738,2.723521570705241
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,3.4956311613712456
IA-LM,11494412,5.732457488131999,1.4248282417532188
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.38762532684053896
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,2.8341325456747963
Granta-519,46943432,2.0409318821812477,1.70045196562753
MOLP-8,46174525,3.423634821116614,4.156087356848057
RCC10RGB,19582717,5.580606305911862,3.9198146524152833
NCI-H1568,71680916,4.3779497666633915,4.641848024405652
SW948,3689413,-2.2648112033429824,-0.4039154566871359
RCC10RGB,252682,6.528801566934436,6.516263069090082
Daudi,135875424,2.734623655159311,3.743891076041643
K-562,4788,4.09681667300412,5.493389053048461
BFTC-909,66577038,2.856590203747272,2.9870697487432882
BICR 22,56649450,1.894872176339528,2.999158341046921
LCLC-97TM1,23635314,-2.2617116518456792,-1.8612337831613235
SaOS-2,16013152,4.240825830990255,4.119375381760217
MOLP-8,5738263,2.3540234006064424,3.3050405288071003
IGROV-1,3552672,2.134472496867482,2.8413574589562494
BFTC-909,6505803,-2.7076869289136147,-0.5114413444588124
NCI-H2452,9952709,3.912471204941481,2.9381980631482683
SW48,4477,0.2937974315698831,0.5570685949048098
IGROV-1,10113978,2.874171865860951,3.010980031724017
Daudi,3465537,3.6729414318228697,2.5477591829493655
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.7855881743093749
WM115,60750,-0.3155979924811316,-2.435153852929516
LCLC-97TM1,3552672,1.9872160910848609,2.8413574589562494
P31/FUJ,16720766,-1.2973124396101832,0.4291253754884592
PaTu 8988t,16722836,1.7927006401716397,1.5333952667080324
RCC10RGB,24785538,4.443576486987547,1.3344504348570345
LCLC-97TM1,54454,2.264936650655555,2.548844675602096
BFTC-909,44202524,2.4582417316930916,1.9639001504219202
NCI-H2452,9956119,4.089312834038711,3.4762974507018756
LCLC-97TM1,44589607,2.470818031732135,2.659070263037081
K-562,9911463,2.5078915917546336,3.732908427020576
RKO,12003241,-0.2410566552434749,-1.0889198012759371
SK-CO-1,9887053,2.665990529661509,3.469815136639831
HEL,9444,3.6260707724362113,4.054048446110465
RERF-LC-MS,54618164,3.9158352593779377,4.02740727006158
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,2.9860814461500107
MOLM-13,400769,-1.4398892181534526,-0.7855881743093749
RKO,54454,4.6965621210229225,2.548844675602096
HEL,3815108,1.7280464955300685,2.885036533777781
HuP-T3,400769,-0.02490432142157,-0.7855881743093749
COR-L105,439501,-1.395093001857319,-2.2321662354381537
P31/FUJ,11717001,4.27266863837082,3.961276339234443
WM115,44566777,1.1755609042254629,0.6972581949653407
Daudi,9823820,1.816535221490948,3.7294514785702977
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,3.456683733824014
SaOS-2,11178236,-4.192404287761835,-3.539769866873396
RKO,107970,2.3673735748138265,2.3029314718240044
Granta-519,3384730,1.8851059301538475,2.4620443610818112
Daudi,3081361,1.2348545680767924,2.3568884936851697
COR-L105,11656518,2.8708923278875846,1.5480979328089313
SK-HEP-1,4261,2.0689452694586596,1.4288257082744877
IA-LM,4261,0.3595729013120086,1.4288257082744877
SW1271,5282054,4.135247135343962,3.5628845676855256
NCI-H1568,44491742,3.692908194165655,4.1566745174283435
K-562,10074640,1.329135681779355,3.066922642013836
IGROV-1,9908783,5.873270433212515,5.056023266605311
MDST8,24951314,1.0921901869172437,1.227614980483031
ALL-SIL,3081361,0.1962192778787347,2.3568884936851697
SaOS-2,4578,4.61303870633514,4.446937148676336
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,-0.4039154566871359
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,1.7724503678159762
IA-LM,25227462,1.9658589227885097,-0.4151865926866767
MOLP-8,71466578,1.6771539715617054,3.983075654179168
HCC1500,11977753,-0.4307765862265268,-1.7159558966047241
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,2.9860814461500107
BFTC-909,568763,0.745825262149274,0.28862358029973745
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,3.801678648950925
RCC10RGB,613753,3.3201179844199498,3.1495845971526135
BICR 22,421610,1.881248812005912,3.1278257636093416
COR-L95,55508,1.7090560645840305,3.1188086218267883
SaOS-2,2945648,3.259308629519986,2.7548400693819435
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.2834565267098785
RKO,409805,3.580644131410829,4.6745070702664995
COR-L95,53495165,-2.3377393798516395,-0.19108456656304296
SK-HEP-1,25154868,3.1824362497542182,4.289494395804131
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-1.1532493383305307
SaOS-2,5978,-3.9287237947590494,-2.3753204421143224
COR-L105,4096211,2.67395928769434,1.856021664538426
LS180,15953870,3.325208983942858,3.4781017448929608
Daudi,66577038,1.2731684674623205,2.9870697487432882
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.3791567205504176
RKO,6918328,0.803085247134139,-0.28710840066117727
SW48,4259181,-1.8199657809061969,0.11236669175956715
SK-CO-1,44185566,2.2410285456889176,2.4057100644299436
K-562,5978,-3.1400031562505393,-2.3753204421143224
SaOS-2,613000,1.0847199338514617,2.227141832343803
LCLC-97TM1,9826308,0.172966057550933,0.12580254156308923
Granta-519,5311,0.5114694341413046,1.2663000347984639
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.3791567205504176
SW1573,4788,4.2029613497215195,5.493389053048461
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,2.9860814461500107
WM115,2729026,3.0250773642114175,2.6325975116350393
IGROV-1,23725625,5.712368491237602,4.726527081330662
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,3.7716438213452004
SK-OV-3,24964624,2.562140083880341,2.2827362159867324
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,1.5478733404534093
MDST8,5278396,3.853168516309647,3.517590475337377
RKO,119607,4.75876667689532,5.129253777214588
MDST8,65064,4.754326425577863,4.739517756868576
MOLP-8,54596558,5.109397009340411,4.397101469450013
WM115,9911830,1.4636751787761997,2.4240324657892436
SK-HEP-1,44486219,4.3977685724309215,4.281343219898981
BFTC-909,15983966,-4.834157449814871,-1.6396194068861514
SU-DHL-1,24901704,2.0463171426909086,3.1103746959488285
NCI-H1568,3025944,3.938114410703908,4.206240213808089
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,3.0665232817889554
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.5570685949048098
RCC10RGB,16725315,5.2458056955252275,4.150060666188836
RKO,53495165,0.8925500623489324,-0.19108456656304296
HCC1500,71304818,1.489157695167493,2.396178486082573
COR-L95,135398738,4.3251787986630195,3.3919135064420334
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.756077717004494
SaOS-2,56949517,5.721423210410403,4.259203439290573
ALL-SIL,644241,-6.056766449232899,2.1017288356510795
MOLM-13,42642645,-6.876168570605093,0.7845058245277501
RCC10RGB,51039095,3.636696049778912,2.682611194240459
ALL-SIL,60700,-4.240130526526249,-0.4482559328189002
PaTu 8902,15547703,4.581249636071297,3.114669509763707
BFTC-909,11609586,2.9417391320909134,2.621607380466062
SW48,11455910,-0.1633281652990052,0.9557745122323711
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,2.0276770243216165
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,0.4199080872215506
MDST8,11364421,1.2673702676732186,-2.2476185097624475
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.4554460238042177
IGROV-1,23939,4.412541857664819,4.316990186905579
HCC15,11626560,0.3588759938830249,1.6795489442409048
MOLP-8,1750826,-2.6273703880538166,-1.4739669220989267
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.78247230086659
SaOS-2,3634881,3.4478485283346454,3.1576774496130544
KU-19-19,65064,5.4276979548790285,4.739517756868576
SK-OV-3,53392493,2.9853646548342767,2.4832542501558077
BFTC-909,44607531,1.7004331217528663,1.48117322485652
RKO,9915743,2.8851858618766957,0.5935480801734145
WM115,969516,2.5733075045080405,2.7772567284956553
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,0.9218131221296273
HCC15,1641662,2.7903081608832743,3.3408828038827
PaTu 8988t,24856436,-1.0780184146975675,0.17994774592918095
BICR 22,151289,1.1052603945032196,0.9562867634504244
RKN,10302451,3.971829298943927,3.0143591766147457
Daudi,9840324,5.326423492349393,5.7711165719697215
Granta-519,24978538,-1.4483375486726318,0.6273547794147847
IA-LM,969516,4.593397144463051,2.7772567284956553
LS411N,16741245,4.421981695824733,3.801678648950925
SaOS-2,241158,3.6917409878316136,3.598987869990464
HCC1500,49846579,-4.075833194843517,0.5554913629931677
LS411N,11626560,1.8283516183370416,1.6795489442409048
NCI-H1568,2746,2.7741418395417163,2.8579929499469348
PaTu 8988t,375860,0.0559535091713014,-0.30112130782396007
BICR 22,613753,3.418897622092284,3.1495845971526135
ALL-SIL,52912189,0.8155728349845486,1.6723266261402217
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.6829735349466532
BICR 22,3634881,3.8771660288779457,3.1576774496130544
RKO,3543504,4.836700902585943,4.269325105068445
Granta-519,6918837,-5.331886820340028,-3.046222711611649
SW48,56963564,-0.9893979738252238,0.2569389627451253
Daudi,4259181,-0.0890599021012781,0.11236669175956715
Granta-519,7326481,2.8185757173328927,2.957630994714242
SK-OV-3,4096211,3.632564776557465,1.856021664538426
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,2.3090854497210964
SK-OV-3,24856436,1.946601057004947,0.17994774592918095
Daudi,613753,2.7401651571031618,3.1495845971526135
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-0.8865368208635396
BFTC-909,452548,0.7682850038212578,-0.31026393275322106
P31/FUJ,409805,3.653161003579303,4.6745070702664995
IGROV-1,11404337,-0.7659238947812715,-0.4254091153988029
SU-DHL-1,24753719,3.670729792524347,4.143618673527016
BICR 22,24901704,3.9299918475898408,3.1103746959488285
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,3.732908427020576
NCI-H1568,135411,0.4069452326541798,0.5181226666256136
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-1.6778195760397165
K-562,126941,-4.461586339574126,-2.8921209077069348
Panc 02.03,2113511,6.868929428825361,5.381335299817078
NCI-H2452,44241473,5.273016525632626,4.8543955662784395
RERF-LC-MS,135984461,4.284403636339015,3.6237408287871284
KU-19-19,5329102,2.6076401407195355,2.031058842574058
SaOS-2,49867930,4.412008076102657,4.9782389619557925
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,1.9546333131599372
IGROV-1,54618771,1.2456991772210466,0.9253379925205388
BICR 22,7251185,3.2802016727508105,2.4347287977616
WM115,11178236,-3.130587173648645,-3.539769866873396
BICR 31,168312962,4.404506435623785,1.48933366232238
BICR 31,135421197,2.236076370585341,1.8199795612290348
K-562,72734382,4.39493075447737,4.3578051352274185
Daudi,4521392,3.754955104648716,4.280943620409205
NCI-H1568,9903786,2.4011050725962115,2.756077717004494
Panc 02.03,1242560,3.876690059869664,3.534393132486151
SaOS-2,24771867,1.911103494547597,1.5171458615349627
NCI-H1568,46224516,1.8217130718981496,2.370954746557396
HuP-T3,637858,1.096014734488476,1.8880097009592578
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.1325795715302809
HCC15,9825149,1.99442718669858,2.074054954263997
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,4.0494196828548
LS180,9967941,3.3265068520356227,3.6034131982542865
BICR 22,15953870,4.283514914534557,3.4781017448929608
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.1784388364790748
P31/FUJ,49766530,-2.577046245506879,-0.6944377068647134
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,2.6829735349466532
IGROV-1,5470400,-0.2457809435208252,-0.3765538821264742
K-562,3025944,3.938999685525622,4.206240213808089
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,3.5628845676855256
Panc 02.03,1641662,3.717230762709902,3.3408828038827
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.2359123501503817
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.37491183386883553
SK-CO-1,613753,3.569116813952151,3.1495845971526135
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.57821899028641
LS411N,73707398,1.3643081745247092,1.180307991266282
RKN,60700,0.8209474049972991,-0.4482559328189002
P31/FUJ,52912189,-0.0654684439378525,1.6723266261402217
Granta-519,49793307,-5.0235824363471675,-2.848251171596848
LS180,439501,-1.9142457865624176,-2.2321662354381537
BICR 22,19582717,3.5857042125142247,3.9198146524152833
P31/FUJ,11612883,1.4537759753270971,2.6386482274158856
RCC10RGB,135423438,4.4299924289236055,2.1190856698194294
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.7691529831259722
IGROV-1,24797083,1.5319862293819655,1.277886491385028
WM115,11657048,4.298694485616108,4.509467699195642
SaOS-2,5328940,1.8581375817896455,1.559061663996469
K-562,11427553,0.716330793964625,2.578035472123966
BFTC-909,60700,0.4554202898414442,-0.4482559328189002
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.2827362159867324
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,0.9267255578557378
HEL,656346,0.4971755704716853,0.7582608913284792
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,2.4620443610818112
SK-HEP-1,25126798,3.9918710327668503,3.7921789378214816
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.38762532684053896
HCC1500,568763,-0.919346546730658,0.28862358029973745
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,2.699201704606489
NCI-H2452,71466578,5.120149615089657,3.983075654179168
COR-L105,2871966,0.4959639880090196,0.29730316799892464
SW948,5746,1.511438037719251,0.8084551861824514
WM115,10172275,3.759074377781229,4.171969419171941
PaTu 8988t,11964036,2.992263460840089,1.2382789669868983
SW948,16219061,3.499504842183279,3.135611362850641
LCLC-97TM1,53495165,-0.6427926162361222,-0.19108456656304296
UACC-812,3081361,1.9829916627298712,2.3568884936851697
SaOS-2,5287969,-1.655987163162804,-1.9772070858850965
IGROV-1,25183872,-0.4560099928976716,-0.902802947451298
IGROV-1,44607530,1.2936443589937894,1.715838652040812
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,4.860017480413567
SK-HEP-1,57519531,4.12625544642691,2.4211376500246136
BICR 22,119182,-2.736639797021525,-1.3340160156368264
PaTu 8902,4521392,4.129468839379376,4.280943620409205
LCLC-97TM1,60700,-0.7670870439402468,-0.4482559328189002
ALL-SIL,44607531,0.7892287314343482,1.48117322485652
SW48,16720766,-1.213948450866439,0.4291253754884592
LCLC-97TM1,9911463,3.937478558519083,3.732908427020576
SW1271,6918289,2.985913038733717,1.9146814118519513
SK-HEP-1,25183872,-0.6604608842788147,-0.902802947451298
P31/FUJ,5311281,0.8046363155731003,2.22503529708604
MOLM-13,107970,2.204740997332017,2.3029314718240044
PaTu 8902,44607531,2.4953979740561136,1.48117322485652
BFTC-909,5978,-2.385180460490498,-2.3753204421143224
IGROV-1,9926054,1.8111808945519428,1.9546333131599372
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,1.3153680794849765
SaOS-2,44632017,0.980304929421305,1.0838611345650022
WM115,23582824,-1.5173797182891284,0.7400136078733197
RKO,5746,2.147448518007633,0.8084551861824514
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-3.5071094923394703
COR-L95,11234052,4.796206825131301,3.869960809483736
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-1.57821899028641
MOLM-13,46199207,1.8343479247638497,3.1312366616263048
SK-CO-1,216345,2.2578794962248403,3.7540083674013296
LS180,24951314,1.284825385865239,1.227614980483031
SW1573,71680916,4.0865163925225385,4.641848024405652
LS180,11427553,3.214146965067504,2.578035472123966
HuP-T3,17755052,3.4304742988115366,1.7101929835526413
IGROV-1,44607530,1.2936443589937894,1.715838652040812
HCC1500,11964036,2.769497384705972,1.2382789669868983
LS180,446155,1.950458971830876,2.662752180605146
SK-OV-3,10385095,3.0219456492917485,1.2480392352773622
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.0058447943574325
LS180,23635314,-2.728761007932067,-1.8612337831613235
ALL-SIL,25262965,-0.0785584741633136,-1.6224193967571534
MOLM-13,9956119,3.465056755214706,3.4762974507018756
Panc 02.03,54619267,4.6873070757127335,3.9342007971372475
MDST8,45100481,5.670163105184411,4.430120472879877
P31/FUJ,11427553,0.2126015278922564,2.578035472123966
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.4539899714896953
SW1271,123631,1.9601206845091983,2.2760265557358337
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.3050405288071003
SW1573,11626560,2.096503053081923,1.6795489442409048
COR-L105,11717001,4.401406695561914,3.961276339234443
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.710700657959646
IGROV-1,135984461,4.285945029851472,3.6237408287871284
HuP-T3,16725315,3.145396972494799,4.150060666188836
SK-OV-3,5278396,4.0115131897954175,3.517590475337377
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.134688957161641
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.7691529831259722
HCC1500,7326481,2.1911838281348897,2.957630994714242
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,-0.28710840066117727
RKO,11485656,2.16906736756012,2.2397291078765758
HCC1500,17755052,3.708779056995352,1.7101929835526413
RKN,16720766,0.5941206863048918,0.4291253754884592
SK-OV-3,49766530,0.1985460846164677,-0.6944377068647134
NCI-H1568,11178236,-4.756412327662482,-3.539769866873396
K-562,613000,2.5009117496842292,2.227141832343803
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-1.261852028375895
Daudi,49867930,3.141108082189553,4.9782389619557925
P31/FUJ,451668,0.4769801026955246,-0.17843514405649885
SU-DHL-6,2708,3.434249932793118,4.591243765137335
RKN,11497983,4.544575984994342,2.348631818792911
IGROV-1,23582824,0.3287266354391525,0.7400136078733197
HCC15,2858523,2.7763462118547833,3.0086502241129605
RERF-LC-MS,3025986,-0.71270364092759,-0.8978770871810051
LS180,984333,1.4840791700280882,0.5138000229415411
COR-L95,24901704,3.9540534266274183,3.1103746959488285
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.2359123501503817
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.7691529831259722
COR-L95,409805,3.71634228772174,4.6745070702664995
PaTu 8902,9823820,4.420414335239228,3.7294514785702977
Granta-519,24821094,2.4908648032560183,2.7369152351179045
SU-DHL-1,26596,-2.3613305357908625,-1.5346517263124715
RKN,285033,-0.0275118271199953,-2.1791335812392365
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.38762532684053896
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.5350305453431912
NCI-H2452,9936388,2.1806204942966803,-1.7988236137529168
LS411N,54618771,1.0517408544895162,0.9253379925205388
RKN,72193861,2.3331130274465313,1.3858780169906042
MDST8,46843906,2.4704071908178844,2.723521570705241
HCC15,11485656,2.480533785053976,2.2397291078765758
MDST8,11977753,-2.9914432786855305,-1.7159558966047241
PaTu 8902,168313047,2.1566405666580963,2.4053217165791536
MOLP-8,135928012,3.056644501758044,3.8701906312906376
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.0522756909743434
MOLP-8,10074640,3.1436066614625173,3.066922642013836
HCC15,12001922,1.9087360775911748,1.8522788760744173
LCLC-97TM1,3025986,-2.553955076787079,-0.8978770871810051
BFTC-909,2842253,5.585220688564769,5.203082223374658
RKO,216239,1.9979551619375524,2.1474208097396077
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,3.598987869990464
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,1.710700657959646
Granta-519,135398516,2.1425852334349575,2.0509021680173207
KU-19-19,10385095,1.1563887024661463,1.2480392352773622
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-1.57821899028641
SU-DHL-1,9803433,4.734138876460479,4.847536831977339
HCC15,135999136,4.472611779685761,3.6300382464802663
SW48,11238147,3.1100916590750045,2.694366237977623
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.37491183386883553
BICR 22,409805,3.8456212820768214,4.6745070702664995
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,1.2834565267098785
P31/FUJ,24785538,-0.2737810661065927,1.3344504348570345
Panc 02.03,176870,4.923826321280428,3.0253996189023358
RCC10RGB,322968,3.1449149812629877,3.4956311613712456
HCC15,107970,2.678547076190946,2.3029314718240044
SW1271,71304818,2.7682192858067385,2.396178486082573
LS180,3634881,3.5372782333734696,3.1576774496130544
COR-L105,11214940,1.6414587299435788,1.8119431265240042
SW1271,5287620,-1.7165830209074355,-1.9697846958841214
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,1.4554460238042177
COR-L95,49766530,-0.268325836176492,-0.6944377068647134
P31/FUJ,6450551,0.3392586382091512,2.361538429265863
PaTu 8902,5566,3.0665407385312182,3.029152149495273
SW1271,6610216,4.395476769861187,4.26979744561799
IA-LM,4477,0.1872236957364025,0.5570685949048098
BICR 31,6917907,-2.0849244140580683,-4.864372369867458
Daudi,56949517,3.615784656128556,4.259203439290573
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.7724503678159762
Granta-519,156414,1.3767921664113123,1.1062813598863759
SW1573,60700,0.5293530759970745,-0.4482559328189002
PaTu 8902,11404337,0.5155229173062875,-0.4254091153988029
BICR 22,52947716,-3.710960782083666,-1.4012147836358484
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.2663000347984639
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.0509021680173207
SW48,216239,2.7420558854204105,2.1474208097396077
HCC15,136227924,3.0147456858017923,2.867001064974719
MDST8,400769,0.2052239388954162,-0.7855881743093749
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.4539899714896953
RCC10RGB,4917,3.4531775579708044,3.079848880785536
RERF-LC-MS,73707398,2.0319367406190483,1.180307991266282
LS180,4917,2.9590600733191272,3.079848880785536
Granta-519,46926350,-4.5411361861126,-4.429063309555999
BICR 22,1716436,3.778329286476686,2.948755251800144
LCLC-97TM1,55283,2.725406070596606,2.1635123760949786
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,2.102163121425029
RKN,168312962,-2.199105388969794,1.48933366232238
MOLM-13,54619267,3.3881439662249657,3.9342007971372475
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,0.38762532684053896
COR-L95,1239801,5.40725658561935,3.981036641317754
IGROV-1,10184653,0.79276129336756,1.1325795715302809
HCC1500,16741245,3.4170657459529865,3.801678648950925
LS411N,44491742,5.693616041532359,4.1566745174283435
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.5628845676855256
Granta-519,24753719,3.151565571990212,4.143618673527016
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,1.1345509900924162
RKO,107985,-4.24085601271806,-3.5771139994401464
HEL,322968,3.0393820993226535,3.4956311613712456
Granta-519,46224516,0.9242838162777752,2.370954746557396
LCLC-97TM1,9823820,4.2474508710721315,3.7294514785702977
MOLP-8,23582824,0.4015956903029024,0.7400136078733197
NCI-H2452,60750,1.245026450810127,-2.435153852929516
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.7691529831259722
COR-L95,54596558,4.049100773357865,4.397101469450013
SW948,135398738,3.916695667859345,3.3919135064420334
SK-CO-1,9936388,-6.4137542305703015,-1.7988236137529168
Daudi,60700,-3.752408099295295,-0.4482559328189002
COR-L105,11612883,3.356288934915157,2.6386482274158856
PaTu 8988t,10302451,4.044762571435361,3.0143591766147457
SK-CO-1,44507138,1.8454813707467936,2.3228542035372683
COR-L95,44486219,4.398500193784116,4.281343219898981
LS180,1242560,3.670855291471482,3.534393132486151
PaTu 8988t,25102847,3.84691315859083,2.3366995460793083
SU-DHL-1,1750826,-3.9186889861650713,-1.4739669220989267
IGROV-1,4261,1.934016649932683,1.4288257082744877
IGROV-1,9903786,1.7387584479757865,2.756077717004494
IGROV-1,9935249,3.330117761231163,2.8615383619674972
COR-L95,446155,4.383849487789403,2.662752180605146
COR-L95,9967941,2.195306027237361,3.6034131982542865
BICR 31,49793307,-0.900639036765476,-2.848251171596848
Daudi,52912189,-0.5619081020202099,1.6723266261402217
MOLP-8,9911463,4.2009596294807245,3.732908427020576
LS180,44589607,3.154958497437342,2.659070263037081
Daudi,24821094,0.7293316215174883,2.7369152351179045
RKN,12003241,-0.3350096455718494,-1.0889198012759371
LS411N,148198,-2.2204558676981576,-3.548509713878981
RERF-LC-MS,446155,1.000000375050646,2.662752180605146
MOLM-13,10127622,2.24693559354045,3.6054187258933235
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,2.0335760501929605
P31/FUJ,72734382,3.508076038929844,4.3578051352274185
SU-DHL-1,568763,-0.4525318049600722,0.28862358029973745
SaOS-2,11977753,-0.3684170228919589,-1.7159558966047241
SaOS-2,969516,2.4754458532868067,2.7772567284956553
SU-DHL-1,54619238,4.649416356939895,5.004034610534093
SK-OV-3,6623618,3.404966669354166,2.1468722777789853
WM115,9952709,2.366340614566085,2.9381980631482683
Panc 02.03,10184653,2.526680989613479,1.1325795715302809
SW1271,3634881,2.897813479014186,3.1576774496130544
P31/FUJ,72376,-3.3088434861533704,-2.110114148114304
P31/FUJ,46907787,-0.8407426122417735,1.584957029505121
IA-LM,5351362,3.020488284300014,1.4604743967139864
NCI-H2452,676352,2.443862996701222,2.088896150621564
SU-DHL-1,56973724,1.0008411647005613,2.823032655731692
PaTu 8902,1716436,3.3992265902353425,2.948755251800144
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.066922642013836
MOLM-13,11717001,3.6418982852877457,3.961276339234443
MOLP-8,613753,2.6774354597179,3.1495845971526135
IGROV-1,44137675,1.8406125640672395,3.337336921695599
P31/FUJ,6914657,-6.361388893160888,-4.170094408243688
LS180,60750,-4.478139976515186,-2.435153852929516
SW1271,3062316,-1.9256219632112692,0.9747482048219924
RCC10RGB,219104,3.453227771477981,3.5366182443481806
HuP-T3,6917907,-1.7519392074642692,-4.864372369867458
SU-DHL-1,11656518,1.4392799669460994,1.5480979328089313
MDST8,54626689,6.955475194588027,4.561309020020982
SW48,10410894,3.4061289364485794,3.2189174762180457
HEL,72193861,0.4910118925931417,1.3858780169906042
Panc 02.03,65064,5.367712415574159,4.739517756868576
BFTC-909,984333,1.0937084793466407,0.5138000229415411
IGROV-1,426756,6.142776526139055,4.301139445753315
RKN,11152667,0.0617927102225113,-0.5866736007906306
BICR 22,3025944,4.210034761741456,4.206240213808089
SU-DHL-1,11640390,4.597120644825806,3.2466540190485103
RKO,44589607,3.597229089573096,2.659070263037081
IGROV-1,56963564,1.8260986108097368,0.2569389627451253
Daudi,24180719,3.437659555986817,3.437709308952337
BICR 31,45279963,4.353781648061694,3.660133434789582
KU-19-19,445455,4.442962740031222,4.540053644561405
Panc 02.03,5281672,4.500820026656837,4.4250678360691875
Granta-519,675434,3.9057117034292976,4.463597576567934
WM115,46398810,3.009678027858605,2.510712955745063
BICR 31,119607,5.814089022953436,5.129253777214588
IGROV-1,23635314,-0.611739968448912,-1.8612337831613235
HEL,44819697,-3.010940469478465,-0.6109288989041974
ALL-SIL,5282054,2.788902246408387,3.5628845676855256
WM115,5328940,2.031963430852867,1.559061663996469
BICR 22,11455910,2.0554057071158303,0.9557745122323711
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.0058447943574325
P31/FUJ,4259181,-1.476581151251805,0.11236669175956715
MOLP-8,54619267,3.766514987830834,3.9342007971372475
P31/FUJ,44489367,5.126164790260484,4.726130190399563
RKN,11625818,5.974552631000589,4.10791451089978
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.11065310288154762
BICR 31,5470400,2.045329114611378,-0.3765538821264742
LCLC-97TM1,5738263,3.894572665100205,3.3050405288071003
SW48,2729026,2.3283979545053155,2.6325975116350393
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.2760265557358337
COR-L105,11167602,4.878993593502554,2.4705816300476062
HCC15,9549297,1.5760835884765407,2.3089350530287187
HuP-T3,448949,2.1685596620814565,1.9537365892294993
Granta-519,9915743,0.9460784198503543,0.5935480801734145
MOLP-8,51039095,1.4019996450160122,2.682611194240459
COR-L105,56649450,3.0558986692826595,2.999158341046921
WM115,16038120,1.6321211746217177,0.9090093368534204
K-562,31703,-1.219746708928784,-1.182053713238432
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.0058447943574325
SU-DHL-1,11609586,1.5538406664396571,2.621607380466062
BICR 31,3025944,4.108701914406302,4.206240213808089
SW48,66577038,3.1598846844687545,2.9870697487432882
Daudi,24180125,1.1000611971852634,2.888353933707551
SK-CO-1,6184667,4.676967004326267,2.901063659317265
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-1.6778195760397165
SU-DHL-1,67291369,2.039504043535649,1.794812676489941
IGROV-1,3815108,1.915722485757852,2.885036533777781
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,4.591243765137335
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.2834565267098785
LCLC-97TM1,68056272,3.7652459105524585,3.2394422692786446
NCI-H1568,9926054,1.8156743035592564,1.9546333131599372
SU-DHL-1,2113511,3.6581551041454823,5.381335299817078
HCC15,3503,1.8764785687467953,2.2426858883255045
SaOS-2,3062316,2.2990980703822115,0.9747482048219924
K-562,16736978,2.075477087199636,1.3934160091023764
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.474523360549852
RKN,135440466,3.1815161125023033,2.1401473911994366
SK-CO-1,89928392,1.2451759556756246,1.344325138639762
NCI-H1568,54596558,4.146513733670967,4.397101469450013
LCLC-97TM1,4477,1.1810793422928998,0.5570685949048098
LS180,16741245,4.152630132762677,3.801678648950925
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.1345509900924162
BFTC-909,159324,4.114702101808939,2.0742938672876736
PaTu 8988t,2113511,6.37119394515457,5.381335299817078
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.11065310288154762
IGROV-1,5291,3.6852809555447985,3.5530526201153183
PaTu 8902,16038120,1.215016097060631,0.9090093368534204
ALL-SIL,10302451,-1.1728976190372558,3.0143591766147457
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.144908880465776
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.0163468544412688
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-3.5071094923394703
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,1.0163468544412688
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.4347287977616
SW948,7326481,3.486606738365962,2.957630994714242
HCC15,44507138,1.6295786006094204,2.3228542035372683
RERF-LC-MS,16725315,4.583339442818838,4.150060666188836
P31/FUJ,148198,-3.664233852608881,-3.548509713878981
HEL,49850262,3.2265871136708997,3.414452598711333
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.7921789378214816
BFTC-909,60750,-1.7298046099952136,-2.435153852929516
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-1.261852028375895
NCI-H1568,675434,4.067969537829177,4.463597576567934
COR-L95,19582717,3.635233206850296,3.9198146524152833
COR-L95,148198,-4.800055382400855,-3.548509713878981
BICR 22,44819697,0.2156040754176,-0.6109288989041974
SK-OV-3,46224516,3.444215787907748,2.370954746557396
HCC15,5281672,5.6563329698974965,4.4250678360691875
HEL,6918328,-0.4966077251990671,-0.28710840066117727
NCI-H1568,24785538,0.5698046292147018,1.3344504348570345
RKN,23582824,1.7370647325872666,0.7400136078733197
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-1.57821899028641
SU-DHL-1,322968,2.585334286015635,3.4956311613712456
BICR 31,24797083,1.8361324304615187,1.277886491385028
SK-HEP-1,3062316,3.432714145613195,0.9747482048219924
PaTu 8902,2729026,2.7803221257085884,2.6325975116350393
SK-OV-3,11609586,4.251063762376387,2.621607380466062
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.206240213808089
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.1062813598863759
Granta-519,44607530,1.7224857333943702,1.715838652040812
NCI-H1568,15953870,3.42403550557497,3.4781017448929608
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.3848601780620533
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.6829735349466532
MOLP-8,252682,6.161004481234046,6.516263069090082
SW1573,126941,-1.0305779796426808,-2.8921209077069348
BICR 31,9927531,5.661036072082279,4.578027762171671
RCC10RGB,441298,3.7731685554529384,2.5423368047098167
MOLM-13,387447,-5.119095777855545,-4.3765957253648695
Granta-519,216345,1.0997896286755158,3.7540083674013296
LCLC-97TM1,107985,-4.222636663811031,-3.5771139994401464
LS180,3384730,2.894746509752001,2.4620443610818112
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-1.7988236137529168
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,2.8579929499469348
KU-19-19,44493528,4.383684457454455,4.333966846288542
LS411N,53232,4.5193815700089655,2.8161144578264046
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,1.584957029505121
LS411N,6438330,3.3380693145982816,2.016737971321332
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,1.1658534217096055
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,1.710700657959646
BFTC-909,16725315,4.495652912061774,4.150060666188836
RKN,124202324,3.704376342602573,2.1784388364790748
LCLC-97TM1,10127622,3.458194652659875,3.6054187258933235
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.9860814461500107
SaOS-2,5494449,1.7356769079300427,2.624769648445017
HEL,702558,3.166026376934585,4.9782351440396395
KU-19-19,11612883,2.975593545287462,2.6386482274158856
BICR 31,6914657,-2.1990076047646703,-4.170094408243688
PaTu 8988t,2858523,3.414247843041017,3.0086502241129605
SW48,9911830,1.5953282800372102,2.4240324657892436
Daudi,11178236,-7.583909031047052,-3.539769866873396
Granta-519,44819697,-1.094231558387569,-0.6109288989041974
MDST8,2828334,6.077771510152207,6.082620037824382
RKN,9911463,4.114615883902867,3.732908427020576
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,0.7705130043498147
SaOS-2,9903786,2.3206358959344264,2.756077717004494
RKO,44607530,2.6096687798301677,1.715838652040812
SK-CO-1,11455910,1.152685438196598,0.9557745122323711
SK-OV-3,25183872,-0.070614613180641,-0.902802947451298
WM115,25227462,1.5125525407178182,-0.4151865926866767
HCC15,2126,5.047391044285817,4.466606494133751
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,3.7294514785702977
HuP-T3,11238147,3.6375005285241033,2.694366237977623
SU-DHL-1,168313047,2.0629090722275945,2.4053217165791536
BICR 22,5335621,5.24838502551373,4.560420742529089
SK-OV-3,135398516,2.140261030425796,2.0509021680173207
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,2.69961445504738
RKO,11214940,1.6564081526645635,1.8119431265240042
SW948,9935249,-1.8483271913214137,2.8615383619674972
NCI-H1568,2871966,-1.5477941874243064,0.29730316799892464
WM115,54626689,3.4845925362433,4.561309020020982
IGROV-1,46398810,2.003787621940583,2.510712955745063
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.11065310288154762
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,2.93841691857644
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.0665232817889554
BFTC-909,3025944,6.464154930724253,4.206240213808089
BFTC-909,10113978,3.8739618499623094,3.010980031724017
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-3.5071094923394703
BFTC-909,24748573,2.672786285704278,1.9565115912575295
MDST8,23582824,0.3553467044538872,0.7400136078733197
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,0.9218131221296273
SW948,53392493,1.921137473015096,2.4832542501558077
LCLC-97TM1,5287620,-2.537847801025228,-1.9697846958841214
HCC1500,3552672,1.623977684405255,2.8413574589562494
SW1271,2113511,4.856200971437617,5.381335299817078
RKO,11238147,3.3996395604326977,2.694366237977623
MDST8,56963564,1.9609696235744132,0.2569389627451253
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,0.7705130043498147
MDST8,73707398,0.930898424190815,1.180307991266282
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.2834565267098785
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,2.0058447943574325
HCC1500,107970,1.6380228058856745,2.3029314718240044
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,2.6275548088442098
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.560420742529089
MDST8,11222830,1.739834123793711,1.5350294688251391
MOLM-13,11364421,-4.614262921489179,-2.2476185097624475
MDST8,89928392,1.3331112546959425,1.344325138639762
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-1.261852028375895
RERF-LC-MS,148124,-5.592640359076286,-2.0460232384010055
PaTu 8988t,219104,4.30352428274638,3.5366182443481806
SaOS-2,16659841,3.6368059645085737,3.7845234388741966
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.117207225291035
ALL-SIL,25183872,-1.1896517316661384,-0.902802947451298
HuP-T3,3503,2.6961085729175465,2.2426858883255045
SaOS-2,148124,-5.379251304292956,-2.0460232384010055
SW48,25102847,1.5289459974072863,2.3366995460793083
PaTu 8902,6852167,4.282216220168943,2.69961445504738
ALL-SIL,11396600,2.960335319566646,3.4309758536883517
LS411N,54649381,4.0879656113234315,3.7880999548273127
LCLC-97TM1,56649450,1.9268896253969057,2.999158341046921
Panc 02.03,42642645,1.4849485241267697,0.7845058245277501
PaTu 8902,5328940,2.100447742300893,1.559061663996469
Daudi,10127622,5.05479511248997,3.6054187258933235
SaOS-2,15983966,-4.612114381732812,-1.6396194068861514
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.474523360549852
MOLP-8,11214940,2.188017762346292,1.8119431265240042
SW48,44607531,-0.0703962424187993,1.48117322485652
IA-LM,637858,2.795809218533269,1.8880097009592578
LS180,119182,-2.2864715680735603,-1.3340160156368264
SK-CO-1,135411,-1.9906675184189948,0.5181226666256136
SW1271,15983966,-1.9627382742922743,-1.6396194068861514
LCLC-97TM1,11485656,2.4293249862604913,2.2397291078765758
Daudi,135984461,3.9990978127252728,3.6237408287871284
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,0.9557745122323711
SW1271,24180719,4.447587763279296,3.437709308952337
RERF-LC-MS,4917,3.617944790726347,3.079848880785536
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.534393132486151
COR-L105,44185566,3.03526972595121,2.4057100644299436
MOLP-8,8515,3.727464051425151,3.7716438213452004
Daudi,11656518,1.0836561052202376,1.5480979328089313
MDST8,10302451,4.267643132743765,3.0143591766147457
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,2.144908880465776
MOLP-8,135398738,4.11621412508813,3.3919135064420334
RCC10RGB,568763,0.4218853975706897,0.28862358029973745
SW1271,285033,0.340737243750418,-2.1791335812392365
Granta-519,67156097,-3.3327998752636483,-1.0279170724737183
WM115,11964036,0.4423113132234746,1.2382789669868983
SK-CO-1,156414,0.1991331726980137,1.1062813598863759
BICR 22,568763,1.1340411223212885,0.28862358029973745
P31/FUJ,176870,1.9707243184949097,3.0253996189023358
SW1271,24748573,2.5868513601661336,1.9565115912575295
MOLP-8,72199292,1.2541603744267094,1.1233129488647187
RKO,5282054,3.8735499096789856,3.5628845676855256
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,2.474523360549852
HCC1500,16722836,2.402902940836366,1.5333952667080324
Panc 02.03,46199207,3.8452319744534886,3.1312366616263048
PaTu 8988t,71304818,2.8353343090304257,2.396178486082573
IGROV-1,241158,3.288496474515495,3.598987869990464
Daudi,71751553,3.830487233171358,4.504570481353087
COR-L95,46174525,3.763282126483136,4.156087356848057
NCI-H2452,2126,4.762499509878762,4.466606494133751
HCC15,11228183,0.6025691709173914,1.8712017695678478
HCC1500,11404337,-1.1638452247583002,-0.4254091153988029
PaTu 8988t,16725315,5.4103858057829095,4.150060666188836
MDST8,4378219,1.9480435949418269,2.6822409618839944
IGROV-1,5351362,1.961059142684053,1.4604743967139864
HuP-T3,44489675,3.6946366435409352,3.8856289571074525
SW1271,4259181,0.7411137136724786,0.11236669175956715
RKO,5978,-3.7617282032773582,-2.3753204421143224
MOLM-13,11485656,-3.968420003132376,2.2397291078765758
K-562,24821094,1.908113699718487,2.7369152351179045
SW1573,89183176,3.862510153781557,3.4938336610308007
K-562,24180719,3.2747438118023533,3.437709308952337
LS411N,4788,5.997281207159956,5.493389053048461
IGROV-1,66577038,3.2148239132520455,2.9870697487432882
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,3.456683733824014
Daudi,9549297,1.403366421117492,2.3089350530287187
UACC-812,11427553,3.574449796486334,2.578035472123966
MOLM-13,52912189,-1.0667663091505395,1.6723266261402217
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.2359123501503817
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.6829735349466532
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.2359123501503817
IGROV-1,24821094,1.720998716331183,2.7369152351179045
Granta-519,11427553,-0.9723301484726812,2.578035472123966
MOLM-13,208908,2.7636340376000317,1.8663560178908947
IGROV-1,9915743,-0.4757488934941289,0.5935480801734145
Panc 02.03,241158,4.402915180139186,3.598987869990464
IGROV-1,24748573,-1.0654275876710166,1.9565115912575295
COR-L105,5287969,-1.8496230723467,-1.9772070858850965
MOLP-8,10296883,2.725727750190508,3.795028277273254
SW948,241158,4.5321951743877005,3.598987869990464
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.1474208097396077
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,1.4554460238042177
SU-DHL-6,10302451,3.370117636140473,3.0143591766147457
IGROV-1,9936388,2.10108466287406,-1.7988236137529168
HCC15,72376,-1.512462057486854,-2.110114148114304
COR-L95,6450551,2.8920154707175776,2.361538429265863
NCI-H1568,5738263,3.2402226460817323,3.3050405288071003
RKO,54619267,4.028311361432676,3.9342007971372475
RERF-LC-MS,4261,2.068565192175152,1.4288257082744877
K-562,73707371,5.645446798773975,5.18278851064184
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,2.3791567205504176
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,0.5350305453431912
WM115,122327,3.780637240577924,4.7007618437932
WM115,25150857,2.4679229997528394,2.336756962918186
SK-CO-1,11178236,-3.2010052407962215,-3.539769866873396
RKN,753704,4.966407297087677,4.832125608051433
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.0665232817889554
SW1271,227681,3.2917347097405725,2.9941233013598234
MDST8,568763,0.1407924711645573,0.28862358029973745
BICR 31,5566,3.2898773587253096,3.029152149495273
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,3.472185389430271
RERF-LC-MS,6450551,1.967154760545028,2.361538429265863
IGROV-1,2874250,4.893662837169153,4.0377213891771015
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.5350305453431912
HCC15,56946209,-3.385198311974778,-4.2202975286026225
BFTC-909,136227924,2.3418993883842134,2.867001064974719
Granta-519,1750826,-3.7858867937492984,-1.4739669220989267
P31/FUJ,11625818,3.2136174191857174,4.10791451089978
COR-L105,10322450,4.112392966182136,3.669858075898477
HCC1500,5566,2.905130044911903,3.029152149495273
SW48,51039095,1.7096770563148074,2.682611194240459
SW1271,8515,5.208985199998064,3.7716438213452004
KU-19-19,73707398,1.7453733414385195,1.180307991266282
K-562,11707110,1.6681367726124623,-0.02846554242907695
COR-L95,16065773,1.8842547212847705,2.3641186374244216
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.5071094923394703
IA-LM,11178236,-6.720771550362321,-3.539769866873396
MOLP-8,54596490,4.413151323823571,4.945697156281648
ALL-SIL,44202524,-0.4119558263455749,1.9639001504219202
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,3.456683733824014
MDST8,6918328,-0.3527629143091293,-0.28710840066117727
BICR 31,104842,-0.0442586507462943,-3.040993872013826
BICR 31,6852167,2.001013365002547,2.69961445504738
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,1.0163468544412688
IA-LM,24821094,3.0699000024292293,2.7369152351179045
IGROV-1,73707398,0.8848064516600974,1.180307991266282
SaOS-2,46191454,1.8159544721998524,1.3518500781597358
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.2834565267098785
LS411N,25150857,2.959758413524705,2.336756962918186
HuP-T3,11175137,3.603877049706456,2.477950770888125
LS411N,135984461,5.061110843141604,3.6237408287871284
IGROV-1,4261,1.934016649932683,1.4288257082744877
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.102163121425029
HCC1500,9952709,2.298703589628035,2.9381980631482683
SK-OV-3,176870,3.5610869734905255,3.0253996189023358
PaTu 8902,9952709,4.3707417693645745,2.9381980631482683
P31/FUJ,56973724,0.796880831995934,2.823032655731692
RKO,2729026,2.3662843020346753,2.6325975116350393
RKO,387447,-4.452540898932811,-4.3765957253648695
SK-CO-1,135398738,3.5773200936681584,3.3919135064420334
BFTC-909,3552672,4.498195948808332,2.8413574589562494
Panc 02.03,7251185,3.0530850004567767,2.4347287977616
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,0.38762532684053896
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.0058447943574325
Panc 02.03,53392493,3.617637281515077,2.4832542501558077
LCLC-97TM1,446155,3.780165105352184,2.662752180605146
BICR 31,23725625,6.004496967521932,4.726527081330662
RCC10RGB,11612883,4.41570881394896,2.6386482274158856
WM115,5280436,2.216411919293008,3.153394505533252
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,1.2359123501503817
NCI-H1568,10184653,1.3826991243685076,1.1325795715302809
LS180,10427712,4.740953715848998,4.184108330161863
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,1.710700657959646
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.2569389627451253
HuP-T3,12003241,-0.2833744856936582,-1.0889198012759371
Daudi,9884685,-1.7998414591903729,0.4230357541133405
SK-CO-1,44259,0.6005082969424771,0.9267255578557378
MDST8,10231331,0.2022855962524302,1.6547412916072393
SK-CO-1,4261,0.7789911540114764,1.4288257082744877
P31/FUJ,10074640,2.9862675466657764,3.066922642013836
SK-CO-1,12001922,1.782153173177779,1.8522788760744173
SaOS-2,16720766,-1.9505026731708328,0.4291253754884592
RCC10RGB,216239,3.3222265979679375,2.1474208097396077
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.8865368208635396
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,0.38762532684053896
COR-L105,72734382,5.425179503032161,4.3578051352274185
LS180,11640390,3.36619781023128,3.2466540190485103
K-562,25262965,-1.232298297425116,-1.6224193967571534
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.7691529831259722
LCLC-97TM1,135411,0.5874500365845237,0.5181226666256136
SU-DHL-1,46398810,1.696894130738712,2.510712955745063
P31/FUJ,6610216,4.336076332167018,4.26979744561799
BICR 22,5291,3.723640910280853,3.5530526201153183
HEL,44632017,1.0842639602191189,1.0838611345650022
Granta-519,4261,1.1412453306659267,1.4288257082744877
Granta-519,56963564,-0.5609340564012296,0.2569389627451253
MDST8,53392493,2.9375507482716334,2.4832542501558077
LS411N,44819697,-0.923326266781905,-0.6109288989041974
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,2.474523360549852
NCI-H1568,5291,3.770643134542437,3.5530526201153183
BFTC-909,11612883,3.5324782187628827,2.6386482274158856
RCC10RGB,11955716,4.4260489213830425,-1.4856643985320634
SW1271,11626560,1.376954486231794,1.6795489442409048
SW48,46943432,0.8743166493146273,1.70045196562753
HEL,3062316,2.2727573444408633,0.9747482048219924
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,1.710700657959646
RCC10RGB,5329102,2.357265375302505,2.031058842574058
ALL-SIL,9866186,-0.4181259896802407,0.7577083020821866
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,1.7724503678159762
HEL,23635314,-2.6594801266287154,-1.8612337831613235
Daudi,10074640,1.7373836938395748,3.066922642013836
RKO,26596,-1.341584325458414,-1.5346517263124715
WM115,11167602,1.5239005360441813,2.4705816300476062
IGROV-1,2746,2.8413672686351212,2.8579929499469348
Daudi,24978538,2.467871482925033,0.6273547794147847
RKO,2858523,3.1569923390566332,3.0086502241129605
LS411N,15983966,2.6804451752833978,-1.6396194068861514
SK-OV-3,452548,0.7579906967862455,-0.31026393275322106
MOLP-8,25262965,-4.805551534468427,-1.6224193967571534
LCLC-97TM1,46215462,1.4949685345148778,1.762132613731386
BICR 22,439501,-2.4052901035443,-2.2321662354381537
SW48,10184653,-2.0074491437034094,1.1325795715302809
P31/FUJ,168313016,4.690131242833582,4.725757076386842
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,2.699201704606489
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.2359123501503817
LS411N,54613361,3.867376577775082,-0.11678183903518824
COR-L105,24772860,-1.435746068442861,-2.2690769633318126
K-562,11222830,1.892206265748428,1.5350294688251391
Daudi,10385095,0.347773175212431,1.2480392352773622
HCC1500,44137675,4.199849963716895,3.337336921695599
SW1573,11404337,-1.3449252751203844,-0.4254091153988029
SK-HEP-1,46191454,1.8876467264614776,1.3518500781597358
P31/FUJ,135999136,4.068676884464422,3.6300382464802663
RCC10RGB,25150857,2.370598483016253,2.336756962918186
NCI-H2452,57330099,4.302779847582817,4.311542343968036
IGROV-1,10127622,3.2581804056600165,3.6054187258933235
COR-L105,5282054,3.9571885951378505,3.5628845676855256
LCLC-97TM1,53481919,3.8027519676947232,3.8547522793737237
NCI-H2452,3025986,-0.5496531660815697,-0.8978770871810051
WM115,11955716,-2.4505472507691013,-1.4856643985320634
BFTC-909,637858,2.264716830291231,1.8880097009592578
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.2359123501503817
Daudi,1641662,2.995591169153073,3.3408828038827
MOLP-8,446155,0.367312642153156,2.662752180605146
RERF-LC-MS,135999136,4.400683337930441,3.6300382464802663
WM115,5738263,3.851280366828244,3.3050405288071003
MOLM-13,65628,2.9573007313246924,4.026684176415168
HEL,9936388,-3.337900467930123,-1.7988236137529168
SW48,104842,-4.777281812432541,-3.040993872013826
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.5350305453431912
Granta-519,11626560,0.2073830225530282,1.6795489442409048
SK-CO-1,969516,2.7975557975376035,2.7772567284956553
SW948,11640390,3.051257470103826,3.2466540190485103
HCC15,10302451,3.767869991537956,3.0143591766147457
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.78247230086659
PaTu 8988t,46943432,6.478561461465468,1.70045196562753
K-562,208908,1.7214906675478436,1.8663560178908947
NCI-H1568,11612883,2.467781963295413,2.6386482274158856
LCLC-97TM1,9884685,-0.6945268748645868,0.4230357541133405
Granta-519,6918328,-2.2526378564537355,-0.28710840066117727
Granta-519,5470400,-3.2597420844446163,-0.3765538821264742
LS180,10231331,0.7625893939503741,1.6547412916072393
SW1271,46199207,3.134892747913181,3.1312366616263048
HEL,11404337,-0.835651629585067,-0.4254091153988029
Daudi,216345,1.872370108624604,3.7540083674013296
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,1.1345509900924162
RKN,54613361,0.2026815444056028,-0.11678183903518824
LS180,452548,0.7544699085550369,-0.31026393275322106
RKN,44493528,4.408823872302737,4.333966846288542
SK-HEP-1,11238147,2.1467729161342524,2.694366237977623
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-1.1532493383305307
COR-L95,11364421,1.7062947816433405,-2.2476185097624475
KU-19-19,452548,1.4010535434747853,-0.31026393275322106
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.13551970928241
IGROV-1,44819697,-0.8326420176056434,-0.6109288989041974
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.860017480413567
RERF-LC-MS,2729026,3.1361811776879644,2.6325975116350393
RKN,4788,5.902938799554125,5.493389053048461
K-562,216239,1.6121414929675577,2.1474208097396077
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.6325975116350393
IGROV-1,2746,2.8413672686351212,2.8579929499469348
IGROV-1,637858,1.814476597989254,1.8880097009592578
HuP-T3,11214940,1.8541641961456377,1.8119431265240042
IGROV-1,46907787,2.182756719431072,1.584957029505121
P31/FUJ,445643,6.117258311867223,3.9383569867901693
Granta-519,3854666,0.1662242620713641,1.85063491630251
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,2.144908880465776
LCLC-97TM1,135440466,1.105929023295497,2.1401473911994366
RERF-LC-MS,56649450,3.38813984116235,2.999158341046921
SK-CO-1,11612883,2.4661452350243493,2.6386482274158856
SK-HEP-1,44137675,4.549525792934436,3.337336921695599
HCC15,72193870,4.3690783386047025,2.884467083403444
HCC1500,2746,2.6069735713089006,2.8579929499469348
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,2.0335760501929605
Daudi,11222830,0.8543881776084605,1.5350294688251391
WM115,2749,6.3303951951253445,1.7932893499757152
K-562,9840324,5.675524269237515,5.7711165719697215
MDST8,10113978,3.624916965791189,3.010980031724017
NCI-H2452,44507138,2.753685109279225,2.3228542035372683
MOLM-13,5282054,3.1361279245897857,3.5628845676855256
BICR 31,9911830,2.2138272662609064,2.4240324657892436
HEL,6917907,-5.38656193144065,-4.864372369867458
IGROV-1,2858523,3.196384505087132,3.0086502241129605
MOLP-8,322968,-1.2094679469942695,3.4956311613712456
BICR 22,3503,2.960513829073252,2.2426858883255045
ALL-SIL,10113978,1.6173510565910796,3.010980031724017
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.4539899714896953
RERF-LC-MS,119182,-0.645974794966856,-1.3340160156368264
LS411N,4261,1.591263829932159,1.4288257082744877
SW948,4096211,1.12279899109382,1.856021664538426
K-562,11485656,1.7795111963017332,2.2397291078765758
MOLM-13,53232,2.182263698942312,2.8161144578264046
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.6109288989041974
IGROV-1,3689413,-0.3633634632064185,-0.4039154566871359
RCC10RGB,12001922,2.277970650057297,1.8522788760744173
RERF-LC-MS,246676,4.480243243269967,4.505551974581321
HCC15,374536,0.7951987879889547,1.7732341041149164
MOLP-8,11977753,-4.876868381891939,-1.7159558966047241
Panc 02.03,2874250,4.438896474206821,4.0377213891771015
COR-L95,613753,3.031049367391043,3.1495845971526135
SW1573,9840324,5.095993559480237,5.7711165719697215
SW48,24901704,1.780712261537264,3.1103746959488285
BICR 22,6918328,0.5113628660513942,-0.28710840066117727
Daudi,54613361,-0.5183638298018372,-0.11678183903518824
LCLC-97TM1,25102847,2.141917897082315,2.3366995460793083
HuP-T3,3081361,3.872954779649628,2.3568884936851697
LS180,969516,2.6818241036299275,2.7772567284956553
SW1271,2945648,2.4921907486938646,2.7548400693819435
BICR 31,25126798,3.691910729857057,3.7921789378214816
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.6778195760397165
Daudi,262093,0.7533038243356376,2.6275548088442098
RKN,20959075,-2.033811748726601,-3.173507428051674
KU-19-19,702558,5.449368171937104,4.9782351440396395
SaOS-2,2842253,6.143936300195383,5.203082223374658
RERF-LC-MS,26596,-1.2372341703529914,-1.5346517263124715
PaTu 8988t,5329102,3.3339986936080717,2.031058842574058
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.48117322485652
SaOS-2,73707398,0.8491853151273433,1.180307991266282
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,1.710700657959646
SaOS-2,984333,4.259432573695519,0.5138000229415411
LCLC-97TM1,53232,3.007779101776312,2.8161144578264046
KU-19-19,3503,3.0769201112014803,2.2426858883255045
WM115,57330099,5.984461482923693,4.311542343968036
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.596877521367719
LCLC-97TM1,44491742,4.237702230509644,4.1566745174283435
SK-CO-1,9915743,2.0474134916136184,0.5935480801734145
HCC15,73707398,1.6988346513711203,1.180307991266282
HCC15,4477,-0.3802251277588812,0.5570685949048098
BICR 22,26596,-1.8883514509946957,-1.5346517263124715
SaOS-2,445091,4.479630914494518,4.3274252089919045
HCC1500,3503,2.0705498046235817,2.2426858883255045
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.860017480413567
RCC10RGB,71304818,3.488257335656729,2.396178486082573
RKO,241158,4.5302703569847305,3.598987869990464
SW1271,168313016,5.582938604018868,4.725757076386842
SW948,10385095,1.3660359707166476,1.2480392352773622
RERF-LC-MS,3543504,3.1700226881436193,4.269325105068445
LS180,5311,1.1738972820475675,1.2663000347984639
RERF-LC-MS,5291,3.9873816513243785,3.5530526201153183
RCC10RGB,53481919,4.9196370953200805,3.8547522793737237
Daudi,44241473,5.233980827552566,4.8543955662784395
Panc 02.03,10127622,3.4148938287456776,3.6054187258933235
BICR 31,49836020,4.313223650735915,2.5464279658175073
Daudi,54618305,3.9105424608095847,4.084826955496459
SK-HEP-1,5746,3.319924463812582,0.8084551861824514
ALL-SIL,67156097,-2.3407546390754037,-1.0279170724737183
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.277886491385028
P31/FUJ,613753,2.9305719806169432,3.1495845971526135
PaTu 8988t,1641662,3.634680635371761,3.3408828038827
SU-DHL-1,15953870,1.992339234699044,3.4781017448929608
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,1.1345509900924162
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.3153680794849765
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,1.5478733404534093
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,2.9860814461500107
SK-CO-1,11364421,1.7180407971266538,-2.2476185097624475
COR-L105,16722836,1.79329711252707,1.5333952667080324
IGROV-1,439501,-2.1510551928674557,-2.2321662354381537
ALL-SIL,50905018,3.9646846974495418,4.441836356719809
SW48,25126798,2.5731969050098993,3.7921789378214816
PaTu 8988t,10113978,4.3652834043747335,3.010980031724017
SK-OV-3,12003241,-1.2313805329375749,-1.0889198012759371
Daudi,1317464,3.6966432302020817,4.148586664919221
WM115,5978,4.185238310426041,-2.3753204421143224
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.3791567205504176
ALL-SIL,24785538,-0.5874123218373029,1.3344504348570345
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,0.38762532684053896
IGROV-1,9967941,2.9735049794712545,3.6034131982542865
SK-HEP-1,11977753,-1.1270659898133608,-1.7159558966047241
COR-L105,676352,1.9469411585028615,2.088896150621564
MDST8,11485656,2.867381561993162,2.2397291078765758
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,2.8341325456747963
SW48,6918736,-2.164113269607571,-1.741781295359962
SK-HEP-1,445455,4.37046727572682,4.540053644561405
Daudi,4096211,1.4831417361144643,1.856021664538426
LCLC-97TM1,16038120,-0.9192372639718316,0.9090093368534204
BFTC-909,3384730,4.46542670181497,2.4620443610818112
K-562,36462,1.3855340321895664,1.5076124324231743
SK-HEP-1,5329102,2.506246240472525,2.031058842574058
WM115,25161177,2.874219730459086,4.097137926934978
HCC1500,119607,4.730010050453825,5.129253777214588
IGROV-1,24964624,0.5052308994941754,2.2827362159867324
HCC15,421610,3.960173561996767,3.1278257636093416
ALL-SIL,4788,4.920956242868583,5.493389053048461
IGROV-1,49766530,-0.195540678413639,-0.6944377068647134
SK-HEP-1,11175137,3.0126176485486114,2.477950770888125
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,2.8341325456747963
K-562,54678924,1.7343444538293111,1.9473085147454567
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.3097742666845045
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.4705816300476062
COR-L105,6505803,1.059348129706536,-0.5114413444588124
P31/FUJ,25183872,-2.108478877482417,-0.902802947451298
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,1.133687221210622
NCI-H1568,9444,4.259676436179719,4.054048446110465
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.0276770243216165
KU-19-19,19582717,2.992815973528006,3.9198146524152833
RKN,36462,2.460575122343829,1.5076124324231743
P31/FUJ,3062316,2.2346133515561415,0.9747482048219924
MOLM-13,36314,-7.769941141611737,-1.2422497803043113
HEL,44484440,3.2564839193688524,3.4463009263421043
RERF-LC-MS,168313016,4.277512101574917,4.725757076386842
HCC1500,637858,1.1010846881251866,1.8880097009592578
COR-L105,11178236,-3.064044900311784,-3.539769866873396
IGROV-1,44202524,1.8303703172382677,1.9639001504219202
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.11065310288154762
MOLP-8,11175137,1.914718066408171,2.477950770888125
LCLC-97TM1,1641662,3.5570250788057187,3.3408828038827
SK-HEP-1,46199207,3.772137058295689,3.1312366616263048
SW1573,6917907,-6.296104468024424,-4.864372369867458
HEL,89183176,1.9576500820122449,3.4938336610308007
SU-DHL-6,49793307,-4.306431914357451,-2.848251171596848
K-562,6918837,-4.262812875828109,-3.046222711611649
Daudi,44493528,3.680262260756896,4.333966846288542
RERF-LC-MS,5311281,3.366561586065275,2.22503529708604
IGROV-1,675434,4.336225379212549,4.463597576567934
NCI-H1568,216345,3.8344110950672823,3.7540083674013296
SU-DHL-1,9926054,1.6936537424309908,1.9546333131599372
Panc 02.03,9911830,3.8856260346392903,2.4240324657892436
HCC1500,2729026,1.749867272011919,2.6325975116350393
ALL-SIL,42642645,-2.33031271995146,0.7845058245277501
Daudi,9911463,2.4252044126403915,3.732908427020576
NCI-H1568,45279963,3.534456091536717,3.660133434789582
RKO,135999136,6.045591123054076,3.6300382464802663
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.3153680794849765
SW948,9903786,1.6902329933335576,2.756077717004494
RCC10RGB,9956119,4.44093701823858,3.4762974507018756
SW1271,25154868,5.0403607075499375,4.289494395804131
K-562,65628,4.517417686157834,4.026684176415168
SU-DHL-1,613753,2.797885663964736,3.1495845971526135
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.5350305453431912
HCC1500,44566777,0.0909506116020526,0.6972581949653407
NCI-H1568,54454,3.61375646412465,2.548844675602096
SW948,44507138,2.949706410080911,2.3228542035372683
SK-CO-1,17759555,4.047587343089958,3.5392373768677334
HEL,568763,0.2288469977463405,0.28862358029973745
BFTC-909,3815108,3.5118939741133075,2.885036533777781
ALL-SIL,24901704,-0.1489296834412312,3.1103746959488285
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.7691529831259722
KU-19-19,24772860,-1.0696999794461075,-2.2690769633318126
MOLP-8,9866186,-0.5209158528959533,0.7577083020821866
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.2349426527428076
HuP-T3,71304818,3.5647709327393287,2.396178486082573
MOLM-13,11683005,2.7238157220539345,3.769580038308904
HEL,54618771,0.7283869495698151,0.9253379925205388
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,3.0665232817889554
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,3.0665232817889554
NCI-H1568,25150857,2.4294918673251416,2.336756962918186
RKN,6438330,1.1013294242613172,2.016737971321332
HCC15,644241,2.326085716096255,2.1017288356510795
LS180,2708,3.937371430907984,4.591243765137335
LS180,51037431,3.4786862718788747,3.10082796495436
K-562,16741245,3.9224206604880583,3.801678648950925
RERF-LC-MS,44185566,3.014427147988128,2.4057100644299436
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,0.9218131221296273
RKN,5566,3.4992110401170944,3.029152149495273
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.4554460238042177
MOLP-8,216345,2.155670358283386,3.7540083674013296
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,2.344610112805219
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,0.11065310288154762
PaTu 8902,46224516,2.4477060426075723,2.370954746557396
RCC10RGB,241158,4.984223152954295,3.598987869990464
HCC15,11612883,1.9950389922708311,2.6386482274158856
HCC15,969516,3.14053560758236,2.7772567284956553
LS180,9866186,-0.1716689837079009,0.7577083020821866
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,2.0335760501929605
RCC10RGB,24964624,2.93015987785669,2.2827362159867324
MDST8,216345,3.5638732818875094,3.7540083674013296
RCC10RGB,10302451,3.839480938635774,3.0143591766147457
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,5.87798299213578
WM115,44491742,3.78432787650886,4.1566745174283435
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,2.8341325456747963
KU-19-19,262093,2.7281718696395303,2.6275548088442098
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,2.6829735349466532
COR-L105,1242560,3.3237423881291233,3.534393132486151
MDST8,16736978,0.980275670291684,1.3934160091023764
NCI-H1568,16722836,1.2045551605263336,1.5333952667080324
WM115,5282054,2.577591804396212,3.5628845676855256
IGROV-1,25195348,3.0698662305180275,3.08171494739702
PaTu 8902,148198,-2.774580136562139,-3.548509713878981
HEL,26596,-1.8679385890512872,-1.5346517263124715
Daudi,25126798,3.548189682848153,3.7921789378214816
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,2.8341325456747963
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.1345509900924162
PaTu 8988t,56946209,-4.946927234389905,-4.2202975286026225
SK-CO-1,2945648,3.4071568821077993,2.7548400693819435
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.4199080872215506
BFTC-909,3136844,3.2427360302120403,4.214923916993912
IA-LM,71304818,3.3887828048220094,2.396178486082573
NCI-H2452,122327,4.606448802646307,4.7007618437932
LS180,12003241,-0.6460664270988897,-1.0889198012759371
SK-HEP-1,16741245,3.65273757252914,3.801678648950925
RCC10RGB,6918638,2.235907203261483,0.3065957347013626
WM115,16065773,1.4979025411384967,2.3641186374244216
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.074054954263997
Daudi,54678924,0.8831010429483725,1.9473085147454567
MOLP-8,9903786,1.299688823902182,2.756077717004494
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.437709308952337
WM115,219104,4.514482202684108,3.5366182443481806
Daudi,25150857,0.8259987709661276,2.336756962918186
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,3.456683733824014
BICR 22,25262965,-4.220207088048826,-1.6224193967571534
BICR 22,25126798,3.759096897040898,3.7921789378214816
HCC15,11717001,5.339668805105819,3.961276339234443
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.2349426527428076
BICR 31,6918328,1.2499033439512497,-0.28710840066117727
COR-L95,25150857,1.208080540357677,2.336756962918186
ALL-SIL,104842,-6.679847729141338,-3.040993872013826
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,2.361538429265863
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.78247230086659
IGROV-1,11612883,1.8715405446213529,2.6386482274158856
HEL,9926054,1.596813412273358,1.9546333131599372
HCC15,11404337,-0.219975280966356,-0.4254091153988029
LS411N,168313047,3.2811764574410893,2.4053217165791536
HuP-T3,168313200,4.289513738947004,2.9593589282331023
RKO,216468,3.08027711257304,2.5020743765616316
HCC15,5566,3.133848096057735,3.029152149495273
SaOS-2,2130404,2.752105467907615,3.195187949563447
PaTu 8902,6623618,2.257974787323956,2.1468722777789853
Granta-519,45279963,2.8131243875516097,3.660133434789582
BICR 31,6918638,1.4401869695378149,0.3065957347013626
IGROV-1,2729026,2.3541792737160296,2.6325975116350393
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,2.0335760501929605
PaTu 8988t,126941,-4.347732149803542,-2.8921209077069348
BICR 31,44607531,1.4420456412349776,1.48117322485652
RKO,227681,3.9032876810461814,2.9941233013598234
Granta-519,5278396,3.331153353007608,3.517590475337377
MOLM-13,11214940,0.2452206847669268,1.8119431265240042
Granta-519,6914657,-5.464946920891912,-4.170094408243688
SW1271,72199292,4.741032264194907,1.1233129488647187
LCLC-97TM1,3676137,5.47833794075875,4.517112669127141
BICR 31,6505803,0.2507928346620714,-0.5114413444588124
NCI-H2452,9927531,4.529523169776047,4.578027762171671
HEL,107970,2.2652057864285893,2.3029314718240044
P31/FUJ,73707398,-0.9687174770786582,1.180307991266282
SK-CO-1,3634881,3.2176217097393867,3.1576774496130544
ALL-SIL,71680916,4.0231197218666015,4.641848024405652
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.3791567205504176
NCI-H2452,54678924,3.78052585603054,1.9473085147454567
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-3.173507428051674
RKN,9840324,5.059199694090175,5.7711165719697215
LS411N,25195348,3.7393125277208608,3.08171494739702
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.764962937653422
BICR 31,11497983,4.106423080888053,2.348631818792911
RKN,3825829,4.2934517576030276,3.8869840981378028
Panc 02.03,104842,-1.6275579890051994,-3.040993872013826
SK-HEP-1,4378219,1.9889575503272792,2.6822409618839944
NCI-H1568,11609586,2.169671625299293,2.621607380466062
NCI-H2452,24772860,-2.067021978185303,-2.2690769633318126
HCC1500,2828334,6.090675120485649,6.082620037824382
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-1.6396194068861514
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,1.7724503678159762
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.5530526201153183
SK-CO-1,426756,3.753929508081783,4.301139445753315
SaOS-2,46215462,2.3169135098646483,1.762132613731386
IGROV-1,216468,0.5330864756407336,2.5020743765616316
RERF-LC-MS,25262965,-1.1343637554659964,-1.6224193967571534
NCI-H1568,53392493,1.829675716879907,2.4832542501558077
WM115,6438330,2.009543324889134,2.016737971321332
P31/FUJ,9908783,6.361014450142155,5.056023266605311
HCC1500,5291,3.388112901698238,3.5530526201153183
HCC1500,216345,2.2086555393223293,3.7540083674013296
SK-CO-1,16722836,1.1930735523198912,1.5333952667080324
MDST8,2858523,3.149165485885388,3.0086502241129605
IA-LM,44486219,4.346993548383093,4.281343219898981
P31/FUJ,10427712,4.089067276268696,4.184108330161863
K-562,24771867,1.7261535062160185,1.5171458615349627
SW948,2742550,2.6149964231270166,3.8595787492072238
COR-L95,2113511,4.880906118348224,5.381335299817078
BFTC-909,82146,3.493415453952883,3.596877521367719
BICR 31,4261,2.904745052497421,1.4288257082744877
BFTC-909,119607,6.015893315993201,5.129253777214588
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.2349426527428076
Granta-519,262093,1.5974758737964725,2.6275548088442098
COR-L105,4521392,4.261553030698096,4.280943620409205
HuP-T3,52912189,2.4400429797195065,1.6723266261402217
HCC15,168313016,4.627209757330862,4.725757076386842
MDST8,15983966,1.9809932367095728,-1.6396194068861514
Granta-519,9866186,-0.14818829969678,0.7577083020821866
SK-HEP-1,462382,1.018219313736715,0.5714028853239661
Daudi,7251185,0.6493905196982933,2.4347287977616
HEL,3385,2.274300648457042,3.472185389430271
NCI-H2452,44185566,2.4757676958398824,2.4057100644299436
SW1573,9884685,-1.2788581073527363,0.4230357541133405
RKN,6505803,1.4092626649390017,-0.5114413444588124
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,2.8341325456747963
RERF-LC-MS,11427553,2.91041132641442,2.578035472123966
SW948,107985,-3.1361927230844255,-3.5771139994401464
IGROV-1,24951314,0.9075718706849548,1.227614980483031
IGROV-1,753704,6.461140333581179,4.832125608051433
LCLC-97TM1,54143018,-1.232378656007133,0.31711465707788644
SU-DHL-1,16038120,-4.191759239414132,0.9090093368534204
SK-HEP-1,65064,5.472205201006758,4.739517756868576
COR-L105,2733526,5.6711261994322,3.714359432422819
HuP-T3,56649450,4.499318873015619,2.999158341046921
SW48,16741245,3.865069024996995,3.801678648950925
HCC15,89183176,3.7013914070621903,3.4938336610308007
SU-DHL-1,135928012,2.7237506411412427,3.8701906312906376
HCC1500,24901704,3.772063812557438,3.1103746959488285
K-562,6505803,-1.797722788015983,-0.5114413444588124
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-3.5071094923394703
ALL-SIL,9936388,-6.364749169872344,-1.7988236137529168
P31/FUJ,5284616,2.141886646431612,1.1658534217096055
RKN,654092,-2.299209260296745,-0.4472857419901597
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.7691529831259722
Panc 02.03,462382,1.1832417961450334,0.5714028853239661
P31/FUJ,11609586,2.709581392176905,2.621607380466062
COR-L105,322968,4.452130073523545,3.4956311613712456
RKO,135398516,4.318914396092429,2.0509021680173207
Panc 02.03,44185566,3.1312758482446976,2.4057100644299436
NCI-H1568,72376,-1.5373297187690371,-2.110114148114304
Daudi,11494412,-0.3802447608890573,1.4248282417532188
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.6829735349466532
SW1271,2126,5.27764055734565,4.466606494133751
RERF-LC-MS,10296883,4.230661493555322,3.795028277273254
SK-CO-1,53232,1.9491581074450712,2.8161144578264046
HCC1500,11222830,1.0956735100670385,1.5350294688251391
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.0163468544412688
LCLC-97TM1,16219061,3.747043694071086,3.135611362850641
HCC15,3543504,4.297283358198234,4.269325105068445
SW1271,6918837,-1.9255423784418917,-3.046222711611649
SaOS-2,53301938,5.583232766578932,1.0245419866483008
UACC-812,9866186,1.6792636289805696,0.7577083020821866
RKO,5278396,3.510721289362286,3.517590475337377
K-562,16722836,1.308803334400655,1.5333952667080324
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.699201704606489
P31/FUJ,9935249,2.700947453739227,2.8615383619674972
IGROV-1,5351362,1.961059142684053,1.4604743967139864
IGROV-1,44819697,-0.8326420176056434,-0.6109288989041974
HCC1500,5746,0.8617369744590151,0.8084551861824514
BICR 31,15547703,3.2095649219178006,3.114669509763707
P31/FUJ,72193861,-0.3659416399435479,1.3858780169906042
PaTu 8902,24964624,3.11499425545507,2.2827362159867324
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.0163468544412688
SK-OV-3,24901704,3.989938255280614,3.1103746959488285
LCLC-97TM1,2113511,6.012866888022406,5.381335299817078
SaOS-2,3081361,3.085781742119062,2.3568884936851697
IGROV-1,15983966,1.7101486625531308,-1.6396194068861514
MDST8,6852167,1.3374988720553735,2.69961445504738
MOLM-13,67291369,-0.0488061328139809,1.794812676489941
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,0.7705130043498147
MOLP-8,9926054,1.7939353525170396,1.9546333131599372
SU-DHL-1,168312962,-2.257405592485961,1.48933366232238
LCLC-97TM1,219104,3.650486733954163,3.5366182443481806
HuP-T3,984333,1.5721860041126483,0.5138000229415411
Panc 02.03,4477,0.984097917718396,0.5570685949048098
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.8341325456747963
IGROV-1,9929138,6.483056540257463,5.665997549800987
SaOS-2,11175137,1.9690729540796783,2.477950770888125
LCLC-97TM1,9915743,-0.0836077976930932,0.5935480801734145
PaTu 8988t,9907093,4.39010034793255,4.134688957161641
LS180,73707398,1.191690395470446,1.180307991266282
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.3366995460793083
Daudi,11960529,3.700971671461623,4.006371718195
RKO,4259181,-0.4049041326260317,0.11236669175956715
MOLM-13,31703,-4.683228669920675,-1.182053713238432
SW1271,4477,0.3648589081307944,0.5570685949048098
HuP-T3,216239,2.9976543037230665,2.1474208097396077
HCC15,9903786,1.5576741113339283,2.756077717004494
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,1.2359123501503817
Daudi,1239801,3.0112900662314717,3.981036641317754
PaTu 8988t,25126798,4.088623680113087,3.7921789378214816
RKN,227681,3.7901732699912585,2.9941233013598234
K-562,216468,1.7844503846326911,2.5020743765616316
NCI-H1568,11234052,4.07711650557102,3.869960809483736
RERF-LC-MS,17755052,1.8057357372617977,1.7101929835526413
HEL,135999136,1.6019096984193502,3.6300382464802663
HEL,9887053,3.0781159437380974,3.469815136639831
RKO,11625818,4.5581118700811105,4.10791451089978
HuP-T3,322968,2.6241189840020787,3.4956311613712456
BFTC-909,11317348,4.568727931072339,2.3090854497210964
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.456683733824014
MDST8,1716436,1.1500764778734351,2.948755251800144
ALL-SIL,16741245,1.8101156107911176,3.801678648950925
Granta-519,16722836,1.0937584859115594,1.5333952667080324
PaTu 8902,10385095,2.391345219233966,1.2480392352773622
WM115,3038522,1.9104775831242309,2.9847437848386558
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,2.0335760501929605
RKO,11497983,5.954072388877685,2.348631818792911
BICR 31,46174525,4.37434163277974,4.156087356848057
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.3153680794849765
PaTu 8902,73707398,2.5949502925816397,1.180307991266282
MOLP-8,1641662,3.485304007232308,3.3408828038827
HuP-T3,11640390,3.629059315953643,3.2466540190485103
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.8547522793737237
LS411N,49850262,4.021647044836445,3.414452598711333
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,2.9381980631482683
SW1573,24951314,1.273840217876839,1.227614980483031
RKO,441298,2.3183923582018107,2.5423368047098167
COR-L95,5335621,4.389010810876702,4.560420742529089
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,2.93841691857644
MOLM-13,24785538,0.0261170120397283,1.3344504348570345
Granta-519,374536,-1.3755413186728007,1.7732341041149164
HuP-T3,9911830,2.533690069517969,2.4240324657892436
HCC15,11640390,4.25082988279064,3.2466540190485103
Daudi,375860,-0.7416229308895455,-0.30112130782396007
BFTC-909,16722836,1.424017650466323,1.5333952667080324
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.2359123501503817
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,1.78247230086659
LS411N,46398810,3.253541487295017,2.510712955745063
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.3791567205504176
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,1.9565115912575295
BICR 31,136227924,2.8140968842668923,2.867001064974719
SK-CO-1,24753719,4.51149350773187,4.143618673527016
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.2349426527428076
SW1271,57330099,4.656552081384507,4.311542343968036
ALL-SIL,60750,-4.149254188873004,-2.435153852929516
MDST8,42642645,1.1052716804296012,0.7845058245277501
ALL-SIL,25062766,1.575972356073685,2.0522756909743434
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.860017480413567
SW948,11455910,0.6774609071475187,0.9557745122323711
SK-CO-1,11485656,2.076616779710352,2.2397291078765758
P31/FUJ,387447,-5.269499156732966,-4.3765957253648695
SaOS-2,54765302,6.138432086002101,3.905112278839675
KU-19-19,3384730,2.4463371108200995,2.4620443610818112
SW48,56946209,-4.8342224094221455,-4.2202975286026225
RERF-LC-MS,71304818,2.1402027844306986,2.396178486082573
SaOS-2,5351362,1.054118918695375,1.4604743967139864
SW1271,60700,-2.0966401571631805,-0.4482559328189002
SK-OV-3,12001922,2.3689117655248197,1.8522788760744173
BICR 22,11222830,2.7513096778080293,1.5350294688251391
HEL,637858,1.821308587756956,1.8880097009592578
LS411N,11609586,3.7769222068832384,2.621607380466062
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,1.78247230086659
SW1573,53392493,3.256582971351183,2.4832542501558077
IGROV-1,71466380,4.863636874274779,4.275465599745589
SK-HEP-1,119607,5.888068080296772,5.129253777214588
K-562,5329102,1.5928854941533903,2.031058842574058
RERF-LC-MS,24901704,2.6292316786888295,3.1103746959488285
RKO,54649381,4.449908747747005,3.7880999548273127
KU-19-19,6438330,3.038685724131264,2.016737971321332
RERF-LC-MS,6917907,-5.461995819879327,-4.864372369867458
Daudi,6852167,0.8630196090584432,2.69961445504738
RKN,2708,5.19327789915259,4.591243765137335
SK-CO-1,51039095,2.6345691844177006,2.682611194240459
HEL,9935249,3.1121102066484827,2.8615383619674972
Daudi,6184667,1.7615544136572183,2.901063659317265
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.2827362159867324
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.117207225291035
LCLC-97TM1,5978,-5.540378308178224,-2.3753204421143224
SaOS-2,135999136,4.306712196094447,3.6300382464802663
IGROV-1,5311,1.0068816368200209,1.2663000347984639
PaTu 8902,10184653,3.3664490630517023,1.1325795715302809
IGROV-1,54678924,1.4704159748793169,1.9473085147454567
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,-0.11678183903518824
IGROV-1,16720766,-0.0562020789376145,0.4291253754884592
RCC10RGB,31703,2.24368059098483,-1.182053713238432
SW48,4261,1.3708847234833408,1.4288257082744877
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-1.57821899028641
Granta-519,11494412,-1.422706675432074,1.4248282417532188
BFTC-909,10302451,3.622269240471498,3.0143591766147457
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,-0.31026393275322106
SU-DHL-1,11497983,5.985793176782232,2.348631818792911
HEL,44486219,4.241945120616936,4.281343219898981
HuP-T3,9926054,1.9266750805140576,1.9546333131599372
Granta-519,5281672,3.715092894597705,4.4250678360691875
NCI-H2452,568763,0.2251625503779925,0.28862358029973745
Daudi,15547703,2.9729250708388815,3.114669509763707
RERF-LC-MS,1566236,3.687566928717542,2.2263982365179604
SW48,3689413,2.066117060158584,-0.4039154566871359
RKN,11396600,3.670395083293249,3.4309758536883517
COR-L95,25227462,1.0954609187473372,-0.4151865926866767
P31/FUJ,11497983,-3.9754433923569295,2.348631818792911
COR-L105,11977753,-3.381629820862821,-1.7159558966047241
SaOS-2,10302451,5.268852772808677,3.0143591766147457
WM115,25126798,4.207732195436686,3.7921789378214816
HEL,6918736,-2.4872933380365483,-1.741781295359962
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,2.9860814461500107
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.2359123501503817
BICR 31,11626560,1.5769037831027732,1.6795489442409048
SaOS-2,53481919,3.9662352208904,3.8547522793737237
NCI-H2452,4378219,4.095695943124218,2.6822409618839944
RKO,135440466,3.093117295091816,2.1401473911994366
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,2.474523360549852
IGROV-1,4521392,5.131794979216607,4.280943620409205
WM115,6610355,3.646348527159068,4.45123297085854
IA-LM,46199207,3.643614442277753,3.1312366616263048
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,0.9218131221296273
RERF-LC-MS,4259181,-1.273108977623296,0.11236669175956715
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.0665232817889554
LCLC-97TM1,9866186,0.636434294421894,0.7577083020821866
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,3.456683733824014
BICR 31,285033,-1.6333817403557132,-2.1791335812392365
SW1573,24821094,3.391149888356164,2.7369152351179045
RERF-LC-MS,984333,0.876742343627688,0.5138000229415411
SW1573,2828334,5.538488922798482,6.082620037824382
BFTC-909,11214940,1.666026285351028,1.8119431265240042
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-1.6778195760397165
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.1188086218267883
MOLM-13,16722836,-1.8349401857846608,1.5333952667080324
MOLP-8,135398516,0.6877200142840878,2.0509021680173207
NCI-H1568,56649450,2.3390116545362956,2.999158341046921
COR-L105,5329102,2.9490674090485007,2.031058842574058
BICR 22,104842,-5.460039616101889,-3.040993872013826
ALL-SIL,44507138,0.0905903694215729,2.3228542035372683
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,1.4554460238042177
Daudi,252682,5.82526834825694,6.516263069090082
SK-CO-1,24785538,-2.301834394825824,1.3344504348570345
HCC15,4788,6.208189927463216,5.493389053048461
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.776063215737675
SK-HEP-1,5282054,5.2464488654660935,3.5628845676855256
K-562,2729026,2.90327889883348,2.6325975116350393
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-3.5071094923394703
IGROV-1,135398744,6.402844237905131,6.625444078703129
Panc 02.03,44819697,-0.6097657869730747,-0.6109288989041974
COR-L95,6252,1.2572884944075156,-0.10942982547788271
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.227141832343803
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.31711465707788644
RKO,135411,0.3039750611139232,0.5181226666256136
SW1271,5284616,3.4240840801047825,1.1658534217096055
Daudi,9803433,4.921870042846492,4.847536831977339
HuP-T3,1566236,2.433067651410228,2.2263982365179604
NCI-H1568,11364421,1.3511041801335055,-2.2476185097624475
SaOS-2,54678924,2.353285364311993,1.9473085147454567
NCI-H1568,6438330,1.052967118553252,2.016737971321332
SaOS-2,56946209,-2.927880316628738,-4.2202975286026225
MDST8,71304818,3.102141708789901,2.396178486082573
MDST8,16722836,1.8236379945665244,1.5333952667080324
COR-L95,5460769,3.3963309413836815,2.3447175553942796
SW1573,5328940,2.8151731448483424,1.559061663996469
P31/FUJ,44486219,4.066329818545256,4.281343219898981
SK-CO-1,44819697,-0.0659450585917303,-0.6109288989041974
NCI-H1568,3689413,-2.0602171008804935,-0.4039154566871359
SW48,4788,5.795432827385499,5.493389053048461
IGROV-1,11625818,2.877471533668122,4.10791451089978
HEL,5282054,3.8014373831294073,3.5628845676855256
Granta-519,2858523,3.0573334835342725,3.0086502241129605
Granta-519,2708,2.6467102550113357,4.591243765137335
SaOS-2,10074640,3.1546787022314264,3.066922642013836
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,0.11065310288154762
NCI-H1568,462382,0.4864277786958156,0.5714028853239661
PaTu 8902,6450551,4.419968438595772,2.361538429265863
NCI-H1568,89183176,4.755399227223714,3.4938336610308007
SK-HEP-1,89183176,6.199387598364303,3.4938336610308007
COR-L95,3689413,-1.01311028513846,-0.4039154566871359
SW48,322968,2.620984302451229,3.4956311613712456
NCI-H1568,2113511,4.994259934049027,5.381335299817078
RERF-LC-MS,10074640,3.277461458690314,3.066922642013836
P31/FUJ,11485656,1.9746673234827223,2.2397291078765758
NCI-H2452,24978538,1.4440845227299357,0.6273547794147847
SW948,46398810,1.81837356763434,2.510712955745063
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.8865368208635396
SW48,5280436,3.9386259808510737,3.153394505533252
NCI-H1568,16013152,3.794215458313736,4.119375381760217
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,0.4199080872215506
SaOS-2,72193861,0.3662001709486771,1.3858780169906042
SW1271,6623618,2.240401111492455,2.1468722777789853
BICR 31,11964036,0.7129684858082154,1.2382789669868983
MOLM-13,71466445,2.28410988708537,3.3478019143630626
SW1271,5280436,5.166796757102748,3.153394505533252
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.78247230086659
SK-HEP-1,5470400,0.5577708849126581,-0.3765538821264742
SW1271,73707398,1.637161284255629,1.180307991266282
Panc 02.03,24771867,4.320948526904658,1.5171458615349627
K-562,11494412,-0.907204058397288,1.4248282417532188
HuP-T3,4477,0.7500067469313434,0.5570685949048098
WM115,44489675,3.6522428576041888,3.8856289571074525
IGROV-1,10074640,3.2681490579824426,3.066922642013836
LCLC-97TM1,387447,-4.752686001320434,-4.3765957253648695
NCI-H2452,136227331,4.192235498443636,4.306903331742339
BICR 22,44566777,0.9464577594296588,0.6972581949653407
Daudi,44462760,2.2846011846998184,3.143997930658831
HuP-T3,11222830,1.7699584455080513,1.5350294688251391
BFTC-909,10184653,1.6906150005550105,1.1325795715302809
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,1.4539899714896953
SK-CO-1,5460769,-0.7722931098274061,2.3447175553942796
IGROV-1,9884685,-0.088911709267569,0.4230357541133405
SW948,10074640,3.6458957710098927,3.066922642013836
RCC10RGB,2729026,3.187414345119047,2.6325975116350393
SU-DHL-1,25105715,2.6102250612439857,3.410449786117574
SaOS-2,2708,4.307882235107384,4.591243765137335
SW48,11485656,-1.6768123952056315,2.2397291078765758
LS411N,5738263,3.6843208102291127,3.3050405288071003
LCLC-97TM1,89928392,0.9843618500255806,1.344325138639762
IGROV-1,5328940,0.347812751869877,1.559061663996469
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.3848601780620533
MOLP-8,6184667,3.7618917164892296,2.901063659317265
HEL,9907093,4.271492923268933,4.134688957161641
SU-DHL-1,409805,5.150132871505728,4.6745070702664995
IGROV-1,5287620,-1.5394168430569777,-1.9697846958841214
HCC15,6184667,2.403880665872793,2.901063659317265
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.129253777214588
BFTC-909,11152667,-0.3524603871752078,-0.5866736007906306
BICR 22,10427712,4.255154443676342,4.184108330161863
RCC10RGB,73707398,3.9170227295506304,1.180307991266282
SK-HEP-1,4788,5.857315027837397,5.493389053048461
SaOS-2,11167602,3.026359974607451,2.4705816300476062
IGROV-1,3825829,4.144093606877803,3.8869840981378028
Daudi,53232,2.2893399383043116,2.8161144578264046
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.082620037824382
LS180,5470400,-3.6342626980574657,-0.3765538821264742
NCI-H1568,322968,3.6220797151302673,3.4956311613712456
SU-DHL-1,25150857,1.7165355924738273,2.336756962918186
NCI-H2452,9926054,2.7849990975548726,1.9546333131599372
RKO,5280436,4.655813696583822,3.153394505533252
Panc 02.03,25126798,4.246913180768056,3.7921789378214816
BICR 22,5460769,-1.4539525700949456,2.3447175553942796
RERF-LC-MS,4521392,4.229663793191115,4.280943620409205
COR-L95,65628,4.016533332946612,4.026684176415168
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,1.1233129488647187
BFTC-909,11507802,1.7199271215311116,1.3590460953824346
HCC15,16115403,-5.315255617661217,-4.875275216600306
Panc 02.03,24797083,1.7288458125332262,1.277886491385028
Granta-519,16065773,1.8580334509866892,2.3641186374244216
MOLP-8,67291369,0.6739245689833524,1.794812676489941
LCLC-97TM1,71304818,2.70820846116735,2.396178486082573
COR-L105,10113978,3.5062120769458907,3.010980031724017
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.2834565267098785
ALL-SIL,5460769,0.8731159867521163,2.3447175553942796
MOLM-13,89928392,-0.0278317389216686,1.344325138639762
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.0665232817889554
SaOS-2,6852167,2.181246544986129,2.69961445504738
SK-CO-1,135999136,4.853872243910513,3.6300382464802663
LCLC-97TM1,5329102,1.5800226001590805,2.031058842574058
RCC10RGB,3825829,4.92777419243283,3.8869840981378028
WM115,16722836,2.5522609953991577,1.5333952667080324
KU-19-19,6610355,5.477302473020379,4.45123297085854
HCC15,5311281,-0.1593612251340344,2.22503529708604
WM115,11656518,-0.7680829336702796,1.5480979328089313
IGROV-1,675434,4.336225379212549,4.463597576567934
BICR 31,322968,4.229982613329669,3.4956311613712456
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,2.0058447943574325
MOLM-13,409805,3.504188648592109,4.6745070702664995
NCI-H2452,68056272,5.088176766324353,3.2394422692786446
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,0.7705130043498147
RERF-LC-MS,25102847,0.6953191965745218,2.3366995460793083
SU-DHL-1,5278396,2.36959409949266,3.517590475337377
HCC1500,9935249,2.2800833668468266,2.8615383619674972
HEL,46907787,-1.2802643066913908,1.584957029505121
Daudi,64971,1.9256728094608813,2.5328398474495826
KU-19-19,168313047,3.3084179069540696,2.4053217165791536
HCC1500,9903786,4.21203406645071,2.756077717004494
BFTC-909,3689413,0.9841636034152118,-0.4039154566871359
MDST8,9911830,3.786562744766562,2.4240324657892436
WM115,262093,2.5199436905866905,2.6275548088442098
IGROV-1,5311281,3.3250623444804206,2.22503529708604
ALL-SIL,4261,-0.4593745111072439,1.4288257082744877
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.902802947451298
NCI-H1568,25105715,3.512540774448481,3.410449786117574
COR-L95,12001922,1.5177554079359803,1.8522788760744173
Granta-519,25154868,5.041568583050757,4.289494395804131
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,1.4554460238042177
SK-HEP-1,3503,1.99172511033101,2.2426858883255045
BICR 22,2749,1.4483580801045477,1.7932893499757152
SU-DHL-1,10231331,2.149159497852676,1.6547412916072393
SU-DHL-1,132496,3.861580575323874,1.8612675858669119
NCI-H1568,11955716,5.84501437277453,-1.4856643985320634
COR-L105,11647372,1.8386560750541856,0.8954839509867156
PaTu 8988t,702558,5.248840045640507,4.9782351440396395
RKO,219104,3.7756995047121658,3.5366182443481806
RERF-LC-MS,119607,4.38818595494476,5.129253777214588
SK-OV-3,969516,2.624811361400939,2.7772567284956553
SU-DHL-1,67156097,-2.1897423830418155,-1.0279170724737183
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-1.6224193967571534
MDST8,10296883,3.644541291105843,3.795028277273254
BICR 31,135411,1.1842135795155395,0.5181226666256136
NCI-H1568,17755052,1.5920713080731803,1.7101929835526413
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,1.2359123501503817
Granta-519,3062316,1.222650334372554,0.9747482048219924
MOLM-13,11609586,0.2693262849825738,2.621607380466062
MDST8,65628,4.39024768664476,4.026684176415168
LS411N,11222830,1.85641131377126,1.5350294688251391
P31/FUJ,5278396,3.2564464707559786,3.517590475337377
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,2.8341325456747963
HCC1500,11228183,-3.1075364778620544,1.8712017695678478
Panc 02.03,3503,2.8594786206641514,2.2426858883255045
MOLM-13,12001922,1.648284949914827,1.8522788760744173
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,1.1345509900924162
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.37491183386883553
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,2.93841691857644
RCC10RGB,135875424,5.859031260595621,3.743891076041643
LS180,44491742,4.531352051294965,4.1566745174283435
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.860017480413567
SW948,5460769,-0.6640669541383749,2.3447175553942796
BFTC-909,9866186,1.150003196853964,0.7577083020821866
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-3.5071094923394703
Daudi,322968,1.8489038189519929,3.4956311613712456
LS180,135999136,4.321194581518088,3.6300382464802663
MOLP-8,4259181,0.2540996075245788,0.11236669175956715
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.2047817895412443
BICR 31,17755052,0.616652074058669,1.7101929835526413
Daudi,10427712,3.475831712716563,4.184108330161863
ALL-SIL,6252,-2.462384672511242,-0.10942982547788271
IGROV-1,57330099,4.391385744785918,4.311542343968036
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.2663000347984639
LS411N,5746,2.615146419652584,0.8084551861824514
WM115,11625818,2.666283825244439,4.10791451089978
SK-CO-1,17755052,1.6143754050867285,1.7101929835526413
BFTC-909,4788,5.986704833543041,5.493389053048461
BFTC-909,613000,3.1980696015333137,2.227141832343803
RCC10RGB,9933475,1.608288384582936,1.793439230086884
COR-L95,11964036,1.1862097811542611,1.2382789669868983
IGROV-1,12003241,-2.0122972114546904,-1.0889198012759371
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-1.0279170724737183
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.5478733404534093
LS411N,676352,3.0047981548436873,2.088896150621564
NCI-H1568,6918638,-0.3782949656582497,0.3065957347013626
HCC15,654092,-0.5163256778254894,-0.4472857419901597
MOLM-13,72193870,3.075841334601934,2.884467083403444
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,2.888353933707551
SK-HEP-1,1716436,3.791424957504218,2.948755251800144
IGROV-1,637858,1.814476597989254,1.8880097009592578
IA-LM,44137675,5.685431340913792,3.337336921695599
RKO,49793307,-1.4433237106321422,-2.848251171596848
Panc 02.03,1750826,-0.0877771412327358,-1.4739669220989267
P31/FUJ,216239,3.114152508734425,2.1474208097396077
BICR 22,9911463,4.403388511465592,3.732908427020576
LS180,3503,2.1233569957286673,2.2426858883255045
NCI-H1568,135440466,1.9451121966001212,2.1401473911994366
LS180,6917907,-5.898955627831861,-4.864372369867458
NCI-H2452,3503,2.8949427881039367,2.2426858883255045
LCLC-97TM1,9952709,3.284131025623194,2.9381980631482683
MOLM-13,168313047,1.872191765635252,2.4053217165791536
RKN,65064,4.855719732775604,4.739517756868576
SK-CO-1,1716436,3.109025551437123,2.948755251800144
Panc 02.03,322968,4.613737356937267,3.4956311613712456
SU-DHL-1,16115403,-5.307217729681928,-4.875275216600306
Daudi,5738263,2.220866513982768,3.3050405288071003
SW48,10074640,2.891302128524984,3.066922642013836
SW48,3552672,5.820012420560967,2.8413574589562494
Daudi,568763,-0.9358982895655849,0.28862358029973745
HCC1500,11234052,4.300499145525321,3.869960809483736
WM115,16741245,4.109793610684897,3.801678648950925
SK-CO-1,6917907,-6.103253673111458,-4.864372369867458
SW48,100016,6.031440310304127,5.87798299213578
SW948,12003241,-1.7903806895013192,-1.0889198012759371
SK-HEP-1,9840324,5.848573782723059,5.7711165719697215
ALL-SIL,5328940,-0.9694628184696558,1.559061663996469
BICR 22,2858523,3.373464702278958,3.0086502241129605
NCI-H2452,17755052,2.4746667711045514,1.7101929835526413
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-1.1532493383305307
P31/FUJ,654092,-2.277731190350674,-0.4472857419901597
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.456683733824014
BICR 22,16736978,1.4452527998079976,1.3934160091023764
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.5771139994401464
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.6778195760397165
ALL-SIL,9843750,4.4328493438561845,4.073035208557732
IGROV-1,168313047,1.93821625738322,2.4053217165791536
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.7724503678159762
RCC10RGB,24797083,3.688734393817597,1.277886491385028
IGROV-1,67291369,1.8066430555976296,1.794812676489941
SK-HEP-1,135875424,4.97106166770821,3.743891076041643
SK-OV-3,676352,2.4999853996447423,2.088896150621564
IGROV-1,3689413,-0.3633634632064185,-0.4039154566871359
MOLM-13,2126,3.944929409626795,4.466606494133751
SW1271,25150857,2.216244024484901,2.336756962918186
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.7691529831259722
Granta-519,3689413,-2.6080640580656977,-0.4039154566871359
UACC-812,11955716,-3.4049141440551765,-1.4856643985320634
WM115,6918638,1.2765614986990457,0.3065957347013626
MOLM-13,119182,-3.013346002661584,-1.3340160156368264
HuP-T3,25150857,2.779922499061356,2.336756962918186
RKN,400769,-0.3685197718994141,-0.7855881743093749
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.133687221210622
COR-L95,9927531,5.207677506691081,4.578027762171671
RKO,439501,-1.8401322759847645,-2.2321662354381537
COR-L105,135875424,4.584511127602178,3.743891076041643
MDST8,67156097,-2.036194319435593,-1.0279170724737183
SK-CO-1,11640390,3.1287755311468715,3.2466540190485103
NCI-H2452,9915743,1.4140850498548845,0.5935480801734145
COR-L95,54626689,4.626807564914302,4.561309020020982
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,0.38762532684053896
SW48,15983966,-4.810478602921179,-1.6396194068861514
RERF-LC-MS,53495165,1.4938275665549956,-0.19108456656304296
SW1573,10026128,4.237670104162456,4.298711695867744
BICR 22,5328940,1.2238467278980267,1.559061663996469
IGROV-1,25150857,3.031865110078871,2.336756962918186
SW48,54649381,3.6753624817280706,3.7880999548273127
RKN,11485656,2.343665915939472,2.2397291078765758
IGROV-1,216239,2.21703825410177,2.1474208097396077
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,1.2359123501503817
SaOS-2,675434,4.709862103920263,4.463597576567934
WM115,439501,-0.2667789802830004,-2.2321662354381537
RKO,11152667,-2.010180339323448,-0.5866736007906306
BICR 22,702558,5.841545864846151,4.9782351440396395
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.4554460238042177
IGROV-1,52912189,2.3966568144845666,1.6723266261402217
SU-DHL-1,219104,2.7039031158758395,3.5366182443481806
SW1271,19582717,5.373754052547774,3.9198146524152833
IGROV-1,119182,0.2112476135388779,-1.3340160156368264
SW1573,25150857,3.3863948467965717,2.336756962918186
LCLC-97TM1,1566236,1.804143498427706,2.2263982365179604
SW48,6252,-1.782590172996294,-0.10942982547788271
MOLP-8,168313200,3.062868142984741,2.9593589282331023
SU-DHL-6,969516,2.321858620209541,2.7772567284956553
K-562,44632017,0.5936262556123562,1.0838611345650022
BFTC-909,56973724,3.22598802973391,2.823032655731692
NCI-H1568,24180125,3.319632294157453,2.888353933707551
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,0.7705130043498147
RKO,15547703,3.988071110220001,3.114669509763707
COR-L105,446155,1.2274898824574871,2.662752180605146
WM115,25062766,1.993857010637035,2.0522756909743434
HCC15,42642645,-0.8684016042996798,0.7845058245277501
IGROV-1,3136844,5.214591389089975,4.214923916993912
COR-L95,16659841,4.2643844802603725,3.7845234388741966
NCI-H1568,107985,-3.6136890416333665,-3.5771139994401464
HEL,9967941,3.646907071964301,3.6034131982542865
NCI-H1568,5311,0.289477139532769,1.2663000347984639
HCC1500,24964624,2.92457410282952,2.2827362159867324
LCLC-97TM1,44185566,1.2712415312804253,2.4057100644299436
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.11236669175956715
RKO,135421197,1.472175761257966,1.8199795612290348
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.2047817895412443
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,2.9860814461500107
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-3.5071094923394703
P31/FUJ,119607,5.165578068786105,5.129253777214588
SW1271,44507138,3.04083255973368,2.3228542035372683
MOLP-8,72734382,2.92105223846654,4.3578051352274185
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,2.699201704606489
RKN,12001922,2.582060834791438,1.8522788760744173
MOLM-13,3025986,-2.268401268397509,-0.8978770871810051
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,-0.11678183903518824
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,4.739517756868576
BICR 22,387447,-3.632542993789297,-4.3765957253648695
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-0.8865368208635396
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.117207225291035
MDST8,44819697,0.5968481057166135,-0.6109288989041974
COR-L95,54613361,1.8571878459944453,-0.11678183903518824
PaTu 8988t,25183872,-1.065851307698322,-0.902802947451298
HCC1500,969516,2.5012208253247374,2.7772567284956553
LS411N,51039095,3.380080993968732,2.682611194240459
IA-LM,10385095,1.8174613436578264,1.2480392352773622
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,0.7705130043498147
MOLP-8,44589607,1.928632926439859,2.659070263037081
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.3153680794849765
SK-HEP-1,5311,2.3418360503567386,1.2663000347984639
NCI-H2452,24889392,3.037712354939189,3.7858620057203916
SU-DHL-1,4378219,1.8683369375684944,2.6822409618839944
NCI-H2452,2858523,2.6943426896823284,3.0086502241129605
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,2.0335760501929605
IA-LM,119607,5.918153428689206,5.129253777214588
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,1.8119431265240042
COR-L105,46224516,3.053099263199949,2.370954746557396
SW948,3062316,3.151526592835161,0.9747482048219924
BICR 22,6610216,4.672862717569176,4.26979744561799
SW948,16736978,1.371465793072688,1.3934160091023764
IGROV-1,2828334,6.070696247039626,6.082620037824382
RCC10RGB,44185566,3.1564704709707856,2.4057100644299436
Granta-519,135999136,4.28714374371566,3.6300382464802663
BFTC-909,654092,0.6323398211983356,-0.4472857419901597
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.0665232817889554
P31/FUJ,17755052,1.7010190253681206,1.7101929835526413
SU-DHL-1,2945648,2.120687124348465,2.7548400693819435
LCLC-97TM1,16720766,-2.0806199642234704,0.4291253754884592
HCC15,3025944,3.8616867083103648,4.206240213808089
LCLC-97TM1,53392493,1.9813066602409652,2.4832542501558077
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.8341325456747963
COR-L95,675434,4.0325297307826125,4.463597576567934
SaOS-2,11213558,1.0641156085827448,1.4781707184028035
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,1.710700657959646
KU-19-19,1716436,3.531012736022478,2.948755251800144
SU-DHL-1,11485656,1.6397040363022437,2.2397291078765758
SK-CO-1,16736978,2.1510378918389415,1.3934160091023764
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.2359123501503817
HCC1500,136227924,2.675203690625814,2.867001064974719
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.38762532684053896
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.4833676274788345
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.0665232817889554
Daudi,219104,1.6178665476553538,3.5366182443481806
WM115,5284373,2.6004259651165644,2.7079346453511217
SU-DHL-6,216345,3.116690602340157,3.7540083674013296
HuP-T3,5460769,4.291069487745317,2.3447175553942796
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,5.004034610534093
Daudi,8515,3.193004700442435,3.7716438213452004
HCC15,3815108,3.1337581441750277,2.885036533777781
IGROV-1,5280436,3.2616766817665086,3.153394505533252
COR-L95,107970,2.0048060228155333,2.3029314718240044
BICR 31,25150857,2.3687059872087217,2.336756962918186
IA-LM,6918837,-2.975709639111599,-3.046222711611649
WM115,3025986,-1.3268545497049868,-0.8978770871810051
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.344610112805219
SW48,17759555,2.861947497664063,3.5392373768677334
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,2.117207225291035
SW1271,9956119,4.3828310926576375,3.4762974507018756
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,1.7691529831259722
MDST8,24772860,-2.900176299695688,-2.2690769633318126
SaOS-2,4259181,-0.1317601722396107,0.11236669175956715
PaTu 8988t,5746,3.0775825889142543,0.8084551861824514
SaOS-2,4521392,4.5837419847316845,4.280943620409205
SaOS-2,445455,5.662681927298568,4.540053644561405
IGROV-1,148198,-2.659972993252853,-3.548509713878981
SK-CO-1,11404337,-0.5084033800481932,-0.4254091153988029
Granta-519,4578,4.680400709321271,4.446937148676336
RKO,4261,2.924548439505643,1.4288257082744877
MOLP-8,54618164,3.908946135671936,4.02740727006158
HCC15,24978538,-1.0517559532383662,0.6273547794147847
COR-L105,2945648,3.0602962908492386,2.7548400693819435
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,4.860017480413567
NCI-H2452,4705,3.641149380662554,3.0428654274536564
SK-CO-1,54143018,-0.6826828748975821,0.31711465707788644
MDST8,26596,-1.25574590011264,-1.5346517263124715
NCI-H2452,54454,2.511734775409603,2.548844675602096
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.2834565267098785
RERF-LC-MS,16038120,1.5599846769821624,0.9090093368534204
SK-OV-3,44185566,3.1295797630764266,2.4057100644299436
BICR 31,148124,2.7085675831815292,-2.0460232384010055
P31/FUJ,439501,-2.3575947617146475,-2.2321662354381537
BICR 22,11152667,-1.8276171650012312,-0.5866736007906306
COR-L95,56973724,4.268430703602559,2.823032655731692
RERF-LC-MS,54626689,4.221264321270605,4.561309020020982
IGROV-1,1641662,3.5854177848263675,3.3408828038827
MOLM-13,613753,2.871004682812888,3.1495845971526135
IGROV-1,11404337,-0.7659238947812715,-0.4254091153988029
SW48,219104,2.280685064057957,3.5366182443481806
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,1.78247230086659
Granta-519,9935249,0.0212855082517002,2.8615383619674972
MOLM-13,2749,0.3899767988765278,1.7932893499757152
WM115,1750826,-0.9273267035114736,-1.4739669220989267
SK-OV-3,2858523,3.2787147644650716,3.0086502241129605
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.2834565267098785
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,2.7772567284956553
SW948,25183872,-1.604238480901096,-0.902802947451298
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,1.1345509900924162
IGROV-1,6914657,-4.141311308759326,-4.170094408243688
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.860017480413567
HCC15,6610216,4.23435184261858,4.26979744561799
NCI-H1568,10074640,3.1711026687004855,3.066922642013836
SW48,4917,2.351047632498956,3.079848880785536
MOLP-8,46215462,1.266580776259001,1.762132613731386
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.6829735349466532
COR-L105,387447,-4.5302496546864885,-4.3765957253648695
MOLP-8,44462760,3.111101001788515,3.143997930658831
BICR 31,44819697,0.4590360698509347,-0.6109288989041974
HuP-T3,9956119,4.370077084995815,3.4762974507018756
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.38762532684053896
KU-19-19,66577038,3.864819378735941,2.9870697487432882
BICR 22,5746,-1.0393569299451335,0.8084551861824514
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.016737971321332
SW48,67156097,-2.150931452918296,-1.0279170724737183
SaOS-2,25150857,2.491525195617086,2.336756962918186
NCI-H1568,613753,3.056586098825006,3.1495845971526135
LS180,44137675,2.850653785387247,3.337336921695599
RKN,11364421,-3.590581417405073,-2.2476185097624475
HuP-T3,23582824,1.5911146583975455,0.7400136078733197
SW48,446155,2.2181780639059907,2.662752180605146
SU-DHL-1,44202524,0.8334918459072751,1.9639001504219202
RERF-LC-MS,11404337,1.609147033115388,-0.4254091153988029
K-562,44486219,4.057183894108205,4.281343219898981
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.0058447943574325
PaTu 8988t,46199207,3.796589685342678,3.1312366616263048
LS180,11964036,0.9251272605785624,1.2382789669868983
SW948,8515,3.759025323790885,3.7716438213452004
SaOS-2,374536,3.743747938767685,1.7732341041149164
SW948,135875424,4.663257041681152,3.743891076041643
SK-HEP-1,72376,-0.6035227354554765,-2.110114148114304
SK-CO-1,1242560,3.64748499205759,3.534393132486151
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.117207225291035
MOLP-8,3025986,-4.599162344151263,-0.8978770871810051
SW48,25150857,2.2099211562472125,2.336756962918186
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,3.6054187258933235
LCLC-97TM1,3465537,1.1142431298706064,2.5477591829493655
NCI-H1568,9887053,3.9549233487650666,3.469815136639831
SW48,5746,-2.6538895977275745,0.8084551861824514
LS180,44484440,3.4848015178596343,3.4463009263421043
Daudi,25183872,-3.2629659020313393,-0.902802947451298
IGROV-1,984333,0.6618578113050116,0.5138000229415411
COR-L95,135999136,4.28146486500778,3.6300382464802663
RERF-LC-MS,4788,5.0822281264538365,5.493389053048461
HuP-T3,2828334,6.159425491986346,6.082620037824382
RKN,3854666,2.132003481112045,1.85063491630251
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.088896150621564
PaTu 8902,54639665,4.483683562011812,2.8742701773668493
ALL-SIL,24180125,1.6553840753953686,2.888353933707551
SK-CO-1,12003241,-0.9578793579943758,-1.0889198012759371
BFTC-909,104842,-1.584917163766509,-3.040993872013826
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.435153852929516
MOLP-8,24772860,-3.493237790177901,-2.2690769633318126
SK-OV-3,49836020,-5.2191550029019025,2.5464279658175073
K-562,46199207,1.8646546122938352,3.1312366616263048
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,1.2160403056527411
MOLM-13,6450551,0.4092106163446157,2.361538429265863
BICR 31,1566236,4.637821170940002,2.2263982365179604
SW1271,54454,2.1914366041236204,2.548844675602096
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.0665232817889554
SaOS-2,9952709,3.1448975558697545,2.9381980631482683
HuP-T3,54618771,0.8132197250487964,0.9253379925205388
IGROV-1,6918736,-0.950858733923241,-1.741781295359962
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,-0.4472857419901597
Granta-519,53392493,1.7904738197895116,2.4832542501558077
NCI-H2452,445643,4.078319116283011,3.9383569867901693
HuP-T3,5281321,0.1098786391841839,-1.3097742666845045
NCI-H2452,654092,0.1220899319284023,-0.4472857419901597
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.1190856698194294
MOLM-13,56973724,0.5307136138302019,2.823032655731692
BICR 31,439501,-2.4499261286992007,-2.2321662354381537
MOLP-8,44495899,4.403173191891281,4.541868125737901
Daudi,44632017,0.5148090574579154,1.0838611345650022
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.2359123501503817
SU-DHL-1,10077130,2.6641926349973875,3.2681369737435437
SaOS-2,9549297,2.000544043325996,2.3089350530287187
LCLC-97TM1,24785538,-0.7280489014481334,1.3344504348570345
HuP-T3,10302451,3.3244038223924868,3.0143591766147457
Panc 02.03,73707398,1.687012904299387,1.180307991266282
SW948,25161177,4.032512886861284,4.097137926934978
COR-L105,17755052,1.2153053156846572,1.7101929835526413
HCC1500,11719255,2.4435237001116685,3.1221102230298534
RERF-LC-MS,5287620,-3.2415128958876123,-1.9697846958841214
WM115,72193861,3.0084505907765795,1.3858780169906042
K-562,2113511,5.3605896450220785,5.381335299817078
RERF-LC-MS,24772860,-2.3078196081029136,-2.2690769633318126
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-1.57821899028641
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,1.7691529831259722
MOLP-8,15547703,2.3372930335131663,3.114669509763707
LS180,4378219,2.066313424484697,2.6822409618839944
SW1271,168313047,1.8206519834924395,2.4053217165791536
RKO,123631,2.6120370559458155,2.2760265557358337
NCI-H2452,3011155,5.255477653901917,3.2201851439403857
Daudi,16722836,0.8830828668869325,1.5333952667080324
PaTu 8988t,6505803,-0.6279165545759258,-0.5114413444588124
SW1573,5280436,3.0542460563059253,3.153394505533252
MOLM-13,262093,0.9014616367149992,2.6275548088442098
IGROV-1,BRD-K55473186,4.387806234483854,4.097702021052896
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,2.0276770243216165
SW948,5287969,-2.4513180825948515,-1.9772070858850965
P31/FUJ,54619267,3.5260071244925575,3.9342007971372475
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.4539899714896953
SW1271,11396600,3.626770708484224,3.4309758536883517
IA-LM,676352,2.5463710414635696,2.088896150621564
SW48,148198,-2.7635683141359277,-3.548509713878981
K-562,6918328,-1.3297822316036851,-0.28710840066117727
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.410449786117574
Daudi,135423438,1.6157885595086947,2.1190856698194294
Daudi,6438330,0.2626238759101729,2.016737971321332
Daudi,44543605,5.193449926403497,4.160012106477824
SaOS-2,71751553,4.337892909522829,4.504570481353087
MOLP-8,23939,4.352572888875192,4.316990186905579
SW48,2858523,2.8468158768410965,3.0086502241129605
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,2.8341325456747963
COR-L105,9911463,4.222864246171191,3.732908427020576
SW1271,11167602,2.369450835450289,2.4705816300476062
SW48,135928012,3.696922095661256,3.8701906312906376
Granta-519,53232,4.0944047749373915,2.8161144578264046
COR-L95,2871966,-0.8178907803151099,0.29730316799892464
MOLM-13,17759555,3.648246486561575,3.5392373768677334
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,2.144908880465776
SK-OV-3,44589607,4.1377534493712265,2.659070263037081
RERF-LC-MS,44543605,4.169252612552019,4.160012106477824
Granta-519,49836020,3.8229564713378057,2.5464279658175073
SW948,5278396,3.777624651516773,3.517590475337377
HCC15,400769,-0.8695567043490428,-0.7855881743093749
ALL-SIL,3038522,2.34327176020718,2.9847437848386558
SW948,135440466,1.4177296224023617,2.1401473911994366
PaTu 8902,400769,0.6580342998730634,-0.7855881743093749
IGROV-1,5746,1.9055212643377857,0.8084551861824514
COR-L95,25195348,4.044301101066811,3.08171494739702
BICR 22,24180125,3.296229177015365,2.888353933707551
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.3848601780620533
RKO,73707398,0.9128481241529548,1.180307991266282
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.117207225291035
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.1345509900924162
IGROV-1,15953870,2.712793598656007,3.4781017448929608
WM115,71466445,4.303064097958205,3.3478019143630626
COR-L105,9956119,4.279642090153805,3.4762974507018756
BICR 22,168312962,0.5954564951508424,1.48933366232238
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.4554460238042177
LCLC-97TM1,46843906,2.6060669508648675,2.723521570705241
HCC15,9840324,6.2076616503129,5.7711165719697215
RKN,24964624,2.2448388370498704,2.2827362159867324
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.7724503678159762
K-562,10410894,3.650757753763785,3.2189174762180457
SW48,124202324,1.4616392816877528,2.1784388364790748
IA-LM,15547703,3.104636726250569,3.114669509763707
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,1.1345509900924162
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.114669509763707
MDST8,49850262,3.692937134795778,3.414452598711333
UACC-812,52947716,-6.767186414102593,-1.4012147836358484
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.4240324657892436
HEL,11427553,2.263048189869726,2.578035472123966
IGROV-1,5281321,-1.4962463697398798,-1.3097742666845045
IGROV-1,135421197,1.96820638017286,1.8199795612290348
LCLC-97TM1,104842,-3.469971777740615,-3.040993872013826
RCC10RGB,374536,3.743226525407361,1.7732341041149164
COR-L95,107985,-2.989419812710682,-3.5771139994401464
RCC10RGB,72199289,4.762339751475906,5.20760114161056
NCI-H1568,11485656,1.8106242285910237,2.2397291078765758
MOLP-8,9549297,1.4376511571672042,2.3089350530287187
Daudi,24951314,0.2263717121921743,1.227614980483031
BFTC-909,7326481,3.4905195575106527,2.957630994714242
BFTC-909,6623618,2.802037410677928,2.1468722777789853
HuP-T3,5287620,-3.5836939395445913,-1.9697846958841214
COR-L95,568763,-0.4949329271490838,0.28862358029973745
SaOS-2,216239,3.028726771334262,2.1474208097396077
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.4554460238042177
Daudi,5311281,1.0302556341787754,2.22503529708604
LS411N,3503,3.033347172376105,2.2426858883255045
BICR 22,4705,3.4365696424802477,3.0428654274536564
Granta-519,6918638,-1.0102021398050984,0.3065957347013626
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.477950770888125
SW48,54618164,3.7830586534540616,4.02740727006158
MOLM-13,25105715,3.5182090361281326,3.410449786117574
Daudi,11175137,1.084300991963852,2.477950770888125
SW1573,42642645,1.1024283721976142,0.7845058245277501
P31/FUJ,11364421,-5.080526011220062,-2.2476185097624475
MOLP-8,12003241,-1.4499361325619826,-1.0889198012759371
Granta-519,10410894,1.4137063553430784,3.2189174762180457
RCC10RGB,57519531,5.003664553369681,2.4211376500246136
HEL,11625818,4.404342627749774,4.10791451089978
SK-HEP-1,1242560,3.752923936287399,3.534393132486151
SW48,3062316,-0.5038339303633423,0.9747482048219924
HEL,219104,3.0071408108258253,3.5366182443481806
SK-CO-1,3025944,4.807689572392986,4.206240213808089
SK-OV-3,52912189,0.2062426244094619,1.6723266261402217
COR-L105,51039095,3.4251018662752073,2.682611194240459
HEL,65064,3.1933308972510113,4.739517756868576
Daudi,9929138,3.458684768924583,5.665997549800987
SK-OV-3,11404337,1.4011927232423718,-0.4254091153988029
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,2.957630994714242
MDST8,11178236,-3.494725666780331,-3.539769866873396
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.5350305453431912
WM115,119182,-0.4924283039006125,-1.3340160156368264
COR-L95,56649450,4.0191520211736895,2.999158341046921
HCC15,5278396,3.283293724206623,3.517590475337377
LS180,54143018,-0.5111931850291043,0.31711465707788644
MOLM-13,10427712,3.427914513597021,4.184108330161863
NCI-H2452,1566236,3.5735792412039022,2.2263982365179604
ALL-SIL,452548,-3.3771532504793194,-0.31026393275322106
KU-19-19,409805,5.730069773001202,4.6745070702664995
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.38762532684053896
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.5392373768677334
SW948,11955716,-2.1355637415890323,-1.4856643985320634
RERF-LC-MS,11609586,3.546222239883878,2.621607380466062
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,2.699201704606489
WM115,5311,1.988201906885666,1.2663000347984639
HCC1500,5311,1.250436307916732,1.2663000347984639
KU-19-19,5282054,4.451216911386669,3.5628845676855256
PaTu 8902,4788,6.453607861068675,5.493389053048461
PaTu 8902,4261,2.3507697687761224,1.4288257082744877
SW48,68056272,2.992212540747962,3.2394422692786446
HCC1500,56963564,1.3630245510511625,0.2569389627451253
Panc 02.03,25183872,-0.079390979301081,-0.902802947451298
LS411N,11964036,1.3999141622104765,1.2382789669868983
BFTC-909,135440466,2.535274686795805,2.1401473911994366
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.93841691857644
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,3.9342007971372475
LS180,25183872,-0.6080839156226316,-0.902802947451298
PaTu 8902,71304818,2.9919229428361263,2.396178486082573
BICR 22,216345,4.525930969601246,3.7540083674013296
NCI-H1568,374536,1.2941902477204823,1.7732341041149164
LCLC-97TM1,135423438,1.8911988038183152,2.1190856698194294
NCI-H1568,56963564,0.2273202395709376,0.2569389627451253
K-562,9927531,3.3022164605184763,4.578027762171671
SW948,2858523,3.1308292618704905,3.0086502241129605
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.5350305453431912
SK-OV-3,5287620,-0.5544150043477152,-1.9697846958841214
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.517112669127141
NCI-H1568,5311037,3.1621369524545155,3.9433489656963694
WM115,15953870,3.7155207356015207,3.4781017448929608
Daudi,445643,2.8458589584694307,3.9383569867901693
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.4554460238042177
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.6944377068647134
NCI-H2452,156414,1.7996451609117237,1.1062813598863759
Daudi,53301938,4.372641532954565,1.0245419866483008
PaTu 8902,9907093,4.385383441203628,4.134688957161641
SW48,136227924,1.7122170056378203,2.867001064974719
P31/FUJ,4096211,0.7441609883240002,1.856021664538426
IGROV-1,6610355,3.969940996770339,4.45123297085854
PaTu 8902,4917,3.0649190232675525,3.079848880785536
IGROV-1,613753,3.483244781428779,3.1495845971526135
SU-DHL-1,3136844,3.883215489826005,4.214923916993912
HEL,446155,2.11086977892158,2.662752180605146
HuP-T3,46907787,1.2763139172323097,1.584957029505121
ALL-SIL,2729026,2.163276094007301,2.6325975116350393
NCI-H2452,54613361,3.2620625907056744,-0.11678183903518824
BICR 22,448949,3.2035793217055124,1.9537365892294993
SW948,5280436,1.724516723779293,3.153394505533252
BICR 31,25154868,5.458998944130281,4.289494395804131
LCLC-97TM1,44632017,0.6758650901814578,1.0838611345650022
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-3.5071094923394703
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.456683733824014
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.4288257082744877
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.860017480413567
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,0.7577083020821866
SW948,409805,5.995103866916248,4.6745070702664995
P31/FUJ,16736978,2.2012912480094444,1.3934160091023764
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.78247230086659
PaTu 8902,19582717,4.67665303596855,3.9198146524152833
SaOS-2,24775005,3.5680490412807555,3.778654827630856
Granta-519,327653,2.833903719231272,3.018652636936018
ALL-SIL,446155,2.369103686447931,2.662752180605146
HCC1500,445643,3.796669497386567,3.9383569867901693
COR-L95,7326481,3.0640813007839105,2.957630994714242
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,1.7724503678159762
LS180,53232,2.536426383073758,2.8161144578264046
P31/FUJ,10127622,1.4388313131004449,3.6054187258933235
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,2.9860814461500107
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.11065310288154762
SaOS-2,11214940,4.2656495802712735,1.8119431265240042
RKO,637858,2.400395947377078,1.8880097009592578
NCI-H2452,3552672,4.527548939486843,2.8413574589562494
Daudi,168312962,0.2834059413422853,1.48933366232238
P31/FUJ,216468,2.1049028903625673,2.5020743765616316
MOLP-8,11656518,1.844531268869525,1.5480979328089313
MOLP-8,5426,4.334733303826167,4.746710128133936
SW48,54454,2.31662951125423,2.548844675602096
K-562,4521392,4.220123235241678,4.280943620409205
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,3.0665232817889554
RKO,1641662,3.3091455873155367,3.3408828038827
BICR 31,135875424,5.0736941678127945,3.743891076041643
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.102163121425029
Daudi,44607530,0.9746569917988196,1.715838652040812
SK-HEP-1,25150857,3.0587845310763297,2.336756962918186
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-1.1532493383305307
Granta-519,23635314,-4.977140911540282,-1.8612337831613235
LCLC-97TM1,24753719,4.6973214087473405,4.143618673527016
P31/FUJ,11640390,3.1324724534083277,3.2466540190485103
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,0.9218131221296273
K-562,6450551,-0.0734681627771844,2.361538429265863
Daudi,56946209,-7.191237665956405,-4.2202975286026225
Panc 02.03,25154868,5.464083731960118,4.289494395804131
P31/FUJ,5311,0.3390662723443479,1.2663000347984639
SaOS-2,11485656,2.155652122560971,2.2397291078765758
IGROV-1,3025944,3.9702787396819503,4.206240213808089
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-3.5071094923394703
PaTu 8988t,11494412,2.1257430484232525,1.4248282417532188
IGROV-1,53495165,1.3981720287668329,-0.19108456656304296
LCLC-97TM1,42642645,0.0997949580151915,0.7845058245277501
HCC1500,36314,3.7134374865247017,-1.2422497803043113
NCI-H2452,3815108,3.5712952235347455,2.885036533777781
WM115,11214940,3.8761690772861126,1.8119431265240042
SW48,676352,1.4830170410483523,2.088896150621564
MOLM-13,25262965,-3.0495150612642465,-1.6224193967571534
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-1.1532493383305307
Panc 02.03,148198,-4.053337817942692,-3.548509713878981
SW1573,71466380,3.629171273590213,4.275465599745589
SU-DHL-1,151289,-1.0536473601541108,0.9562867634504244
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,0.7705130043498147
COR-L105,285033,-1.0049053408998423,-2.1791335812392365
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-1.6778195760397165
Daudi,135440466,1.490781603812653,2.1401473911994366
NCI-H2452,6918878,3.5446658281374277,1.9069091595174383
PaTu 8902,123631,3.453096327622384,2.2760265557358337
COR-L95,15547703,3.222652754514603,3.114669509763707
NCI-H1568,123631,1.2596294102093508,2.2760265557358337
P31/FUJ,216345,2.9363986514954203,3.7540083674013296
HEL,4261,0.4865008011530605,1.4288257082744877
SK-HEP-1,5280436,-0.1709015599208282,3.153394505533252
SaOS-2,25062766,1.5016836694759386,2.0522756909743434
RERF-LC-MS,51037431,2.0455212647735364,3.10082796495436
HCC15,11656518,2.9308462534519024,1.5480979328089313
RKO,10127622,3.209405126939437,3.6054187258933235
COR-L105,9927531,5.197941564874311,4.578027762171671
NCI-H2452,6623618,2.534886377212576,2.1468722777789853
SK-HEP-1,16725315,5.326615386804391,4.150060666188836
SW1271,11152667,-1.5987482479879582,-0.5866736007906306
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.2834565267098785
SU-DHL-6,3825829,3.5283611337160155,3.8869840981378028
RCC10RGB,11656518,3.9855029209510215,1.5480979328089313
SaOS-2,67156097,-1.585481519484996,-1.0279170724737183
BFTC-909,5566,2.8568699448622263,3.029152149495273
SW948,4788,6.033471365822279,5.493389053048461
LCLC-97TM1,1750826,-2.0890062190589544,-1.4739669220989267
MDST8,3689413,-1.6812703512916511,-0.4039154566871359
SW48,9926054,0.5681768331785455,1.9546333131599372
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,1.2359123501503817
SU-DHL-1,262093,1.7952973078733698,2.6275548088442098
BFTC-909,439501,-2.4866456286351095,-2.2321662354381537
HCC15,123631,2.7523193051058974,2.2760265557358337
P31/FUJ,60750,-3.4241008025920396,-2.435153852929516
Daudi,9927531,3.2507934675389447,4.578027762171671
MOLM-13,5281672,4.456656164404507,4.4250678360691875
IGROV-1,11222830,1.5703285223102077,1.5350294688251391
SK-CO-1,5311,2.0479844637297617,1.2663000347984639
COR-L105,15953870,3.0827686267342957,3.4781017448929608
PaTu 8988t,9866186,1.4965239773376473,0.7577083020821866
IGROV-1,124202324,2.2563058955522157,2.1784388364790748
PaTu 8988t,9936388,-7.900053622036252,-1.7988236137529168
HCC1500,11152667,3.4439033763408644,-0.5866736007906306
MDST8,54618305,4.422279328619345,4.084826955496459
MOLM-13,3825829,3.189823245525434,3.8869840981378028
BICR 22,3081361,1.798482521796042,2.3568884936851697
SW1271,3854666,4.252835819462087,1.85063491630251
HuP-T3,285033,-3.1273004056463916,-2.1791335812392365
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,1.133687221210622
SK-OV-3,6610216,4.5015440272840275,4.26979744561799
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-4.2202975286026225
SU-DHL-1,10090485,4.45721233802345,4.776418823086279
COR-L105,54765302,4.547071050564395,3.905112278839675
SaOS-2,44491742,4.263847553999534,4.1566745174283435
RCC10RGB,BRD-K55473186,4.42890698658841,4.097702021052896
SW1271,2742550,3.530952260660614,3.8595787492072238
Daudi,148198,-7.679285276133229,-3.548509713878981
RKN,104842,-2.3241286690000265,-3.040993872013826
SK-CO-1,3689413,1.2567954519757167,-0.4039154566871359
Panc 02.03,24180719,3.694319415808187,3.437709308952337
MDST8,637858,1.7716899628344815,1.8880097009592578
BICR 22,11404337,-1.5250786338229352,-0.4254091153988029
NCI-H1568,82146,4.486561599154294,3.596877521367719
LCLC-97TM1,52912189,1.3140510236946998,1.6723266261402217
BFTC-909,6918328,0.6354681535452512,-0.28710840066117727
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,1.7724503678159762
SW48,10385095,0.7767009249070084,1.2480392352773622
RKO,56649450,4.8662264096692684,2.999158341046921
SW948,45279963,3.8052773477912782,3.660133434789582
RCC10RGB,3038522,2.595581097335362,2.9847437848386558
BICR 31,3689413,0.760898743899782,-0.4039154566871359
RERF-LC-MS,5282054,4.065617468844444,3.5628845676855256
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.0665232817889554
K-562,25161177,2.405708421255354,4.097137926934978
ALL-SIL,11497983,-4.396279985993102,2.348631818792911
SW1271,446155,1.3369653200346725,2.662752180605146
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.28862358029973745
Daudi,10296883,2.545577320776033,3.795028277273254
COR-L105,52912189,0.1952406080619365,1.6723266261402217
RERF-LC-MS,36314,3.6884025033565897,-1.2422497803043113
SU-DHL-1,25062766,2.372674975426994,2.0522756909743434
BICR 22,126941,-2.054722221433598,-2.8921209077069348
P31/FUJ,46398810,1.6622931867453647,2.510712955745063
K-562,15953870,3.5143251027161613,3.4781017448929608
MOLP-8,89183176,2.6780353354925706,3.4938336610308007
MOLM-13,9967941,3.903949930542719,3.6034131982542865
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.4211376500246136
SW1271,5291,3.239071539524422,3.5530526201153183
K-562,56963564,-0.0263606087054764,0.2569389627451253
LCLC-97TM1,54613361,-0.0023609252607709,-0.11678183903518824
Granta-519,24771867,-1.6352261980607803,1.5171458615349627
RERF-LC-MS,5287969,-2.0564845219287555,-1.9772070858850965
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,0.11065310288154762
IGROV-1,168312962,3.022863957843741,1.48933366232238
SaOS-2,6505803,-1.001039194104569,-0.5114413444588124
Panc 02.03,5460769,1.6540560754425335,2.3447175553942796
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.0163468544412688
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.477950770888125
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,1.78247230086659
HCC15,135440466,1.473766152733558,2.1401473911994366
Panc 02.03,448949,3.46549633046868,1.9537365892294993
SW48,119182,-2.1563748503052103,-1.3340160156368264
SK-OV-3,36462,2.5052417836250496,1.5076124324231743
LS411N,46199207,3.2917214979820506,3.1312366616263048
Daudi,71466380,2.956949879575845,4.275465599745589
RCC10RGB,44566777,1.0790521939265936,0.6972581949653407
P31/FUJ,446155,2.867326521256313,2.662752180605146
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.5478733404534093
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.38762532684053896
BICR 31,71576739,4.400142576070014,2.9192684489841567
SW1573,6623618,2.3278245092002936,2.1468722777789853
ALL-SIL,969516,2.19071597716798,2.7772567284956553
COR-L105,241158,4.618729119434587,3.598987869990464
Daudi,24797083,-0.0937737057199073,1.277886491385028
HEL,5566,2.9283259495001133,3.029152149495273
BICR 22,44137675,4.05989667865121,3.337336921695599
Granta-519,3503,1.8528122642218805,2.2426858883255045
WM115,5287969,-2.3112325385791093,-1.9772070858850965
NCI-H2452,3062316,-0.5574526988915461,0.9747482048219924
PaTu 8988t,12003241,-0.7673639150441187,-1.0889198012759371
SK-CO-1,44589607,2.7511810771029213,2.659070263037081
RKN,23939,4.640348748177221,4.316990186905579
IGROV-1,72734382,4.633226130326536,4.3578051352274185
BICR 22,46215462,1.5294433170369757,1.762132613731386
MOLM-13,2949965,3.7040534246432624,2.715769249487813
HCC1500,46215462,1.5254849350202837,1.762132613731386
K-562,25183872,-1.1768480549542706,-0.902802947451298
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.3765538821264742
IGROV-1,3081361,0.99973562532788,2.3568884936851697
NCI-H1568,9908783,4.863315848037401,5.056023266605311
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,2.9860814461500107
SW48,25195348,3.355247289110599,3.08171494739702
HCC1500,135411,2.801194317933856,0.5181226666256136
BFTC-909,10410894,3.671861694905457,3.2189174762180457
COR-L105,2708,5.5167338716905885,4.591243765137335
SW1271,9927531,4.558020454092029,4.578027762171671
NCI-H1568,44462760,4.02669785413772,3.143997930658831
COR-L95,11612883,2.9601999054336106,2.6386482274158856
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,2.699201704606489
SaOS-2,46199207,3.779046434903352,3.1312366616263048
MDST8,15547703,1.8320295844693912,3.114669509763707
SK-HEP-1,23725625,4.972795252846745,4.726527081330662
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.2349426527428076
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.261852028375895
HCC1500,24797083,1.1358144177435396,1.277886491385028
MOLM-13,11647372,-0.8512376057901615,0.8954839509867156
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,1.4539899714896953
K-562,5335621,4.97915810125604,4.560420742529089
COR-L95,2858523,3.028185885315027,3.0086502241129605
HCC1500,9911463,3.4774936591741703,3.732908427020576
RKO,452548,0.942587279069954,-0.31026393275322106
MOLP-8,126941,4.086011311839599,-2.8921209077069348
P31/FUJ,3384730,-0.5934712638177775,2.4620443610818112
LCLC-97TM1,16725315,3.732120983026874,4.150060666188836
HuP-T3,60700,1.2793809884126126,-0.4482559328189002
SaOS-2,9956119,4.053594307296879,3.4762974507018756
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,0.11065310288154762
SK-CO-1,46199207,2.9466484543003197,3.1312366616263048
SK-OV-3,11175137,3.182781765506491,2.477950770888125
LS180,11222830,1.8684195070218452,1.5350294688251391
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.0276770243216165
K-562,23582824,1.4169931108164455,0.7400136078733197
COR-L95,3025986,-1.3264557881304966,-0.8978770871810051
NCI-H2452,16065773,1.9140766169124153,2.3641186374244216
MOLM-13,54454,1.7928295036604598,2.548844675602096
LS180,119607,5.442141379439383,5.129253777214588
Granta-519,644241,4.377614733152813,2.1017288356510795
IGROV-1,46199207,3.293579955374855,3.1312366616263048
IGROV-1,3038522,3.6829378423722416,2.9847437848386558
HuP-T3,135875424,4.261865095251217,3.743891076041643
IGROV-1,89928392,1.4824233552493276,1.344325138639762
KU-19-19,5280436,3.7375704611092657,3.153394505533252
SW1573,54678924,1.9184875438403524,1.9473085147454567
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,2.0276770243216165
SK-HEP-1,11364421,3.0648019303900624,-2.2476185097624475
P31/FUJ,11507802,-0.4015560413947272,1.3590460953824346
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,3.0665232817889554
NCI-H1568,89928392,1.1949851991515912,1.344325138639762
WM115,11222830,1.2308018153574234,1.5350294688251391
SU-DHL-6,9908783,5.938767725153886,5.056023266605311
HCC1500,25150857,1.1801270031504156,2.336756962918186
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,0.5935480801734145
NCI-H1568,4521392,3.7910777113602303,4.280943620409205
COR-L95,25183872,0.0728708482253017,-0.902802947451298
IGROV-1,227681,3.5439813498262347,2.9941233013598234
PaTu 8902,6918878,3.691618711508776,1.9069091595174383
K-562,1242560,3.4884556471232293,3.534393132486151
BICR 31,53495165,2.344314514368125,-0.19108456656304296
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,2.144908880465776
BICR 22,17755052,1.4011116930942769,1.7101929835526413
Daudi,17755052,0.1512024273398794,1.7101929835526413
HEL,67156097,-1.6398778776875675,-1.0279170724737183
BICR 31,44486219,4.3544536670303025,4.281343219898981
SU-DHL-1,119182,-1.9070320733957784,-1.3340160156368264
WM115,135440466,3.0586385090162085,2.1401473911994366
IGROV-1,11152667,-1.4116509977729443,-0.5866736007906306
BICR 31,10385095,1.3759128494100044,1.2480392352773622
RKO,969516,2.537841036798478,2.7772567284956553
Granta-519,123631,2.886011281362197,2.2760265557358337
HEL,4477,0.140225607998234,0.5570685949048098
HCC15,568763,0.562622735167329,0.28862358029973745
HCC1500,9926054,1.7367797854287812,1.9546333131599372
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.0163468544412688
SW948,444795,4.960330673315111,3.7799917274901733
SW948,119607,5.410714093672246,5.129253777214588
RERF-LC-MS,9936388,-8.273067767637817,-1.7988236137529168
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.11065310288154762
KU-19-19,4261,0.7367611445661113,1.4288257082744877
SU-DHL-6,387447,-5.553627026103078,-4.3765957253648695
SK-HEP-1,3825829,4.395950359013269,3.8869840981378028
COR-L95,9903786,3.7357721387912513,2.756077717004494
SK-HEP-1,44185566,3.236949395761265,2.4057100644299436
COR-L95,73707398,1.0347493154641954,1.180307991266282
SW1271,66577038,2.7134536861777807,2.9870697487432882
RERF-LC-MS,36462,1.1230283698314445,1.5076124324231743
LS180,5278396,3.460947025625347,3.517590475337377
Daudi,3062316,-6.775500959037878,0.9747482048219924
K-562,107970,1.9304513771469212,2.3029314718240044
HCC1500,3854666,1.4433352503078565,1.85063491630251
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,0.4199080872215506
HCC1500,11455910,0.2448151005088887,0.9557745122323711
MOLP-8,46907787,-2.434163875600539,1.584957029505121
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.78247230086659
RERF-LC-MS,53392493,1.949934555719578,2.4832542501558077
MDST8,6610216,4.3863838734153,4.26979744561799
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,0.9218131221296273
LS411N,216345,4.369072592416217,3.7540083674013296
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,1.710700657959646
SW48,2841722,4.762546821441249,4.375424781932207
SW48,9956119,3.393025538441131,3.4762974507018756
PaTu 8988t,44607531,1.764787957031886,1.48117322485652
HCC15,16741245,4.574628343563009,3.801678648950925
SW948,89928392,1.4444572178844948,1.344325138639762
SK-OV-3,25126798,3.9960730178767,3.7921789378214816
RKN,54143018,1.3184566027416504,0.31711465707788644
NCI-H2452,24180719,2.8480667171601852,3.437709308952337
COR-L95,9915743,0.942320604231091,0.5935480801734145
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,1.1345509900924162
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,3.0665232817889554
ALL-SIL,387447,-4.904935645240703,-4.3765957253648695
SW1271,54649381,4.56488530045006,3.7880999548273127
KU-19-19,4259181,2.3072251676522835,0.11236669175956715
SW948,25105715,3.628389782970242,3.410449786117574
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-1.1532493383305307
LS180,19582717,2.9052461851112565,3.9198146524152833
Daudi,676352,1.3635905677607614,2.088896150621564
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.6778195760397165
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,-0.30112130782396007
SW48,9915743,2.691515978939234,0.5935480801734145
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.344610112805219
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,1.4554460238042177
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.4554460238042177
Granta-519,3025944,4.149663954634143,4.206240213808089
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.156087356848057
SW1271,2841722,4.036476035404804,4.375424781932207
SW948,53232,2.3961531254319466,2.8161144578264046
SK-CO-1,25183872,-2.2315902989777725,-0.902802947451298
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.0163468544412688
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,2.0276770243216165
P31/FUJ,6918328,-1.424420935100909,-0.28710840066117727
HuP-T3,71680916,4.329506074723249,4.641848024405652
P31/FUJ,262093,1.035147161622815,2.6275548088442098
SaOS-2,11228183,2.7080984165628754,1.8712017695678478
NCI-H1568,6852167,2.376266672184036,2.69961445504738
RKO,4477,1.7070595719756474,0.5570685949048098
Granta-519,46199207,2.493616790778817,3.1312366616263048
IGROV-1,5470400,-0.2457809435208252,-0.3765538821264742
IGROV-1,409805,5.990596261907717,4.6745070702664995
PaTu 8902,15983966,2.4191743534269463,-1.6396194068861514
RERF-LC-MS,31703,0.0184985959907658,-1.182053713238432
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.6778195760397165
P31/FUJ,46224516,2.421293495972869,2.370954746557396
BFTC-909,10127622,5.216996592058982,3.6054187258933235
HuP-T3,55508,4.397520768584908,3.1188086218267883
HuP-T3,10385095,0.7178899916931367,1.2480392352773622
RKO,16013152,4.038378204585466,4.119375381760217
RCC10RGB,6918328,1.0053978601828475,-0.28710840066117727
SW948,9444,4.221430823371368,4.054048446110465
WM115,53392493,1.845382538513501,2.4832542501558077
HCC15,44185566,3.08334642122707,2.4057100644299436
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.4199080872215506
UACC-812,25262965,-4.249514707304517,-1.6224193967571534
WM115,51037431,2.6247692404465868,3.10082796495436
SW948,5311281,0.0185560472432188,2.22503529708604
HCC15,44607531,1.6724658843452191,1.48117322485652
MOLP-8,6450551,1.973885798572914,2.361538429265863
MOLP-8,7251185,0.7855879803762651,2.4347287977616
SaOS-2,5479543,4.655800274360292,3.2992765862159215
IGROV-1,4917,2.985904350427039,3.079848880785536
Daudi,3825829,3.2006002080342544,3.8869840981378028
UACC-812,148198,-2.7739066615342236,-3.548509713878981
Granta-519,1242560,3.55554960326222,3.534393132486151
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.4482559328189002
HEL,17759555,4.966386069896687,3.5392373768677334
SW1271,119607,6.141140067390372,5.129253777214588
Daudi,3038522,1.648170780235362,2.9847437848386558
PaTu 8988t,969516,4.442820223092304,2.7772567284956553
HuP-T3,4521392,4.351966444408677,4.280943620409205
BFTC-909,2113511,5.65564772398506,5.381335299817078
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,2.756077717004494
SW1271,24856436,1.0602186643720275,0.17994774592918095
HEL,24180125,3.3188099636510495,2.888353933707551
WM115,10077130,4.784184630126653,3.2681369737435437
SK-HEP-1,5281321,-2.075735756673856,-1.3097742666845045
UACC-812,10184653,-4.111635019949291,1.1325795715302809
BICR 31,55283,4.60336009153674,2.1635123760949786
MOLM-13,11178236,-3.317575610691226,-3.539769866873396
COR-L105,57519531,4.553300256365288,2.4211376500246136
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,2.885036533777781
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,0.38762532684053896
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,2.9860814461500107
ALL-SIL,11317348,-1.373590167325895,2.3090854497210964
LS411N,6914657,-4.299110458286086,-4.170094408243688
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-1.0889198012759371
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,2.948755251800144
LS180,57519531,1.9809210286085912,2.4211376500246136
LCLC-97TM1,60750,-0.9490237417659374,-2.435153852929516
SU-DHL-1,49850262,3.2383746822480384,3.414452598711333
SK-OV-3,9911830,2.8997016876614863,2.4240324657892436
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.11065310288154762
RERF-LC-MS,15983966,-4.090154567310139,-1.6396194068861514
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.0276770243216165
RERF-LC-MS,24951314,1.4075693116182684,1.227614980483031
SK-HEP-1,11494412,3.332434654266433,1.4248282417532188
BICR 31,51039095,3.0794813668201546,2.682611194240459
Panc 02.03,11178236,-2.8028080099743624,-3.539769866873396
SU-DHL-1,24772860,-2.736237819232434,-2.2690769633318126
Daudi,6610216,3.2134188501838494,4.26979744561799
NCI-H2452,53392493,2.782389188766079,2.4832542501558077
NCI-H1568,445091,4.097432324473231,4.3274252089919045
K-562,9926054,1.8612748023096723,1.9546333131599372
HCC1500,24978538,-1.6021545775061432,0.6273547794147847
COR-L95,25126798,4.203058281978897,3.7921789378214816
LS180,44819697,-0.9723932292423276,-0.6109288989041974
BICR 22,5281321,-1.7077192732848236,-1.3097742666845045
PaTu 8902,656346,4.145274855759625,0.7582608913284792
BFTC-909,42642645,1.561027146692027,0.7845058245277501
IGROV-1,49836020,5.658436828096057,2.5464279658175073
Daudi,168313200,1.4988300519601074,2.9593589282331023
MOLM-13,24779724,4.7751629548446894,4.725601600845458
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.5071094923394703
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.261852028375895
RKN,2828334,5.965623907482328,6.082620037824382
NCI-H2452,5280436,4.838161671645799,3.153394505533252
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,2.0522756909743434
BICR 22,637858,2.779101364791116,1.8880097009592578
RERF-LC-MS,56963564,0.3267097404636779,0.2569389627451253
RCC10RGB,2949965,2.9970768068045577,2.715769249487813
WM115,10074640,2.7921613557017473,3.066922642013836
KU-19-19,25154868,3.204596310046931,4.289494395804131
BICR 22,49793307,-5.020228152199773,-2.848251171596848
SU-DHL-1,5460769,-0.475427190707336,2.3447175553942796
NCI-H2452,9868037,3.199558399493599,2.82815333449006
SaOS-2,9823820,4.1201217228566565,3.7294514785702977
SU-DHL-1,9444,2.825333870881758,4.054048446110465
HCC1500,53495165,1.6495193303321407,-0.19108456656304296
RCC10RGB,9952709,4.37754893062567,2.9381980631482683
Granta-519,73707398,-0.348610297970246,1.180307991266282
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.0838611345650022
MOLM-13,26596,-2.2068545341754295,-1.5346517263124715
K-562,52912189,0.5484446218637569,1.6723266261402217
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-1.261852028375895
IGROV-1,375860,0.7731558163124775,-0.30112130782396007
IA-LM,11964036,4.998383188027045,1.2382789669868983
MDST8,387447,-2.914953377887094,-4.3765957253648695
IA-LM,9915743,1.455667571666015,0.5935480801734145
LS180,6918328,-0.1069758097146191,-0.28710840066117727
PaTu 8988t,6610216,5.064895456595333,4.26979744561799
SU-DHL-1,104842,-6.410970225096146,-3.040993872013826
P31/FUJ,56946209,-4.67609529352027,-4.2202975286026225
SW948,6917907,-5.884345700630281,-4.864372369867458
BICR 22,53232,4.030024483575548,2.8161144578264046
PaTu 8902,568763,1.8312011651342244,0.28862358029973745
ALL-SIL,6505803,0.7073572306495796,-0.5114413444588124
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.2359123501503817
LS411N,10302451,4.220534629483678,3.0143591766147457
RKN,11238147,3.9265768628415487,2.694366237977623
PaTu 8902,135440466,3.176809791892748,2.1401473911994366
MOLM-13,119607,3.836878131829583,5.129253777214588
HEL,11612883,1.9962168488272864,2.6386482274158856
COR-L95,11485656,1.8696119642586884,2.2397291078765758
MDST8,675434,4.4652962141660595,4.463597576567934
IGROV-1,11507802,1.5049911819213722,1.3590460953824346
SK-HEP-1,2708,5.260013220141412,4.591243765137335
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.102163121425029
SU-DHL-1,5738263,2.757121948334044,3.3050405288071003
Granta-519,54626689,4.523537450364534,4.561309020020982
SW948,135421197,1.7477185084776832,1.8199795612290348
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.5350305453431912
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-1.1532493383305307
BICR 22,4917,3.6655313291566327,3.079848880785536
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.195187949563447
MOLP-8,16736978,0.6033273838828506,1.3934160091023764
SW948,11396600,3.556168564723583,3.4309758536883517
IGROV-1,2113511,5.982902824257526,5.381335299817078
Panc 02.03,16725315,5.289216895099664,4.150060666188836
K-562,9549297,1.810271401171294,2.3089350530287187
SU-DHL-1,60700,-3.861884777487788,-0.4482559328189002
MDST8,89183176,5.515733421140453,3.4938336610308007
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,2.474523360549852
WM115,10113978,3.3670712397266698,3.010980031724017
SW48,25154868,5.084018259884556,4.289494395804131
Granta-519,107985,-5.079154139769343,-3.5771139994401464
IA-LM,15953870,4.160803294534019,3.4781017448929608
RKO,19582717,4.345992572306107,3.9198146524152833
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,2.474523360549852
ALL-SIL,2742550,3.1857763586562577,3.8595787492072238
COR-L95,375860,0.21091681928276,-0.30112130782396007
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,1.2349426527428076
COR-L95,702558,5.203109308170341,4.9782351440396395
ALL-SIL,5329102,0.5818325089631969,2.031058842574058
MDST8,9911463,4.372295154952754,3.732908427020576
LS411N,44607531,1.9881484499388475,1.48117322485652
Daudi,68056272,2.8001037652797818,3.2394422692786446
MOLP-8,4521392,3.737637773211522,4.280943620409205
MDST8,20959075,-2.855250986095604,-3.173507428051674
IA-LM,400769,-0.2498086542393983,-0.7855881743093749
IA-LM,16722836,2.5380745713557893,1.5333952667080324
HCC15,445091,5.451686926059382,4.3274252089919045
HCC15,11507802,1.1916077520331714,1.3590460953824346
MOLM-13,9903786,0.7109980532390177,2.756077717004494
SW948,24901704,3.213341299668661,3.1103746959488285
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.370954746557396
SU-DHL-1,10427712,3.576020229714379,4.184108330161863
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.5771139994401464
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.7691529831259722
Granta-519,51039095,1.7779321154646133,2.682611194240459
RERF-LC-MS,65628,5.693639897620667,4.026684176415168
SaOS-2,2828334,6.074749772556143,6.082620037824382
SW48,3815108,2.5063295630391806,2.885036533777781
SK-CO-1,11626560,0.3943389380121196,1.6795489442409048
HEL,107985,-3.965696416470184,-3.5771139994401464
KU-19-19,60700,0.8700483452505813,-0.4482559328189002
Daudi,5280436,1.0789231424034973,3.153394505533252
MOLP-8,54613361,-0.8734170036218252,-0.11678183903518824
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-2.2321662354381537
SK-CO-1,24978538,-0.5683899539074425,0.6273547794147847
SU-DHL-1,54649381,3.644517842316546,3.7880999548273127
SU-DHL-1,44493528,3.922242735424854,4.333966846288542
P31/FUJ,5282054,2.945149434876345,3.5628845676855256
SK-OV-3,49850262,4.3958011115665006,3.414452598711333
IA-LM,10184653,0.8510906912410041,1.1325795715302809
NCI-H1568,36314,4.092621701538515,-1.2422497803043113
BICR 22,46843906,2.889476079217857,2.723521570705241
SU-DHL-6,9444,3.111459322097769,4.054048446110465
ALL-SIL,10410894,2.969142576372873,3.2189174762180457
ALL-SIL,9549297,0.2429486516660708,2.3089350530287187
Daudi,46926350,-6.041265180126537,-4.429063309555999
RKO,1750826,1.760307875609834,-1.4739669220989267
PaTu 8988t,4477,0.4312443696129938,0.5570685949048098
Granta-519,5282054,2.5814189459390957,3.5628845676855256
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.3848601780620533
IA-LM,16065773,2.795317455347302,2.3641186374244216
RCC10RGB,156422,4.423389512885201,3.8435202478608215
IGROV-1,11214940,1.360660548899077,1.8119431265240042
Panc 02.03,16720766,4.473005389666903,0.4291253754884592
Granta-519,3081361,1.7559432073327723,2.3568884936851697
MOLP-8,52947716,-7.872176911001468,-1.4012147836358484
KU-19-19,5281321,2.871465791170073,-1.3097742666845045
IGROV-1,5282054,3.614574021382022,3.5628845676855256
MDST8,4261,1.8348924416255383,1.4288257082744877
MOLP-8,100016,7.090961588333011,5.87798299213578
Granta-519,168313200,2.290121636997186,2.9593589282331023
HCC1500,462382,0.0787876699821948,0.5714028853239661
IGROV-1,10113978,2.874171865860951,3.010980031724017
IGROV-1,BRD-K55473186,4.387806234483854,4.097702021052896
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.5530526201153183
P31/FUJ,10410894,5.368264014178215,3.2189174762180457
BFTC-909,3025986,-2.0399601309440336,-0.8978770871810051
MOLP-8,24771867,-5.187641849515016,1.5171458615349627
BICR 31,11214940,4.966543096658616,1.8119431265240042
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.2359123501503817
UACC-812,9936388,-5.022392750910281,-1.7988236137529168
ALL-SIL,24772860,-3.38763553354356,-2.2690769633318126
MOLP-8,11626560,-0.689912231097504,1.6795489442409048
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.2359123501503817
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.5478733404534093
SW948,262093,3.1804911198162036,2.6275548088442098
SW948,216239,1.8650010893863176,2.1474208097396077
SW948,11364421,-5.809742751249139,-2.2476185097624475
HEL,10302451,3.814274659252608,3.0143591766147457
K-562,46398810,1.812730009869126,2.510712955745063
Daudi,216239,1.5780166370194677,2.1474208097396077
LS411N,10231331,0.2083934704449227,1.6547412916072393
MOLP-8,46926350,-5.986975596425451,-4.429063309555999
SK-HEP-1,11964036,3.325100881793091,1.2382789669868983
Granta-519,11485656,1.6660529916447626,2.2397291078765758
K-562,2871966,0.96376622724181,0.29730316799892464
P31/FUJ,54454,2.7341923640247123,2.548844675602096
SW48,54613361,-1.8010952783890095,-0.11678183903518824
NCI-H2452,46843906,4.012061875028764,2.723521570705241
HEL,135875424,2.9448279330391927,3.743891076041643
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.150060666188836
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.0058447943574325
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.682611194240459
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,1.1345509900924162
HCC1500,54678924,1.846277418486191,1.9473085147454567
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,1.2047817895412443
MOLP-8,9927531,5.438833274000949,4.578027762171671
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.117207225291035
HCC15,9952709,3.084010703088348,2.9381980631482683
K-562,3503,1.244026999465694,2.2426858883255045
SaOS-2,3689413,0.0712794264513353,-0.4039154566871359
MDST8,10427712,3.921886084986449,4.184108330161863
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,2.694366237977623
SU-DHL-1,1716436,3.093009546519781,2.948755251800144
PaTu 8902,25105715,3.5553172149604375,3.410449786117574
HuP-T3,24771867,4.228511460696379,1.5171458615349627
RKN,31703,-0.7196573309741882,-1.182053713238432
MDST8,60700,1.1908209554887386,-0.4482559328189002
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.3848601780620533
HEL,54454,2.1583735480761437,2.548844675602096
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.2047817895412443
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,0.11065310288154762
SU-DHL-1,135875424,2.8587183873170847,3.743891076041643
SU-DHL-1,36462,-1.6063137198477124,1.5076124324231743
MOLM-13,73707386,2.881964792667641,2.6861216111986805
P31/FUJ,3854666,0.6136756098719494,1.85063491630251
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,-0.5114413444588124
MOLM-13,159324,-0.2587959593058327,2.0742938672876736
SW948,19582717,2.742329976582949,3.9198146524152833
SK-CO-1,444795,5.109688629113172,3.7799917274901733
Daudi,400769,-1.3686052359334673,-0.7855881743093749
SK-HEP-1,10296883,4.4971190241998835,3.795028277273254
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.0889198012759371
LS180,17759555,2.746757712453425,3.5392373768677334
MOLM-13,156414,-0.1970532812518614,1.1062813598863759
ALL-SIL,72376,-2.2514410459425043,-2.110114148114304
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.0276770243216165
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.37491183386883553
HCC1500,51039095,2.9997605815390935,2.682611194240459
WM115,44185566,3.0030021210520794,2.4057100644299436
COR-L105,4705,0.5312031062005766,3.0428654274536564
Granta-519,8515,3.731909716775835,3.7716438213452004
ALL-SIL,11234052,3.5011978223530926,3.869960809483736
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.37491183386883553
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.0838611345650022
Granta-519,613753,3.0344429390603493,3.1495845971526135
HuP-T3,5329102,2.4996480668272527,2.031058842574058
SU-DHL-1,2828334,5.462697908299577,6.082620037824382
SK-OV-3,51039095,2.3576173335626147,2.682611194240459
UACC-812,5470400,-2.2578344499942418,-0.3765538821264742
HCC15,9935249,4.091947122155354,2.8615383619674972
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,0.7705130043498147
SW1271,322968,3.7653444240208263,3.4956311613712456
COR-L105,54678924,1.4327429630461548,1.9473085147454567
Panc 02.03,31703,0.91391851070637,-1.182053713238432
NCI-H1568,5329102,1.5348278867114138,2.031058842574058
Granta-519,9887053,0.035640336798207,3.469815136639831
IA-LM,6610216,4.173583896241699,4.26979744561799
NCI-H1568,119182,-0.8732650634834633,-1.3340160156368264
IGROV-1,159324,2.8766947154825044,2.0742938672876736
NCI-H1568,5566,2.911706555521376,3.029152149495273
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,0.5350305453431912
NCI-H2452,10385095,2.425738192808243,1.2480392352773622
HuP-T3,16065773,2.155269900494742,2.3641186374244216
SW948,448949,1.5714288146717783,1.9537365892294993
NCI-H2452,107985,-2.625758680845612,-3.5771139994401464
RCC10RGB,1750826,-3.277944046627699,-1.4739669220989267
Granta-519,16736978,1.0160166250823044,1.3934160091023764
HEL,104842,-4.135712202151618,-3.040993872013826
MOLP-8,71466445,1.892906464336944,3.3478019143630626
MDST8,262093,2.389063867163299,2.6275548088442098
COR-L95,4259181,0.8580425806970188,0.11236669175956715
Daudi,45279963,2.6753649589319854,3.660133434789582
IGROV-1,656346,1.6285470744333117,0.7582608913284792
SK-HEP-1,10427712,4.527720982072863,4.184108330161863
SaOS-2,11647372,0.6261520317366223,0.8954839509867156
COR-L105,53495165,0.9627099148057476,-0.19108456656304296
Granta-519,11404337,-2.8078628280004048,-0.4254091153988029
SW1573,25154868,3.281093993360062,4.289494395804131
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,1.78247230086659
BICR 31,3503,3.4488620791118993,2.2426858883255045
SK-CO-1,3062316,0.5910144260309655,0.9747482048219924
RKN,6917907,-6.438038185084336,-4.864372369867458
LS411N,23635314,4.011909681168236,-1.8612337831613235
WM115,11234052,4.1182935305671435,3.869960809483736
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-1.1532493383305307
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.4199080872215506
RERF-LC-MS,11485656,1.5190166417661397,2.2397291078765758
PaTu 8988t,46224516,2.924922546378164,2.370954746557396
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,0.7705130043498147
SK-CO-1,5287620,-2.837552470898679,-1.9697846958841214
PaTu 8988t,24772860,-1.5593380796956875,-2.2690769633318126
PaTu 8988t,6184667,3.5063575702163345,2.901063659317265
BICR 22,36462,0.4717839486114671,1.5076124324231743
RKN,16722836,2.340122812915413,1.5333952667080324
Panc 02.03,54618164,4.482290203520866,4.02740727006158
BFTC-909,2841722,4.3094465275997536,4.375424781932207
COR-L105,2746,3.1035280268076217,2.8579929499469348
IGROV-1,9929138,6.483056540257463,5.665997549800987
HCC1500,2708,5.151987441269929,4.591243765137335
MOLM-13,11238147,1.4582306649534449,2.694366237977623
RERF-LC-MS,11364421,-3.8493036468537265,-2.2476185097624475
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,5.87798299213578
RERF-LC-MS,16736978,2.30801467798398,1.3934160091023764
LS180,44241473,4.435457667187811,4.8543955662784395
SW48,16722836,0.2197322523934369,1.5333952667080324
NCI-H2452,9444,3.5242093703527697,4.054048446110465
SU-DHL-1,5284616,2.4488241799592143,1.1658534217096055
K-562,54454,3.689215856042272,2.548844675602096
HEL,2945648,2.719646445320408,2.7548400693819435
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.2359123501503817
HuP-T3,9936388,0.6940852338085793,-1.7988236137529168
LCLC-97TM1,10427712,4.124790087544491,4.184108330161863
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.4539899714896953
SW1271,135398738,5.657599080768866,3.3919135064420334
RKN,216468,4.351451769225332,2.5020743765616316
SW1271,46224516,1.263100640010589,2.370954746557396
SK-OV-3,60750,-4.210978436614257,-2.435153852929516
SU-DHL-1,11455910,0.1271925880707346,0.9557745122323711
Granta-519,25161177,3.429453868131532,4.097137926934978
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.6778195760397165
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,2.6829735349466532
UACC-812,16065773,1.9582746458630844,2.3641186374244216
MOLP-8,2858523,3.112163707938977,3.0086502241129605
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,-0.10942982547788271
IGROV-1,6505803,-0.2382223795960626,-0.5114413444588124
HEL,24772860,-2.0205510075596425,-2.2690769633318126
HCC15,4917,3.2753021602409267,3.079848880785536
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,0.5350305453431912
P31/FUJ,6184667,2.9500590386465393,2.901063659317265
MOLP-8,46843906,0.174682801852784,2.723521570705241
NCI-H2452,54618305,4.302077073898344,4.084826955496459
BICR 22,8515,4.348804794701894,3.7716438213452004
COR-L105,24821094,-1.121187296223131,2.7369152351179045
HCC1500,4788,5.676843976237076,5.493389053048461
SK-HEP-1,2746,4.04921422913523,2.8579929499469348
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.37491183386883553
COR-L95,46199207,3.11604668311128,3.1312366616263048
MOLM-13,1641662,2.418131669664625,3.3408828038827
WM115,135984461,4.094268409164816,3.6237408287871284
LS411N,10127622,0.4126946340819594,3.6054187258933235
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,2.348631818792911
ALL-SIL,11364421,-5.245070547120315,-2.2476185097624475
NCI-H1568,44607531,1.2688225542701184,1.48117322485652
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.8865368208635396
SW948,104842,-0.6555530305877334,-3.040993872013826
SK-CO-1,46907787,4.316773762169295,1.584957029505121
HuP-T3,104842,-2.1883971380944054,-3.040993872013826
IGROV-1,11178236,-2.8618715106425725,-3.539769866873396
HCC1500,71751553,4.671922723370954,4.504570481353087
SW1271,54618771,-0.1319273231055389,0.9253379925205388
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,2.9381980631482683
IGROV-1,654092,-1.340387623873854,-0.4472857419901597
HCC1500,44819697,2.691999336982048,-0.6109288989041974
HEL,44137675,4.224171499328968,3.337336921695599
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-1.1532493383305307
COR-L95,5328940,2.113977806947162,1.559061663996469
SK-OV-3,3825829,4.139200001280225,3.8869840981378028
Panc 02.03,216468,3.8655539989600176,2.5020743765616316
SW948,25195348,3.534636067330416,3.08171494739702
MOLM-13,9444,3.2439366633039426,4.054048446110465
NCI-H1568,24821094,1.7576462865100984,2.7369152351179045
MOLP-8,1566236,0.7132031003128095,2.2263982365179604
HuP-T3,11455910,1.0919804440303738,0.9557745122323711
MDST8,44185566,3.0590843033834116,2.4057100644299436
NCI-H2452,216345,4.1608899350266615,3.7540083674013296
SaOS-2,23635314,-2.530968731721941,-1.8612337831613235
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,2.0276770243216165
LS180,168312962,-1.039638615515642,1.48933366232238
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,1.78247230086659
BICR 22,322968,4.6496227244818416,3.4956311613712456
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,2.9860814461500107
RKO,6918837,-1.4612228483082623,-3.046222711611649
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,1.7724503678159762
SW48,613753,3.5910736246612323,3.1495845971526135
IGROV-1,44507138,2.359177395411688,2.3228542035372683
WM115,52947716,-6.8465929822900815,-1.4012147836358484
RKN,73707398,1.136221501718042,1.180307991266282
HCC1500,4477,0.2789780560390432,0.5570685949048098
Granta-519,11719255,2.4006867045586953,3.1221102230298534
HCC1500,6918736,0.2919336581768246,-1.741781295359962
IGROV-1,4477,1.1767656777594142,0.5570685949048098
IA-LM,11609586,4.073174168632335,2.621607380466062
NCI-H2452,11404337,-0.3859535574072682,-0.4254091153988029
Daudi,136227924,1.3476403322374937,2.867001064974719
SK-OV-3,387447,-3.0618968905277164,-4.3765957253648695
MOLM-13,3854666,0.5101644656521153,1.85063491630251
RKN,46843906,3.906010302389018,2.723521570705241
ALL-SIL,1641662,2.105441320822025,3.3408828038827
MOLP-8,46199207,3.622115707782432,3.1312366616263048
HEL,17755052,2.5427584711612554,1.7101929835526413
MOLP-8,9915743,0.5160575940701332,0.5935480801734145
NCI-H2452,135398516,0.2354885350790482,2.0509021680173207
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,0.7705130043498147
SW1573,9911463,3.734935340044018,3.732908427020576
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,2.117207225291035
IGROV-1,23725625,5.712368491237602,4.726527081330662
IGROV-1,54143018,0.8385018685685798,0.31711465707788644
WM115,135875424,2.968517855352779,3.743891076041643
SW948,16659841,2.968981271202921,3.7845234388741966
SW48,25183872,-1.521332471338628,-0.902802947451298
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,1.2834565267098785
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.2359123501503817
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.2047817895412443
WM115,5284616,2.9108529677003565,1.1658534217096055
SW948,4705,1.720002028261835,3.0428654274536564
HCC1500,71680916,4.362866442203444,4.641848024405652
PaTu 8902,17755052,3.1533076581920936,1.7101929835526413
COR-L95,11427553,2.745819698220539,2.578035472123966
MOLP-8,11707110,-0.9708482925672104,-0.02846554242907695
HCC15,5351362,1.1207822529279785,1.4604743967139864
SaOS-2,11234052,4.364959006359101,3.869960809483736
SK-OV-3,6918837,-1.7709381590236568,-3.046222711611649
RKN,10113978,4.430129932581481,3.010980031724017
Panc 02.03,5566,2.8367562997211815,3.029152149495273
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,1.78247230086659
Granta-519,4096211,0.4087245803445845,1.856021664538426
SK-HEP-1,72193861,3.0367238048594603,1.3858780169906042
SW948,9933475,1.7222383900333498,1.793439230086884
SW48,9936388,-6.68623848822316,-1.7988236137529168
NCI-H1568,11222830,1.5738139714037271,1.5350294688251391
IGROV-1,24856436,0.4840146383282276,0.17994774592918095
SW1271,25105715,2.9104912505007143,3.410449786117574
IA-LM,11238147,3.064975348903814,2.694366237977623
PaTu 8988t,23635314,0.3317794086663004,-1.8612337831613235
Granta-519,3136844,3.153984140395424,4.214923916993912
COR-L105,24951314,2.139685821030411,1.227614980483031
IGROV-1,135398744,6.402844237905131,6.625444078703129
LCLC-97TM1,156414,1.5907536031970133,1.1062813598863759
BICR 22,46926350,-6.042960620867506,-4.429063309555999
Granta-519,387447,-5.4996124066637435,-4.3765957253648695
BFTC-909,51039095,2.7594177275421403,2.682611194240459
Panc 02.03,5746,2.615751109567445,0.8084551861824514
SW948,71466380,3.8629020707603914,4.275465599745589
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-1.1532493383305307
COR-L105,24856436,1.5602990639828938,0.17994774592918095
K-562,327653,3.3038748071855175,3.018652636936018
Daudi,16725315,3.035985748437892,4.150060666188836
LCLC-97TM1,6917907,-8.098980466082804,-4.864372369867458
NCI-H2452,4261,1.8682088943565944,1.4288257082744877
SU-DHL-6,241158,1.5794519300851928,3.598987869990464
IGROV-1,9840324,5.720969888694302,5.7711165719697215
COR-L95,10074640,3.0551355702246292,3.066922642013836
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,1.133687221210622
BICR 31,5460769,3.9433617709959696,2.3447175553942796
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.8865368208635396
ALL-SIL,171352865,4.1926931777749346,3.764962937653422
PaTu 8988t,5351362,2.286773409161727,1.4604743967139864
COR-L105,54618164,4.149947168538197,4.02740727006158
K-562,168312962,1.3008721680360658,1.48933366232238
NCI-H2452,3634881,3.1517111283550854,3.1576774496130544
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.78247230086659
LS411N,2858523,3.1062955336512603,3.0086502241129605
NCI-H1568,65628,3.926137474064237,4.026684176415168
SW1573,25126798,4.147065453172024,3.7921789378214816
SU-DHL-1,9868037,1.568771805047012,2.82815333449006
HCC15,46174525,4.292402667650191,4.156087356848057
HCC15,54626689,4.436341034968849,4.561309020020982
K-562,241158,3.183928650435804,3.598987869990464
HEL,400769,-1.0010167847558078,-0.7855881743093749
MOLP-8,24180125,2.8280981087253605,2.888353933707551
LCLC-97TM1,6918837,-2.241539398034031,-3.046222711611649
SW948,52947716,2.6983492764143984,-1.4012147836358484
HuP-T3,11609586,3.0975126346448056,2.621607380466062
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,2.659070263037081
K-562,9911830,-1.954559593888618,2.4240324657892436
Panc 02.03,54454,5.027619058009229,2.548844675602096
Daudi,9967941,1.9498714635628245,3.6034131982542865
SK-CO-1,46224516,2.9108482414820833,2.370954746557396
IGROV-1,56963564,1.8260986108097368,0.2569389627451253
PaTu 8902,119607,6.110313748168657,5.129253777214588
SK-OV-3,1750826,-0.3132155362058529,-1.4739669220989267
NCI-H1568,11507802,1.223292685938289,1.3590460953824346
SU-DHL-1,6918736,-2.1290482192432396,-1.741781295359962
MOLM-13,6252,-1.803091878000868,-0.10942982547788271
HuP-T3,16659841,4.694527425679891,3.7845234388741966
COR-L105,135440466,2.282908830244017,2.1401473911994366
COR-L105,36462,5.237060103367249,1.5076124324231743
LS180,16038120,0.768362963165676,0.9090093368534204
COR-L95,11719255,2.8113582651389684,3.1221102230298534
K-562,71466380,4.109476883218819,4.275465599745589
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.2834565267098785
LCLC-97TM1,65064,4.239331302053654,4.739517756868576
ALL-SIL,11626560,-1.2475078800938888,1.6795489442409048
IGROV-1,9903786,1.7387584479757865,2.756077717004494
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.129253777214588
UACC-812,3025944,3.7003704595595894,4.206240213808089
HCC15,52912189,2.9796194932949875,1.6723266261402217
SK-CO-1,24951314,2.193758155281627,1.227614980483031
IGROV-1,208908,2.822483792004996,1.8663560178908947
BICR 31,2945648,3.0787524499283023,2.7548400693819435
WM115,11485656,3.738489726762909,2.2397291078765758
IGROV-1,126941,-2.246216453812328,-2.8921209077069348
KU-19-19,135411,0.3258457054887789,0.5181226666256136
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-1.1532493383305307
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,2.102163121425029
MOLP-8,25105715,3.7016775455761968,3.410449786117574
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.261852028375895
NCI-H1568,25126798,3.633705991567496,3.7921789378214816
LCLC-97TM1,3689413,0.1289764847745495,-0.4039154566871359
SW48,5311,0.4861581581750583,1.2663000347984639
LS180,409805,6.164182483443964,4.6745070702664995
ALL-SIL,17759555,3.7861470032844418,3.5392373768677334
K-562,7326481,2.6072018104551824,2.957630994714242
SK-CO-1,8515,5.207883928071115,3.7716438213452004
NCI-H1568,439501,-2.6831567396736022,-2.2321662354381537
BICR 31,3634881,3.594506321194918,3.1576774496130544
KU-19-19,656346,4.826208082880011,0.7582608913284792
SW1271,10410894,3.9794007270318903,3.2189174762180457
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.4039154566871359
SK-HEP-1,16722836,2.576451725849178,1.5333952667080324
RERF-LC-MS,10113978,3.210216765519601,3.010980031724017
LS180,54454,2.0147485365690945,2.548844675602096
NCI-H1568,9866186,-0.23967308205821,0.7577083020821866
IGROV-1,10302451,0.4135234554742116,3.0143591766147457
PaTu 8988t,9935249,3.4642640806067897,2.8615383619674972
HuP-T3,65064,5.168937665689206,4.739517756868576
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,1.710700657959646
LCLC-97TM1,44543605,5.020704141539917,4.160012106477824
KU-19-19,3062316,3.300727237006398,0.9747482048219924
IA-LM,54143018,6.360653223606267,0.31711465707788644
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,1.710700657959646
PaTu 8988t,11497983,4.771256524847766,2.348631818792911
IA-LM,7326481,3.2597510497719964,2.957630994714242
MOLP-8,57519531,1.794840771759573,2.4211376500246136
Panc 02.03,387447,-4.21908064053878,-4.3765957253648695
Panc 02.03,9866186,1.4364847380387245,0.7577083020821866
BFTC-909,56946209,-2.8280109825858943,-4.2202975286026225
K-562,46843906,1.6079735978006011,2.723521570705241
IGROV-1,3038522,3.6829378423722416,2.9847437848386558
COR-L95,9933475,1.8209744616881691,1.793439230086884
NCI-H1568,54613361,-1.9115789745186575,-0.11678183903518824
PaTu 8988t,11178236,-5.843883599227575,-3.539769866873396
IGROV-1,24856436,0.4840146383282276,0.17994774592918095
HEL,5746,-1.0378501544368317,0.8084551861824514
LS180,216345,2.343571728213523,3.7540083674013296
MOLM-13,11234052,1.8885372726820036,3.869960809483736
IGROV-1,656346,1.6285470744333117,0.7582608913284792
IGROV-1,613753,3.483244781428779,3.1495845971526135
RERF-LC-MS,44632017,0.7768655843829712,1.0838611345650022
LCLC-97TM1,10113978,4.598206277837053,3.010980031724017
LS180,136227924,2.415770069388299,2.867001064974719
Granta-519,5978,-7.678617575463935,-2.3753204421143224
MOLM-13,2828334,5.861258184508348,6.082620037824382
ALL-SIL,3815108,1.81429533281988,2.885036533777781
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.0058447943574325
LS180,10385095,1.937933801431244,1.2480392352773622
SW1271,7326481,3.1173859417421985,2.957630994714242
COR-L105,176870,-0.2151307909405896,3.0253996189023358
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.456683733824014
HEL,6918878,-0.4197772532459504,1.9069091595174383
RCC10RGB,44589607,3.0966280095343777,2.659070263037081
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.5350305453431912
SW48,89183176,5.513741245898386,3.4938336610308007
KU-19-19,168312962,-2.211081322704064,1.48933366232238
LCLC-97TM1,11656518,-4.424964199082896,1.5480979328089313
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.301139445753315
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,2.0335760501929605
WM115,6918328,0.4200257259119496,-0.28710840066117727
RKO,44491742,4.905526099010324,4.1566745174283435
SU-DHL-1,5280436,3.4353188558540895,3.153394505533252
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.102163121425029
P31/FUJ,702558,3.294053878414949,4.9782351440396395
MDST8,322968,3.292336134337166,3.4956311613712456
MOLP-8,66577038,2.4807994544381997,2.9870697487432882
NCI-H2452,216239,2.289885444542123,2.1474208097396077
LS411N,24951314,1.1768436480242177,1.227614980483031
HCC15,5291,3.948819619575577,3.5530526201153183
RERF-LC-MS,11152667,0.0782441689403026,-0.5866736007906306
NCI-H1568,285033,-1.965656578387781,-2.1791335812392365
K-562,119607,4.708269214175102,5.129253777214588
MOLM-13,6918328,-1.6668605659600593,-0.28710840066117727
HuP-T3,51039095,3.318948357155543,2.682611194240459
COR-L105,3025944,3.915005293474353,4.206240213808089
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.3848601780620533
NCI-H2452,42642645,0.8357005775142816,0.7845058245277501
PaTu 8988t,67156097,0.822255948885768,-1.0279170724737183
P31/FUJ,44507138,1.0120664141515707,2.3228542035372683
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.38762532684053896
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,1.0163468544412688
HCC15,10074640,3.1199478074334106,3.066922642013836
IGROV-1,53392493,2.352084848618059,2.4832542501558077
SK-HEP-1,135398516,1.8011759760648425,2.0509021680173207
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,2.144908880465776
IGROV-1,1242560,3.902441161940491,3.534393132486151
IGROV-1,24901704,3.0789156375765936,3.1103746959488285
RERF-LC-MS,23635314,-3.639251677232653,-1.8612337831613235
KU-19-19,56946209,-3.434845070293707,-4.2202975286026225
SK-CO-1,11427553,2.3636745936222177,2.578035472123966
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.6829735349466532
Panc 02.03,6852167,4.143336119644561,2.69961445504738
NCI-H1568,26596,-1.690126811671561,-1.5346517263124715
ALL-SIL,100016,4.099229681419155,5.87798299213578
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-0.8865368208635396
BICR 22,219104,4.618531153522784,3.5366182443481806
HuP-T3,4378219,2.0668857590794767,2.6822409618839944
IGROV-1,11647372,-0.6595372928368528,0.8954839509867156
BICR 31,46843906,2.802485697538939,2.723521570705241
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,1.4554460238042177
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,1.9639001504219202
PaTu 8902,65064,4.553320484088526,4.739517756868576
NCI-H1568,10410894,1.924104691976128,3.2189174762180457
SU-DHL-1,72376,-3.386078956410557,-2.110114148114304
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.3153680794849765
NCI-H1568,16659841,3.88074746768202,3.7845234388741966
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,2.117207225291035
LS411N,54618164,4.167426775220608,4.02740727006158
MOLP-8,5287969,-2.4943575090146903,-1.9772070858850965
Granta-519,24856436,-2.399051702227432,0.17994774592918095
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.4199080872215506
BICR 22,3689413,1.1307119933583345,-0.4039154566871359
SW948,11494412,0.3616963479580831,1.4248282417532188
RCC10RGB,3552672,3.073432883089278,2.8413574589562494
LCLC-97TM1,72376,-4.375427192181232,-2.110114148114304
SW948,11234052,4.776317924055416,3.869960809483736
P31/FUJ,89928392,-0.2575535361410093,1.344325138639762
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.5350305453431912
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,1.7691529831259722
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.2359123501503817
NCI-H2452,2742550,5.209305166760603,3.8595787492072238
SW48,9884685,-1.5395746259931604,0.4230357541133405
SU-DHL-1,16722836,1.4294085247204618,1.5333952667080324
MOLP-8,11640390,2.6566405323234057,3.2466540190485103
RKN,5113032,5.131058822839954,4.970396511864891
Panc 02.03,5311,2.7910052639268415,1.2663000347984639
HuP-T3,36462,3.380707637397105,1.5076124324231743
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-1.1532493383305307
K-562,6852167,3.2696177089982807,2.69961445504738
KU-19-19,16725315,4.810213458660102,4.150060666188836
Daudi,44819697,-3.048561633253287,-0.6109288989041974
NCI-H2452,73707398,1.4673083704761625,1.180307991266282
SU-DHL-1,6438330,0.8462618394668467,2.016737971321332
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,2.3791567205504176
IGROV-1,400769,-0.5589612210030486,-0.7855881743093749
PaTu 8988t,6918736,-0.015847459349983,-1.741781295359962
NCI-H2452,12003241,-1.7557808561862691,-1.0889198012759371
SW48,89928392,0.7467993581529679,1.344325138639762
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,3.743891076041643
NCI-H2452,71466380,5.164331301376758,4.275465599745589
Panc 02.03,4917,3.7856869354758342,3.079848880785536
SW48,25062766,1.0755009410821956,2.0522756909743434
IGROV-1,4259181,0.1937358171291443,0.11236669175956715
BICR 31,46926350,-4.294934659479777,-4.429063309555999
Granta-519,72199292,2.8103945289975623,1.1233129488647187
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.1474208097396077
MOLM-13,11222830,0.9845802392597008,1.5350294688251391
SK-HEP-1,676352,1.798347685811885,2.088896150621564
SK-CO-1,36314,-5.371942323616045,-1.2422497803043113
P31/FUJ,71466380,4.574945433624961,4.275465599745589
PaTu 8988t,11427553,3.005069211450264,2.578035472123966
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.2263982365179604
NCI-H1568,151289,0.8908355813530987,0.9562867634504244
SW48,216345,1.323366684487305,3.7540083674013296
SK-HEP-1,44819697,-0.1381867301228731,-0.6109288989041974
BFTC-909,24951314,2.3445794180209565,1.227614980483031
SK-CO-1,107985,-2.728069079888901,-3.5771139994401464
BICR 22,168313016,4.910867780923905,4.725757076386842
SW48,3025986,-2.1875732043663048,-0.8978770871810051
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-1.6778195760397165
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.6829735349466532
HCC15,446155,0.1844871361320988,2.662752180605146
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.38762532684053896
BFTC-909,56963564,-0.1720168824982637,0.2569389627451253
MOLP-8,151289,0.9447515089929442,0.9562867634504244
HEL,11609586,2.7821230127549663,2.621607380466062
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,2.9870697487432882
SW948,46174525,3.747184504681747,4.156087356848057
HCC15,11964036,0.8100768326008368,1.2382789669868983
SK-OV-3,53232,3.610813443380856,2.8161144578264046
NCI-H2452,9884685,3.2183676658345868,0.4230357541133405
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.9218131221296273
K-562,44241473,4.342180714885996,4.8543955662784395
HCC1500,65628,4.452955395596753,4.026684176415168
MOLM-13,24771867,-2.755307399303063,1.5171458615349627
RERF-LC-MS,168312962,0.3496483928324376,1.48933366232238
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,3.3848601780620533
NCI-H1568,44589607,2.521775448277625,2.659070263037081
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.93841691857644
Granta-519,5280436,1.7342596657129103,3.153394505533252
NCI-H1568,72199292,0.3941551729128716,1.1233129488647187
SK-CO-1,439501,-2.410857533331093,-2.2321662354381537
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,2.474523360549852
PaTu 8902,3038522,3.855914834510199,2.9847437848386558
SU-DHL-1,159324,0.2044468524757833,2.0742938672876736
BFTC-909,46398810,2.674147192871529,2.510712955745063
LCLC-97TM1,148198,-1.8422045751990368,-3.548509713878981
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,2.0276770243216165
LS180,5351362,1.0497784443121565,1.4604743967139864
NCI-H1568,5311281,2.6261557759532974,2.22503529708604
SW1271,44589607,3.6432775089048888,2.659070263037081
RKO,54143018,-0.3751060369564643,0.31711465707788644
COR-L105,44607530,0.5885750535327339,1.715838652040812
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-0.8865368208635396
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,2.0058447943574325
SW948,387447,-4.931777613053621,-4.3765957253648695
BICR 31,168313016,4.3680397842259095,4.725757076386842
LS411N,36314,3.823716751686664,-1.2422497803043113
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.7705130043498147
MDST8,67291369,1.5579520311273356,1.794812676489941
RERF-LC-MS,3062316,3.070306969339253,0.9747482048219924
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.261852028375895
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-1.57821899028641
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,0.7705130043498147
MOLP-8,11964036,0.2292639686830329,1.2382789669868983
RKN,66577038,3.4891743358782104,2.9870697487432882
PaTu 8988t,5978,-2.779195325360685,-2.3753204421143224
RKO,8515,4.32265921632429,3.7716438213452004
SU-DHL-1,46907787,0.92481130470373,1.584957029505121
COR-L95,216468,4.837628080392179,2.5020743765616316
SW948,462382,0.505941174695894,0.5714028853239661
NCI-H1568,448949,1.6827994040181535,1.9537365892294993
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.6795489442409048
NCI-H2452,10184653,1.4868368660739673,1.1325795715302809
NCI-H2452,1285940,4.318373702463549,4.0494196828548
SW48,52912189,0.0060801339095902,1.6723266261402217
RERF-LC-MS,46926350,-4.177207395055215,-4.429063309555999
P31/FUJ,5978,-3.805650321394954,-2.3753204421143224
Daudi,4917,1.6956741153412938,3.079848880785536
LS411N,44507138,1.8249335905604152,2.3228542035372683
RERF-LC-MS,10231331,0.9954911948227504,1.6547412916072393
HCC15,4261,-0.2961876318733478,1.4288257082744877
P31/FUJ,16722836,0.3472605187822769,1.5333952667080324
MOLP-8,45279963,3.839697844480557,3.660133434789582
NCI-H2452,446155,1.665772886963468,2.662752180605146
NCI-H2452,11609586,3.752552997604344,2.621607380466062
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,0.9253379925205388
IA-LM,9933475,1.89794527933904,1.793439230086884
MOLP-8,4477,0.6768027916096236,0.5570685949048098
IGROV-1,42642645,0.3750175292659389,0.7845058245277501
IGROV-1,6852167,1.5305143027352028,2.69961445504738
Daudi,5287969,-2.32062356362434,-1.9772070858850965
WM115,44607530,1.3586937130527126,1.715838652040812
SU-DHL-6,5291,3.0098231219330422,3.5530526201153183
IA-LM,53392493,3.818463276064527,2.4832542501558077
MOLP-8,5328940,1.3442597724286955,1.559061663996469
NCI-H1568,11626560,1.7284579168385834,1.6795489442409048
NCI-H1568,9967941,2.084939505363619,3.6034131982542865
BICR 31,24856436,1.9770307243044476,0.17994774592918095
LS411N,6918289,4.168112514533401,1.9146814118519513
SK-CO-1,49766530,2.416603727276247,-0.6944377068647134
LS180,15547703,3.0095925001469577,3.114669509763707
SK-CO-1,24771867,2.6665073598645086,1.5171458615349627
MOLP-8,17755052,-0.3093261728985458,1.7101929835526413
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.6778195760397165
NCI-H2452,6610216,4.12804282735119,4.26979744561799
RERF-LC-MS,16065773,2.958049600168222,2.3641186374244216
SaOS-2,6610216,4.351676798413151,4.26979744561799
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,1.4539899714896953
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,4.4833676274788345
NCI-H1568,3854666,0.7326561551321923,1.85063491630251
SU-DHL-1,11404337,-0.9851913382580488,-0.4254091153988029
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.591243765137335
K-562,2746,2.4328857060914797,2.8579929499469348
Daudi,16038120,0.2901991168563289,0.9090093368534204
MOLM-13,71466380,3.777949844495899,4.275465599745589
Panc 02.03,11955716,-1.8470517927785437,-1.4856643985320634
LCLC-97TM1,2858523,3.382646598163124,3.0086502241129605
SK-HEP-1,11234052,4.66363668535284,3.869960809483736
HCC1500,322968,2.559368987278369,3.4956311613712456
COR-L95,24772860,-0.7858558168975444,-2.2690769633318126
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,1.7724503678159762
SW1271,89928392,3.428275427880058,1.344325138639762
RCC10RGB,24821094,3.8097926200280225,2.7369152351179045
HEL,24753719,3.7144242054355985,4.143618673527016
K-562,445091,4.14956176193418,4.3274252089919045
HEL,136227924,2.725456875957553,2.867001064974719
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.3791567205504176
LCLC-97TM1,159324,3.194316902825419,2.0742938672876736
RERF-LC-MS,57519531,1.5399611647939,2.4211376500246136
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.4199080872215506
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.133687221210622
HCC1500,51037431,2.242858518427135,3.10082796495436
ALL-SIL,12003241,-5.746631994241774,-1.0889198012759371
P31/FUJ,44819697,-1.8374306821299025,-0.6109288989041974
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.1532493383305307
MDST8,107970,2.8941750874079744,2.3029314718240044
SK-OV-3,3503,3.0304882575129497,2.2426858883255045
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,2.8341325456747963
HCC1500,9927531,5.051014893697188,4.578027762171671
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,2.699201704606489
HCC15,5328940,2.162982624771584,1.559061663996469
Panc 02.03,11626927,4.481877662185247,3.2332289192719035
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-1.57821899028641
SU-DHL-6,2749,-0.5951367082815587,1.7932893499757152
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.114669509763707
MDST8,135398516,1.8788362071916904,2.0509021680173207
MOLM-13,5328940,0.1532905912336842,1.559061663996469
WM115,4477,-0.2872762876800434,0.5570685949048098
ALL-SIL,5746,-1.6673474530311534,0.8084551861824514
PaTu 8902,25150857,2.644837375624729,2.336756962918186
MDST8,219104,3.7181204954875864,3.5366182443481806
Daudi,11228183,2.4864875823277557,1.8712017695678478
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.1495845971526135
Daudi,984333,-2.2486456844128333,0.5138000229415411
Granta-519,12003241,-2.1147517064841925,-1.0889198012759371
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,4.4833676274788345
SW48,387447,-4.885505238560258,-4.3765957253648695
COR-L105,36314,4.185071185075879,-1.2422497803043113
HuP-T3,4705,2.7233440783632608,3.0428654274536564
Panc 02.03,54678924,2.4878586568917536,1.9473085147454567
SW1573,16065773,3.287625611468905,2.3641186374244216
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.4781017448929608
COR-L95,10385095,1.3959867651371194,1.2480392352773622
P31/FUJ,2945648,2.3869646223252365,2.7548400693819435
PaTu 8902,55283,3.4956890773009097,2.1635123760949786
COR-L105,89183176,5.033590250009003,3.4938336610308007
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,0.9218131221296273
HCC1500,445091,4.393350110080019,4.3274252089919045
SK-CO-1,11175137,2.477148698701912,2.477950770888125
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,0.9218131221296273
BFTC-909,54618771,2.8225313881877545,0.9253379925205388
HCC1500,73707398,0.9868057798362108,1.180307991266282
WM115,135398516,0.1940094116062491,2.0509021680173207
SW948,11977753,-4.015233583581633,-1.7159558966047241
KU-19-19,446155,2.785852834205258,2.662752180605146
BFTC-909,3854666,1.1654585644167257,1.85063491630251
ALL-SIL,327653,2.0915878780614623,3.018652636936018
RERF-LC-MS,2749,2.1448012118135176,1.7932893499757152
SK-CO-1,3503,2.662166466999906,2.2426858883255045
IA-LM,60700,0.8821511316384938,-0.4482559328189002
Panc 02.03,10302451,3.706546166543765,3.0143591766147457
SaOS-2,45279963,3.893370234288743,3.660133434789582
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.0086502241129605
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.1532493383305307
K-562,11626560,-0.7477726232652755,1.6795489442409048
PaTu 8902,252682,7.782026892174048,6.516263069090082
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.17994774592918095
HCC1500,9887053,4.8738692747205175,3.469815136639831
IGROV-1,11717001,4.394306548697183,3.961276339234443
NCI-H2452,9911463,3.657985193851277,3.732908427020576
HuP-T3,11707110,2.782188957571083,-0.02846554242907695
COR-L105,5287620,-2.2558017577268665,-1.9697846958841214
K-562,9907093,4.115761716505682,4.134688957161641
SW1573,53245473,3.5468633352222287,3.5412534206723127
COR-L95,100016,6.620829555802918,5.87798299213578
Granta-519,11178236,-5.517610268531398,-3.539769866873396
IA-LM,3503,2.293282991199797,2.2426858883255045
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.37491183386883553
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.57821899028641
MOLM-13,23635314,-2.1464398793300408,-1.8612337831613235
WM115,45100481,5.666571363096329,4.430120472879877
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-1.261852028375895
COR-L105,5351362,1.5942690709113274,1.4604743967139864
IGROV-1,6610216,4.310938387105607,4.26979744561799
SK-CO-1,4521392,4.292734672993078,4.280943620409205
RERF-LC-MS,53232,1.207294902086358,2.8161144578264046
NCI-H2452,16038120,1.767482091574877,0.9090093368534204
LS180,107985,-4.080313435814333,-3.5771139994401464
SU-DHL-1,24785538,0.8988368126388477,1.3344504348570345
IGROV-1,11977753,-2.2284230058029433,-1.7159558966047241
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.1468722777789853
SW48,24964624,1.8073600797801577,2.2827362159867324
RKO,9911830,2.9376280530386123,2.4240324657892436
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,1.5478733404534093
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.8865368208635396
HEL,5287620,-1.51108604946339,-1.9697846958841214
MDST8,11964036,-0.5107320494490124,1.2382789669868983
HCC1500,10385095,0.8648832931247582,1.2480392352773622
SW48,702558,4.851481027043998,4.9782351440396395
BICR 22,15547703,3.054989624104991,3.114669509763707
LCLC-97TM1,375860,-0.9613247940016756,-0.30112130782396007
BICR 22,5566,3.0896765386345244,3.029152149495273
SW948,36462,2.9711779559511604,1.5076124324231743
SaOS-2,135411,0.7043200334589346,0.5181226666256136
SW1271,24889392,3.729104653817525,3.7858620057203916
K-562,4917,1.7461656699737091,3.079848880785536
MOLM-13,11964036,-0.3903680086882432,1.2382789669868983
SU-DHL-1,9907093,3.802209526559384,4.134688957161641
MOLP-8,44507138,3.0437239609683515,2.3228542035372683
HCC15,441298,2.404091830829315,2.5423368047098167
IGROV-1,246676,4.485924799339535,4.505551974581321
IGROV-1,3136844,5.214591389089975,4.214923916993912
Daudi,119182,-1.0022442636317743,-1.3340160156368264
SK-CO-1,2742550,3.074063089907043,3.8595787492072238
COR-L95,5291,3.794551144961864,3.5530526201153183
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,2.901063659317265
WM115,16219061,2.9198343751130036,3.135611362850641
RERF-LC-MS,2871966,0.0193381278585586,0.29730316799892464
SW1271,44607531,2.0262821909932964,1.48117322485652
NCI-H2452,53495165,2.6100799702143824,-0.19108456656304296
SaOS-2,3825829,3.573326366415088,3.8869840981378028
HEL,1242560,2.170830105823081,3.534393132486151
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,2.699201704606489
MOLM-13,135423438,-5.2048777869707035,2.1190856698194294
RKO,3815108,2.4813915623878264,2.885036533777781
SK-CO-1,57519531,1.3464743023672243,2.4211376500246136
SU-DHL-1,2729026,1.1961155288156848,2.6325975116350393
MOLP-8,57330099,4.408814311331857,4.311542343968036
SK-HEP-1,25262965,-1.9202339310426983,-1.6224193967571534
HCC15,71466445,3.952377160133232,3.3478019143630626
Daudi,49793307,-5.375388093698208,-2.848251171596848
RCC10RGB,52947716,3.397847809230189,-1.4012147836358484
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.117207225291035
MOLM-13,10074640,2.6694741782411975,3.066922642013836
HCC1500,16736978,0.2362509616809698,1.3934160091023764
WM115,11228183,1.7654096487865938,1.8712017695678478
Granta-519,25150857,0.8022216450857215,2.336756962918186
RERF-LC-MS,2858523,3.0171071482923826,3.0086502241129605
K-562,71466578,3.85538032532176,3.983075654179168
RKO,135875424,3.829354185480349,3.743891076041643
HEL,4096211,2.9626104821001524,1.856021664538426
LCLC-97TM1,67156097,-2.339870774569048,-1.0279170724737183
COR-L95,3503,2.5200783295079834,2.2426858883255045
SW48,11609586,2.634017068041322,2.621607380466062
SU-DHL-1,375860,-0.8487932986720208,-0.30112130782396007
SU-DHL-1,5351362,0.9282229173955964,1.4604743967139864
SK-OV-3,6917907,1.1533351492785058,-4.864372369867458
PaTu 8988t,65064,5.1728218990125,4.739517756868576
RKN,3503,2.6546301780010144,2.2426858883255045
IA-LM,23582824,0.7235929041173603,0.7400136078733197
IGROV-1,54143018,0.8385018685685798,0.31711465707788644
Daudi,11214940,1.5157277988308535,1.8119431265240042
SW948,4261,0.2066749270482282,1.4288257082744877
HuP-T3,15547703,4.355520728687953,3.114669509763707
NCI-H2452,24748573,1.1942514329138498,1.9565115912575295
IGROV-1,159324,2.8766947154825044,2.0742938672876736
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,0.7705130043498147
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,1.133687221210622
SU-DHL-1,3465537,3.713885766889003,2.5477591829493655
NCI-H1568,60700,-0.8736945480852499,-0.4482559328189002
P31/FUJ,3689413,-2.495432751898851,-0.4039154566871359
PaTu 8902,16722836,2.3982166809874768,1.5333952667080324
SW1271,452548,-0.0979853591066759,-0.31026393275322106
HCC1500,9444,4.370086947523025,4.054048446110465
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.8865368208635396
MDST8,44137675,1.8173250203578384,3.337336921695599
IGROV-1,5460769,1.6083174601829917,2.3447175553942796
SK-CO-1,10302451,2.4520332675877605,3.0143591766147457
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.38762532684053896
SU-DHL-1,3384730,1.173741268518712,2.4620443610818112
LS411N,11178236,-2.533537215148808,-3.539769866873396
COR-L105,216239,2.81147830727615,2.1474208097396077
MDST8,1750826,-3.2078848487443716,-1.4739669220989267
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-1.1532493383305307
SW1573,3025986,2.659291536752942,-0.8978770871810051
SK-OV-3,73707398,1.4890038437616029,1.180307991266282
LCLC-97TM1,12003241,-0.8351557307101188,-1.0889198012759371
BFTC-909,1750826,-0.1726466566192349,-1.4739669220989267
WM115,44819697,0.4217395821242636,-0.6109288989041974
Daudi,57330099,4.348234162675926,4.311542343968036
HCC15,6852167,3.485797740848402,2.69961445504738
IGROV-1,23939,4.412541857664819,4.316990186905579
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,3.3848601780620533
MDST8,159324,4.143261975826356,2.0742938672876736
IGROV-1,9840324,5.720969888694302,5.7711165719697215
LCLC-97TM1,36314,-6.600382606146434,-1.2422497803043113
UACC-812,11494412,1.976870257251046,1.4248282417532188
LS180,24785538,2.36344296814186,1.3344504348570345
SW1271,46398810,2.1181317502001864,2.510712955745063
COR-L95,8515,4.297389552329342,3.7716438213452004
HEL,67291369,-0.0398574366947598,1.794812676489941
WM115,65064,5.519507799834776,4.739517756868576
K-562,11178236,-5.937287665657859,-3.539769866873396
MOLM-13,46398810,-0.3461491770759903,2.510712955745063
Daudi,49836020,3.49644839546437,2.5464279658175073
SaOS-2,135659046,3.828911922642458,3.604307380358917
MOLM-13,156422,2.6570896066322054,3.8435202478608215
IGROV-1,11222830,1.5703285223102077,1.5350294688251391
MOLM-13,3062316,-0.5121609334560062,0.9747482048219924
RCC10RGB,24775005,3.7293513155953737,3.778654827630856
Daudi,135411,0.411387979123234,0.5181226666256136
HEL,6623618,1.8836955043929509,2.1468722777789853
IGROV-1,5702613,4.420745339537274,3.145942765655066
BICR 31,3025986,-1.7152493432112506,-0.8978770871810051
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,1.78247230086659
HuP-T3,46926350,-3.9956296104835447,-4.429063309555999
SW948,11964036,0.9329377934210036,1.2382789669868983
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-0.8865368208635396
BICR 31,168313200,4.293337148285007,2.9593589282331023
LCLC-97TM1,613753,3.2994086878019693,3.1495845971526135
NCI-H1568,2858523,2.9099207435493306,3.0086502241129605
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,2.8341325456747963
WM115,168312962,-0.8720769549309708,1.48933366232238
COR-L105,3136844,4.323289843330604,4.214923916993912
SaOS-2,24964624,2.194529135867758,2.2827362159867324
IGROV-1,322968,4.140599241163106,3.4956311613712456
SU-DHL-1,44259,0.9870469643742532,0.9267255578557378
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,2.6829735349466532
Daudi,7326481,2.37278983949268,2.957630994714242
HCC1500,5284616,3.2143502285360395,1.1658534217096055
Granta-519,6918736,-3.0470654964091346,-1.741781295359962
K-562,53232,2.317344808959498,2.8161144578264046
KU-19-19,6914657,-4.990300196809823,-4.170094408243688
Granta-519,72376,-3.0273971733074463,-2.110114148114304
SW948,54678924,1.3690911042909353,1.9473085147454567
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,3.6300382464802663
SU-DHL-1,2858523,2.096941494706986,3.0086502241129605
HCC15,11427553,0.4296382841284133,2.578035472123966
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.2047817895412443
PaTu 8902,9444,4.223556509018044,4.054048446110465
Granta-519,10074640,3.4462174196318864,3.066922642013836
NCI-H2452,11213558,2.927858740250081,1.4781707184028035
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.0143591766147457
SU-DHL-1,17755052,1.573040093702568,1.7101929835526413
HCC1500,44185566,2.7833515387265435,2.4057100644299436
BFTC-909,107970,2.2861723254681774,2.3029314718240044
WM115,46191454,1.770414974730312,1.3518500781597358
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,2.474523360549852
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,0.7705130043498147
SW48,984333,0.702746968378095,0.5138000229415411
MOLM-13,4378219,1.3750720877022855,2.6822409618839944
SK-CO-1,104842,-6.47047720162668,-3.040993872013826
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.1401473911994366
SU-DHL-1,753704,3.8222320630358344,4.832125608051433
NCI-H2452,11640390,3.686004280320225,3.2466540190485103
IA-LM,44185566,3.1900951690600596,2.4057100644299436
SW948,24748573,3.0928652753553685,1.9565115912575295
HCC15,16722836,0.9313515315756092,1.5333952667080324
SK-CO-1,2858523,3.0692168261278345,3.0086502241129605
BICR 22,984333,1.5288435331300914,0.5138000229415411
WM115,46907787,1.8634039559333693,1.584957029505121
K-562,135398516,2.1877631842117315,2.0509021680173207
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.8865368208635396
SW1271,56649450,5.123918884487689,2.999158341046921
MOLM-13,73707438,4.222752629567675,4.210679418158044
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,1.5478733404534093
IGROV-1,9908783,5.873270433212515,5.056023266605311
COR-L105,100016,7.1590039780101895,5.87798299213578
MOLP-8,2733487,6.371854996101937,6.1630813151494985
HuP-T3,40482356,5.071639396405957,5.431371047145914
Daudi,10231331,6.134507235467236,1.6547412916072393
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.4199080872215506
ALL-SIL,135398738,2.8388897343309214,3.3919135064420334
Granta-519,15953870,3.078322892664931,3.4781017448929608
SW1573,16722836,2.4665820842388606,1.5333952667080324
RKN,262093,2.5285063130840344,2.6275548088442098
COR-L105,16736978,0.0668136597141226,1.3934160091023764
SU-DHL-1,3854666,0.5155348387571919,1.85063491630251
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.5071094923394703
HCC15,1242560,4.141842055686159,3.534393132486151
Daudi,227681,2.3413610492173533,2.9941233013598234
BICR 22,9825149,1.9632507246672848,2.074054954263997
KU-19-19,57519531,2.7709295903751987,2.4211376500246136
HEL,675434,4.82305615478698,4.463597576567934
LCLC-97TM1,9927531,5.703886109604247,4.578027762171671
HCC1500,60700,0.3261825799377537,-0.4482559328189002
SK-HEP-1,3025986,-0.7748266135658505,-0.8978770871810051
LS180,5281321,-2.3743222213125703,-1.3097742666845045
RERF-LC-MS,11234052,4.094456859515875,3.869960809483736
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.4199080872215506
RERF-LC-MS,753704,5.128075002459309,4.832125608051433
ALL-SIL,71304818,1.8469641946240791,2.396178486082573
LCLC-97TM1,2733526,4.142341185184233,3.714359432422819
SW1271,6918328,0.5991052607451842,-0.28710840066117727
SW1271,24901704,3.681572165465946,3.1103746959488285
Granta-519,11656518,1.6452745070498538,1.5480979328089313
NCI-H2452,3025944,3.797054601848671,4.206240213808089
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,1.4539899714896953
RKN,24951314,1.3743916622304369,1.227614980483031
SW1271,25126798,3.686543071113652,3.7921789378214816
IGROV-1,6450551,2.579641476451469,2.361538429265863
IGROV-1,54454,2.453541831966438,2.548844675602096
COR-L95,9936388,1.0197606854481494,-1.7988236137529168
Daudi,42611257,3.0497080994784307,3.0669311087446527
BICR 22,54618771,-1.5156377594303725,0.9253379925205388
LCLC-97TM1,23939,4.339779460008714,4.316990186905579
NCI-H2452,46191454,2.4313233431346366,1.3518500781597358
COR-L105,42642645,1.1549939076973508,0.7845058245277501
MOLP-8,11609586,0.3617141221652126,2.621607380466062
BICR 31,613753,3.1747241586791772,3.1495845971526135
SU-DHL-1,5328940,1.3431964509037,1.559061663996469
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-1.9697846958841214
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.3848601780620533
BFTC-909,11455910,1.958059547603208,0.9557745122323711
RERF-LC-MS,322968,4.758979615786181,3.4956311613712456
KU-19-19,5351362,1.814646406429004,1.4604743967139864
MOLM-13,54649381,3.864277780400009,3.7880999548273127
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,2.0276770243216165
NCI-H2452,72199292,1.1345413256627164,1.1233129488647187
MOLP-8,676352,1.5936675202889017,2.088896150621564
HCC1500,676352,1.5631676801704226,2.088896150621564
COR-L95,51037431,4.395819234826154,3.10082796495436
Daudi,5328940,0.4604914818199462,1.559061663996469
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.5350305453431912
IA-LM,168313200,3.804941602819176,2.9593589282331023
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.57821899028641
RKO,119182,-2.4803685643523,-1.3340160156368264
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.117207225291035
PaTu 8988t,25227462,0.2940996568558364,-0.4151865926866767
SU-DHL-1,9929138,3.6810672504095385,5.665997549800987
SU-DHL-1,12003241,0.0778318253848937,-1.0889198012759371
RKN,15547703,3.1395613683678287,3.114669509763707
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.117207225291035
MOLP-8,375860,-0.9263291950812266,-0.30112130782396007
PaTu 8988t,11234052,5.58672838892775,3.869960809483736
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.7691529831259722
SK-CO-1,126941,-2.257482818819106,-2.8921209077069348
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.2834565267098785
LS180,3038522,3.8311766422201727,2.9847437848386558
SW948,1566236,2.0550116218076235,2.2263982365179604
Granta-519,89928392,0.2978525114312038,1.344325138639762
MOLP-8,19582717,2.2376953494036624,3.9198146524152833
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,1.0163468544412688
K-562,2874250,4.395305106833161,4.0377213891771015
SU-DHL-1,11234052,1.0073590907004168,3.869960809483736
BICR 22,73707398,1.4183060149157571,1.180307991266282
COR-L95,46926350,-4.41571269577794,-4.429063309555999
Daudi,25154868,2.925803317483448,4.289494395804131
HEL,16725315,4.4825385691379145,4.150060666188836
IGROV-1,67291369,1.8066430555976296,1.794812676489941
PaTu 8988t,11404337,-0.5897258437911538,-0.4254091153988029
SK-CO-1,9911463,3.850014047184169,3.732908427020576
LS411N,89928392,2.6081309937571655,1.344325138639762
SW948,374536,1.478775672326772,1.7732341041149164
Daudi,3543504,2.1992036346279997,4.269325105068445
NCI-H2452,5746,2.2152642195731818,0.8084551861824514
K-562,451668,2.928523807666895,-0.17843514405649885
RERF-LC-MS,71680916,4.2559060280924665,4.641848024405652
BFTC-909,5311281,3.2468587214362175,2.22503529708604
HCC15,54649381,3.779002151510325,3.7880999548273127
SaOS-2,6252,5.899001284083339,-0.10942982547788271
SK-CO-1,2828334,6.603893313093487,6.082620037824382
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,3.7716438213452004
RKN,56946209,-4.407104587623599,-4.2202975286026225
P31/FUJ,54618164,3.783909273991047,4.02740727006158
P31/FUJ,46943432,0.8368365469264624,1.70045196562753
SU-DHL-1,24180719,4.350105317542874,3.437709308952337
SK-CO-1,10113978,3.831664495659769,3.010980031724017
Granta-519,16659841,3.0104726191973756,3.7845234388741966
HCC15,5329102,1.9423862085433257,2.031058842574058
RKO,9903786,4.184024439899693,2.756077717004494
Daudi,76446078,6.274042769130843,4.473999410152771
SU-DHL-1,5113032,6.615586057729586,4.970396511864891
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,2.3791567205504176
IA-LM,219104,4.299166533144503,3.5366182443481806
P31/FUJ,5329102,0.6917422477571054,2.031058842574058
PaTu 8988t,5278396,4.086122365965545,3.517590475337377
LCLC-97TM1,8515,3.105500626842055,3.7716438213452004
ALL-SIL,36314,-6.574209880787115,-1.2422497803043113
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,1.2349426527428076
SU-DHL-1,252682,6.908372017357921,6.516263069090082
MOLM-13,24753719,4.086009941734247,4.143618673527016
LS411N,119607,5.818355117504778,5.129253777214588
MOLM-13,66577038,2.3893764671204853,2.9870697487432882
HCC1500,25183872,-1.4621663438631347,-0.902802947451298
KU-19-19,6917907,-4.52253618895935,-4.864372369867458
MOLM-13,11396600,-0.7885098330267027,3.4309758536883517
SW1271,25195348,2.4923805554625407,3.08171494739702
NCI-H2452,15983966,-3.826639310361129,-1.6396194068861514
BICR 22,6184667,3.547514920621151,2.901063659317265
IGROV-1,11396600,3.99372654279783,3.4309758536883517
PaTu 8902,24748573,3.607230896648149,1.9565115912575295
MDST8,54613361,0.3905773320508885,-0.11678183903518824
SW948,136227924,2.9576701343794145,2.867001064974719
HEL,135411,-2.1892340188273836,0.5181226666256136
RKN,322968,3.2277505791227776,3.4956311613712456
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.4781017448929608
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,0.11065310288154762
COR-L105,444795,5.02091820523187,3.7799917274901733
RERF-LC-MS,11175137,3.6286013190581503,2.477950770888125
RKN,54619267,4.894700718514424,3.9342007971372475
MDST8,54143018,0.2489025697900608,0.31711465707788644
LCLC-97TM1,4917,2.8423920861921803,3.079848880785536
Granta-519,60700,-4.015034522335836,-0.4482559328189002
MOLP-8,56649450,1.2499213171679169,2.999158341046921
RERF-LC-MS,11719255,3.775646564562419,3.1221102230298534
BFTC-909,12001922,1.803559970478093,1.8522788760744173
MOLP-8,3384730,1.892166165987978,2.4620443610818112
RKO,176870,5.862868084879783,3.0253996189023358
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.6778195760397165
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,0.9218131221296273
IGROV-1,24772860,-3.2892316801587835,-2.2690769633318126
IA-LM,6450551,2.2909353415785403,2.361538429265863
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.5423368047098167
BFTC-909,6252,5.031852570794812,-0.10942982547788271
BICR 31,9907093,4.585915925811977,4.134688957161641
MDST8,285033,-1.9150900594470792,-2.1791335812392365
MOLM-13,375860,-1.005106987112833,-0.30112130782396007
P31/FUJ,16725315,4.109597365862544,4.150060666188836
IGROV-1,216345,3.498629789107092,3.7540083674013296
SW1271,208908,1.7498569635536685,1.8663560178908947
COR-L95,11507802,0.9381723124038672,1.3590460953824346
RERF-LC-MS,6918328,0.3946668064090056,-0.28710840066117727
NCI-H1568,426756,4.294080241318686,4.301139445753315
K-562,67156097,-2.769244311294464,-1.0279170724737183
LS411N,2729026,2.9791300415919646,2.6325975116350393
SK-HEP-1,2729026,3.094345392685322,2.6325975116350393
Panc 02.03,54618771,1.0884531427161812,0.9253379925205388
MDST8,5282054,3.0885738072945776,3.5628845676855256
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-1.182053713238432
HEL,54143018,-0.2807045945993052,0.31711465707788644
COR-L105,5278396,3.038896363429305,3.517590475337377
SU-DHL-6,6450551,1.9173550036200224,2.361538429265863
LCLC-97TM1,1716436,2.9898763561132276,2.948755251800144
K-562,54619267,3.679496217482672,3.9342007971372475
Granta-519,1641662,2.857235389717828,3.3408828038827
PaTu 8902,219104,4.25826825351418,3.5366182443481806
NCI-H2452,24779724,6.409137734448782,4.725601600845458
RCC10RGB,2126,5.809199309072596,4.466606494133751
HuP-T3,24753719,4.122061219367772,4.143618673527016
RKN,44197249,3.9607888926275217,3.652871643911023
SU-DHL-1,44543605,4.013392575246718,4.160012106477824
HEL,11455910,0.7002369428142345,0.9557745122323711
SK-HEP-1,5281672,4.68841423543723,4.4250678360691875
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-1.57821899028641
BICR 31,23582824,0.6119811525421108,0.7400136078733197
SW48,57330099,4.121753491452113,4.311542343968036
MOLP-8,3825829,4.0673932001437,3.8869840981378028
Granta-519,5746,-3.467826904777232,0.8084551861824514
K-562,46215462,1.6076592131491731,1.762132613731386
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,0.11065310288154762
MOLM-13,6852167,0.0474303723036755,2.69961445504738
PaTu 8902,44819697,-0.6077719001286086,-0.6109288989041974
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,3.456683733824014
HCC15,135875424,4.57405525423842,3.743891076041643
BFTC-909,6918736,-1.9066217610366931,-1.741781295359962
MOLP-8,25195348,2.8158250690550215,3.08171494739702
KU-19-19,11175137,2.6409229524549858,2.477950770888125
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,2.117207225291035
SU-DHL-1,15983966,-4.109397573586815,-1.6396194068861514
Granta-519,4705,3.4024179319436483,3.0428654274536564
SaOS-2,6450551,2.5324870379200113,2.361538429265863
SU-DHL-1,6918837,-2.995399398295858,-3.046222711611649
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.456683733824014
SW1573,159324,2.9705070550476274,2.0742938672876736
LS180,11625818,4.457813695022962,4.10791451089978
Granta-519,10296883,3.749738066673353,3.795028277273254
Panc 02.03,285033,-1.023489563814438,-2.1791335812392365
SU-DHL-1,11175137,1.828860424721981,2.477950770888125
HEL,124202324,1.0355607531680788,2.1784388364790748
NCI-H1568,702558,5.469457182473135,4.9782351440396395
IGROV-1,46191454,1.3777495915525844,1.3518500781597358
WM115,55283,3.7426713954425415,2.1635123760949786
SW948,7251185,1.827873481109932,2.4347287977616
MDST8,4521392,4.294685623216763,4.280943620409205
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.2834565267098785
LS180,11455910,2.088798844266998,0.9557745122323711
NCI-H2452,151289,3.721937933525537,0.9562867634504244
LCLC-97TM1,11214940,1.4536772193180694,1.8119431265240042
RKO,25062766,2.7314931301361476,2.0522756909743434
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,1.4554460238042177
COR-L105,3385,6.244906352702261,3.472185389430271
IGROV-1,375860,0.7731558163124775,-0.30112130782396007
SU-DHL-1,9936388,0.846879508636978,-1.7988236137529168
MOLP-8,11955716,-2.2423093620343666,-1.4856643985320634
IGROV-1,11455910,-0.2792640061206097,0.9557745122323711
HEL,216468,1.594172428774628,2.5020743765616316
K-562,216345,3.9110155346915088,3.7540083674013296
SK-HEP-1,6450551,3.663777137244395,2.361538429265863
Daudi,5460769,0.2326576177581661,2.3447175553942796
BICR 22,1750826,0.8880077925102622,-1.4739669220989267
RERF-LC-MS,11238147,2.4729298726299147,2.694366237977623
BFTC-909,54649381,4.487285574329416,3.7880999548273127
RERF-LC-MS,9926054,1.8051014319834384,1.9546333131599372
IA-LM,1750826,-4.675530321169698,-1.4739669220989267
BICR 22,46398810,2.733805979632988,2.510712955745063
WM115,445643,3.76443753653658,3.9383569867901693
LS411N,3689413,2.701640891749041,-0.4039154566871359
SW48,71304818,2.1411626536950323,2.396178486082573
HuP-T3,5291,4.150853397708747,3.5530526201153183
SW48,9911463,3.374803590447597,3.732908427020576
Daudi,16219061,1.2860438148144782,3.135611362850641
SaOS-2,9911830,2.995519789289086,2.4240324657892436
BFTC-909,5329102,1.9658448878596055,2.031058842574058
NCI-H1568,53495165,-0.6133813456223128,-0.19108456656304296
BICR 22,6918878,1.3704913724877863,1.9069091595174383
SK-OV-3,4259181,0.9080230343390464,0.11236669175956715
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.344610112805219
BFTC-909,445091,4.3207806819680625,4.3274252089919045
WM115,2130404,3.451007656106494,3.195187949563447
RCC10RGB,11152667,2.8531679730856268,-0.5866736007906306
HEL,5460769,3.63888115942649,2.3447175553942796
HEL,969516,2.4495484774391296,2.7772567284956553
MDST8,11152667,-1.6082048518025778,-0.5866736007906306
WM115,54596490,4.400808012137458,4.945697156281648
NCI-H2452,1716436,2.783046357832639,2.948755251800144
MOLM-13,4917,2.9272389210025955,3.079848880785536
ALL-SIL,119182,-4.503247338331098,-1.3340160156368264
MDST8,3552672,1.9687663546279843,2.8413574589562494
HCC15,16720766,-0.3160262480808965,0.4291253754884592
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,1.8522788760744173
MOLM-13,12003241,-3.578107028375036,-1.0889198012759371
SW948,24856436,-0.402936098482521,0.17994774592918095
HCC1500,44202524,3.676243999694772,1.9639001504219202
Daudi,4261,-0.6156785773872924,1.4288257082744877
MDST8,11507802,0.9258202338292296,1.3590460953824346
BFTC-909,54626689,4.365294423210906,4.561309020020982
NCI-H1568,16741245,4.262204040009308,3.801678648950925
HCC1500,25154868,1.8923567203600569,4.289494395804131
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.4554460238042177
COR-L105,3825829,4.424164708702568,3.8869840981378028
HEL,10074640,3.098757234686198,3.066922642013836
RKO,44202524,1.4476976505001866,1.9639001504219202
SK-HEP-1,6852167,5.53454213252302,2.69961445504738
